10-K 1 d772201d10k.htm 10-K 10-K
falseFY0001418076NYhttp://fasb.org/us-gaap/2023#UnrealizedGainLossOnInvestmentshttp://fasb.org/us-gaap/2023#UnrealizedGainLossOnInvestmentsIndicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.Floating rate debt investments typically bear interest at a rate determined by reference to the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2023.Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2023 in these controlled investments are as follows:The Company also holds this security on its Consolidated Statements of Assets and Liabilities.Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2023.Assumes $2.5 billion in total assets (inclusive of temporary cash assets of $332 million) and $1.2 billion in total debt outstanding, which reflects our total assets and total debt outstanding as of December 31, 2023, and a cost of funds of 5.88%. Excludes non-leverage related expenses.Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2023, on a fair value basis, non-qualifying assets in the portfolio represented 26.6% of the total assets of the Company.Investment is on non-accrual status.Kaseya, Inc. may elect to defer up to 2.50% of the coupon as PIK.Non-income producing security.Denotes a Level 1 investment.Denotes investments in which we are an “Affiliated Person” but do not exercise a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2023 (beginning with the date at which the Company became an Affiliated Person) in these affiliated investments are as follows:Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.See note 12 to the consolidated financial statements.Through this entity and other intermediate entities, the Company owns approximately 7.3% of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former Amerimark Interactive, LLC.See note 14 to the consolidated financial statements.See note 10 to the consolidated financial statements.See note 13 to the consolidated financial statements.See note 18 to the consolidated financial statements.Denotes a subsidiary of SLR Equipment Finance.Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2022 in these controlled investments are as follows: Name of Issuer Fair Value at December 31, 2021 Gross Additions Gross Reductions Realized Gain (Loss) Change in Unrealized Gain (Loss) Interest/ Dividend Income Fair Value at December 31, 2022 Equipment Operating Leases, LLC $ 18,939 $ —  $ 15,833 $ —  $ 635 $ 749 $ 3,741 Kingsbridge Holdings, LLC 80,000 —  —  —  (87 ) 7,402 80,000 KBH Topco, LLC (Kingsbridge) 145,996 —  —  —  2,448 15,225 148,444 Loyer Capital LLC 10,725 —  3,500 —  136 1,003 7,361 RD Holdco, Inc. (Rug Doctor, common equity) —  —  —  —  —  —  —  RD Holdco, Inc. (Rug Doctor, class B).. 5,216 —  —  —  (5,216 ) —  —  RD Holdco, Inc. (Rug Doctor, warrants).. —  —  —  —  —  —  —  RD Holdco, Inc. (debt) 11,829 685 —  —  (5,280 ) (18 ) 6,521 SLR Business Credit —  81,583 —  —  7,787 5,150 89,370 SLR Credit Solutions 298,766 —  —  —  (10,006 ) 20,500 288,760 SLR Equipment Finance (equity) 129,102 —  —  —  (8,282 ) —  120,820 SLR Equipment Finance (debt) —  5,000 —  —  —  379 5,000 SLR Healthcare ABL —  34,335 —  —  15 2,595 34,350 SLR Senior Lending Program LLC —  9,500 —  —  (74 ) —  9,426 SOAGG LLC 1,121 —  447 —  (674 ) 647 —  SOINT, LLC 4,509 266 942 —  (32 ) 266 3,801 $ 706,203 $ 131,369 $ 20,722 $ —  $ (18,630 ) $ 53,898 $ 797,594 Indicates an investment that is wholly held by the Company through NEFPASS LLC.Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR or PRIME rate. These instruments are often subject to a SOFR or PRIME rate floor.Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2022.SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.See note 11 to the consolidated financial statements. Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK.Calculated as of the respective high or low closing price divided by NAV and subtracting 1.In accordance with ASC 820-10, certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 18 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.The Company controls the funding of these commitments and may cancel them at its discretion.In the event that the shares of common stock are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load and the “Example” will be updated accordingly.The prospectus supplement corresponding to each offering will disclose the applicable offering expenses and total stockholder transaction expenses.The expenses of the dividend reinvestment plan are included in “other expenses.”Annual Expenses are presented in this manner because common stockholders will bear all costs of running the Company.Our 1.50% base management fee under the Advisory Agreement (giving effect to the Letter Agreement) is based on our gross assets, which is defined as all the assets of SLRC, excluding temporary assets, including those acquired using borrowings for investment purposes, and assumes our gross assets remain consistent with gross assets for the fiscal year ended December 31, 2023. The base management fee is reduced to 1.00% on gross assets that exceed 200% of total net assets as of the immediately preceding quarter.Assumes that annual incentive fees earned by our investment adviser, SLR Capital Partners, remain consistent with the incentive fees earned by SLR Capital Partners for the fiscal year ended December 31, 2023. The incentive fee consists of two parts:We have historically and will in the future borrow funds from time to time to make investments to the extent we determine that the economic situation is conducive to doing so. The costs associated with our outstanding borrowings are indirectly borne by our investors. For purposes of this section, we have computed interest expense using the average consolidated balance outstanding for borrowings during the fiscal year ended December 31, 2023. We used SOFR or a similar base rate on December 31, 2023 and the interest rate on the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes and the 2024 Unsecured Notes on December 31, 2023. We have also included, as applicable, the estimated market discount or amortization of fees incurred in establishing the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes and the 2024 Unsecured Notes as of December 31, 2023. Additionally, we included the estimated cost of commitment fees for unused balances on the Credit Facility and the SPV Credit Facility. As of December 31, 2023, we had $507.0 million outstanding under the Credit Facility, $206.3 million outstanding under the SPV Credit Facility and $135 million, $50 million, $75 million, $125 million and $85 million outstanding under the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes and the 2024 Unsecured Notes, respectively. We may also issue preferred stock, subject to our compliance with applicable requirements under the 1940 Act, although we have no immediate intention to do so.The holders of shares of our common stock indirectly bear the expenses of our investment in SLR Senior Lending Program LLC (“SSLP”). No management fee is charged on our investments in SSLP in connection with the administrative services provided to SSLP. Future expenses for SSLP may be substantially higher or lower because certain expenses may fluctuate over time.“Other expenses” are based on estimated amounts for the current fiscal year, which considers the amounts incurred for the fiscal year ended December 31, 2023 and include our overhead expenses, including payments under our Administration Agreement based on our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement.The Company became an Affiliated Person to Bayside Opco, LLC and Bayside Parent, LLC on May 31, 2023 and to Amerimark Intermediate Holdings, LLC and SLR- AMI Topco Blocker, LLC on June 16, 2023.Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are co-borrowers.Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making follow-on investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis, non-qualifying assets in the portfolio represented 24.2% of the total assets of the Company.The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.Interest is paid in kind (“PIK”).Spread is 5.75% Cash / 0.50% PIK. Service fees are included within the Company’s Consolidated Statements of Operations as other income. Aggregate net unrealized appreciation for U.S. federal income tax purposes is $2,567; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $97,678 and $95,111, respectively, based on a tax cost of $2,152,199. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each co-Borrowers. Amerimark may elect to defer up to 8.00% of the coupon as PIK.On April 1, 2022, in connection with the Mergers (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839.Includes contribution of basis from Oldco AI, LLC to SLR-AMI Topco Blocker, LLC.BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.OmniGuide Holdings, Inc. may elect to defer up to 10.00% of the coupon as PIK. Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK. Aggregate net unrealized appreciation for U.S. federal income tax purposes is $17,187; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $161,053 and $143,866, respectively, based on a tax cost of $2,069,489. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of December 31, 2023, asset coverage was 183.4%.Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.NAV per share is determined as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low sales prices. The net asset values shown are based on outstanding shares at the end of each period.Vapotherm, Inc. may elect to defer up to 9.00% of the coupon as PIK 0001418076 2023-01-01 2023-12-31 0001418076 2022-01-01 2022-12-31 0001418076 2021-01-01 2021-12-31 0001418076 2022-12-31 0001418076 2023-12-31 0001418076 2024-02-23 0001418076 2023-06-30 0001418076 2023-05-09 0001418076 2023-05-09 2023-05-09 0001418076 2019-01-01 2019-12-31 0001418076 2020-01-01 2020-12-31 0001418076 2021-12-31 0001418076 2020-12-31 0001418076 2019-12-31 0001418076 2019-12-18 2019-12-18 0001418076 2022-04-01 2022-04-01 0001418076 2023-09-30 0001418076 2023-03-31 0001418076 2022-09-30 0001418076 2022-06-30 0001418076 2022-03-31 0001418076 2017-12-31 0001418076 2018-12-31 0001418076 2013-12-31 0001418076 2014-12-31 0001418076 2015-12-31 0001418076 2016-12-31 0001418076 2023-10-01 2023-12-31 0001418076 2023-07-01 2023-09-30 0001418076 2023-04-01 2023-06-30 0001418076 2023-01-01 2023-03-31 0001418076 2022-10-01 2022-12-31 0001418076 2022-07-01 2022-09-30 0001418076 2022-04-01 2022-06-30 0001418076 2022-01-01 2022-03-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2023-12-31 0001418076 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2023-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2023-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2023-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputRecoverableAmountMember slrc:ValuationTechniqueRecoveryApproachMember 2023-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember us-gaap:IncomeApproachValuationTechniqueMember 2023-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember us-gaap:IncomeApproachValuationTechniqueMember 2023-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember us-gaap:IncomeApproachValuationTechniqueMember 2023-12-31 0001418076 slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember slrc:ValuationApproachMarketMultipleMember 2023-12-31 0001418076 slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember us-gaap:IncomeApproachValuationTechniqueMember 2023-12-31 0001418076 slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember us-gaap:IncomeApproachValuationTechniqueMember 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember slrc:ValuationApproachMarketMultipleMember 2023-12-31 0001418076 slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember us-gaap:IncomeApproachValuationTechniqueMember 2023-12-31 0001418076 slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember us-gaap:IncomeApproachValuationTechniqueMember 2023-12-31 0001418076 slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember us-gaap:IncomeApproachValuationTechniqueMember 2023-12-31 0001418076 slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember slrc:ValuationApproachMarketMultipleMember 2023-12-31 0001418076 slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember slrc:ValuationApproachMarketMultipleMember 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember srt:WeightedAverageMember us-gaap:MarketApproachValuationTechniqueMember 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember srt:MaximumMember us-gaap:MarketApproachValuationTechniqueMember 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember srt:MinimumMember us-gaap:MarketApproachValuationTechniqueMember 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember slrc:ValuationApproachMarketMultipleMember 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember slrc:ValuationApproachMarketMultipleMember 2023-12-31 0001418076 slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember us-gaap:IncomeApproachValuationTechniqueMember 2023-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2023-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2023-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember 2023-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2023-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2023-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2023-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2023-12-31 0001418076 slrc:CreditFacilityOneMember 2023-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2023-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2023-12-31 0001418076 slrc:NmcSeniorCreditFacilityMember 2023-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:SeniorSecuredCommitmentsMember 2023-12-31 0001418076 slrc:SlrBusinessCreditMember 2023-12-31 0001418076 slrc:KbhtMember 2023-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2023-12-31 0001418076 slrc:CreditFacilityMember 2023-12-31 0001418076 srt:MinimumMember slrc:SlrHealthcareAblMember 2023-12-31 0001418076 srt:MaximumMember slrc:SlrHealthcareAblMember 2023-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember 2023-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2023-12-31 0001418076 slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember 2023-12-31 0001418076 slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember slrc:CreditFacilityMember 2023-12-31 0001418076 slrc:CitiBankNaMember us-gaap:LineOfCreditMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember 2023-12-31 0001418076 slrc:CitiBankNaMember slrc:TermLoanMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember 2023-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2023-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2023-12-31 0001418076 slrc:MedrinaLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:BaymarkHealthServicesIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:HighStreetBuyerIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:TaucManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:EnverusHoldingsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:EnsHoldingsIiiCorpLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:MontefioreNyackHospitalMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:OutsetMedicalInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:ApeelTechnologyIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:HumanInterestIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:WorldInsuranceAssociatesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:SpectrumPharmaceuticalsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:ArcutisBiotherapeuticsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:CerapedicsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:AccessionRiskManagementGroupIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:GlookoInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:AllStatesAgPartsLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:WCI-BXCPurchaserLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:ExactcareParentIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:CrewlineBuyerIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:MeditrinaInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtd.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:NacHoldingsCorporationMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:CompositeTechnologyAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:PinnacleTreatmentCentersInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:IvyFertilityServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:PlasticsManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:PediatricHomeRespiratoryServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:MauricesIncorporatedMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:CopperRiverSeafoodsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:OneTouchDirectLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:GsmAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:SunmedGroupHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:ErieConstructionMidwestLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:RxsenseHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:SparMarketingForceInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:SlrHealthcareAblMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:OrthopedicCarePartnersManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:UltimateBakedGoodsMidcoLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:SouthernOrthodonticPartnersManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:KidDistroHoldingsLlcDistroKidMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:BasicFunInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:LuxuryAssetCapitalLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:SlrCreditSolutionsMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:UrologyManagementHoldingsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:BaysideOpcoLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:UvpManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:AMFLeveredIILLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:VertosMedicalInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:TheTownsendCompanyLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:KaseyaIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:UnitedDigestiveMSOParentLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:DeepintentInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:WestNRParentIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:LegacyServicePartnersLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:AlkemeIntermediateHoldingsLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:RetinaMidcoIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:CvausaManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:SlrEquipmentFinanceMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:ScpEyeCareLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:IcimsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:ArdelyxIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:TilleyDistributionIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:BdgMediaInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2023-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2023-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2023-12-31 0001418076 slrc:TermLoansMember 2023-12-31 0001418076 slrc:CreditFacilityOneMember 2023-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2023-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2023-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2023-12-31 0001418076 slrc:CreditFacilityMember 2023-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2023-12-31 0001418076 Fertility (ITC) Investment Holdco, LLC | Health Care Providers and Services | S+650 | 1.00% | 11.97% | 1/3/29 2023-12-31 0001418076 Erie Construction Mid-west, LLC | Building Products | S+475 | 1.00% | 10.20% | 7/30/27 2023-12-31 0001418076 ENS Holdings III Corp and ES Opco USA LLC | Trading Companies and Distributors | S+475 | 10.20% | 11.13% | 12/31/25 2023-12-31 0001418076 CVAUSA Management, LLC | Health Care Providers and Services | S+650 | 1.00% | 11.74% | 5/22/29 2023-12-31 0001418076 CC SAG Holdings Corp | Diversified Consumer Services | S+575 | 0.75% | 11.22% | 6/29/28 2023-12-31 0001418076 BayMark Health Services, Inc | Health Care Providers and Services | S+500 | 1.00% | 10.61% | 6/11/27 2023-12-31 0001418076 Alkeme Intermediary Holdings, LLC | Insurance| S+650 | 1.00% | 11.96% | 10/28/26 2023-12-31 0001418076 Aegis Toxicology Sciences Corporation | Health Care Providers and Services | S+550 | 1.00% | 11.13% | 5/9/25 2023-12-31 0001418076 High Street Buyer, Inc | Insurance | S+575 | 0.75% | 11.25% | 4/16/28 2023-12-31 0001418076 Higginbotham Insurance Agency, Inc | Insurance | S+550 | 1.00% | 10.96% | 11/25/28 2023-12-31 0001418076 GSM Acquisition Corp | Leisure Equipment and Products | S+500 | 1.00% | 11.13% | 10.47 2023-12-31 0001418076 Foundation Consumer Brands, LLC | Personal Products | S+625 | 1.00% | 11.79% | 2/12/27 2023-12-31 0001418076 United Digestive MSO Parent, LLC | Health Care Providers and Services | S+675 | 1.00% | 12.25% | 3/30/29 2023-12-31 0001418076 Urology Management Holdings, Inc | Health Care Providers and Services | S+650 | 1.00% | 11.93% | 6/15/26 2023-12-31 0001418076 Vessco Midco Holdings, LLC | Water Utilities | S+450 | 1.00% | 9.96% | 11/2/26 2023-12-31 0001418076 West-NR Parent, Inc | Insurance | S+625 | 1.00% | 11.70% | 12/27/27 2023-12-31 0001418076 Apex Service Partners, LLC | Diversified Consumer Services | S+700 | 1.00% | 11.87% |10/24/30 2023-12-31 0001418076 All States Ag Parts, LLC | Trading Companies and Distributors| S+600 | 1.00% | 11.61% | 9/1/26 2023-12-31 0001418076 RQM+ Corp | Life Sciences Tools and Services | S+575 | 1.00% | 11.36% | 8/12/26 2023-12-31 0001418076 RxSense Holdings LLC | Diversified Consumer Services | S+500 | 1.00% | 10.48% | 3/13/26 2023-12-31 0001418076 SunMed Group Holdings, LLC | Health Care Equipment and Supplies | S+550 | 0.75% | 10.96% | 6/16/28 2023-12-31 0001418076 The Townsend Company, LLC | Commercial Services and Supplies | S+625 | 1.00% | 11.61% | 8/15/29 2023-12-31 0001418076 Tilley Distribution, Inc | Trading Companies and Distributors | S+600 | 1.00% | 11.50% | 12/31/26 2023-12-31 0001418076 Ultimate Baked Goods Midco LLC | Packaged Foods and Meats | S+625 | 1.00% | 11.71% | 8/13/27 2023-12-31 0001418076 Kaseya, Inc | Software | S+600 | 0.75% | 11.38% | 6/23/29 2023-12-31 0001418076 Kid Distro Holdings, LLC | Software | S+550 | 1.00% | 11.00% | 10/1/27 2023-12-31 0001418076 Maxor Acquisition, Inc | Health Care Providers and Services| S+675 | 1.00% | 12.48% | 3/1/29 2023-12-31 0001418076 ONS MSO, LLC | Health Care Providers and Services | S+625 | 1.00% | 11.62% | 7/8/26 2023-12-31 0001418076 Pinnacle Treatment Centers, Inc | Health Care Providers and Services | S+650 | 1.00% | 11.95% | 1/2/26 2023-12-31 0001418076 Plastics Management, LLC | Health Care Providers and Services | S+500 | 1.00% | 10.45% | 8/18/27 2023-12-31 0001418076 iCIMS, Inc | Software | S+725 | 0.75% | 12.62% | 8/18/28 2023-12-31 0001418076 Atria Wealth Solutions, Inc | Diversified Financial Services | S+650 | 1.00% | 11.97% | 5/31/24 2023-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2023-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember us-gaap:InvestorMember 2023-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember srt:ManagementMember 2023-12-31 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramLlcMember slrc:SlrSeniorLendingProgramSpvLlcMember 2023-12-31 0001418076 Senior Secured Loans - 129.5% | Second Lien Asset-Based Senior Secured Loans | FGI Worldwide LLC | Diversified Financial Services | S+650 | 1.00% | 11.86% | 4/17/2023 | 4/17/2028 2023-12-31 0001418076 Senior Secured Loans - 129.5% | Second Lien Bank Debt/Senior Secured Loans | RD Holdco, Inc. | Diversified Consumer Services | S+975 | 1.00% | - | 12/23/2013 | 10/12/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Alimera Sciences, Inc. | Pharmaceuticals | S+515 | 4.60% | 10.50% | 12/31/2019 | 5/1/2028 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Arcutis Biotherapeutics, Inc. | Pharamceuticals | S+745 | 0.10% | 12.90% | 12/22/2021 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Ardelyx, Inc. | Pharmaceuticals | S+795 | 1.00% | 13.32% | 2/23/2022 | 3/1/2027 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | BridgeBio Pharma, Inc. | Biotechnology | - | - | 9.00% | 11/17/2021 | 11/17/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Vapotherm, Inc.Health Care Equipment & Supplies | S+930 | 1.00% | 14.75% | 2/18/2022 | 2/1/2027 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Outset Medical, Inc. | Health Care Equipment & Supplies | S+515 | 2.75% | 10.50% | 11/3/2022 | 11/1/2027 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Vessco Midco Holdings, LLC | Water Utilities | P+350 | 1.00% | 12.00% | 4/1/2022 | 11/2/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | WCI-BXC Purchaser, LLC | Distributors | S+625 | 1.00% | 11.64% | 11/6/2023 | 11/6/2030 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | West-NR Parent, Inc. | Insurance | S+625 | 1.00% | 11.70% | 8/1/2023 | 12/27/2027 2023-12-31 0001418076 Senior Secured Loans - 129.5% | Second Lien Asset-Based Senior Secured Loans | AMF Levered II, LLC | Diversified Financial Services | S+705 | 1.00% | 12.52% | 12/24/2021 | 8/21/2028 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | TAUC Management, LLC | Health Care Providers & Services | P+450 | 1.00% | 13.00% | 4/1/2022| 2/12/2027 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | SunMed Group Holdings, LLC | Health Care Equipment & Supplies | S+550 | 0.75% | 10.96% | 6/16/2021 | 6/16/2028 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Stryten Resources LLC | Auto Parts and Equipment | S+800 | 1.00% | 13.47% | 8/11/2021 | 10/12/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | SPAR Marketing Force, Inc | Media | P+190 | - | 10.40% | 12/1/2023 | 10/10/2024 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Southern Orthodontic Partners Management, LLC | Health Care Providers & Services | S+625 | 1.00% | 11.72% | 6/3/2022 | 1/27/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Vertos Medical, Inc. | Health Care Equipment & Supplies | S+515 | 4.75% | 10.50% | 6/14/2023 | 7/1/2028 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Cerapedics, Inc. | iotechnology | S+620 | 2.75% | 11.55% | 12/27/2022 | 1/1/2028 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Glooko, Inc. | Health Care Technology | S+790 | 0.10% | 13.35% | 9/30/2021 | 10/1/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Meditrina, Inc. | Health Care Equipment & Supplies | S+550 | 3.45% | 10.85% | 12/20/2022 | 12/1/2027 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Neuronetics, Inc. | Health Care Equipment & Supplies | S+565 | 3.95% | 11.00% | 3/2/2020 | 3/29/2028 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | OmniGuide Holdings, Inc. | Health Care Equipment & Supplies | S+580 | 5.31% | 11.25% | 7/30/2018 | 11/1/2025 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Ultimate Baked Goods Midco LLC (Rise Baking) | Packaged Foods & Meats | S+625 | 1.00% | 10.96% | 8/12/2021 | 8/13/2027 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | United Digestive MSO Parent, LLC | Health Care Providers & Services | S+675 | 1.00% | 12.25% | 3/30/2023 | 3/30/2029 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Urology Management Holdings, Inc | Health Care Providers & Services | S+6 | 1.00% | 11.93% | 2/7/2023 | 6/15/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | UVP Management, LLC | Health Care Providers & Services | S+625 | 1.00% | 11.75% | 9/18/2023 | 9/15/2025 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Tilley Distribution, Inc. | Trading Companies & Distributors | S+600 | 1.00% | 11.50% | 4/1/2022 | 12/31/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | The Townsend Company, LLC | Commercial Services & Supplies | S+625 | 1.00% | 11.61% | 8/17/2023 | 8/15/2029 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | GSM Acquisition Corp. | Leisure Equipment & Products | S+500 | 1.00% | 10.47% | 4/1/2022 | 11/16/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Foundation Consumer Brands, LLC | Personal Products | S+625 | 1.00% | 11.79% | 2/12/2021 | 2/12/2027 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Fertility (ITC) Investment Holdco, LLC | Health Care Providers & Services | S+650 | 1.00% | 11.97% | 1/4/2023 | 1/3/2029 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Exactcare Parent, Inc. | Health Care Providers & Services | S+650 | 1.00% | 11.89% | 11/3/2023 | 11/5/2029 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) | Trading Companies & Distributors | S+475 | 1.00% | 10.20% | 4/1/2022 | 12/31/2025 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Enhanced Permanent Capital, LLC | Capital Markets | S+700 | 1.00% | 12.44% | 12/29/2020 | 12/29/2025 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Peter C. Foy & Associates Insurance Services, LLC | Insurance | S+600 | 0.75% | 11.47% | 4/1/2022 | 11/1/2028 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Pinnacle Treatment Centers, Inc. | Health Care Providers & Services | S+650 | 1.00% | 11.86% | 1/22/2020 | 1/2/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Plastics Management, LLC | Health Care Providers & Services | S+500 | 1.00% | 10.45% | 4/1/2022 | 8/18/2027 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Retina Midco, Inc. | Health Care Providers & Services | S+575 | 1.00% | 11.38% | 12/18/2023 | 1/31/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | RQM+ Corp. | Life Sciences Tools & Services | S+575 | 1.00% | 11.36% | 8/20/2021 | 8/12/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | RxSense Holdings LLC | Diversified Consumer Services | S+500 | 1.00% | 10.48% | 4/1/2022 | 3/13/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | SCP Eye Care, LLC | Health Care Providers & Services | S+575 | 1.00% | 11.17% | 10/6/2022 | 10/5/2029 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | SHO Holding I Corporation (Shoes for Crews) | Footwear | S+523 | 1.00% | 10.87% | 4/1/2022 | 4/27/2024 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Kaseya, Inc. | Software | S+600 | 0.75% | 10.86% | 6/22/2022 | 6/23/2029 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Higginbotham Insurance Agency, Inc.| Insurance | S+550 | 1.00% | 10.96% | 4/1/2022 | 11/25/2028 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Human Interest Inc|Internet Software & Services | S+785 | 1.00% | 13.19% | 6/30/2022 | 7/1/2027 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | iCIMS, Inc.| Software | S+725 | 0.75% | 12.10% | 8/18/2022 | 8/18/2028 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Medrina, LLC | Health Care Providers & Services | S+625 | 1.00%| 11.67% | 10/20/2023 | 10/20/2029 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Maxor Acquisition, Inc. | Health Care Providers & Services | S+675 | 1.00% | 12.48% | 3/1/2023 | 3/1/2029 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Luxury Asset Capital, LLC | Thrifts & Mortgage Finance | S+675 | 1.00% | 12.21% | 7/15/2022 | 7/15/2027 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Logix Holding Company, LLC | Communications Equipment | P+475 | 1.00% | 13.25% | 9/14/2018 | 12/22/2024 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Kingsbridge Holdings, LLC | Multi-Sector Holdings | S+700 | 1.00% | 12.52% | 12/21/2018 | 12/21/2024 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Kid Distro Holdings, LLC (Distro Kid) | Software | S+550 | 1.00% | 11.00% | 9/24/2021 | 10/1/2027 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | DeepIntent, Inc. | Media | P+175 | - | 10.25% | 12/1/2023 | 3/25/2025 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | CVAUSA Management, LLC | Health Care Providers & Services | S+650 | 1.00% | 11.74% | 5/22/2023 | 5/22/2029 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Crewline Buyer, Inc. | IT Services | S+675 | 1.00% | 12.10% | 11/8/2023 |11/8/2030 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt / Senior Secured Loans | Copper River Seafoods, Inc. | Food Products | P+275 | - | 11.25% | 12/1/2023 | 4/23/2025 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | CC SAG Holdings Corp. (Spectrum Automotive) | Diversified Consumer Services | S+575 | 0.75% | 11.22% | 6/29/2021 | 6/29/2028 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | BDG Media, Inc. | Media | P+525 | 5.50% | 13.75% | 7/18/2022 | 7/31/2025 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Bayside Parent, LLC | Healthcare Providers & Services | S+1000 | 1.00% | 15.50% | 5/31/2023 | 5/31/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Bayside Opco, LLC | Healthcare Providers & Services | S+725 | 1.00% | 12.75% | 5/31/2023 | 5/31/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | BayMark Health Services, Inc. | Health Care Providers & Services | S+500 | 1.00% | 10.61% | 4/1/2022 | 6/11/2027 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Basic Fun, Inc. | Specialty Retail | S+650 | 1.00% | 12.14% | 10/30/2020 | 7/2/2024 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Atria Wealth Solutions, Inc.| Diversified Financial Services | S+650 | 1.00% | 11.97% | 9/14/2018 | 5/31/2024 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | All States Ag Parts, LLC | Trading Companies & Distributors | S+600 | 1.00% | 11.61% | 4/1/2022 | 9/1/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Alkeme Intermediary Holdings, LLC | Insurance | S+650 | 1.00 % | 11.96 % | 9/20/2023 |10/28/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Aegis Toxicology Sciences Corporation | Health Care Providers & Services | S+550 | 1.00% | 11.13% | 5/7/2018 | 5/9/2025 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Accession Risk Management Group, Inc. (f/k/a RSC Acquisition, Inc.)| Insurance | S+550 | 0.75% | 11.00% | 4/1/2022 | 11/1/2029 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Orthopedic Care Partners Management, LLC | Health Care Providers & Services | S+650 | 1.00% | 12.11% | 8/17/2022 | 5/16/2024 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | ONS MSO, LLC | Health Care Providers & Services | S+625 | 1.00% | 11.62% | 2/10/2023 | 7/8/2026 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | One Touch Direct, LLC. | Commercial Services & Supplies | P+75 | -| 9.25% | 12/1/2023 | 3/31/2025 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | NSPC Intermediate Corp. (National Spine) | Health Care Providers & Services | S+800 | 1.00% | 13.53% | 4/1/2022 | 2/13/2026 2023-12-31 0001418076 Equipment Financing 26.0% | AFG Dallas III, LLC | Diversified Consumer Services | 10.00-11.29% | 8/11/2022 | 8/11/2026-3/1/2027 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | AFG Dallas III, LLC | Diversified Consumer Services | 10.00-11.29% | 8/11/2022 | 8/11/2026-3/1/2027 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Boart Longyear Company | Metals & Mining | 8.31-10.44% | 5/28/2020 | 7/1/2024-10/7/2026 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Air Methods Corporation | Airlines | 7.08-7.13% | 11/3/2021 | 11/3/2026-11/23/2026 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.6% | Aero Operating LLC | Commercial Services & Supplies | 8.47-9.64% | 2/12/2021 | 3/1/2025-12/1/2026 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing - 26.0% | A&A Crane and Rigging, LLC | Commercial Services & Supplies | 7.78% | 3/27/2023 | 3/27/2028 2023-12-31 0001418076 Equipment Financing 26.6% | Aero Operating LLC | Commercial Services & Supplies | 8.47-9.64% | 2/12/2021 | 3/1/2025-12/1/2026 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Air Methods Corporation | Airlines | 7.08-7.13% | 11/3/2021 | 11/3/2026-11/23/2026 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | AmeraMex International, Inc | Commercial Services & Supplies |10.00% | 3/29/2019 | 4/15/2025 2023-12-31 0001418076 Equipment Financing 26.0% | Bazzini, LLC | Food & Staples Retailing |10.46% |12/23/2022 |1/1/2028 2023-12-31 0001418076 Equipment Financing 26.0% | Boart Longyear Company | Metals & Mining | 8.31-10.44% | 5/28/2020 | 7/1/2024-10/7/2026 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Bowman Energy Solutions, LLC | Commercial Services & Supplies | 7.42% | 7/1/2022 | 8/1/2026 2023-12-31 0001418076 Equipment Financing 26.0% | C-Port/Stone LLC | Oil, Gas & Consumable Fuels | 8.54% | 10/7/2022 | 11/1/2027 2023-12-31 0001418076 Equipment Financing 26.0% | Miranda Logistics Enterprise, Inc | Construction & Engineering | 7.69% | 4/14/2023 | 4/14/2028 2023-12-31 0001418076 Equipment Financing 26.0% | Mountain Air Helicopters Inc | Commercial Services & Supplies | 10.00% | 7/31/2017 | 2/28/2025 2023-12-31 0001418076 Equipment Financing 26.0% | Nimble Crane LLC | Commercial Services & Supplies | 9.18% | 7/13/2023 | 7/13/2028 2023-12-31 0001418076 Equipment Financing 26.0% | No Limit Construction Services, LLC | Commercial Services & Supplies | 7.73% | 5/5/2023 | 6/1/2028 2023-12-31 0001418076 Equipment Financing 26.0% | Ozzies, Inc | Commercial Services & Supplies | 10.72% | 12/23/2022 | 1/1/2027 2023-12-31 0001418076 Equipment Financing 26.0% | PCX Aerostructures LLC | Aerospace & Defense | 9.32% | 11/23/2022 | 12/1/2028 2023-12-31 0001418076 Equipment Financing 26.0% | Rane Light Metal Castings Inc | Machinery | 10.00% | 6/1/2020 | 6/1/2024 2023-12-31 0001418076 Equipment Financing 26.0% | Rango, Inc | Commercial Services & Supplies | 9.33% | 9/24/2019 | 11/1/2024 2023-12-31 0001418076 Equipment Financing 26.0% | Rayzors Edge LLC | Diversified Consumer Services | 7.69-8.27% | 5/19/2023 | 5/18/2030-6/30/2030 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Rayzors Edge LLC | Diversified Consumer Services | 7.69-8.27% | 5/19/2023 | 5/18/2030-6/30/2030 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | RH Land Construction, LLC & Harbor Dredging LA, Inc | Construction & Engineering | 8.08% | 5/10/2023 | 5/10/2026 2023-12-31 0001418076 Equipment Financing 26.0% | Royal Express Inc | Road & Rail | 9.53% | 1/17/2019 | 2/1/2024 2023-12-31 0001418076 Equipment Financing 26.0% | Rotten Rock Hardscaping & Tree Service | Diversified Consumer Services | 8.21% | 12/6/2022 | 12/6/2027 2023-12-31 0001418076 Equipment Financing 26.0% | Rutt Services, LLC | Commercial Services & Supplies | 8.95% | 8/11/2023 | 8/11/2030 2023-12-31 0001418076 Equipment Financing 26.0% | Signet Marine Corporation | Transportation Infrastructure | 8.50% | 10/31/2022 | 11/1/2029 2023-12-31 0001418076 Equipment Financing 26.0% | SLR Equipment Finance | Multi-Sector Holdings | 8.50% | 1/24/2022 | 1/27/2024 2023-12-31 0001418076 Equipment Financing 26.0% | Smiley Lifting Solutions, LLC | Commercial Services & Supplies | 7.82-8.61% | 6/30/2022 | 9/15/2026-6/27/2030 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Smiley Lifting Solutions, LLC | Commercial Services & Supplies | 7.82-8.61% | 6/30/2022 | 9/15/2026-6/27/2030 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | ST Coaches, LLC | Road & Rail | 8.50% | 7/31/2017 | 1/25/2025 2023-12-31 0001418076 Equipment Financing 26.0% | Star Coaches Inc | Road & Rail | 8.42% | 3/9/2018 | 4/1/2025 2023-12-31 0001418076 Equipment Financing 26.0% | Superior Transportation, Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Superior Transportation, Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | The Smedley Company & Smedley Services, Inc | Commercial Services & Supplies | 4.07% | 7/31/2017 | 1/15/2028 2023-12-31 0001418076 Equipment Financing 26.0% | Trinity Equipment, Inc | Commercial Services & Supplies | 8.78-8.93% | 5/4/2023 | 5/4/2028-5/19/2028 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Trinity Equipment, Inc | Commercial Services & Supplies | 8.78-8.93% | 5/4/2023 | 5/4/2028-5/19/2028 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Trinity Equipment Rentals, Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Trinity Equipment Rentals, Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | U.S. Crane & Rigging, LLC | Commercial Services & Supplies | 8.73%-10.92% | 12/23/2022 | 3/1/2027-9/1/2028 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | U.S. Crane & Rigging, LLC | Commercial Services & Supplies | 8.73%-10.92% | 12/23/2022 | 3/1/2027-9/1/2028 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Up Trucking Services, LLC | Road & Rail | 11.21% | 3/23/2018 | 8/1/2024 2023-12-31 0001418076 Equipment Financing 26.0% | Lux Vending, LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 7/20/2024-10/1/2024 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Lux Credit Consultants, LLC | Road & Rail | 8.28-12.09 % | 6/17/2021 | 12/1/2024-12/1/2026 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | First American Commercial Bancorp, Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Energy Drilling Services, LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Drillers Choice, Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Complete Equipment Rentals, LLC | Commercial Services & Supplies | 6.75-7.15% | 3/23/2023 | 4/1/2028-6/1/2028 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Clubcorp Holdings, Inc | Hotels, Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | CKD Holdings, Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Carolinas Contracting, LLC | Diversified Consumer Services | 8.40-8.72% | 3/7/2023 | 3/7/2028-5/18/2028 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Lux Vending, LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 7/20/2024-10/1/2024 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Lux Credit Consultants, LLC | Road & Rail | 8.28-12.09 % | 6/17/2021 | 12/1/2024-12/1/2026 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Loc Performance Products, LLC | Machinery | 10.50% | 12/29/2022 | 6/1/2027 2023-12-31 0001418076 Equipment Financing 26.0% | Kool Pak, LLC | Road & Rail | 8.58% | 2/5/2018 | 3/1/2024 2023-12-31 0001418076 Equipment Financing 26.0% | International Automotive Components Group, North America, Inc | Auto Components | 7.95% | 6/23/2021 | 6/23/2025 2023-12-31 0001418076 Equipment Financing 26.0% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Hawkeye Contracting Company, LLC | Construction & Engineering | 10.50% | 10/8/2021 | 11/1/2025 2023-12-31 0001418076 Equipment Financing 26.0% | GMT Corporation | Machinery | 10.71% | 10/23/2018 | 1/1/2026 2023-12-31 0001418076 Equipment Financing 26.0% | Georgia Jet, Inc | Airlines | 8.00% | 12/4/2017 | 1/4/2024 2023-12-31 0001418076 Equipment Financing 26.0% | First National Capital, LLC | Diversified Financial Services | 9.00% | 11/5/2021 | 8/1/2026 2023-12-31 0001418076 Equipment Financing 26.0% | First American Commercial Bancorp, Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Extreme Steel Crane & Rigging, LLC | Commercial Services & Supplies | 9.52% | 3/3/2023 | 3/3/2027 2023-12-31 0001418076 Equipment Financing 26.0% | Equipment Operating Leases, LLC | Multi-Sector Holdings | 8.37% | 4/27/2018 | 4/27/2025 2023-12-31 0001418076 Equipment Financing 26.0% | Environmental Protection & Improvement Company, LLC | Road & Rail | 8.25% | 9/30/2020 | 10/1/2027 2023-12-31 0001418076 Equipment Financing 26.0% | Energy Drilling Services, LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Drillers Choice, Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Double S Industrial Contractors, Inc | Commercial Services & Supplies | 8.60% | 7/28/2023 | 8/1/2027 2023-12-31 0001418076 Equipment Financing 26.0% | Dongwon Autopart Technology Inc | Auto Components | 7.96% | 2/2/2021 |1/1/2026 2023-12-31 0001418076 Equipment Financing 26.0% | Complete Equipment Rentals, LLC | Commercial Services & Supplies | 6.75-7.15% | 3/23/2023 | 4/1/2028-6/1/2028 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Clubcorp Holdings, Inc | Hotels, Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | CKD Holdings, Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Carolinas Contracting, LLC | Diversified Consumer Services | 8.40-8.72% | 3/7/2023 | 3/7/2028-5/18/2028 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Capital City Jet Center, Inc | Airlines | 10.00% | 4/4/2018 | 6/22/2026 2023-12-31 0001418076 Preferred Equity - 0.4% | SOINT LLC | Aerospace & Defense | 5.00% | 6/8/2012 | 6/30/2025 2023-12-31 0001418076 Equipment Financing 26.0% | Wind River Environmental, LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Wind River Environmental, LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Zamborelli Enterprises Pacific Southern Foundation | Diversified Consumer Services | 8.91% | 12/7/2022 | 1/1/2027 2023-12-31 0001418076 Equipment Financing 26.0% | Worldwide Flight Services, Inc | Transportation Infrastructure | 8.32-9.93% | 9/23/2022 | 9/23/2027-8/16/2028 srt:MaximumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Worldwide Flight Services, Inc | Transportation Infrastructure | 8.32-9.93% | 9/23/2022 | 9/23/2027-8/16/2028 srt:MinimumMember 2023-12-31 0001418076 Equipment Financing 26.0% | Womble Company, Inc | Energy Equipment & Services | 9.11% | 12/27/2019 | 1/1/2025 2023-12-31 0001418076 Equipment Financing 26.0% | Waste Pro of Florida, Inc. & Waste Pro USA, Inc | Commercial Services & Supplies | 9.17% | 4/18/2023 | 4/18/2028 2023-12-31 0001418076 Cash Equivalents - 33.7% | U.S. Treasury Bill | Government | 12/29/2023 | 2/27/2024 2023-12-31 0001418076 Equipment Financing 26.0% | Superior Transportation, Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 2023-12-31 0001418076 Equipment Financing 26.0% | Worldwide Flight Services, Inc | Transportation Infrastructure | 8.32-9.93% | 9/23/2022 | 9/23/2027-8/16/2028 2023-12-31 0001418076 Equipment Financing 26.0% | Wind River Environmental, LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 2023-12-31 0001418076 Equipment Financing 26.0% | Carolinas Contracting, LLC | Diversified Consumer Services | 8.40-8.72% | 3/7/2023 | 3/7/2028-5/18/2028 2023-12-31 0001418076 Equipment Financing 26.0% | CKD Holdings, Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 2023-12-31 0001418076 Equipment Financing 26.0% | Clubcorp Holdings, Inc | Hotels, Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 2023-12-31 0001418076 Equipment Financing 26.0% | Complete Equipment Rentals, LLC | Commercial Services & Supplies | 6.75-7.15% | 3/23/2023 | 4/1/2028-6/1/2028 2023-12-31 0001418076 Equipment Financing 26.0% | Drillers Choice, Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 2023-12-31 0001418076 Equipment Financing 26.0% | Energy Drilling Services, LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 2023-12-31 0001418076 Equipment Financing 26.0% | First American Commercial Bancorp, Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 2023-12-31 0001418076 Equipment Financing 26.0% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 2023-12-31 0001418076 Equipment Financing 26.0% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 2023-12-31 0001418076 Equipment Financing 26.0% | Lux Credit Consultants, LLC | Road & Rail | 8.28-12.09 % | 6/17/2021 | 12/1/2024-12/1/2026 2023-12-31 0001418076 Equipment Financing 26.0% | Lux Vending, LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 7/20/2024-10/1/2024 2023-12-31 0001418076 Equipment Financing 26.0% | Trinity Equipment, Inc | Commercial Services & Supplies | 8.78-8.93% | 5/4/2023 | 5/4/2028-5/19/2028 2023-12-31 0001418076 Equipment Financing 26.0% | Trinity Equipment Rentals, Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 2023-12-31 0001418076 Equipment Financing 26.0% | U.S. Crane & Rigging, LLC | Commercial Services & Supplies | 8.73%-10.92% | 12/23/2022 | 3/1/2027-9/1/2028 2023-12-31 0001418076 Equipment Financing 26.0% | Smiley Lifting Solutions, LLC | Commercial Services & Supplies | 7.82-8.61% | 6/30/2022 | 9/15/2026-6/27/2030 2023-12-31 0001418076 Equipment Financing 26.0% | Rayzors Edge LLC | Diversified Consumer Services | 7.69-8.27% | 5/19/2023 | 5/18/2030-6/30/2030 2023-12-31 0001418076 Equipment Financing 26.6% | Aero Operating LLC | Commercial Services & Supplies | 8.47-9.64% | 2/12/2021 | 3/1/2025-12/1/2026 2023-12-31 0001418076 Equipment Financing 26.0% | Boart Longyear Company | Metals & Mining | 8.31-10.44% | 5/28/2020 | 7/1/2024-10/7/2026 2023-12-31 0001418076 Equipment Financing 26.0% | AFG Dallas III, LLC | Diversified Consumer Services | 10.00-11.29% | 8/11/2022 | 8/11/2026-3/1/2027 2023-12-31 0001418076 Equipment Financing 26.0% | Air Methods Corporation | Airlines | 7.08-7.13% | 11/3/2021 | 11/3/2026-11/23/2026 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | SLR Healthcare ABL | Diversified Financial Services | 04/01/2022 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | SLR Senior Lending Program LLC | Asset Management | 12/01/2022 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Vapotherm, Inc. Warrants | Health Care Equipment&Supplies | 2/18/2022 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Venus Concept Ltd. Warrants (f/k/a Restoration Robotics) | Health Care Equipment&Supplies | 05/10/2018 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Vertos Medical, Inc. Warrants | Health Care Equipment&Supplies | 6/14/2023 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Assertio Holdings, Inc. | Pharmaceuticals | 7/31/2023 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | aTyr Pharma, Inc. Warrants | Pharmaceuticals | 11/18/2016 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Bayside Parent, LLC | Health Care Providers&Services | 5/31/2023 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | CardioFocus, Inc. Warrants | Health Care Equipment&Supplies | 3/31/2017 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Centrexion Therapeutics, Inc. Warrants | Pharmaceuticals | 6/28/2019 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Conventus Orthopaedics, Inc. Warrants | Health Care Equipment&Supplies | 6/15/2016 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Delphinus Medical Technologies, Inc. Warrants | Health Care Equipment&Supplies | 8/18/2017 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Essence Group Holdings Corporation (Lumeris) Warrants | Health Care Technology | 3/22/2017 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | KBH Topco LLC (Kingsbridge). | Multi-Sector Holdings | 11/3/2020 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Meditrina, Inc. Warrants | Health Care Equipment&Supplies | 12/20/2022 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | NSPC Holdings, LLC (National Spine) | Health Care Providers&Services | 2/13/2023 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | RD Holdco, Inc. (Rug Doctor) | Diversified Consumer Services | 12/23/2013 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | RD Holdco, Inc. (Rug Doctor) ClassB | Diversified Consumer Services | 12/23/2013 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Senseonics Holdings, Inc. | Health Care Equipment&Supplies | 7/25/2019 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | SLR-AMI Topco Blocker, LLC | Internet &Catalog Retail | 6/16/2023 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | SLR Business Credit | Diversified Financial Services |4/1/2022 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | SLR Credit Solutions | Diversified Financial Services | 12/28/2012 2023-12-31 0001418076 Equipment Financing 26.0% | SLR Equipment Finance Equity Interests | Multi-Sector Holdings | 7/31/2017 2023-12-31 0001418076 Equipment Financing 26.0% | Total Equipment Financing 2023-12-31 0001418076 Cash Equivalents - 33.7% | Total Investments & Cash Equivalents - 250.5% 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Total Common Equity/Equity Interests/Warrants 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Total Investments - 218.4% 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Total First Lien Life Science Senior Secured Loans 2023-12-31 0001418076 Senior Secured Loans - 129.5% | Second Lien Asset-Based Senior Secured Loans 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans 2023-12-31 0001418076 Senior Secured Loans - 129.5% | Total First Lien Bank Debt/Senior Secured Loans 2023-12-31 0001418076 Cash Equivalents - 33.7% | Liabilities in Excess of Other Assets - (150.5%) 2023-12-31 0001418076 Cash Equivalents - 33.7% | Net Assets - 100.0% 2023-12-31 0001418076 slrc:IcimsInc.Member 2023-12-31 0001418076 slrc:VapothermInc.Member 2023-12-31 0001418076 slrc:BridgeBioPharmaIncMember 2023-12-31 0001418076 slrc:KaseyaIncMember 2023-12-31 0001418076 slrc:DiversifiedFinancialServicesMember 2023-12-31 0001418076 slrc:MultiSectorHoldingsMember 2023-12-31 0001418076 slrc:HealthCareProvidersAndServicesMember 2023-12-31 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2023-12-31 0001418076 slrc:PharmaceuticalsMember 2023-12-31 0001418076 slrc:BiotechnologyMember 2023-12-31 0001418076 slrc:SoftwareMember 2023-12-31 0001418076 slrc:InsuranceMember 2023-12-31 0001418076 slrc:DiversifiedConsumerServicesMember 2023-12-31 0001418076 slrc:CommercialServicesAndSuppliesMember 2023-12-31 0001418076 us-gaap:AssetManagement1Member 2023-12-31 0001418076 slrc:CapitalMarketsMember 2023-12-31 0001418076 slrc:MediaMember 2023-12-31 0001418076 slrc:ThriftsAndMortgageFinanceMember 2023-12-31 0001418076 slrc:PersonalProductsMember 2023-12-31 0001418076 slrc:PackagedFoodsAndMeatsMember 2023-12-31 0001418076 slrc:AutoPartsAndEquipmentMember 2023-12-31 0001418076 slrc:RoadAndRailMember 2023-12-31 0001418076 slrc:LifeSciencesToolsAndServicesMember 2023-12-31 0001418076 slrc:InternetSoftwareAndServicesMember 2023-12-31 0001418076 slrc:InternetAndCatalogRetailMember 2023-12-31 0001418076 slrc:TransportationInfrastructureMember 2023-12-31 0001418076 slrc:CommunicationsEquipmentMember 2023-12-31 0001418076 slrc:HealthCareTechnologyMember 2023-12-31 0001418076 slrc:TradingCompaniesAndDistributorsMember 2023-12-31 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2023-12-31 0001418076 slrc:AerospaceAndDefenseMember 2023-12-31 0001418076 slrc:OilGasAndConsumableFuelsMember 2023-12-31 0001418076 slrc:FootwearMember 2023-12-31 0001418076 slrc:AutoComponentsMember 2023-12-31 0001418076 slrc:ItServicesMember 2023-12-31 0001418076 slrc:FoodProductsMember 2023-12-31 0001418076 slrc:MachineryMember 2023-12-31 0001418076 slrc:AirlinesMember 2023-12-31 0001418076 slrc:DistributorsMember 2023-12-31 0001418076 slrc:MetalsAndMiningMember 2023-12-31 0001418076 slrc:LeisureEquipmentAndProductsMember 2023-12-31 0001418076 slrc:SpecialtyRetailMember 2023-12-31 0001418076 slrc:FoodAndStaplesRetailingMember 2023-12-31 0001418076 slrc:ConstructionAndEngineeringMember 2023-12-31 0001418076 slrc:ConsumerFinanceMember 2023-12-31 0001418076 slrc:EnergyEquipmentAndServicesMember 2023-12-31 0001418076 slrc:WaterUtilitiesMember 2023-12-31 0001418076 slrc:ASCHoldcoLLCMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueMeasurementsRecurringMember slrc:MeasuredAtNetAssetValueMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember srt:WeightedAverageMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember srt:MaximumMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:MeasurementInputReturnOnEquityMember srt:MinimumMember us-gaap:MarketApproachValuationTechniqueMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember srt:WeightedAverageMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember srt:MaximumMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember slrc:MeasurementInputComparableMultipleMember srt:MinimumMember slrc:ValuationApproachMarketMultipleMember 2022-12-31 0001418076 slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember srt:WeightedAverageMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember srt:MaximumMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 slrc:PreferredEquityMember slrc:MeasurementInputMarketYieldMember srt:MinimumMember us-gaap:IncomeApproachValuationTechniqueMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member slrc:BlackScholesPricingModelMember 2022-12-31 0001418076 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputEbitdaMultipleMember 2022-12-31 0001418076 slrc:TermLoanAndCreditFacilityMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-12-31 0001418076 slrc:SlrBusinessCreditMember slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:KbhtMember 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-12-31 0001418076 slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember slrc:SeniorSecuredCommitmentsMember 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2022-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2022-12-31 0001418076 slrc:MedrinaLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:BaymarkHealthServicesIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:HighStreetBuyerIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:TaucManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:AmericanTeleconferencingServicesLtd.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:EnsHoldingsIiiCorpLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:MontefioreNyackHospitalMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:OutsetMedicalInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:CcSagHoldingsCorp.SpectrumAutomotiveMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:ApeelTechnologyIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:WorldInsuranceAssociatesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:HumanInterestIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:SpectrumPharmaceuticalsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:MauricesIncorporatedMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:AtriaWealthSolutionsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:ArcutisBiotherapeuticsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:CerapedicsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:AccessionRiskManagementGroupIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:GlookoInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:AllStatesAgPartsLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:WCI-BXCPurchaserLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:ExactcareParentIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:CrewlineBuyerIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:MeditrinaInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:EnverusHoldingsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:IvyFertilityServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:NacHoldingsCorporationMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:CompositeTechnologyAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:PinnacleTreatmentCentersInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:PediatricHomeRespiratoryServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:PlasticsManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:VesscoMidcoHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:OneTouchDirectLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:SunmedGroupHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:SlrEquipmentFinanceMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:PeterC.FoyAssociatesInsuranceServicesLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:SlrHealthcareAblMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:RxsenseHoldingsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:SparMarketingForceInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:OrthopedicCarePartnersManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UltimateBakedGoodsMidcoLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:SouthernOrthodonticPartnersManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:KidDistroHoldingsLlcDistroKidMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:BasicFunInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:FoundationConsumerBrandsLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:LuxuryAssetCapitalLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:SlrCreditSolutionsMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UrologyManagementHoldingsIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:BaysideOpcoLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UvpManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:AMFLeveredIILLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:VertosMedicalInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:TheTownsendCompanyLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:KaseyaIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:UnitedDigestiveMSOParentLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:DeepintentInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:WestNRParentIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:LegacyServicePartnersLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:AlkemeIntermediateHoldingsLLCMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:RetinaMidcoIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:CvausaManagementLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:TilleyDistributionIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:GsmAcquisitionCorpMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:ErieConstructionMidwestLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:ScpEyeCareLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:IcimsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:ArdelyxIncMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:CopperRiverSeafoodsInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:BdgMediaInc.Member slrc:UnfundedDebtAndEquityCommitmentsMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-12-31 0001418076 slrc:TermLoansMember 2022-12-31 0001418076 slrc:CreditFacilityOneMember 2022-12-31 0001418076 slrc:CreditFacilityMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFiveUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2022-12-31 0001418076 Atria Wealth Solutions, Inc | Diversified Financial Services |S+600 | 1.00% | 10.84% | 2/29/24 2022-12-31 0001418076 BayMark Health Services, Inc | Health Care Providers and Services | L+500 | 1.00% | 9.73% | 6/11/27 2022-12-31 0001418076 ENS Holdings III Corp and ES Opco USA LLC | Trading Companies and Distributors |L+475 | 1.00% | 9.43% |12/31/25 2022-12-31 0001418076 Foundation Consumer Brands, LLC | Personal Products |L+550 | 1.00% | 10.15% | 2/12/27 2022-12-31 0001418076 High Street Buyer, Inc | Insurance | L+600 | 0.75% | 10.73% | 4/16/28 2022-12-31 0001418076 Ivy Fertility Services, LLC | Health Care Providers and Services | L+625 | 1.00% | 10.39% | 2/25/26 2022-12-31 0001418076 Kid Distro Holdings, LLC | Software |L+575 | 1.00% | 10.48% | 10/1/27 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember us-gaap:InvestorMember 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember srt:ManagementMember 2022-12-31 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramLlcMember slrc:SlrSeniorLendingProgramSpvLlcMember 2022-12-31 0001418076 Equipment Financing 26.0% | Air Methods Corporation | Airlines | 7.08-7.13% | 11/3/2021 | 11/3/2026-11/23/2026 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | AFG Dallas III, LLC | Diversified Consumer Services | 10.00-11.29% | 8/11/2022 | 8/11/2026-3/1/2027 2022-12-31 0001418076 Equipment Financing 26.6% | Aero Operating LLC | Commercial Services & Supplies | 8.47-9.64% | 2/12/2021 | 3/1/2025-12/1/2026 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Air Methods Corporation | Airlines | 7.08-7.13% | 11/3/2021 | 11/3/2026-11/23/2026 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Zamborelli Enterprises Pacific Southern Foundation | Diversified Consumer Services | 8.91% | 12/7/2022 | 1/1/2027 2022-12-31 0001418076 Equipment Financing 26.0% | Worldwide Flight Services, Inc | Transportation Infrastructure | 8.32-9.36% | 9/23/2022 | 9/23/2027-10/28/2027 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Worldwide Flight Services, Inc | Transportation Infrastructure | 8.32-9.36% | 9/23/2022 | 9/23/2027-10/28/2027 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Womble Company, Inc | Energy Equipment & Services | 9.11% | 12/27/2019 | 1/1/2025 2022-12-31 0001418076 Equipment Financing 26.0% | Wind River Environmental, LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Wind River Environmental, LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% | Aero Operating LLC | Commercial Services & Supplies | 8.47-9.64% | 2/12/2021 | 3/1/2025-12/1/2026 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | First National Capital, LLC | Diversified Financial Services | 9.00% | 11/5/2021 | 8/1/2026 2022-12-31 0001418076 Equipment Financing 26.6% | Freightsol LLC | Road&Rail | 12.51-12.89% | 4/9/2019 | 11/1/2023 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% | Freightsol LLC | Road&Rail | 12.51-12.89% | 4/9/2019 | 11/1/2023 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.6% | Garda CL Technical Services, Inc. | Commercial Services&Supplies | 8.30-8.77% | 3/22/2018 | 6/5/2023-10/5/2023 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% | Garda CL Technical Services, Inc. | Commercial Services&Supplies | 8.30-8.77% | 3/22/2018 | 6/5/2023-10/5/2023 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Georgia Jet, Inc | Airlines | 8.00% | 12/4/2017 | 1/4/2024 2022-12-31 0001418076 Equipment Financing 26.0% | GMT Corporation | Machinery | 10.71% | 10/23/2018 | 1/1/2026 2022-12-31 0001418076 Equipment Financing 26.0% | Hawkeye Contracting Company, LLC | Construction & Engineering | 10.50% | 10/8/2021 | 11/1/2025 2022-12-31 0001418076 Equipment Financing 26.0% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | International Automotive Components Group, North America, Inc | Auto Components | 7.95% | 6/23/2021 | 6/23/2025 2022-12-31 0001418076 Equipment Financing 26.0% | Kool Pak, LLC | Road & Rail | 8.58% | 2/5/2018 | 3/1/2024 2022-12-31 0001418076 Equipment Financing 26.0% | Loc Performance Products, LLC | Machinery | 10.50% | 12/29/2022 | 6/1/2027 2022-12-31 0001418076 Equipment Financing 26.0% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Lux Credit Consultants, LLC | Road & Rail | 8.28-12.09 % | 6/17/2021 | 12/1/2024-12/1/2026 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Lux Credit Consultants, LLC | Road & Rail | 8.28-12.09 % | 6/17/2021 | 12/1/2024-12/1/2026 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | First American Commercial Bancorp, Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | First American Commercial Bancorp, Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Equipment Operating Leases, LLC | Multi-Sector Holdings | 8.37% | 4/27/2018 | 4/27/2025 2022-12-31 0001418076 Equipment Financing 26.0% | Environmental Protection & Improvement Company, LLC | Road & Rail | 8.25% | 9/30/2020 | 10/1/2027 2022-12-31 0001418076 Equipment Financing 26.0% | Energy Drilling Services, LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Energy Drilling Services, LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% | EasyPak, LLC | Containers&Packaging | 0.0901 | 1/6/2021 | 1/1/2024 2022-12-31 0001418076 Equipment Financing 26.0% | Drillers Choice, Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 2022-12-31 0001418076 Equipment Financing 26.0% | Dongwon Autopart Technology Inc | Auto Components | 7.96% | 2/2/2021 |1/1/2026 2022-12-31 0001418076 Equipment Financing 26.0% | Clubcorp Holdings, Inc | Hotels, Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Clubcorp Holdings, Inc | Hotels, Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | CKD Holdings, Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | CKD Holdings, Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% | Champion Air, LLC | Airlines | 0.1 | 3/19/2018 | 1/1/2023 2022-12-31 0001418076 Equipment Financing 26.0% | Capital City Jet Center, Inc | Airlines | 10.00% | 4/4/2018 | 6/22/2026 2022-12-31 0001418076 Equipment Financing 26.0% | C-Port/Stone LLC | Oil, Gas & Consumable Fuels | 8.54% | 10/7/2022 | 11/1/2027 2022-12-31 0001418076 Equipment Financing 26.0% | Bowman Energy Solutions, LLC | Commercial Services & Supplies | 7.42% | 7/1/2022 | 8/1/2026 2022-12-31 0001418076 Equipment Financing 26.0% | Boart Longyear Company | Metals & Mining | 8.31-10.44% | 5/28/2020 | 7/1/2024-10/7/2026 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Boart Longyear Company | Metals & Mining | 8.31-10.44% | 5/28/2020 | 7/1/2024-10/7/2026 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Bazzini, LLC | Food & Staples Retailing |10.46% |12/23/2022 |1/1/2028 2022-12-31 0001418076 Equipment Financing 26.0% | AmeraMex International, Inc | Commercial Services & Supplies |10.00% | 3/29/2019 | 4/15/2025 2022-12-31 0001418076 Equipment Financing 26.0% | Rango, Inc | Commercial Services & Supplies | 9.33-9.79% | 9/24/2019 | 4/1/2023-11/1/2024 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Rane Light Metal Castings Inc | Machinery | 10.00% | 6/1/2020 | 6/1/2024 2022-12-31 0001418076 Equipment Financing 26.0% | PCX Aerostructures LLC | Aerospace & Defense | 9.32% | 11/23/2022 | 12/1/2028 2022-12-31 0001418076 Equipment Financing 26.0% | Ozzies, Inc | Commercial Services & Supplies | 10.72% | 12/23/2022 | 1/1/2027 2022-12-31 0001418076 Equipment Financing 26.0% | Mountain Air Helicopters, Inc | Commercial Services & Supplies | 10.00% | 7/31/2017 | 2/28/2025 2022-12-31 0001418076 Equipment Financing 26.0% | Lux Vending, LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 8/20/2024-10/1/2024 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | SLR Equipment Finance | Multi-Sector Holdings | 8.50% | 1/24/2022 | 1/24/2023 2022-12-31 0001418076 Equipment Financing 26.0% | Signet Marine Corporation | Transportation Infrastructure | 8.50% | 10/31/2022 | 7/1/2029 2022-12-31 0001418076 Equipment Financing 26.0% | Rotten Rock Hardscaping & Tree Service | Diversified Consumer Services | 8.21% | 12/6/2022 | 12/6/2027 2022-12-31 0001418076 Equipment Financing 26.0% | Royal Express Inc | Road & Rail | 9.53% | 1/17/2019 | 2/1/2024 2022-12-31 0001418076 Equipment Financing 26.0% | Royal Coach Lines, Inc | Road & Rail | 9.56% | 11/21/2019 | 8/1/2025 2022-12-31 0001418076 Equipment Financing 26.0% | Rango, Inc | Commercial Services & Supplies | 9.33-9.79% | 9/24/2019 | 4/1/2023-11/1/2024 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Superior Transportation, Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Star Coaches Inc | Road & Rail | 8.42% | 3/9/2018 | 4/1/2025 2022-12-31 0001418076 Equipment Financing 26.0% | ST Coaches, LLC | Road & Rail | 8.47-8.58% | 7/31/2017 | 7/1/2023-1/25/2025 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | ST Coaches, LLC | Road & Rail | 8.47-8.58% | 7/31/2017 | 7/1/2023-1/25/2025 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Smiley Lifting Solutions, LLC | Commercial Services & Supplies | 7.82-8.28% | 6/30/2022 | 9/15/2026-12/29/2029 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Smiley Lifting Solutions, LLC | Commercial Services & Supplies | 7.82-8.28% | 6/30/2022 | 9/15/2026-12/29/2029 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Up Trucking Services, LLC | Road & Rail | 11.21% | 3/23/2018 | 8/1/2024 2022-12-31 0001418076 Equipment Financing 26.0% | U.S. Crane & Rigging, LLC | Commercial Services & Supplies | 10.92% |12/23/2022 | 3/1/2027 2022-12-31 0001418076 Equipment Financing 26.0% | Trinity Equipment Rentals, Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Trinity Equipment Rentals, Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | The Smedley Company & Smedley Services, Inc | Commercial Services & Supplies | 4.07% | 7/31/2017 | 1/15/2028 2022-12-31 0001418076 Equipment Financing 26.0% | Superior Transportation, Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Lux Vending, LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 8/20/2024-10/1/2024 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.6% | Freightsol LLC | Road&Rail | 12.51-12.89% | 4/9/2019 | 11/1/2023 2022-12-31 0001418076 Equipment Financing 26.0% | AFG Dallas III, LLC | Diversified Consumer Services | 10.00-11.29% | 8/11/2022 | 8/11/2026-3/1/2027 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | AFG Dallas III, LLC | Diversified Consumer Services | 10.00-11.29% | 8/11/2022 | 8/11/2026-3/1/2027 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Capital City Jet Center, Inc | Airlines | 10.00% | 4/4/2018 | 6/22/2026 srt:MinimumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Capital City Jet Center, Inc | Airlines | 10.00% | 4/4/2018 | 6/22/2026 srt:MaximumMember 2022-12-31 0001418076 Equipment Financing 26.0% | Superior Transportation, Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 2022-12-31 0001418076 Equipment Financing 26.0% | Worldwide Flight Services, Inc | Transportation Infrastructure | 8.32-9.36% | 9/23/2022 | 9/23/2027-10/28/2027 2022-12-31 0001418076 Equipment Financing 26.0% | Wind River Environmental, LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 2022-12-31 0001418076 Equipment Financing 26.0% | Trinity Equipment Rentals, Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 2022-12-31 0001418076 Equipment Financing 26.0% | Smiley Lifting Solutions, LLC | Commercial Services & Supplies | 7.82-8.28% | 6/30/2022 | 9/15/2026-12/29/2029 2022-12-31 0001418076 Equipment Financing 26.0% | ST Coaches, LLC | Road & Rail | 8.47-8.58% | 7/31/2017 | 7/1/2023-1/25/2025 2022-12-31 0001418076 Equipment Financing 26.0% | Rango, Inc | Commercial Services & Supplies | 9.33-9.79% | 9/24/2019 | 4/1/2023-11/1/2024 2022-12-31 0001418076 Equipment Financing 26.0% | Lux Vending, LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 8/20/2024-10/1/2024 2022-12-31 0001418076 Equipment Financing 26.0% | Air Methods Corporation | Airlines | 7.08-7.13% | 11/3/2021 | 11/3/2026-11/23/2026 2022-12-31 0001418076 Equipment Financing 26.6% | Aero Operating LLC | Commercial Services & Supplies | 8.47-9.64% | 2/12/2021 | 3/1/2025-12/1/2026 2022-12-31 0001418076 Equipment Financing 26.0% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 2022-12-31 0001418076 Equipment Financing 26.6% | Garda CL Technical Services, Inc. | Commercial Services&Supplies | 8.30-8.77% | 3/22/2018 | 6/5/2023-10/5/2023 2022-12-31 0001418076 Equipment Financing 26.0% | First American Commercial Bancorp, Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 2022-12-31 0001418076 Equipment Financing 26.0% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 2022-12-31 0001418076 Equipment Financing 26.0% | Boart Longyear Company | Metals & Mining | 8.31-10.44% | 5/28/2020 | 7/1/2024-10/7/2026 2022-12-31 0001418076 Equipment Financing 26.0% | Lux Credit Consultants, LLC | Road & Rail | 8.28-12.09 % | 6/17/2021 | 12/1/2024-12/1/2026 2022-12-31 0001418076 Equipment Financing 26.0% | CKD Holdings, Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 2022-12-31 0001418076 Equipment Financing 26.0% | Clubcorp Holdings, Inc | Hotels, Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 2022-12-31 0001418076 Equipment Financing 26.0% | Energy Drilling Services, LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 2022-12-31 0001418076 Equipment Financing 26.0% | SLR Equipment Finance Equity Interests | Multi-Sector Holdings | 7/31/2017 2022-12-31 0001418076 Equipment Financing 26.0% | Total Equipment Financing 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Glooko, Inc. | Health Care Technology | L+790 | 0.10% | 12.07% | 9/30/2021 | 10/1/2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Cerapedics, Inc. | Biotechnology | S+620 | 2.75% | 10.52% | 12/27/2022 | 1/1/2028 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Centrexion Therapeutics, Inc. | Pharmaceuticals | L+725 | 2.45% | 11.42% | 6/28/2019 | 1/1/2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | BridgeBio Pharma, Inc. | Biotechnology | - | - | 9.00% | 11/17/2021 | 11/17/2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Ardelyx, Inc. | Pharmaceuticals | L+795 | 0.10% | 12.12% | 2/23/2022 | 3/1/2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Arcutis Biotherapeutics, Inc. | Pharamceuticals | L+745 | 0.10% | 11.62% | 12/22/2021 | 1/1/2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Apeel Technology, Inc. | Biotechnology | S+625 | 1.00% | 8.75% | 6/29/2022 | 6/1/2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Alimera Sciences, Inc. | Pharmaceuticals | L+765 | 1.78% | 11.82% | 12/31/2019 | 7/1/2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Human Interest Inc | Internet Software & Services | S+785 | 1% | 11.97% | 6/30/2022 | 07-01-2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | iCIMS, Inc. | Software | S+725 | 0.75% | 11.52% | 8/18/2022 | 8/18/2028 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Ivy Fertility Services, LLC | Health Care Providers & Services | L+625 | 1% | 10.39% | 12/22/2021 | 2/25/2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Kaseya, Inc. | Software | S+575 | 0.75% | 10.33% | 6/22/2022 | 6/23/2029 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Kid Distro Holdings, LLC (Distro Kid) | Software | L+575 | 1% | 10.48% | 9/24/2021 | 10/1/2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Kingsbridge Holdings, LLC | Multi-Sector Holdings| L+700 |1% |10.75% | 12/21/2018 | 12/21/2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | KORE Wireless Group, Inc. | Wireless Telecommunication Services | S+550 | - | 10.08% | 12/21/2018 | 12/21/2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Logix Holding Company, LLC | Communications Equipment | L+575 | 1% | 10.13% | 9/14/2018 | 12/22/2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Luxury Asset Capital, LLC | Thrifts & Mortgage Finance | S+675 | 1% | 10.99% | 7/15/2022 | 7/15/2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Maurices, Incorporated | Specialty Retail | S+675 | 1% | 8.74% | 8/27/2021 | 06-01-2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Montefiore Nyack Hospital | Health Care Providers & Services | L+495 | - | 9.72% | 08-09-2022 | 11/15/2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | NAC Holdings Corporation (Jaguar) | Insurance | S+525 | 1% | 9.45% | 7/30/2021 | 9/28/2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | PPT Management Holdings, LLC | Health Care Providers & Services| L+850 | 1% | 12.83% | 9/14/2018 | 1/30/2023 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | PhyNet Dermatology LLC | Health Care Providers & Services | S+625 | 1% | 9.81% | 09/05/2018 | 8/16/2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | RxSense Holdings LLC | Diversified Consumer Services | L+500 | 1% | 9.41% | 04-01-2022 | 3/13/2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | RSC Acquisition, Inc. | Insurance | S+550 | 0.75% | 9.26% | 04-01-2022 | 11-01-2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | RQM+ Corp. | Life Sciences Tools & Services | S+575 | 1% | 10.97% | 8/20/2021 | 8/12/2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Plastics Management, LLC | Health Care Providers & Services | S+500 | 1% | 9.89% | 4/1/2022 | 8/18/2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Pinnacle Treatment Centers, Inc. | Health Care Providers & Services | S+650 | 1% | 10.57% | 1/22/2020 | 1/2/2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Peter C. Foy & Associates Insurance Services, LLC | Insurance | S+600 | 0.75% | 10.44% | 04-01-2022 | 11-01-2028 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Pediatric Home Respiratory Services, LLC | Health Care Providers & Services | S+625 | 1% | 10.67% | 8/19/2022 | 12/04/2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Orthopedic Care Partners Management, LLC | Health Care Providers & Services | S+650 | 1% | 10.91% | 8/17/2022 | 5/16/2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | One Touch Direct, LLC | Commercial Services & Supplies | P+75 | - | 8.25% | 04-03-2020 | 3/30/2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | National Spine and Pain Centers, LLC | Health Care Providers & Services | L+500 | 1% | 7.31% | 04-01-2022 | 06-02-2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | BayMark Health Services,Inc. | Health Care Providers & Services | L+500 | 1% | 9.73% | 04-01-2022 | 06-11-2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | BDG Media, Inc | Media | L+900 | 0.25% | 13.17% | 7/18/2022 | 4/27/2023 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | CC SAG Holdings Corp. (Spectrum Automotive) | Diversified Consumer Services | L+575 | 0.75% | 10.48% | 6/29/2021 | 6/29/2028 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Composite Technology Acquisition Corp. | Building Products | L+475 | 1% | 9.73% | 04-01-2022 | 02-01-2025 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Copper River Seafoods, Inc. | Food Products | P+275 | - | 10.25 | 8/31/2022 | 4/23/2025 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | American Teleconferencing Services, Ltd. | Communications Equipment | L+650 | 1.00% | - | 9/17/2021 | 1/31/2023 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | AmeriMark Intermediate Holdings, LLC | Internet & Catalog Retail | L+800 | 1.00% | 14.77% | 7/28/2021 | 10/15/2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Apex Services Partners,LLC | Diversified Consumer Services | S+5251% | 9.8% | 8/31/2022 | 7/31/2025 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans|Atria Wealth Solutions, Inc. | Diversified Financial Services | S+600 | 1% | 10.84% | 9/14/2018 | 2/29/2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Basic Fun, Inc. | Specialty Retail | L+550 | 1% | 10.27% | 10/30/2020 | 10/30/2023 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | GSM Acquisition Corp. | Leisure Equipment & Products | S+500 | 1% | 9.03% | 04-01-2022 | 11/16/2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Higginbotham Insurance Agency, Inc. | Insurance| L+525 | 0.75% | 9.63% | 04-01-2022 | 11/25/2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | High Street Buyer, Inc. | Insurance | L+600 | 0.75% | 10.73% | 04-01-2022 | 4/16/2028 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Aegis Toxicology Sciences Corporation | Health Care Providers & Services | L+550 | 1.00% | 10.09% | 5/7/2018 | 5/9/2025 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | All State Ag Parts, LLC | Trading Companies & Distributors | S+575 | 1.00% | 10.19% | 4/1/2022 | 9/1/2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | American Teleconferencing Services, Ltd. | Communications Equipment | L+650 | 1.00% | - | 5/5/2016 | 9/9/2021 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | DeepIntent, Inc | Media | P+175 | - | 9.25 | 10-12-2022 | 3/25/2025 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Enhanced Permanent Capital, LLC | Capital Markets | L+700 | 1% | 10.13% | 12/29/2020 | 12/29/2025 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) | Trading Companies & Distributors | S+475 | 1% | 9.43% | 04-01-2022 | 12/31/2025 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Enverus Holdings, Inc. (fka Drilling Info Holdings) | ITServices | L+450 | - | 8.88 | 04-01-2022 | 7/30/2025 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Erie Construction Mid-west, LLC | Building Products | S+475 | 1% | 9.79% | 04-01-2022 | 7/30/2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Foundation Consumer Brands, LLC | Personal Products | L+550 | 1% | 10.15% | 02-12-2021 | 02-12-2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Vapotherm, Inc. | Health Care Equipment & Supplies | S+830 | 1.00% | 12.58% | 2/18/2022 | 2/1/2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Spectrum Pharmaceuticals, Inc. | Biotechnology | S+570 | 2.30% | 9.88% | 9/21/2022 | 9/1/2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Outset Medical, Inc. | Health Care Equipment & Supplies | S+515 | 2.75% | 9.33% | 11/3/2022 | 11/1/2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | OmniGuide Holdings, Inc. | Health Care Equipment & Supplies | L+1405 | 0.10% | 18.22% | 7/30/2018 | 7/1/2023 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Neuronetics, Inc. | Health Care Equipment & Supplies | L+765 | 1.66% | 11.82% | 3/2/2020 | 2/28/2025 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Meditrina, Inc. | Health Care Equipment & Supplies | S+550 | 3.45% | 9.82% | 12/20/2022 | 12/1/2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | Second Lien Bank Debt/Senior Secured Loans | RD Holdco, Inc. | Diversified Consumer Services | S+975 | 1.00% | - | 12/23/2013 | 10/12/2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | Second Lien Asset-Based Senior Secured Loans | ACRES Commercial Mortgage, LLC | S+705 | 1.00% | 11.38% | 12/24/2021 | 8/21/2028 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | World Insurance Associates, LLC | Insurance | S+575 | 1% | 9.31% | 04-01-2022 | 04-01-2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Vessco Midco Holdings, LLC | Water Utilities | L+450 | 1% | 7.87% | 04-01-2022 | 11-02-2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Ultimate Baked Goods Midco LLC (Rise Baking) | Packaged Foods & Meats | L+650 | 1% | 10.88% | 08-12-2021 | 8/13/2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Tilley Distribution, Inc. | Trading Companies & Distributors | S+550 | 1% | 10.14% | 04-01-2022 | 12/31/2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | TAUC Management, LLC | Health Care Providers & Services | L+525 | 1% | 9.98% | 04-01-2022 | 02-12-2027 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | SunMed Group Holdings, LLC | Health Care Equipment & Supplies | L+575 | 0.75% | 10.48% | 6/16/2021 | 6/16/2028 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Stryten Resources LLC | Auto Parts & Equipment | S+800 | 1% | 12.44% | 08-11-2021 | 10-12-2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | SPAR Marketing Force, Inc | Media | P+95 | - | 8.45% | 7/18/2022 | 10-10-2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Southern Orthodontic Partners Management, LLC | Health Care Providers & Services | S+600 | 1% | 10.77% | 06-03-2022 | 1/27/2026 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | SHO Holding I Corporation (Shoes for Crews) | Footwear | L+523 | 1% | 9.66% | 04-01-2022 | 4/27/2024 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | SCP Eye Care, LLC | Health Care Providers & Services | S+575 | 1% | 9.46% | 10-06-2022 | 10-05-2029 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Total First Lien Life Science Senior Secured Loans 2022-12-31 0001418076 Senior Secured Loans - 124.6% | Total First Lien Bank Debt/Senior Secured Loans 2022-12-31 0001418076 slrc:AmerimarkMember 2022-12-31 0001418076 slrc:IcimsInc.Member 2022-12-31 0001418076 slrc:VapothermInc.Member 2022-12-31 0001418076 slrc:OmniGuideHoldingsIncMember 2022-12-31 0001418076 slrc:BridgeBioPharmaIncMember 2022-12-31 0001418076 Preferred Equity 0.4% | SOINT, LLC | Aerospace & Defense | 5.00% | 06/08/2012 | 6/30/2023 2022-12-31 0001418076 Cash Equivalents 41.8% | U.S. Treasury Bill | Government | 12/30/2022 | 2/23/2023 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Spectrum Pharmaceuticals, Inc. Warrants | Biotechnology | 9/21/2022 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Vapotherm, Inc. Warrants | Health Care Equipment&Supplies | 2/18/2022 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | aTyr Pharma, Inc. Warrants | Pharmaceuticals | 11/18/2016 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | SLR Senior Lending Program LLC | Asset Management | 12/1/2022 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Senseonics Holdings, Inc.|Health Care Equipment&Supplies | 7/25/2019 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Venus Concept Ltd. Warrants(f/k/a Restoration Robotics) | Health Care Equipment&Supplies | 5/10/2018 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | SLR Healthcare ABL | Diversified Financial Services | 4/1/2022 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | SLR Business Credit | Diversified Financial Services | 4/1/2022 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | SLR Credit Solutions | Diversified Financial Services | 12/28/2012 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | RD Holdco, Inc. (Rug Doctor) | Diversified Consumer Services | 12/23/2013 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | RD Holdco, Inc. (Rug Doctor) ClassB | Diversified Consumer Services | 12/23/2013 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | RD Holdco, Inc. (Rug Doctor) WarrantsDiversified Consumer Services | 12/23/2013 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Delphinus Medical Technologies, Inc. Warrants | Health Care Equipment & Supplies | 8/18/2017 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Essence Group Holdings Corporation (Lumeris) Warrants | Health Care Technology | 3/22/2017 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Centrexion Therapeutics, Inc. Warrants | Pharmaceuticals | 6/28/2019 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Meditrina, Inc. Warrants | Health Care Equipment&Supplies | 12/20/2022 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Conventus Orthopaedics, Inc. Warrants | Health Care Equipment & Supplies | 6/15/2016 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | CardioFocus, Inc. Warrants | Health Care Equipment &Supplies | 3/31/2017 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | KBH Topco LLC (Kingsbridge) | Multi-Sector Holdings | 11/3/2020 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 2022-12-31 0001418076 Cash Equivalents 41.8% | Total Investments & Cash Equivalents 250.5% 2022-12-31 0001418076 Cash Equivalents 41.8% | Liabilities in Excess of Other Assets (150.5%) 2022-12-31 0001418076 Cash Equivalents 41.8% | Net Assets 100.0% 2022-12-31 0001418076 slrc:DiversifiedFinancialServicesMember 2022-12-31 0001418076 slrc:MultiSectorHoldingsMember 2022-12-31 0001418076 slrc:HealthCareProvidersAndServicesMember 2022-12-31 0001418076 slrc:HealthCareEquipmentAndSuppliesMember 2022-12-31 0001418076 slrc:PharmaceuticalsMember 2022-12-31 0001418076 slrc:SoftwareMember 2022-12-31 0001418076 slrc:ConstructionAndEngineeringMember 2022-12-31 0001418076 slrc:EnergyEquipmentAndServicesMember 2022-12-31 0001418076 slrc:ContainersAndPackagingMember 2022-12-31 0001418076 slrc:MachineryMember 2022-12-31 0001418076 slrc:FootwearMember 2022-12-31 0001418076 slrc:MetalsAndMiningMember 2022-12-31 0001418076 slrc:FoodAndStaplesRetailingMember 2022-12-31 0001418076 slrc:WaterUtilitiesMember 2022-12-31 0001418076 slrc:ConsumerFinanceMember 2022-12-31 0001418076 slrc:FoodProductsMember 2022-12-31 0001418076 slrc:AutoComponentsMember 2022-12-31 0001418076 slrc:AirlinesMember 2022-12-31 0001418076 slrc:HotelsRestaurantsAndLeisureMember 2022-12-31 0001418076 slrc:OilGasAndConsumableFuelsMember 2022-12-31 0001418076 slrc:AerospaceAndDefenseMember 2022-12-31 0001418076 slrc:TransportationInfrastructureMember 2022-12-31 0001418076 slrc:CommunicationsEquipmentMember 2022-12-31 0001418076 slrc:ItServicesMember 2022-12-31 0001418076 slrc:LeisureEquipmentAndProductsMember 2022-12-31 0001418076 slrc:SpecialtyRetailMember 2022-12-31 0001418076 us-gaap:AssetManagement1Member 2022-12-31 0001418076 slrc:CommercialServicesAndSuppliesMember 2022-12-31 0001418076 slrc:InternetAndCatalogRetailMember 2022-12-31 0001418076 slrc:InternetSoftwareAndServicesMember 2022-12-31 0001418076 slrc:BuildingProductsMember 2022-12-31 0001418076 slrc:TradingCompaniesAndDistributorsMember 2022-12-31 0001418076 slrc:HealthCareTechnologyMember 2022-12-31 0001418076 slrc:CapitalMarketsMember 2022-12-31 0001418076 slrc:ThriftsAndMortgageFinanceMember 2022-12-31 0001418076 slrc:LifeSciencesToolsAndServicesMember 2022-12-31 0001418076 slrc:AutoPartsAndEquipmentMember 2022-12-31 0001418076 slrc:PackagedFoodsAndMeatsMember 2022-12-31 0001418076 slrc:WirelessTelecommunicationServicesMember 2022-12-31 0001418076 slrc:InsuranceMember 2022-12-31 0001418076 slrc:BiotechnologyMember 2022-12-31 0001418076 slrc:DiversifiedConsumerServicesMember 2022-12-31 0001418076 slrc:MediaMember 2022-12-31 0001418076 slrc:RoadAndRailMember 2022-12-31 0001418076 slrc:PersonalProductsMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2023-01-01 2023-12-31 0001418076 srt:MinimumMember 2023-01-01 2023-12-31 0001418076 srt:MaximumMember 2023-01-01 2023-12-31 0001418076 slrc:AdvisoryAgreementMember srt:MaximumMember 2023-01-01 2023-12-31 0001418076 slrc:AdvisoryAgreementMember srt:MinimumMember 2023-01-01 2023-12-31 0001418076 slrc:AdvisoryAgreementMember 2023-01-01 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember 2023-01-01 2023-12-31 0001418076 slrc:EquipmentFinancingMember 2023-01-01 2023-12-31 0001418076 slrc:PreferredEquityMember 2023-01-01 2023-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-01-01 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-01-01 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2023-01-01 2023-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-01-01 2023-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2023-01-01 2023-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-01-01 2023-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputRecoverableAmountMember slrc:ValuationTechniqueRecoveryApproachMember 2023-01-01 2023-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2023-01-01 2023-12-31 0001418076 slrc:SlrBusinessCreditMember 2023-01-01 2023-12-31 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2023-01-01 2023-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2023-01-01 2023-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2023-01-01 2023-12-31 0001418076 slrc:CreditFacilityMember 2023-01-01 2023-12-31 0001418076 slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember 2023-01-01 2023-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2023-01-01 2023-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2023-01-01 2023-12-31 0001418076 slrc:SpreadOneMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:SlramiTopcoBlockerLlcMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmeriMarkIntermediateHoldingsOneLLCMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmerimarkIntermediateHoldingsLlcMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcLoanMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCOneMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLLCEquityMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2023-01-01 2023-12-31 0001418076 slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember srt:MaximumMember slrc:LondonInterbankOfferedRateMember 2023-01-01 2023-12-31 0001418076 slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember srt:MinimumMember slrc:SunsSpvLlcMember 2023-01-01 2023-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2023-01-01 2023-12-31 0001418076 us-gaap:RevolvingCreditFacilityMember slrc:SlrBusinessCreditFacilityMember 2023-01-01 2023-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2023-01-01 2023-12-31 0001418076 slrc:RisksRelatingToOurInvestmentsMember 2023-01-01 2023-12-31 0001418076 slrc:RisksRelatingToOurBusinessAndStructureMember 2023-01-01 2023-12-31 0001418076 slrc:GeneralRiskFactorsMember 2023-01-01 2023-12-31 0001418076 slrc:RisksRelatingToAnInvestmentInOurSecuritiesMember 2023-01-01 2023-12-31 0001418076 slrc:OnAOneThousandInvestmentMember 2023-01-01 2023-12-31 0001418076 Higginbotham Insurance Agency, Inc | Insurance | S+550 | 1.00% | 10.96% | 11/25/28 2023-01-01 2023-12-31 0001418076 High Street Buyer, Inc | Insurance | S+575 | 0.75% | 11.25% | 4/16/28 2023-01-01 2023-12-31 0001418076 Kaseya, Inc | Software | S+600 | 0.75% | 11.38% | 6/23/29 2023-01-01 2023-12-31 0001418076 Maxor Acquisition, Inc | Health Care Providers and Services| S+675 | 1.00% | 12.48% | 3/1/29 2023-01-01 2023-12-31 0001418076 Kid Distro Holdings, LLC | Software | S+550 | 1.00% | 11.00% | 10/1/27 2023-01-01 2023-12-31 0001418076 ONS MSO, LLC | Health Care Providers and Services | S+625 | 1.00% | 11.62% | 7/8/26 2023-01-01 2023-12-31 0001418076 Pinnacle Treatment Centers, Inc | Health Care Providers and Services | S+650 | 1.00% | 11.95% | 1/2/26 2023-01-01 2023-12-31 0001418076 Erie Construction Mid-west, LLC | Building Products | S+475 | 1.00% | 10.20% | 7/30/27 2023-01-01 2023-12-31 0001418076 RQM+ Corp | Life Sciences Tools and Services | S+575 | 1.00% | 11.36% | 8/12/26 2023-01-01 2023-12-31 0001418076 RxSense Holdings LLC | Diversified Consumer Services | S+500 | 1.00% | 10.48% | 3/13/26 2023-01-01 2023-12-31 0001418076 Plastics Management, LLC | Health Care Providers and Services | S+500 | 1.00% | 10.45% | 8/18/27 2023-01-01 2023-12-31 0001418076 CC SAG Holdings Corp | Diversified Consumer Services | S+575 | 0.75% | 11.22% | 6/29/28 2023-01-01 2023-12-31 0001418076 BayMark Health Services, Inc | Health Care Providers and Services | S+500 | 1.00% | 10.61% | 6/11/27 2023-01-01 2023-12-31 0001418076 Atria Wealth Solutions, Inc | Diversified Financial Services | S+650 | 1.00% | 11.97% | 5/31/24 2023-01-01 2023-12-31 0001418076 Apex Service Partners, LLC | Diversified Consumer Services | S+700 | 1.00% | 11.87% |10/24/30 2023-01-01 2023-12-31 0001418076 All States Ag Parts, LLC | Trading Companies and Distributors| S+600 | 1.00% | 11.61% | 9/1/26 2023-01-01 2023-12-31 0001418076 Alkeme Intermediary Holdings, LLC | Insurance| S+650 | 1.00% | 11.96% | 10/28/26 2023-01-01 2023-12-31 0001418076 Urology Management Holdings, Inc | Health Care Providers and Services | S+650 | 1.00% | 11.93% | 6/15/26 2023-01-01 2023-12-31 0001418076 United Digestive MSO Parent, LLC | Health Care Providers and Services | S+675 | 1.00% | 12.25% | 3/30/29 2023-01-01 2023-12-31 0001418076 Vessco Midco Holdings, LLC | Water Utilities | S+450 | 1.00% | 9.96% | 11/2/26 2023-01-01 2023-12-31 0001418076 Fertility (ITC) Investment Holdco, LLC | Health Care Providers and Services | S+650 | 1.00% | 11.97% | 1/3/29 2023-01-01 2023-12-31 0001418076 iCIMS, Inc | Software | S+725 | 0.75% | 12.62% | 8/18/28 2023-01-01 2023-12-31 0001418076 The Townsend Company, LLC | Commercial Services and Supplies | S+625 | 1.00% | 11.61% | 8/15/29 2023-01-01 2023-12-31 0001418076 SunMed Group Holdings, LLC | Health Care Equipment and Supplies | S+550 | 0.75% | 10.96% | 6/16/28 2023-01-01 2023-12-31 0001418076 GSM Acquisition Corp | Leisure Equipment and Products | S+500 | 1.00% | 11.13% | 10.47 2023-01-01 2023-12-31 0001418076 Foundation Consumer Brands, LLC | Personal Products | S+625 | 1.00% | 11.79% | 2/12/27 2023-01-01 2023-12-31 0001418076 West-NR Parent, Inc | Insurance | S+625 | 1.00% | 11.70% | 12/27/27 2023-01-01 2023-12-31 0001418076 CVAUSA Management, LLC | Health Care Providers and Services | S+650 | 1.00% | 11.74% | 5/22/29 2023-01-01 2023-12-31 0001418076 Aegis Toxicology Sciences Corporation | Health Care Providers and Services | S+550 | 1.00% | 11.13% | 5/9/25 2023-01-01 2023-12-31 0001418076 ENS Holdings III Corp and ES Opco USA LLC | Trading Companies and Distributors | S+475 | 10.20% | 11.13% | 12/31/25 2023-01-01 2023-12-31 0001418076 Ultimate Baked Goods Midco LLC | Packaged Foods and Meats | S+625 | 1.00% | 11.71% | 8/13/27 2023-01-01 2023-12-31 0001418076 Tilley Distribution, Inc | Trading Companies and Distributors | S+600 | 1.00% | 11.50% | 12/31/26 2023-01-01 2023-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Higginbotham Insurance Agency, Inc.| Insurance | S+550 | 1.00% | 10.96% | 4/1/2022 | 11/25/2028 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | SHO Holding I Corporation (Shoes for Crews) | Footwear | S+523 | 1.00% | 10.87% | 4/1/2022 | 4/27/2024 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | SCP Eye Care, LLC | Health Care Providers & Services | S+575 | 1.00% | 11.17% | 10/6/2022 | 10/5/2029 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | RxSense Holdings LLC | Diversified Consumer Services | S+500 | 1.00% | 10.48% | 4/1/2022 | 3/13/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | RQM+ Corp. | Life Sciences Tools & Services | S+575 | 1.00% | 11.36% | 8/20/2021 | 8/12/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Retina Midco, Inc. | Health Care Providers & Services | S+575 | 1.00% | 11.38% | 12/18/2023 | 1/31/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Plastics Management, LLC | Health Care Providers & Services | S+500 | 1.00% | 10.45% | 4/1/2022 | 8/18/2027 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Pinnacle Treatment Centers, Inc. | Health Care Providers & Services | S+650 | 1.00% | 11.86% | 1/22/2020 | 1/2/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Peter C. Foy & Associates Insurance Services, LLC | Insurance | S+600 | 0.75% | 11.47% | 4/1/2022 | 11/1/2028 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Orthopedic Care Partners Management, LLC | Health Care Providers & Services | S+650 | 1.00% | 12.11% | 8/17/2022 | 5/16/2024 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | ONS MSO, LLC | Health Care Providers & Services | S+625 | 1.00% | 11.62% | 2/10/2023 | 7/8/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | One Touch Direct, LLC. | Commercial Services & Supplies | P+75 | -| 9.25% | 12/1/2023 | 3/31/2025 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | NSPC Intermediate Corp. (National Spine) | Health Care Providers & Services | S+800 | 1.00% | 13.53% | 4/1/2022 | 2/13/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Medrina, LLC | Health Care Providers & Services | S+625 | 1.00%| 11.67% | 10/20/2023 | 10/20/2029 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Maxor Acquisition, Inc. | Health Care Providers & Services | S+675 | 1.00% | 12.48% | 3/1/2023 | 3/1/2029 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Luxury Asset Capital, LLC | Thrifts & Mortgage Finance | S+675 | 1.00% | 12.21% | 7/15/2022 | 7/15/2027 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Logix Holding Company, LLC | Communications Equipment | P+475 | 1.00% | 13.25% | 9/14/2018 | 12/22/2024 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Kingsbridge Holdings, LLC | Multi-Sector Holdings | S+700 | 1.00% | 12.52% | 12/21/2018 | 12/21/2024 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Kid Distro Holdings, LLC (Distro Kid) | Software | S+550 | 1.00% | 11.00% | 9/24/2021 | 10/1/2027 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Human Interest Inc|Internet Software & Services | S+785 | 1.00% | 13.19% | 6/30/2022 | 7/1/2027 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | iCIMS, Inc.| Software | S+725 | 0.75% | 12.10% | 8/18/2022 | 8/18/2028 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Kaseya, Inc. | Software | S+600 | 0.75% | 10.86% | 6/22/2022 | 6/23/2029 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Wind River Environmental, LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Womble Company, Inc | Energy Equipment & Services | 9.11% | 12/27/2019 | 1/1/2025 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Worldwide Flight Services, Inc | Transportation Infrastructure | 8.32-9.93% | 9/23/2022 | 9/23/2027-8/16/2028 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Zamborelli Enterprises Pacific Southern Foundation | Diversified Consumer Services | 8.91% | 12/7/2022 | 1/1/2027 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | SLR Equipment Finance Equity Interests | Multi-Sector Holdings | 7/31/2017 2023-01-01 2023-12-31 0001418076 Preferred Equity - 0.4% | SOINT LLC | Aerospace & Defense | 5.00% | 6/8/2012 | 6/30/2025 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Assertio Holdings, Inc. | Pharmaceuticals | 7/31/2023 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | aTyr Pharma, Inc. Warrants | Pharmaceuticals | 11/18/2016 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Bayside Parent, LLC | Health Care Providers&Services | 5/31/2023 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | CardioFocus, Inc. Warrants | Health Care Equipment&Supplies | 3/31/2017 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Centrexion Therapeutics, Inc. Warrants | Pharmaceuticals | 6/28/2019 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Conventus Orthopaedics, Inc. Warrants | Health Care Equipment&Supplies | 6/15/2016 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Delphinus Medical Technologies, Inc. Warrants | Health Care Equipment&Supplies | 8/18/2017 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Essence Group Holdings Corporation (Lumeris) Warrants | Health Care Technology | 3/22/2017 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | KBH Topco LLC (Kingsbridge). | Multi-Sector Holdings | 11/3/2020 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Meditrina, Inc. Warrants | Health Care Equipment&Supplies | 12/20/2022 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | NSPC Holdings, LLC (National Spine) | Health Care Providers&Services | 2/13/2023 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | RD Holdco, Inc. (Rug Doctor) | Diversified Consumer Services | 12/23/2013 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | RD Holdco, Inc. (Rug Doctor) ClassB | Diversified Consumer Services | 12/23/2013 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Senseonics Holdings, Inc. | Health Care Equipment&Supplies | 7/25/2019 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | SLR-AMI Topco Blocker, LLC | Internet &Catalog Retail | 6/16/2023 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | SLR Business Credit | Diversified Financial Services |4/1/2022 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | SLR Credit Solutions | Diversified Financial Services | 12/28/2012 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Enhanced Permanent Capital, LLC | Capital Markets | S+700 | 1.00% | 12.44% | 12/29/2020 | 12/29/2025 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | DeepIntent, Inc. | Media | P+175 | - | 10.25% | 12/1/2023 | 3/25/2025 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | CVAUSA Management, LLC | Health Care Providers & Services | S+650 | 1.00% | 11.74% | 5/22/2023 | 5/22/2029 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Crewline Buyer, Inc. | IT Services | S+675 | 1.00% | 12.10% | 11/8/2023 |11/8/2030 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt / Senior Secured Loans | Copper River Seafoods, Inc. | Food Products | P+275 | - | 11.25% | 12/1/2023 | 4/23/2025 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | CC SAG Holdings Corp. (Spectrum Automotive) | Diversified Consumer Services | S+575 | 0.75% | 11.22% | 6/29/2021 | 6/29/2028 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | BDG Media, Inc. | Media | P+525 | 5.50% | 13.75% | 7/18/2022 | 7/31/2025 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Bayside Parent, LLC | Healthcare Providers & Services | S+1000 | 1.00% | 15.50% | 5/31/2023 | 5/31/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Bayside Opco, LLC | Healthcare Providers & Services | S+725 | 1.00% | 12.75% | 5/31/2023 | 5/31/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | BayMark Health Services, Inc. | Health Care Providers & Services | S+500 | 1.00% | 10.61% | 4/1/2022 | 6/11/2027 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Basic Fun, Inc. | Specialty Retail | S+650 | 1.00% | 12.14% | 10/30/2020 | 7/2/2024 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Atria Wealth Solutions, Inc.| Diversified Financial Services | S+650 | 1.00% | 11.97% | 9/14/2018 | 5/31/2024 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | All States Ag Parts, LLC | Trading Companies & Distributors | S+600 | 1.00% | 11.61% | 4/1/2022 | 9/1/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Alkeme Intermediary Holdings, LLC | Insurance | S+650 | 1.00 % | 11.96 % | 9/20/2023 |10/28/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Aegis Toxicology Sciences Corporation | Health Care Providers & Services | S+550 | 1.00% | 11.13% | 5/7/2018 | 5/9/2025 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Accession Risk Management Group, Inc. (f/k/a RSC Acquisition, Inc.)| Insurance | S+550 | 0.75% | 11.00% | 4/1/2022 | 11/1/2029 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | GSM Acquisition Corp. | Leisure Equipment & Products | S+500 | 1.00% | 10.47% | 4/1/2022 | 11/16/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Foundation Consumer Brands, LLC | Personal Products | S+625 | 1.00% | 11.79% | 2/12/2021 | 2/12/2027 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Fertility (ITC) Investment Holdco, LLC | Health Care Providers & Services | S+650 | 1.00% | 11.97% | 1/4/2023 | 1/3/2029 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Exactcare Parent, Inc. | Health Care Providers & Services | S+650 | 1.00% | 11.89% | 11/3/2023 | 11/5/2029 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) | Trading Companies & Distributors | S+475 | 1.00% | 10.20% | 4/1/2022 | 12/31/2025 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Waste Pro of Florida, Inc. & Waste Pro USA, Inc | Commercial Services & Supplies | 9.17% | 4/18/2023 | 4/18/2028 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Smiley Lifting Solutions, LLC | Commercial Services & Supplies | 7.82-8.61% | 6/30/2022 | 9/15/2026-6/27/2030 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | ST Coaches, LLC | Road & Rail | 8.50% | 7/31/2017 | 1/25/2025 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Star Coaches Inc | Road & Rail | 8.42% | 3/9/2018 | 4/1/2025 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Superior Transportation, Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | The Smedley Company & Smedley Services, Inc | Commercial Services & Supplies | 4.07% | 7/31/2017 | 1/15/2028 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Trinity Equipment, Inc | Commercial Services & Supplies | 8.78-8.93% | 5/4/2023 | 5/4/2028-5/19/2028 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Trinity Equipment Rentals, Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | U.S. Crane & Rigging, LLC | Commercial Services & Supplies | 8.73%-10.92% | 12/23/2022 | 3/1/2027-9/1/2028 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Up Trucking Services, LLC | Road & Rail | 11.21% | 3/23/2018 | 8/1/2024 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Rutt Services, LLC | Commercial Services & Supplies | 8.95% | 8/11/2023 | 8/11/2030 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Signet Marine Corporation | Transportation Infrastructure | 8.50% | 10/31/2022 | 11/1/2029 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Double S Industrial Contractors, Inc | Commercial Services & Supplies | 8.60% | 7/28/2023 | 8/1/2027 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Dongwon Autopart Technology Inc | Auto Components | 7.96% | 2/2/2021 |1/1/2026 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Complete Equipment Rentals, LLC | Commercial Services & Supplies | 6.75-7.15% | 3/23/2023 | 4/1/2028-6/1/2028 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Clubcorp Holdings, Inc | Hotels, Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | CKD Holdings, Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Carolinas Contracting, LLC | Diversified Consumer Services | 8.40-8.72% | 3/7/2023 | 3/7/2028-5/18/2028 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Capital City Jet Center, Inc | Airlines | 10.00% | 4/4/2018 | 6/22/2026 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Lux Vending, LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 7/20/2024-10/1/2024 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Miranda Logistics Enterprise, Inc | Construction & Engineering | 7.69% | 4/14/2023 | 4/14/2028 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Mountain Air Helicopters Inc | Commercial Services & Supplies | 10.00% | 7/31/2017 | 2/28/2025 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Nimble Crane LLC | Commercial Services & Supplies | 9.18% | 7/13/2023 | 7/13/2028 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | No Limit Construction Services, LLC | Commercial Services & Supplies | 7.73% | 5/5/2023 | 6/1/2028 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Ozzies, Inc | Commercial Services & Supplies | 10.72% | 12/23/2022 | 1/1/2027 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | PCX Aerostructures LLC | Aerospace & Defense | 9.32% | 11/23/2022 | 12/1/2028 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Rane Light Metal Castings Inc | Machinery | 10.00% | 6/1/2020 | 6/1/2024 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Rango, Inc | Commercial Services & Supplies | 9.33% | 9/24/2019 | 11/1/2024 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Rayzors Edge LLC | Diversified Consumer Services | 7.69-8.27% | 5/19/2023 | 5/18/2030-6/30/2030 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | RH Land Construction, LLC & Harbor Dredging LA, Inc | Construction & Engineering | 8.08% | 5/10/2023 | 5/10/2026 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Royal Express Inc | Road & Rail | 9.53% | 1/17/2019 | 2/1/2024 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Rotten Rock Hardscaping & Tree Service | Diversified Consumer Services | 8.21% | 12/6/2022 | 12/6/2027 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | SLR Equipment Finance | Multi-Sector Holdings | 8.50% | 1/24/2022 | 1/27/2024 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Lux Credit Consultants, LLC | Road & Rail | 8.28-12.09 % | 6/17/2021 | 12/1/2024-12/1/2026 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Loc Performance Products, LLC | Machinery | 10.50% | 12/29/2022 | 6/1/2027 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Kool Pak, LLC | Road & Rail | 8.58% | 2/5/2018 | 3/1/2024 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | International Automotive Components Group, North America, Inc | Auto Components | 7.95% | 6/23/2021 | 6/23/2025 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Hawkeye Contracting Company, LLC | Construction & Engineering | 10.50% | 10/8/2021 | 11/1/2025 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | GMT Corporation | Machinery | 10.71% | 10/23/2018 | 1/1/2026 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Georgia Jet, Inc | Airlines | 8.00% | 12/4/2017 | 1/4/2024 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | First National Capital, LLC | Diversified Financial Services | 9.00% | 11/5/2021 | 8/1/2026 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | First American Commercial Bancorp, Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Extreme Steel Crane & Rigging, LLC | Commercial Services & Supplies | 9.52% | 3/3/2023 | 3/3/2027 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Equipment Operating Leases, LLC | Multi-Sector Holdings | 8.37% | 4/27/2018 | 4/27/2025 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Environmental Protection & Improvement Company, LLC | Road & Rail | 8.25% | 9/30/2020 | 10/1/2027 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Energy Drilling Services, LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Drillers Choice, Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | WCI-BXC Purchaser, LLC | Distributors | S+625 | 1.00% | 11.64% | 11/6/2023 | 11/6/2030 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | West-NR Parent, Inc. | Insurance | S+625 | 1.00% | 11.70% | 8/1/2023 | 12/27/2027 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | Second Lien Asset-Based Senior Secured Loans | AMF Levered II, LLC | Diversified Financial Services | S+705 | 1.00% | 12.52% | 12/24/2021 | 8/21/2028 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | Second Lien Asset-Based Senior Secured Loans | FGI Worldwide LLC | Diversified Financial Services | S+650 | 1.00% | 11.86% | 4/17/2023 | 4/17/2028 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | Second Lien Bank Debt/Senior Secured Loans | RD Holdco, Inc. | Diversified Consumer Services | S+975 | 1.00% | - | 12/23/2013 | 10/12/2026 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Boart Longyear Company | Metals & Mining | 8.31-10.44% | 5/28/2020 | 7/1/2024-10/7/2026 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Bazzini, LLC | Food & Staples Retailing |10.46% |12/23/2022 |1/1/2028 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | AmeraMex International, Inc | Commercial Services & Supplies |10.00% | 3/29/2019 | 4/15/2025 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Air Methods Corporation | Airlines | 7.08-7.13% | 11/3/2021 | 11/3/2026-11/23/2026 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | AFG Dallas III, LLC | Diversified Consumer Services | 10.00-11.29% | 8/11/2022 | 8/11/2026-3/1/2027 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Vertos Medical, Inc. | Health Care Equipment & Supplies | S+515 | 4.75% | 10.50% | 6/14/2023 | 7/1/2028 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Ultimate Baked Goods Midco LLC (Rise Baking) | Packaged Foods & Meats | S+625 | 1.00% | 10.96% | 8/12/2021 | 8/13/2027 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | United Digestive MSO Parent, LLC | Health Care Providers & Services | S+675 | 1.00% | 12.25% | 3/30/2023 | 3/30/2029 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Vapotherm, Inc.Health Care Equipment & Supplies | S+930 | 1.00% | 14.75% | 2/18/2022 | 2/1/2027 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | SunMed Group Holdings, LLC | Health Care Equipment & Supplies | S+550 | 0.75% | 10.96% | 6/16/2021 | 6/16/2028 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Stryten Resources LLC | Auto Parts and Equipment | S+800 | 1.00% | 13.47% | 8/11/2021 | 10/12/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | SPAR Marketing Force, Inc | Media | P+190 | - | 10.40% | 12/1/2023 | 10/10/2024 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Southern Orthodontic Partners Management, LLC | Health Care Providers & Services | S+625 | 1.00% | 11.72% | 6/3/2022 | 1/27/2026 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | C-Port/Stone LLC | Oil, Gas & Consumable Fuels | 8.54% | 10/7/2022 | 11/1/2027 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.0% | Bowman Energy Solutions, LLC | Commercial Services & Supplies | 7.42% | 7/1/2022 | 8/1/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Urology Management Holdings, Inc | Health Care Providers & Services | S+6 | 1.00% | 11.93% | 2/7/2023 | 6/15/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | UVP Management, LLC | Health Care Providers & Services | S+625 | 1.00% | 11.75% | 9/18/2023 | 9/15/2025 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Vessco Midco Holdings, LLC | Water Utilities | P+350 | 1.00% | 12.00% | 4/1/2022 | 11/2/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | Tilley Distribution, Inc. | Trading Companies & Distributors | S+600 | 1.00% | 11.50% | 4/1/2022 | 12/31/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | The Townsend Company, LLC | Commercial Services & Supplies | S+625 | 1.00% | 11.61% | 8/17/2023 | 8/15/2029 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Bank Debt/Senior Secured Loans | TAUC Management, LLC | Health Care Providers & Services | P+450 | 1.00% | 13.00% | 4/1/2022| 2/12/2027 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Cerapedics, Inc. | iotechnology | S+620 | 2.75% | 11.55% | 12/27/2022 | 1/1/2028 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Glooko, Inc. | Health Care Technology | S+790 | 0.10% | 13.35% | 9/30/2021 | 10/1/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Meditrina, Inc. | Health Care Equipment & Supplies | S+550 | 3.45% | 10.85% | 12/20/2022 | 12/1/2027 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Neuronetics, Inc. | Health Care Equipment & Supplies | S+565 | 3.95% | 11.00% | 3/2/2020 | 3/29/2028 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | OmniGuide Holdings, Inc. | Health Care Equipment & Supplies | S+580 | 5.31% | 11.25% | 7/30/2018 | 11/1/2025 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Outset Medical, Inc. | Health Care Equipment & Supplies | S+515 | 2.75% | 10.50% | 11/3/2022 | 11/1/2027 2023-01-01 2023-12-31 0001418076 Equipment Financing - 26.0% | A&A Crane and Rigging, LLC | Commercial Services & Supplies | 7.78% | 3/27/2023 | 3/27/2028 2023-01-01 2023-12-31 0001418076 Equipment Financing 26.6% | Aero Operating LLC | Commercial Services & Supplies | 8.47-9.64% | 2/12/2021 | 3/1/2025-12/1/2026 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Alimera Sciences, Inc. | Pharmaceuticals | S+515 | 4.60% | 10.50% | 12/31/2019 | 5/1/2028 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Arcutis Biotherapeutics, Inc. | Pharamceuticals | S+745 | 0.10% | 12.90% | 12/22/2021 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | Ardelyx, Inc. | Pharmaceuticals | S+795 | 1.00% | 13.32% | 2/23/2022 | 3/1/2027 2023-01-01 2023-12-31 0001418076 Senior Secured Loans - 129.5% | First Lien Life Science Senior Secured Loans | BridgeBio Pharma, Inc. | Biotechnology | - | - | 9.00% | 11/17/2021 | 11/17/2026 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Vertos Medical, Inc. Warrants | Health Care Equipment&Supplies | 6/14/2023 2023-01-01 2023-12-31 0001418076 Cash Equivalents - 33.7% | U.S. Treasury Bill | Government | 12/29/2023 | 2/27/2024 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | SLR Healthcare ABL | Diversified Financial Services | 04/01/2022 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | SLR Senior Lending Program LLC | Asset Management | 12/01/2022 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Vapotherm, Inc. Warrants | Health Care Equipment&Supplies | 2/18/2022 2023-01-01 2023-12-31 0001418076 Common Equity/Equity Interests/Warrants-62.5% | Venus Concept Ltd. Warrants (f/k/a Restoration Robotics) | Health Care Equipment&Supplies | 05/10/2018 2023-01-01 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2022-01-01 2022-12-31 0001418076 slrc:AdvisoryAgreementMember 2022-01-01 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-01-01 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingMember 2022-01-01 2022-12-31 0001418076 slrc:PreferredEquityMember 2022-01-01 2022-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-01-01 2022-12-31 0001418076 slrc:PreferredEquityMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-01-01 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputReturnOnEquityMember us-gaap:MarketApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 slrc:EquipmentFinancingMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputComparableMultipleMember slrc:ValuationApproachMarketMultipleMember 2022-01-01 2022-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember us-gaap:FairValueInputsLevel3Member slrc:MeasurementInputMarketYieldMember us-gaap:IncomeApproachValuationTechniqueMember 2022-01-01 2022-12-31 0001418076 slrc:SlrBusinessCreditMember 2022-01-01 2022-12-31 0001418076 slrc:SharesIssuedInConnectionWithTheMergersMember 2022-01-01 2022-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2022-01-01 2022-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2022-01-01 2022-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2022-01-01 2022-12-31 0001418076 slrc:SpreadOneMember 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Mountain Air Helicopters, Inc | Commercial Services & Supplies | 10.00% | 7/31/2017 | 2/28/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Lux Vending, LLC | Consumer Finance | 12.46-13.26% | 8/20/2021 | 8/20/2024-10/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | SLR Equipment Finance Equity Interests | Multi-Sector Holdings | 7/31/2017 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Zamborelli Enterprises Pacific Southern Foundation | Diversified Consumer Services | 8.91% | 12/7/2022 | 1/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Worldwide Flight Services, Inc | Transportation Infrastructure | 8.32-9.36% | 9/23/2022 | 9/23/2027-10/28/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Womble Company, Inc | Energy Equipment & Services | 9.11% | 12/27/2019 | 1/1/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Royal Express Inc | Road & Rail | 9.53% | 1/17/2019 | 2/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Royal Coach Lines, Inc | Road & Rail | 9.56% | 11/21/2019 | 8/1/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Rango, Inc | Commercial Services & Supplies | 9.33-9.79% | 9/24/2019 | 4/1/2023-11/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Rane Light Metal Castings Inc | Machinery | 10.00% | 6/1/2020 | 6/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | PCX Aerostructures LLC | Aerospace & Defense | 9.32% | 11/23/2022 | 12/1/2028 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Ozzies, Inc | Commercial Services & Supplies | 10.72% | 12/23/2022 | 1/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Star Coaches Inc | Road & Rail | 8.42% | 3/9/2018 | 4/1/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | ST Coaches, LLC | Road & Rail | 8.47-8.58% | 7/31/2017 | 7/1/2023-1/25/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Smiley Lifting Solutions, LLC | Commercial Services & Supplies | 7.82-8.28% | 6/30/2022 | 9/15/2026-12/29/2029 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | SLR Equipment Finance | Multi-Sector Holdings | 8.50% | 1/24/2022 | 1/24/2023 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Signet Marine Corporation | Transportation Infrastructure | 8.50% | 10/31/2022 | 7/1/2029 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Rotten Rock Hardscaping & Tree Service | Diversified Consumer Services | 8.21% | 12/6/2022 | 12/6/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | U.S. Crane & Rigging, LLC | Commercial Services & Supplies | 10.92% |12/23/2022 | 3/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Trinity Equipment Rentals, Inc | Commercial Services & Supplies | 7.94-8.75% | 10/8/2021 | 11/1/2024-12/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | The Smedley Company & Smedley Services, Inc | Commercial Services & Supplies | 4.07% | 7/31/2017 | 1/15/2028 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Superior Transportation, Inc | Road & Rail | 10.22-10.63% | 7/31/2017 | 1/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Wind River Environmental, LLC | Diversified Consumer Services | 8.43-10.00% | 7/31/2019 | 8/1/2024-10/5/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Up Trucking Services, LLC | Road & Rail | 11.21% | 3/23/2018 | 8/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | AFG Dallas III, LLC | Diversified Consumer Services | 10.00-11.29% | 8/11/2022 | 8/11/2026-3/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% | Aero Operating LLC | Commercial Services & Supplies | 8.47-9.64% | 2/12/2021 | 3/1/2025-12/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Lux Credit Consultants, LLC | Road & Rail | 8.28-12.09 % | 6/17/2021 | 12/1/2024-12/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Loyer Capital LLC | Multi-Sector Holdings | 8.73-11.52% | 5/16/2019 | 5/16/2024-9/25/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Loc Performance Products, LLC | Machinery | 10.50% | 12/29/2022 | 6/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Kool Pak, LLC | Road & Rail | 8.58% | 2/5/2018 | 3/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | International Automotive Components Group, North America, Inc | Auto Components | 7.95% | 6/23/2021 | 6/23/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | HTI Logistics Corporation | Commercial Services & Supplies | 9.69-9.94% | 11/15/2018 | 5/1/2024-9/1/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Hawkeye Contracting Company, LLC | Construction & Engineering | 10.50% | 10/8/2021 | 11/1/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | GMT Corporation | Machinery | 10.71% | 10/23/2018 | 1/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Georgia Jet, Inc | Airlines | 8.00% | 12/4/2017 | 1/4/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% | Garda CL Technical Services, Inc. | Commercial Services&Supplies | 8.30-8.77% | 3/22/2018 | 6/5/2023-10/5/2023 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% | Freightsol LLC | Road&Rail | 12.51-12.89% | 4/9/2019 | 11/1/2023 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | First National Capital, LLC | Diversified Financial Services | 9.00% | 11/5/2021 | 8/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | First American Commercial Bancorp, Inc | Diversified Financial Services | 7.50-9.02% | 10/28/2021 | 10/1/2026-3/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Equipment Operating Leases, LLC | Multi-Sector Holdings | 8.37% | 4/27/2018 | 4/27/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Environmental Protection & Improvement Company, LLC | Road & Rail | 8.25% | 9/30/2020 | 10/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Energy Drilling Services, LLC | Diversified Consumer Services | 6.58-9.16% | 8/26/2022 | 11/9/2025-9/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% | EasyPak, LLC | Containers&Packaging | 0.0901 | 1/6/2021 | 1/1/2024 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Drillers Choice, Inc | Commercial Services & Supplies | 8.00-10.08% | 10/31/2022 | 11/1/2027-6/1/2029 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Dongwon Autopart Technology Inc | Auto Components | 7.96% | 2/2/2021 |1/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Clubcorp Holdings, Inc | Hotels, Restaurants & Leisure | 9.36-13.01% | 5/27/2021 | 4/1/2025-5/1/2028 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | CKD Holdings, Inc | Road & Rail | 8.10-8.60% | 9/22/2022 | 6/22/2026-9/22/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.6% | Champion Air, LLC | Airlines | 0.1 | 3/19/2018 | 1/1/2023 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Capital City Jet Center, Inc | Airlines | 10.00% | 4/4/2018 | 6/22/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | C-Port/Stone LLC | Oil, Gas & Consumable Fuels | 8.54% | 10/7/2022 | 11/1/2027 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Bowman Energy Solutions, LLC | Commercial Services & Supplies | 7.42% | 7/1/2022 | 8/1/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Boart Longyear Company | Metals & Mining | 8.31-10.44% | 5/28/2020 | 7/1/2024-10/7/2026 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Bazzini, LLC | Food & Staples Retailing |10.46% |12/23/2022 |1/1/2028 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | AmeraMex International, Inc | Commercial Services & Supplies |10.00% | 3/29/2019 | 4/15/2025 2022-01-01 2022-12-31 0001418076 Equipment Financing 26.0% | Air Methods Corporation | Airlines | 7.08-7.13% | 11/3/2021 | 11/3/2026-11/23/2026 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | KBH Topco LLC (Kingsbridge) | Multi-Sector Holdings | 11/3/2020 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | aTyr Pharma, Inc. Warrants | Pharmaceuticals | 11/18/2016 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Vapotherm, Inc. Warrants | Health Care Equipment&Supplies | 2/18/2022 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Venus Concept Ltd. Warrants(f/k/a Restoration Robotics) | Health Care Equipment&Supplies | 5/10/2018 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | SLR Senior Lending Program LLC | Asset Management | 12/1/2022 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | SLR Business Credit | Diversified Financial Services | 4/1/2022 2022-01-01 2022-12-31 0001418076 Cash Equivalents 41.8% | U.S. Treasury Bill | Government | 12/30/2022 | 2/23/2023 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | RD Holdco, Inc. (Rug Doctor) WarrantsDiversified Consumer Services | 12/23/2013 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | RD Holdco, Inc. (Rug Doctor) ClassB | Diversified Consumer Services | 12/23/2013 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | SLR Healthcare ABL | Diversified Financial Services | 4/1/2022 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | SLR Credit Solutions | Diversified Financial Services | 12/28/2012 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | CardioFocus, Inc. Warrants | Health Care Equipment &Supplies | 3/31/2017 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Delphinus Medical Technologies, Inc. Warrants | Health Care Equipment & Supplies | 8/18/2017 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Centrexion Therapeutics, Inc. Warrants | Pharmaceuticals | 6/28/2019 2022-01-01 2022-12-31 0001418076 Preferred Equity 0.4% | SOINT, LLC | Aerospace & Defense | 5.00% | 06/08/2012 | 6/30/2023 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | RD Holdco, Inc. (Rug Doctor) | Diversified Consumer Services | 12/23/2013 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Conventus Orthopaedics, Inc. Warrants | Health Care Equipment & Supplies | 6/15/2016 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Meditrina, Inc. Warrants | Health Care Equipment&Supplies | 12/20/2022 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Essence Group Holdings Corporation (Lumeris) Warrants | Health Care Technology | 3/22/2017 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Senseonics Holdings, Inc.|Health Care Equipment&Supplies | 7/25/2019 2022-01-01 2022-12-31 0001418076 Common Equity/Equity Interests/Warrants 57.1% | Spectrum Pharmaceuticals, Inc. Warrants | Biotechnology | 9/21/2022 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | SCP Eye Care, LLC | Health Care Providers & Services | S+575 | 1% | 9.46% | 10-06-2022 | 10-05-2029 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | SPAR Marketing Force, Inc | Media | P+95 | - | 8.45% | 7/18/2022 | 10-10-2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Stryten Resources LLC | Auto Parts & Equipment | S+800 | 1% | 12.44% | 08-11-2021 | 10-12-2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | SunMed Group Holdings, LLC | Health Care Equipment & Supplies | L+575 | 0.75% | 10.48% | 6/16/2021 | 6/16/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | TAUC Management, LLC | Health Care Providers & Services | L+525 | 1% | 9.98% | 04-01-2022 | 02-12-2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Tilley Distribution, Inc. | Trading Companies & Distributors | S+550 | 1% | 10.14% | 04-01-2022 | 12/31/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Ultimate Baked Goods Midco LLC (Rise Baking) | Packaged Foods & Meats | L+650 | 1% | 10.88% | 08-12-2021 | 8/13/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Vessco Midco Holdings, LLC | Water Utilities | L+450 | 1% | 7.87% | 04-01-2022 | 11-02-2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | World Insurance Associates, LLC | Insurance | S+575 | 1% | 9.31% | 04-01-2022 | 04-01-2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | Second Lien Asset-Based Senior Secured Loans | ACRES Commercial Mortgage, LLC | S+705 | 1.00% | 11.38% | 12/24/2021 | 8/21/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | Second Lien Bank Debt/Senior Secured Loans | RD Holdco, Inc. | Diversified Consumer Services | S+975 | 1.00% | - | 12/23/2013 | 10/12/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | SHO Holding I Corporation (Shoes for Crews) | Footwear | L+523 | 1% | 9.66% | 04-01-2022 | 4/27/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Southern Orthodontic Partners Management, LLC | Health Care Providers & Services | S+600 | 1% | 10.77% | 06-03-2022 | 1/27/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Alimera Sciences, Inc. | Pharmaceuticals | L+765 | 1.78% | 11.82% | 12/31/2019 | 7/1/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Apeel Technology, Inc. | Biotechnology | S+625 | 1.00% | 8.75% | 6/29/2022 | 6/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Arcutis Biotherapeutics, Inc. | Pharamceuticals | L+745 | 0.10% | 11.62% | 12/22/2021 | 1/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Ardelyx, Inc. | Pharmaceuticals | L+795 | 0.10% | 12.12% | 2/23/2022 | 3/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | BridgeBio Pharma, Inc. | Biotechnology | - | - | 9.00% | 11/17/2021 | 11/17/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Centrexion Therapeutics, Inc. | Pharmaceuticals | L+725 | 2.45% | 11.42% | 6/28/2019 | 1/1/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Cerapedics, Inc. | Biotechnology | S+620 | 2.75% | 10.52% | 12/27/2022 | 1/1/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Glooko, Inc. | Health Care Technology | L+790 | 0.10% | 12.07% | 9/30/2021 | 10/1/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Meditrina, Inc. | Health Care Equipment & Supplies | S+550 | 3.45% | 9.82% | 12/20/2022 | 12/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Neuronetics, Inc. | Health Care Equipment & Supplies | L+765 | 1.66% | 11.82% | 3/2/2020 | 2/28/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | OmniGuide Holdings, Inc. | Health Care Equipment & Supplies | L+1405 | 0.10% | 18.22% | 7/30/2018 | 7/1/2023 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Outset Medical, Inc. | Health Care Equipment & Supplies | S+515 | 2.75% | 9.33% | 11/3/2022 | 11/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Spectrum Pharmaceuticals, Inc. | Biotechnology | S+570 | 2.30% | 9.88% | 9/21/2022 | 9/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Life Science Senior Secured Loans | Vapotherm, Inc. | Health Care Equipment & Supplies | S+830 | 1.00% | 12.58% | 2/18/2022 | 2/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Foundation Consumer Brands, LLC | Personal Products | L+550 | 1% | 10.15% | 02-12-2021 | 02-12-2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | GSM Acquisition Corp. | Leisure Equipment & Products | S+500 | 1% | 9.03% | 04-01-2022 | 11/16/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Higginbotham Insurance Agency, Inc. | Insurance| L+525 | 0.75% | 9.63% | 04-01-2022 | 11/25/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | High Street Buyer, Inc. | Insurance | L+600 | 0.75% | 10.73% | 04-01-2022 | 4/16/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Aegis Toxicology Sciences Corporation | Health Care Providers & Services | L+550 | 1.00% | 10.09% | 5/7/2018 | 5/9/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | All State Ag Parts, LLC | Trading Companies & Distributors | S+575 | 1.00% | 10.19% | 4/1/2022 | 9/1/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Copper River Seafoods, Inc. | Food Products | P+275 | - | 10.25 | 8/31/2022 | 4/23/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | DeepIntent, Inc | Media | P+175 | - | 9.25 | 10-12-2022 | 3/25/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Enhanced Permanent Capital, LLC | Capital Markets | L+700 | 1% | 10.13% | 12/29/2020 | 12/29/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | ENS Holdings III Corp. & ES Opco USA LLC (Bluefin) | Trading Companies & Distributors | S+475 | 1% | 9.43% | 04-01-2022 | 12/31/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Enverus Holdings, Inc. (fka Drilling Info Holdings) | ITServices | L+450 | - | 8.88 | 04-01-2022 | 7/30/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Erie Construction Mid-west, LLC | Building Products | S+475 | 1% | 9.79% | 04-01-2022 | 7/30/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans|Atria Wealth Solutions, Inc. | Diversified Financial Services | S+600 | 1% | 10.84% | 9/14/2018 | 2/29/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Basic Fun, Inc. | Specialty Retail | L+550 | 1% | 10.27% | 10/30/2020 | 10/30/2023 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | BayMark Health Services,Inc. | Health Care Providers & Services | L+500 | 1% | 9.73% | 04-01-2022 | 06-11-2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | BDG Media, Inc | Media | L+900 | 0.25% | 13.17% | 7/18/2022 | 4/27/2023 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | CC SAG Holdings Corp. (Spectrum Automotive) | Diversified Consumer Services | L+575 | 0.75% | 10.48% | 6/29/2021 | 6/29/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Composite Technology Acquisition Corp. | Building Products | L+475 | 1% | 9.73% | 04-01-2022 | 02-01-2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | American Teleconferencing Services, Ltd. | Communications Equipment | L+650 | 1.00% | - | 5/5/2016 | 9/9/2021 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | American Teleconferencing Services, Ltd. | Communications Equipment | L+650 | 1.00% | - | 9/17/2021 | 1/31/2023 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | AmeriMark Intermediate Holdings, LLC | Internet & Catalog Retail | L+800 | 1.00% | 14.77% | 7/28/2021 | 10/15/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Apex Services Partners,LLC | Diversified Consumer Services | S+5251% | 9.8% | 8/31/2022 | 7/31/2025 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Pediatric Home Respiratory Services, LLC | Health Care Providers & Services | S+625 | 1% | 10.67% | 8/19/2022 | 12/04/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Peter C. Foy & Associates Insurance Services, LLC | Insurance | S+600 | 0.75% | 10.44% | 04-01-2022 | 11-01-2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | PhyNet Dermatology LLC | Health Care Providers & Services | S+625 | 1% | 9.81% | 09/05/2018 | 8/16/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Pinnacle Treatment Centers, Inc. | Health Care Providers & Services | S+650 | 1% | 10.57% | 1/22/2020 | 1/2/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Plastics Management, LLC | Health Care Providers & Services | S+500 | 1% | 9.89% | 4/1/2022 | 8/18/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | PPT Management Holdings, LLC | Health Care Providers & Services| L+850 | 1% | 12.83% | 9/14/2018 | 1/30/2023 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Human Interest Inc | Internet Software & Services | S+785 | 1% | 11.97% | 6/30/2022 | 07-01-2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | iCIMS, Inc. | Software | S+725 | 0.75% | 11.52% | 8/18/2022 | 8/18/2028 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Ivy Fertility Services, LLC | Health Care Providers & Services | L+625 | 1% | 10.39% | 12/22/2021 | 2/25/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Kaseya, Inc. | Software | S+575 | 0.75% | 10.33% | 6/22/2022 | 6/23/2029 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Kid Distro Holdings, LLC (Distro Kid) | Software | L+575 | 1% | 10.48% | 9/24/2021 | 10/1/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Kingsbridge Holdings, LLC | Multi-Sector Holdings| L+700 |1% |10.75% | 12/21/2018 | 12/21/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | KORE Wireless Group, Inc. | Wireless Telecommunication Services | S+550 | - | 10.08% | 12/21/2018 | 12/21/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Logix Holding Company, LLC | Communications Equipment | L+575 | 1% | 10.13% | 9/14/2018 | 12/22/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Luxury Asset Capital, LLC | Thrifts & Mortgage Finance | S+675 | 1% | 10.99% | 7/15/2022 | 7/15/2027 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Maurices, Incorporated | Specialty Retail | S+675 | 1% | 8.74% | 8/27/2021 | 06-01-2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Montefiore Nyack Hospital | Health Care Providers & Services | L+495 | - | 9.72% | 08-09-2022 | 11/15/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | NAC Holdings Corporation (Jaguar) | Insurance | S+525 | 1% | 9.45% | 7/30/2021 | 9/28/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | National Spine and Pain Centers, LLC | Health Care Providers & Services | L+500 | 1% | 7.31% | 04-01-2022 | 06-02-2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | One Touch Direct, LLC | Commercial Services & Supplies | P+75 | - | 8.25% | 04-03-2020 | 3/30/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | Orthopedic Care Partners Management, LLC | Health Care Providers & Services | S+650 | 1% | 10.91% | 8/17/2022 | 5/16/2024 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | RQM+ Corp. | Life Sciences Tools & Services | S+575 | 1% | 10.97% | 8/20/2021 | 8/12/2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | RSC Acquisition, Inc. | Insurance | S+550 | 0.75% | 9.26% | 04-01-2022 | 11-01-2026 2022-01-01 2022-12-31 0001418076 Senior Secured Loans - 124.6% | First Lien Bank Debt/Senior Secured Loans | RxSense Holdings LLC | Diversified Consumer Services | L+500 | 1% | 9.41% | 04-01-2022 | 3/13/2026 2022-01-01 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageAndLessThanTwentyFivePercentageOwnedMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesLessThanFivePercentageOwnedMember 2021-01-01 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-01-01 2021-12-31 0001418076 slrc:AdvisoryAgreementMember 2021-01-01 2021-12-31 0001418076 slrc:SlrBusinessCreditMember 2021-01-01 2021-12-31 0001418076 slrc:KingsbridgeHoldingsLlcMember 2021-01-01 2021-12-31 0001418076 slrc:SlrHealthcareAblCreditMember 2021-01-01 2021-12-31 0001418076 slrc:SlrEquipmentFinanceMember 2021-01-01 2021-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember 2021-01-01 2021-12-31 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 2010-02-10 0001418076 us-gaap:IPOMember 2010-02-10 2010-02-10 0001418076 us-gaap:OverAllotmentOptionMember 2010-02-10 0001418076 us-gaap:PrivatePlacementMember 2010-02-10 0001418076 slrc:SunsCompanyMergerMember us-gaap:CommonStockMember 2022-04-01 2022-04-01 0001418076 slrc:CreditFacilityOneMember 2022-04-01 0001418076 slrc:SunsCompanyMergerMember us-gaap:CommonStockMember 2022-04-01 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TermLoansMember 2021-12-31 0001418076 slrc:NefpassFacilityMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2021-12-31 0001418076 slrc:CreditFacilityMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 2021-12-31 0001418076 slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember srt:MinimumMember slrc:SunsSpvLlcMember 2011-08-26 0001418076 slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember srt:MaximumMember slrc:SunsSpvLlcMember 2011-08-26 0001418076 slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember srt:MinimumMember slrc:SecuredOvernightFinancingRateMember 2011-08-26 2011-12-31 0001418076 slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember srt:MaximumMember slrc:SecuredOvernightFinancingRateMember 2011-08-26 2011-12-31 0001418076 slrc:CitiBankNaMember slrc:TermLoanMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember 2021-12-28 0001418076 slrc:CitiBankNaMember us-gaap:LineOfCreditMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember 2021-12-28 0001418076 slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember slrc:SunsSpvLlcMember 2021-12-28 0001418076 slrc:AmendmentAgreementToIncreaseCreditFacilityMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember slrc:SunsSpvLlcMember 2021-12-28 0001418076 slrc:CreditFacilityCommitmentExpiredMember slrc:CitiBankNaMember us-gaap:LineOfCreditMember slrc:SunsSpvLlcMember 2021-12-28 0001418076 slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember srt:MaximumMember slrc:SunsSpvLlcMember 2021-12-28 2021-12-31 0001418076 slrc:CitiBankNaMember slrc:TermLoanAndCreditFacilityMember srt:MinimumMember slrc:SunsSpvLlcMember 2021-12-28 2021-12-31 0001418076 slrc:SlrBusinessCreditFacilityMember slrc:CrystalFinancialMember 2012-11-30 2012-11-30 0001418076 slrc:SlrBusinessCreditFacilityMember slrc:CrystalFinancialMember 2012-12-28 2012-12-28 0001418076 slrc:SlrBusinessCreditFacilityMember slrc:CrystalFinancialMember 2012-12-28 0001418076 us-gaap:RevolvingCreditFacilityMember 2012-12-28 0001418076 slrc:SlrBusinessCreditFacilityMember 2016-07-28 2016-07-28 0001418076 slrc:SlrBusinessCreditFacilityMember slrc:CrystalCapitalFinancialHoldingsLlcMember 2016-07-28 0001418076 slrc:SlrBusinessCreditFacilityMember slrc:CrystalFinancialMember 2016-07-28 0001418076 slrc:SlrEquipmentFinanceMember 2017-07-31 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 2019-09-30 0001418076 slrc:SlrEquipmentFinanceMember 2019-09-30 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 2020-11-03 0001418076 srt:MaximumMember slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 srt:MinimumMember slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:KingsbridgeHoldingsLlcMember 2020-11-03 0001418076 slrc:SlrHealthcareAblMember 2013-09-30 0001418076 slrc:NorthMillCapitalLlcMember 2017-10-20 0001418076 slrc:EspSscCorporationMember 2017-10-20 0001418076 slrc:EspSscCorporationMember 2018-05-01 0001418076 slrc:NorthMillCapitalLlcMember 2018-05-01 0001418076 slrc:SummitFinancialResourcesMember 2019-06-28 0001418076 slrc:NmHoldcoMember 2019-06-28 0001418076 slrc:NmcsCreditFacilityMember 2019-06-28 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 2021-06-03 0001418076 slrc:SunsMember 2021-06-03 0001418076 slrc:NmcsCreditFacilityMember 2021-06-03 0001418076 slrc:FastPayPartnersLlcMember 2021-06-03 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember 2022-10-12 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember srt:ManagementMember 2022-10-12 0001418076 slrc:SlrSeniorLendingProgramLlcMember slrc:UnfundedDebtAndEquityCommitmentsMember us-gaap:InvestorMember 2022-10-12 0001418076 slrc:NmcSeniorCreditFacilityMember 2022-12-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramLlcMember slrc:SlrSeniorLendingProgramSpvLlcMember 2022-12-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramLlcMember slrc:SlrSeniorLendingProgramSpvLlcMember 2022-12-12 2022-12-12 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramLlcMember slrc:SlrSeniorLendingProgramSpvLlcMember us-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember 2022-12-12 2022-12-12 0001418076 Atria Wealth Solutions, Inc | Diversified Financial Services |S+600 | 1.00% | 10.84% | 2/29/24 2022-12-01 2022-12-31 0001418076 ENS Holdings III Corp and ES Opco USA LLC | Trading Companies and Distributors |L+475 | 1.00% | 9.43% |12/31/25 2022-12-01 2022-12-31 0001418076 BayMark Health Services, Inc | Health Care Providers and Services | L+500 | 1.00% | 9.73% | 6/11/27 2022-12-01 2022-12-31 0001418076 Foundation Consumer Brands, LLC | Personal Products |L+550 | 1.00% | 10.15% | 2/12/27 2022-12-01 2022-12-31 0001418076 Ivy Fertility Services, LLC | Health Care Providers and Services | L+625 | 1.00% | 10.39% | 2/25/26 2022-12-01 2022-12-31 0001418076 Kid Distro Holdings, LLC | Software |L+575 | 1.00% | 10.48% | 10/1/27 2022-12-01 2022-12-31 0001418076 High Street Buyer, Inc | Insurance | L+600 | 0.75% | 10.73% | 4/16/28 2022-12-01 2022-12-31 0001418076 slrc:SlrSeniorLendingProgramLlcMember 2022-12-01 2022-12-31 0001418076 us-gaap:SubsequentEventMember slrc:BoardMember 2024-02-27 0001418076 slrc:SlrEquipmentFinanceMember 2023-08-24 0001418076 slrc:SlrEquipmentFinanceMember 2023-08-24 2023-08-24 0001418076 slrc:CrystalFinancialMember 2012-11-30 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2016-01-01 2016-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2015-01-01 2015-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2014-01-01 2014-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2013-01-01 2013-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2020-12-31 0001418076 slrc:TermLoansMember 2020-12-31 0001418076 slrc:NefpassFacilityMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2020-12-31 0001418076 slrc:CreditFacilityMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2020-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2019-12-31 0001418076 slrc:TermLoansMember 2019-12-31 0001418076 slrc:NefpassFacilityMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2019-12-31 0001418076 slrc:SslpFacilityMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-12-31 0001418076 slrc:CreditFacilityMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2018-12-31 0001418076 slrc:TermLoansMember 2018-12-31 0001418076 slrc:NefpassFacilityMember 2018-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2018-12-31 0001418076 slrc:SslpFacilityMember 2018-12-31 0001418076 slrc:CreditFacilityMember 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2018-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2017-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2017-12-31 0001418076 slrc:SeniorSecuredNotesMember 2017-12-31 0001418076 slrc:TermLoansMember 2017-12-31 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-12-31 0001418076 slrc:CreditFacilityMember 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2017-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2016-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2016-12-31 0001418076 slrc:SeniorSecuredNotesMember 2016-12-31 0001418076 slrc:TermLoansMember 2016-12-31 0001418076 slrc:CreditFacilityMember 2016-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2015-12-31 0001418076 slrc:SeniorSecuredNotesMember 2015-12-31 0001418076 slrc:TermLoansMember 2015-12-31 0001418076 slrc:CreditFacilityMember 2015-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2014-12-31 0001418076 slrc:SeniorSecuredNotesMember 2014-12-31 0001418076 slrc:TermLoansMember 2014-12-31 0001418076 slrc:CreditFacilityMember 2014-12-31 0001418076 slrc:TwoThousandAndFortyTwoUnsecuredNotesMember 2013-12-31 0001418076 slrc:SeniorSecuredNotesMember 2013-12-31 0001418076 slrc:TermLoansMember 2013-12-31 0001418076 slrc:CreditFacilityMember 2013-12-31 0001418076 slrc:TwoThousandAndTwentySevenSeriesFUnsecuredNotesMember 2022-01-06 0001418076 slrc:TwoThousandAndTwentySevenUnsecuredNotesMember 2021-09-14 0001418076 slrc:TwoThousandAndTwentyFourUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentySixUnsecuredNotesMember 2019-12-18 0001418076 slrc:TwoThousandAndTwentyThreeUnsecuredNotesMember 2017-11-22 0001418076 slrc:TwoThousandAndTwentyTwoTrancheCNotesMember 2019-12-18 2019-12-18 0001418076 slrc:SeniorSecuredRevolvingCreditFacilityMember slrc:SlrSeniorLendingProgramLlcMember slrc:SlrSeniorLendingProgramSpvLlcMember 2023-10-20 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2022-12-31 0001418076 slrc:EquipmentFinancingMember 2022-12-31 0001418076 slrc:PreferredEquityMember 2022-12-31 0001418076 us-gaap:EquitySecuritiesMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLLCEquityMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcLoanMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCOneMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:SlramiTopcoBlockerLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmerimarkIntermediateHoldingsLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmeriMarkIntermediateHoldingsOneLLCMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2022-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLlcLoanMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCOneMember 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideOpcoLLCMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:SlramiTopcoBlockerLlcMember 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:BaysideParentLLCEquityMember 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmeriMarkIntermediateHoldingsOneLLCMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2023-12-31 0001418076 slrc:CompaniesMoreThanFivePercentageLessThanTwentyFivePercentageOwnedMember slrc:AmerimarkIntermediateHoldingsLlcMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2023-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2023-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2023-12-31 0001418076 us-gaap:EquitySecuritiesMember 2023-12-31 0001418076 slrc:PreferredEquityMember 2023-12-31 0001418076 slrc:EquipmentFinancingMember 2023-12-31 0001418076 slrc:PreferredEquityMember 2021-12-31 0001418076 slrc:EquipmentFinancingMember 2021-12-31 0001418076 slrc:InvestmentInSeniorSecuredLoansMember 2021-12-31 0001418076 us-gaap:EquitySecuritiesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2021-12-31 0001418076 slrc:TwoThousandAndTwentyTwoUnsecuredNotesMember 2022-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SointLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrSeniorLendingProgramLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncCommonEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceDebtMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KingsbridgeHoldingsLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:KbhTopcoLlcKingsbridgeMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:LoyerCapitalLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrEquipmentFinanceEquityMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrHealthcareAblMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrCreditSolutionsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SlrBusinessCreditMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:EquipmentOperatingLeasesLlcMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncClassBMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncWarrantsMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:RdHoldcoIncDebtMember 2021-12-31 0001418076 slrc:CompaniesMoreThanTwentyFivePercentageOwnedMember slrc:SoaggLlcMember 2022-12-31 iso4217:USD xbrli:shares utr:Day xbrli:pure utr:Year iso4217:USD xbrli:shares slrc:issuers slrc:loans slrc:fund slrc:Customers
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
FORM
10-K
 
 
 
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023
OR
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM        TO
COMMISSION
FILE NUMBER:
814-00754
 
 
SLR INVESTMENT CORP.
(Exact name of registrant as specified in its charter)
 
 
 
Maryland
 
26-1381340
(State of Incorporation)
 
(I.R.S. Employer
Identification Number)
500 Park Avenue
New York,
N.Y
.
 
10022
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code:
(212993-1670
Securities registered pursuant to Section 12(b) of the Act:
 
Title of Each Class
 
Trading Symbol
 
Name of Each Exchange on Which Registered
Common Stock, par value $0.01 per share
 
SLRC
 
The NASDAQ Global Select Market
Securities registered pursuant to Section 12(g) of the Act: None
 
 
Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☒ No ☐
Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐ No ☒
Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer      Accelerated filer  
Non-accelerated filer      Smaller Reporting Company  
Emerging growth company       
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐    
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. Yes  No ☐
If securities are registered pursuant to Section 12(b) of the Exchange Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. 
Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to
§240.10D-1(b). ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Act) Yes ☐ No 
The aggregate market value of common stock held by
non-affiliates
of the Registrant on June 30, 2023 based on the closing price on that date of $14.27 on the NASDAQ Global Select Market was approximately $716.5 million. For the purposes of calculating this amount only, all directors and executive officers of the Registrant have been treated as affiliates. There were 54,554,634 shares of the Registrant’s common stock outstanding as of February 23,
2024.
 
Auditor Firm Id: 185
 
Auditor Name: KPMG LLP
 
Auditor Location: New York, NY
 
 
 

SLR INVESTMENT CORP.
FORM
10-K
FOR THE FISCAL YEAR ENDED DECEMBER 31, 2023
TABLE OF CONTENTS
 
        
Page
 
   
PART I
      
Item 1.
       1  
Item 1A.
       31  
Item 1B.
       71  
Item 1C.
       72  
Item 2.
       73  
Item 3.
       73  
Item 4.
       73  
   
PART II
      
Item 5.
       74  
Item 6.
       79  
Item 7.
       79  
Item 7A.
       104  
Item 8.
       106  
Item 9.
       163  
Item 9A.
       163  
Item 9B.
       163  
Item 9C.
       163  
   
PART III
      
Item 10.
       164  
Item 11.
       169  
Item 12.
       171  
Item 13.
       173  
Item 14.
       176  
   
PART IV
      
Item 15.
       178  
Item 16.
       182  
       183  

PART I
 
Item 1.
Business
SLR Investment Corp. (the “Company”, “SLRC”, “we” or “our”), a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
In February 2010, we completed our initial public offering and a concurrent private offering of shares to our senior management team.
We invest primarily in privately held U.S. middle-market companies, where we believe the supply of primary capital is limited and the investment opportunities are most attractive. Our investment objective is to generate both current income and capital appreciation through debt and equity investments. We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. We define “middle market” to refer to companies with annual revenues typically between $50 million and $1 billion. From time to time, we may also invest directly in the debt and equity of public companies that are thinly traded and such investments will not be limited to any minimum or maximum market capitalization. In addition, we may invest in foreign markets, including emerging markets. Our business is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. Our investments generally range between $5 million and $100 million each, although we expect that this investment size will vary proportionately with the size of our capital base and/or with strategic initiatives.
In addition, we may invest a portion of our portfolio in other types of investments, which we refer to as opportunistic investments, which are not our primary focus but are intended to enhance our overall returns. These investments may include, but are not limited to, direct investments in public companies that are not thinly traded and securities of leveraged companies located in select countries outside of the United States. The securities that we invest in are typically rated below investment grade. Securities rated below investment grade are often referred to as “leveraged loans,” “high yield” or “junk” securities, and may be considered “high risk” compared to debt instruments that are rated investment grade. In addition, some of our debt investments will not fully amortize during their lifetime, which means that a borrower may be unable to payoff its debt due to bankruptcy or other reasons and therefore we may
write-off
such debt investment prior to its scheduled maturity. Upon such an occurrence, we may realize a loss or a substantial amount of unpaid principal and interest due upon maturity.
Our investment activities are managed by SLR Capital Partners, LLC (“SLR Capital Partners” or the “Investment Adviser”) and supervised by our board of directors (the “Board” or “board of directors”), a majority of whom are
non-interested,
as such term is defined in section 2(a)(19) of the 1940 Act. SLR Capital Management, LLC (“SLR Capital Management”) provides the administrative services necessary for us to operate.
On April 1, 2022, we acquired SLR Senior Investment Corp., a Maryland corporation (“SUNS”), pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of December 1, 2021, by and among us, SUNS, Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, the Investment Adviser. Pursuant to the Merger Agreement, Merger Sub merged with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger”) and, immediately thereafter, SUNS merged with and into us,
 
1

with us continuing as the surviving company (together with the Merger, the “Mergers”). In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of our common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the Mergers, we issued an aggregate of 12,511,825 shares of our common stock to former SUNS stockholders.
As of December 31, 2023, our investment portfolio totaled $2.2 billion and our net asset value was $986.6 million. Our portfolio was comprised of debt and equity investments in 151 portfolio companies.
SLR Capital Partners
SLR Capital Partners, our investment adviser, is controlled and led by Michael S. Gross, our Chairman and
Co-Chief
Executive Officer, and Bruce Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer. They are supported by a team of investment professionals. SLR Capital Partners’ investment team has extensive experience in leveraged lending and private equity, as well as significant contacts with financial sponsors.
In addition, SLR Capital Partners currently serves as investment adviser to private funds and managed accounts as well as to SCP Private Credit Income BDC LLC, an unlisted BDC that primarily invests in first lien loans to upper middle market private leveraged companies, SLR HC BDC LLC, an unlisted BDC that primarily invests in first lien healthcare cash flow loans and life science loans, and SLR Private Credit BDC II LLC, an unlisted BDC focused on first lien senior secured floating rate loans. As of February 23, 2024, Mr. Gross and Mr. Spohler beneficially owned, either directly or indirectly, approximately 8.0% of our outstanding common stock.
Mr. Gross has over 30 years of experience in the private equity, distressed debt and mezzanine (i.e., actually or structurally subordinated) lending businesses and has been involved in originating, structuring, negotiating, consummating and managing private equity, distressed debt and mezzanine lending transactions. Prior to his current role as our Chairman,
Co-Chief
Executive Officer and President, Mr. Gross founded Apollo Investment Corporation, a publicly traded BDC. He served as its chairman from February 2004 to July 2006 and its chief executive officer from February 2004 to February 2006. Under his management, Apollo Investment Corporation raised approximately $930 million in gross proceeds in an initial public offering in April 2004, built a dedicated investment team and infrastructure and invested approximately $2.3 billion in over 65 companies in conjunction with 50 different private equity sponsors. Mr. Gross is also a founder and a former senior partner of Apollo Global Management, a leading private equity firm. During his tenure at Apollo Global Management, Mr. Gross was a member of the investment committee that was responsible for overseeing more than $13 billion of investments in over 150 companies.
Mr. Gross also has served on the boards of directors of more than 20 public and private companies. As a result, Mr. Gross has developed an extensive network of private equity sponsor relationships as well as relationships with management teams of public and private companies, investment bankers, attorneys and accountants that we believe should provide us with significant business opportunities.
We also rely on the over 30 years of experience of Mr. Spohler, who has served as our Chief Operating Officer and a partner of SLR Capital Partners since its inception and as
Co-Chief
Executive Officer since June 2019. Previously, Mr. Spohler was a managing director and a former
co-head
of U.S. Leveraged Finance for CIBC World Markets. He held numerous senior roles at CIBC World Markets, including serving on the U.S. Management Committee, Global Executive Committee and the Deals Committee, which approves all of CIBC World Markets’ U.S. corporate finance debt capital decisions. During Mr. Spohler’s tenure, he was responsible for senior loan, high yield and mezzanine origination and execution, as well as CIBC World Markets’ below investment grade loan portfolio in the United States. As a
co-head
of U.S. Leveraged Finance, Mr. Spohler oversaw over 300 capital raising and merger and acquisition transactions, comprising over $40 billion in market capitalization.
 
2

SLR Capital Partners’ senior investment professionals have been active participants in the primary and secondary leveraged credit markets throughout their careers. They have effectively managed portfolios of senior secured, distressed and mezzanine debt as well as other investment types. The depth of their prior experience and credit market experience has led them through various stages of the economic cycle as well as several market disruptions.
SLR Capital Management
Pursuant to an administration agreement (the “Administration Agreement”), SLR Capital Management furnishes us with office facilities, equipment and clerical, bookkeeping and record keeping services at such facilities. Under the Administration Agreement, SLR Capital Management also performs, or oversees the performance of, our required administrative services, which include, among other things, being responsible for the financial records which we are required to maintain and preparing reports to our stockholders. In addition, SLR Capital Management assists us in determining and publishing our net asset value, oversees the preparation and filing of our tax returns and the printing and dissemination of reports to our stockholders, and generally oversees the payment of our expenses and the performance of administrative and professional services rendered to us by others. SLR Capital Management also provides managerial assistance, if any, on our behalf to those portfolio companies that request such assistance.
License Agreement
We have entered into a license agreement with SLR Capital Partners pursuant to which SLR Capital Partners has agreed to grant us a
non-exclusive,
royalty-free license to use the name “SLR” and “SOLAR”. Under this agreement, we have a right to use the SLR and SOLAR name for so long as the Third Amended and Restated Investment Advisory and Management Agreement (the “Advisory Agreement”) with our investment adviser is in effect. Other than with respect to this limited license, we will have no legal right to the “SLR” or “SOLAR” name.
Market Opportunity
The Company invests directly and indirectly in leveraged middle-market companies, including in senior secured loans, and to a lesser extent, unsecured loans and equity securities. We believe that the size of this market, coupled with leveraged companies’ need for flexible sources of capital at attractive terms and rates, creates an attractive investment environment for us.
 
   
Middle-market companies continue to face increasing difficulty in accessing the capital markets.
While many middle-market companies were formerly able to raise funds by issuing high-yield bonds, we believe this approach to financing has become more difficult in recent years as institutional investors have sought to invest in larger, more liquid offerings. In addition, many private finance companies that historically financed their lending and investing activities through securitization transactions have lost that source of funding and reduced lending significantly. Moreover, consolidation of lenders and market participants and the illiquid nature of investments have resulted in fewer middle-market lenders and market participants.
 
   
There is a large pool of uninvested private equity capital likely to seek additional capital to support their investments.
We believe there is more than $500 billion of uninvested private equity capital seeking debt financing to support acquisitions.
 
   
The significant amount of debt maturing through 2025 should provide additional demand for capital.
A high volume of financings are expected to mature over the next few years. We believe that this supply of prospective lending opportunities coupled with a lack of available credit in the middle-market lending space may offer attractive risk-adjusted returns to investors. Risk-adjusted return compares returns against the amount of risk incurred. The term “risk-adjusted return” does not imply that an investment is no risk or low risk.
 
3

   
Investing in private middle-market debt provides an attractive risk reward profile.
In general, terms for illiquid, middle-market subordinated debt have been more attractive than those for larger corporations which are typically more liquid. We believe this is because fewer institutions are able to invest in illiquid asset classes.
Therefore, we believe that there is an attractive opportunity to invest in leveraged middle-market companies, including in senior secured loans, unitranche loans and to a lesser extent, unsecured loans and equity securities, and that we are well positioned to serve this market.
Competitive Advantages and Strategy
We believe that we have the following competitive advantages over other providers of financing to leveraged companies.
Management Experience
As managing partner, Mr. Gross has principal management responsibility for SLR Capital Partners, to which he currently dedicates substantially all of his time. Mr. Gross has over 30 years of experience in leveraged finance, private equity and distressed debt investing. Mr. Spohler, our
Co-Chief
Executive Officer, Chief Operating Officer and a partner of SLR Capital Partners, has over 30 years of experience in evaluating and executing leveraged finance transactions.
Investment Capacity
The proceeds from our public offerings and the Concurrent Private Placement, the borrowing capacities under the senior secured credit facility led by Citibank, N.A. (the “Credit Facility”) and the SUNS SPV LLC senior secured credit facility (the “SPV Credit Facility”), our $125 million of unsecured notes due 2024 (the “2024 Unsecured Notes”), our $85 million of unsecured notes due 2025 (the “2025 Unsecured Notes”), our $75 million of unsecured notes due 2026 (the “2026 Unsecured Notes”), our $50 million of unsecured senior notes due 2027 (the “2027 Unsecured Notes”), our $135 million of unsecured notes due 2027 (the “2027 Series F Unsecured Notes”), the available capital at our significant subsidiaries and the expected repayments of existing portfolio company investments provide us with a substantial amount of capital available for deployment into new investment opportunities. We believe we are well positioned for the current marketplace.
The Company’s Leverage
As of December 31, 2023, we had total outstanding borrowings of approximately $1.2 billion. Under the provisions of the 1940 Act, we are permitted to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 150% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. As of December 31, 2023, our asset coverage ratio was 183.4%. We believe our relatively low level of leverage provides us with a competitive advantage as proceeds from our investments are available for reinvestment as opposed to being consumed by debt repayment. We may increase our relative level of debt in the future. However, we do not currently anticipate operating with a substantial amount of debt relative to our total assets.
Proprietary Sourcing and Origination
We believe that SLR Capital Partners’ senior investment professionals’ longstanding relationships with financial sponsors, commercial and investment banks, management teams and other financial intermediaries provide us with a strong pipeline of proprietary origination opportunities. We expect to continue leveraging the relationships Mr. Gross established while sourcing and originating investments at Apollo Investment Corporation as well as the financial sponsor relationships Mr. Spohler developed while he was a
co-head
of CIBC World Markets’ U.S. Leveraged Finance Group.
 
4

Versatile Transaction Structuring and Flexibility of Capital
We believe SLR Capital Partners’ senior investment team’s broad experience and ability to draw upon its extensive experience enable us to identify, assess and structure investments successfully across all levels of a company’s capital structure and to manage potential risk and return at all stages of the economic cycle. The attempt to manage risk does not imply low risk or no risk. While we are subject to significant regulation as a BDC, we are not subject to many of the regulatory limitations that govern traditional lending institutions such as banks. As a result, we believe that we can be more flexible than such lending institutions in selecting and structuring investments, adjusting investment criteria, transaction structures and, in some cases, the types of securities in which we invest.
Emphasis on Achieving Strong Risk-Adjusted Returns
SLR Capital Partners uses a structured investment and risk management process that emphasizes research and analysis. SLR Capital Partners seeks to build our portfolio on a
“bottom-up”
basis, choosing and sizing individual positions based on their relative risk/reward profiles as a function of the associated downside risk, volatility, correlation with the existing portfolio and liquidity. At the same time, SLR Capital Partners takes into consideration a variety of factors in managing our portfolio and imposes portfolio-based risk constraints promoting a more diverse portfolio of investments and limiting issuer and industry concentration. We do not pursue short-term origination targets. We believe this approach enables us to build an attractive investment portfolio that meets our return and value criteria over the long term. We believe it is critical to conduct extensive due diligence on investment targets. In evaluating new investments we, through SLR Capital Partners, conduct a rigorous due diligence process.
Dedication of Resources to Industries with Substantial Information Flow
We dedicate our investing resources to industries characterized by strong cash flow and in which SLR Capital Partners’ investment professionals have deep investment experience. As a result of their investment experience, Messrs. Gross and Spohler, together with SLR Capital Partners’ other senior investment professionals, have long-term relationships with management consultants and management teams in the industries we target, as well as substantial information concerning those industries.
Longer Investment Horizon
Unlike private equity and venture capital funds, we will not be subject to standard periodic capital return requirements. Such requirements typically stipulate that the capital of these funds, together with any capital gains on such invested funds, can only be invested once and must be returned to investors after a
pre-agreed
time period. We believe that our flexibility to make investments with a long-term view and without the capital return requirements of traditional private investment vehicles provides us with the opportunity to generate favorable returns relative to the risks of our invested capital and enables us to be a better long-term partner for our portfolio companies.
Investments
The Company seeks to create a diverse portfolio that includes senior secured loans, and to a lesser extent unsecured loans and equity securities by investing approximately $5 million to $100 million of capital, on average, in the securities of leveraged companies, including middle-market companies. We expect that this investment size will vary with the size of our capital base and/or for strategic initiatives. Structurally, unsecured loans usually rank subordinate in priority of payment to senior debt, such as senior bank debt. As such, other creditors may rank senior to us in the event of insolvency. However, unsecured loans rank senior to common and preferred equity in a borrower’s capital structure. Due to its higher risk profile and often less restrictive covenants as compared to senior loans, unsecured loans generally earn a higher return than senior secured loans.
 
5

In addition to senior secured loans and unsecured loans, we may invest a portion of our portfolio in opportunistic investments, which are not our primary focus, but are intended to enhance our returns to our investors. These investments may include direct investments in public companies that are not thinly traded and securities of leveraged companies located in select countries outside of the United States. The securities that we invest in are typically rated below investment grade. Securities rated below investment grade are speculative and are often referred to as “leveraged loans,” “high yield” or “junk” securities, and may be considered “high risk” compared to debt instruments that are rated investment grade. In addition, some of our debt investments will not fully amortize during their lifetime, which means that a borrower may be unable to payoff its debt due to bankruptcy or other reasons and therefore we may
write-off
such debt investment prior to its scheduled maturity. Upon such an occurrence, we may realize a loss or a substantial amount of unpaid principal and interest due upon maturity. We may invest up to 30% of our total assets in such opportunistic investments, including loans issued by
non-U.S.
issuers, subject to compliance with our regulatory obligations as a BDC under the 1940 Act.
We have and will continue to borrow funds to make investments. As a result, we will be exposed to the risks of leverage, which may be considered a speculative investment technique. The use of leverage magnifies the potential for loss on amounts invested and therefore increases the risks associated with investing in our securities. In addition, the costs associated with our borrowings, including any increase in management fees payable to our investment adviser, SLR Capital Partners, will be borne by our common stockholders.
Moreover, we may acquire investments in the secondary market and, in analyzing such investments, we will seek to employ a substantially similar analytical process as we use for our primary investments.
We may utilize instruments such as forward contracts, currency options and interest rate swaps, caps, collars and floors to seek to hedge against fluctuations in the relative values of our portfolio positions from changes in currency exchange rates and market interest rates. Hedging against a decline in the values of our portfolio positions does not eliminate the possibility of fluctuations in the values of such positions or prevent losses if the values of such positions decline. However, such hedging can establish other positions designed to gain from those same developments, thereby offsetting the decline in the value of such portfolio positions. Such hedging transactions may also limit the opportunity for gain if the values of the underlying portfolio positions should increase. It may not be possible to hedge against an exchange rate or interest rate fluctuation that is so generally anticipated that we are not able to enter into a hedging transaction at an acceptable price. Moreover, for a variety of reasons, we may not seek to establish a perfect correlation between such hedging instruments and the portfolio holdings being hedged. Any such imperfect correlation may prevent us from achieving the intended hedge and expose us to risk of loss. In addition, it may not be possible to hedge fully or perfectly against currency fluctuations affecting the value of securities denominated in
non-U.S.
currencies because the value of those securities is likely to fluctuate as a result of factors not related to currency fluctuations.
Our principal focus is to provide senior secured loans to leveraged companies in a variety of industries. We generally seek to target companies that generate positive cash flows and/or have substantial assets that secure our loans. We generally seek to invest in companies from the broad variety of industries in which our investment adviser has direct experience.
The following is a representative list of the industries in which we may invest:
 
•  Aerospace & Defense
  
•  Household & Personal Products
•  Air Freight & Logistics
  
•  Industrial Conglomerates
•  Airlines
  
•  Insurance
•  Asset Management
  
•  Internet & Catalog Retail
•  Automobiles
  
•  Internet Software & Services
•  Auto Components
  
•  IT Services
 
6

•  Auto Parts & Equipment
  
•  Leisure Equipment & Products
•  Biotechnology
  
•  Life Sciences Tools & Services
•  Building Products
  
•  Machinery
•  Capital Markets
  
•  Media
•  Chemicals
  
•  Metals & Mining
•  Commercial Services & Supplies
  
•  Multiline Retail
•  Communications Equipment
  
•  Multi-Sector Holdings
•  Construction & Engineering
  
•  Oil, Gas & Consumable Fuels
•  Consumer Finance
  
•  Packaged Foods & Meats
•  Containers & Packaging
  
•  Paper & Forest Products
•  Distributors
  
•  Personal Products
•  Diversified Consumer Services
  
•  Pharmaceuticals
•  Diversified Financial Services
  
•  Professional Services
•  Diversified Real Estate Activities
  
•  Research & Consulting Services
•  Diversified Telecommunications Services
  
•  Road & Rail
•  Education Services
  
•  Software
•  Energy Equipment & Services
  
•  Specialty Retail
•  Food Products
  
•  Textiles, Apparel & Luxury Goods
•  Food & Staples Retailing
  
•  Thrifts & Mortgage Finance
•  Footwear
  
•  Trading Companies & Distributors
•  Health Care Equipment & Supplies
  
•  Transportation Infrastructure
•  Health Care Facilities
  
•  Water Utilities
•  Health Care Providers & Services
  
•  Wireless Telecommunications Services
•  Health Care Technology
  
•  Hotels, Restaurants & Leisure
  
We may also invest in other industries if we are presented with attractive opportunities.
We may invest, to the extent permitted by law, in the securities and instruments of other investment companies, including private funds. We may also participate in negotiated
co-investment
transactions with certain affiliates, each of whose investment adviser is SLR Capital Partners, or an investment adviser controlling, controlled by or under common control with SLR Capital Partners and is registered as an investment adviser under the Investment Advisers Act of 1940, as amended (the “Advisers Act”), in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions of the most recent exemptive order obtained from the Securities and Exchange Commission (the “SEC”) on June 13, 2017 (the “Exemptive Order”). Pursuant to the Exemptive Order, we are permitted
to co-invest with
our affiliates if a “required majority” (as defined in Section 57(o) of the 1940 Act) of our independent directors make certain conclusions in connection with
a co-investment transaction,
including, but not limited to, that (1) the terms of the
potential co-investment transaction,
including the consideration to be paid, are reasonable and fair to us and our stockholders and do not involve overreaching in
 
7

respect of us or our stockholders on the part of any person concerned, and (2) the potential co-investment transaction is consistent with the interests of our stockholders and is consistent with our then-current investment objective and strategies.
At December 31, 2023, our portfolio consisted of 151 portfolio companies and was invested 32.5% in cash flow senior secured loans, 27.8% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 23.0% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 16.7% in life science senior secured loans, in each case, measured at fair value. We expect that our portfolio will continue to include primarily senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. In addition, we also expect to invest a portion of our portfolio in opportunistic investments, which are not our primary focus, but are intended to enhance our risk-adjusted returns to stockholders. These investments may include, but are not limited to, securities of public companies and debt and equity securities of companies located outside of the United States.
While our primary investment objective is to maximize current income and capital appreciation through investments in U.S. senior and subordinated loans, other debt securities and equity, we may also invest a portion of the portfolio in opportunistic investments, including foreign securities.
Listed below are our top ten portfolio companies and industries based on their fair value and represented as a percentage of total assets as of December 31, 2023 and December 31, 2022:
TOP TEN PORTFOLIO COMPANIES AND INDUSTRIES AS OF DECEMBER 31, 2023
 
Portfolio Company
  
% of

Total Assets
 
SLR Credit Solutions*
     11.3
Kingsbridge Holdings, LLC*
     9.4
SLR Equipment Finance*
     4.9
SLR Business Credit*
     3.6
Arcutis Biotherapeutics, Inc.
     2.7
Outset Medical, Inc.
     1.8
SLR Senior Lending Program LLC*
     1.7
Enhanced Capital Group, LLC
     1.7
BridgeBio Pharma, Inc.
     1.6
Vapotherm, Inc.
     1.5
 
*
Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment.
 
Industry
  
% of

Total Assets
 
Diversified Financial Services
     18.7
Multi-Sector Holdings
     14.8
Health Care Providers & Services
     11.2
Health Care Equipment & Supplies
     6.5
Pharmaceuticals
     4.9
Biotechnology
     3.1
Software
     3.0
Insurance
     2.5
Diversified Consumer Services
     1.9
Commercial Services & Supplies
     1.9
 
8

TOP TEN PORTFOLIO COMPANIES AND INDUSTRIES AS OF DECEMBER 31, 2022
 
Portfolio Company
  
% of

Total Assets
 
SLR Credit Solutions*
     11.4
Kingsbridge Holdings, LLC*
     9.0
SLR Equipment Finance*
     5.0
SLR Business Credit*
     3.5
Arcutis Biotherapeutics, Inc.
     2.7
BridgeBio Pharma, Inc.
     1.6
Foundation Consumer Brands, LLC
     1.4
Enhanced Capital Group, LLC
     1.4
Outset Medical, Inc.
     1.4
Vapotherm, Inc.
     1.4
 
*
Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment.
 
Industry
  
% of

Total Assets
 
Diversified Financial Services
     18.2
Multi-Sector Holdings
     14.4
Health Care Providers & Services
     6.4
Health Care Equipment & Supplies
     5.4
Pharmaceuticals
     4.5
Software
     3.6
Insurance
     3.5
Biotechnology
     3.2
Diversified Consumer Services
     2.2
Media
     1.6
Set forth below is a brief description of each portfolio company in which we have made an investment that represents 5% or greater of our total assets as of December 31, 2023.
SLR Credit Solutions
We invested in SLR Credit as an independent commercial finance company that provides primarily senior secured loans for both asset-based and cash flow financings to middle-market companies. Its team of experienced, responsive professionals has underwritten, closed and managed more than $20 billion in secured debt commitments across a wide range of industries. As of December 31, 2023, SLR Credit had 31 funded commitments to 26 different issuers with total funded loans of approximately $406.6 million on total assets of $438.4 million. SLR Credit’s competitors include other specialty finance companies and small banks. As with most finance companies, SLR Credit is exposed to interest rate risk, which it mostly mitigates by issuing loans with floating rates.
Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of KBH through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216.6 million to effect the transaction, of which $136.6 million was invested to acquire 87.5% of KBHT’s equity and $80.0 million in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Post the
 
9

transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity. As of December 31, 2023, KBHT had total assets of $857.3 million.
Investment Selection Process
SLR Capital Partners is committed to and utilizes a value-oriented investment philosophy with a focus on the preservation of capital and a commitment to managing downside exposure.
Portfolio Company Characteristics.
We have identified several criteria that we believe are important in identifying and investing in prospective portfolio companies. These criteria provide general guidelines for our investment decisions; however, not all of these criteria will be met by each prospective portfolio company in which we choose to invest.
Stable Earnings and Strong Free Cash Flow.
 
We seek to invest in companies that have demonstrated stable earnings through economic cycles. We target companies that can
de-lever
through consistent generation of cash flows rather than relying solely on growth to service and repay our loans.
Value Orientation.
Our investment philosophy places a premium on fundamental analysis from an investor’s perspective and has a distinct value orientation. We focus on companies in which we can invest at relatively low multiples of operating cash flow and that are profitable at the time of investment on an operating cash flow basis.
Value of Assets.
The prospective value of the assets, if any, that collateralize the loans in which we invest, is an important factor in our credit analysis. Our analysis emphasizes both tangible assets, such as accounts receivable, inventory, equipment and real estate, and intangible assets, such as intellectual property, customer lists, networks and databases. In some of our transactions, the company’s fundings may be derived from a borrowing base determined by the value of the company’s assets.
Strong Competitive Position in Industry.
We seek to invest in target companies that have developed leading market positions within their respective markets and are well positioned to capitalize on growth opportunities. We seek companies that demonstrate significant competitive advantages versus their competitors, which we believe should help to protect their market position and profitability.
Diversified Customer and Supplier Base.
We seek to invest in businesses that have a diversified customer and supplier base. We believe that companies with a diversified customer and supplier base are generally better able to endure economic downturns, industry consolidation, changing business preferences and other factors that may negatively impact their customers, suppliers and competitors.
Exit Strategy.
We predominantly invest in companies that provide multiple alternatives for an eventual exit. We look for opportunities that provide an exit typically within three years of the initial capital commitment.
We generally seek companies that we believe will have or provide a steady stream of cash flow to repay our loans and reinvest in their respective businesses. We believe that such internally generated cash flow, leading to the payment of our interest, and the repayment of our principal, represents a key means by which we will be able to exit from our investments over time.
In addition, we also seek to invest in companies whose business models and expected future cash flows or cash positions offer attractive exit possibilities. These companies include candidates for strategic acquisition by other industry participants and companies that may repay our investments through an initial public offering of common stock or another capital market transaction. We underwrite our investments on a
held-to-maturity
basis, but expensive capital is often repaid prior to stated maturity.
 
10

Experienced and Committed Management.
We generally require that portfolio companies have an experienced management team. We also require portfolio companies have in place proper incentives to induce management to succeed and to act in concert with our interests as investors, including having significant equity interests.
Strong Sponsorship.
We generally aim to invest alongside other sophisticated investors. We typically seek to partner with successful financial sponsors who have historically generated high returns. We believe that investing in these sponsors’ portfolio companies enables us to benefit from their direct involvement and due diligence.
SLR Capital Partners’ investment team works in concert with sponsors to proactively manage investment opportunities by acting as a partner throughout the investment process. We actively focus on the middle-market financial sponsor community, with a particular focus on the
upper-end
of the middle-market (sponsors with equity funds of $500 million to $5 billion). We favor such sponsors because they typically:
 
   
buy larger companies with strong business franchises;
 
   
invest significant amounts of equity in their portfolio companies;
 
   
value flexibility and creativity in structuring their transactions;
 
   
possess longer track records over multiple investment funds;
 
   
have a deeper management bench;
 
   
have better ability to withstand downturns; and
 
   
possess the ability to support portfolio companies with additional capital.
We divide our coverage of these sponsors among our more senior investment professionals, who are responsible for
day-to-day
interaction with financial sponsors. Our coverage approach aims to act proactively, consider all investments in the capital structure, provide quick feedback, deliver on commitments, and are constructive throughout the life cycle of an investment.
Due Diligence
Our “private equity” approach to credit investing typically incorporates extensive
in-depth
due diligence often alongside the private equity sponsor. In conducting due diligence, we will use publicly available information as well as information from relationships with former and current management teams, consultants, competitors and investment bankers. We believe that our due diligence methodology allows us to screen a high volume of potential investment opportunities on a consistent and thorough basis.
Our due diligence typically includes:
 
   
review of historical and prospective financial information;
 
   
review and valuation of assets;
 
   
research relating to the company’s management, industry, markets, products and services and competitors;
 
   
on-site
visits;
 
   
discussions with management, employees, customers or vendors of the potential portfolio company;
 
   
review of senior loan documents; and
 
   
background investigations.
 
11

We also expect to evaluate the private equity sponsor making the investment. Further, due to SLR Capital Partners’ considerable repeat business with sponsors, we have direct experience with the management teams of many sponsors. A private equity sponsor is typically the controlling stockholder upon completion of an investment and as such is considered critical to the success of the investment. The equity sponsor is evaluated along several key criteria, including:
 
   
investment track record;
 
   
industry experience;
 
   
capacity and willingness to provide additional financial support to the company through additional capital contributions, if necessary; and
 
   
reference checks.
Throughout the due diligence process, a deal team is in constant dialogue with the management team of the company in which we are considering investing to ensure that any concerns are addressed as early as possible through the process and that unsuitable investments are filtered out before considerable time has been invested.
Upon the completion of due diligence and a decision to proceed with an investment in a company, the investment professionals leading the investment present the investment opportunity to SLR Capital Partners’ investment committee, which then determines whether to pursue the potential investment. Additional due diligence with respect to any investment may be conducted on our behalf by attorneys and independent accountants prior to the closing of the investment, as well as other outside advisers, as appropriate.
The Investment Committee
All new investments are required to be approved by a consensus of the investment committee of SLR Capital Partners, which is led by Messrs. Gross and Spohler. The members of SLR Capital Partners’ investment committee receive no compensation from us. Such members may be employees or partners of SLR Capital Partners and may receive compensation or profit distributions from SLR Capital Partners.
Investment Structure
Once we determine that a prospective portfolio company is suitable for investment, we work with the management of that company and its other capital providers, including senior, junior and equity capital providers, to structure an investment. We negotiate among these parties to agree on how our investment is expected to perform relative to the other capital in the portfolio company’s capital structure.
The Company seeks to create a diverse portfolio that includes senior secured loans and to a lesser extent, unsecured loans and equity securities by investing approximately $5 million to $100 million of capital. With respect to our senior secured loans, we seek to obtain security interests in the assets of our portfolio companies that serve as collateral in support of the repayment of these loans. This collateral may take the form of first or second priority liens on the assets of a portfolio company.
We structure our unsecured loans primarily subordinated loans that provide for relatively high, fixed or floating interest rates that provide us with significant current interest income. These loans typically have interest-only payments in the early years, with amortization of principal, if any, deferred to the later years of the unsecured loans. In some cases, we may enter into loans that, by their terms, convert into equity or additional debt securities or defer payments of interest for the first few years after our investment. Also, in some cases, our unsecured loans may be collateralized by a subordinated lien on some or all of the assets of the borrower.
Typically, our senior secured and unsecured loans have final maturities of five to ten years. However, we expect that our portfolio companies often may repay these loans early, generally within three to four years from
 
12

the date of initial investment. In some cases and when available, we seek to structure these loans with prepayment premiums to capture foregone interest.
In the case of our senior secured and unsecured loan investments, we tailor the terms of the investment to the facts and circumstances of the transaction and the prospective portfolio company, negotiating a structure that protects our rights and manages our risk while creating incentives for the portfolio company to achieve its business plan and improve its profitability. For example, in addition to seeking a senior or fulcrum position in the capital structure of our portfolio companies, we will seek to limit the downside potential of our investments by:
 
   
requiring a total return on our investments (including both interest and potential capital appreciation) that compensates us for credit risk;
 
   
incorporating “put” rights and call protection into the investment structure; and
 
   
negotiating covenants in connection with our investments that afford our portfolio companies as much flexibility in managing their businesses as possible, consistent with preservation of our capital. Such restrictions may include affirmative and negative covenants, default penalties, lien protection, change of control provisions and board rights, including either observation or participation rights.
Our investments may include equity features, such as warrants or options to buy a minority interest in the portfolio company. Any warrants we receive with our debt securities generally require only a nominal cost to exercise, and thus, as a portfolio company appreciates in value, we may achieve additional investment return from this equity interest. We may structure the warrants to provide provisions protecting our rights as a minority interest holder, as well as puts, or rights to sell such securities back to the company, upon the occurrence of specified events. In many cases, we also obtain registration rights in connection with these equity securities, which may include demand and “piggyback” registration rights. In addition, we may from time to time make direct equity investments in portfolio companies.
We generally seek to hold most of our investments to maturity or repayment, but will sell our investments earlier, including if a liquidity event takes place such as the sale or recapitalization of a portfolio company.
Ongoing Relationships with Portfolio Companies
SLR Capital Partners monitors our portfolio companies on an ongoing basis. SLR Capital Partners monitors the financial trends of each portfolio company to determine if it is meeting its business plan and to assess the appropriate course of action for each company.
SLR Capital Partners has several methods of evaluating and monitoring the performance and fair value of our investments, which include the following:
 
   
Assessment of success in adhering to each portfolio company’s business plan and compliance with covenants;
 
   
Periodic and regular contact with portfolio company management and, if appropriate, the financial or strategic sponsor, to discuss financial position, requirements and accomplishments;
 
   
Comparisons to other SLR invested portfolio companies in the industry, if any;
 
   
Attendance at and participation in board meetings; and
 
   
Review of monthly and quarterly financial statements and financial projections for portfolio companies.
In addition to various risk management and monitoring tools, SLR Capital Partners also uses an investment rating system to characterize and monitor our expected level of returns on each investment in our portfolio.
 
13

We use an investment rating scale of 1 to 4. The following is a description of the conditions associated with each investment rating:
 
Investment
Rating
  
Summary Description
1    Involves the least amount of risk in our portfolio, the portfolio company is performing above expectations, and the trends and risk factors are generally favorable (including a potential exit)
2    Risk that is similar to the risk at the time of origination, the portfolio company is performing as expected, and the risk factors are neutral to favorable; all new investments are initially assessed a grade of 2
3    The portfolio company is performing below expectations, may be out of compliance with debt covenants, and requires procedures for closer monitoring
4    The investment is performing well below expectations and is not anticipated to be repaid in full
SLR Capital Partners monitors and, when appropriate, changes the investment ratings assigned to each investment in our portfolio. As of December 31, 2023 and December 31, 2022 the weighted average investment rating on the fair market value of our portfolio was a 2. In connection with our valuation process, SLR Capital Partners reviews these investment ratings on a quarterly basis.
Valuation Procedures
In December 2020, the SEC adopted Rule
2a-5
under the 1940 Act addressing fair valuation of fund investments. The rule sets forth requirements for good faith determinations of fair value, as well as for the performance of fair value determinations, including related oversight and reporting obligations. The rule also defines “readily available market quotations” for purposes of the definition of “value” under the 1940 Act, and the SEC noted that this definition will apply in all contexts under the 1940 Act. The Company complies with Rule
2a-5’s
valuation requirements.
We conduct the valuation of our assets, pursuant to which our net asset value is determined, at all times consistent with U.S. generally accepted accounting principles (“GAAP”) and the 1940 Act. The Board will (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
It is anticipated that in respect of many of the Company’s assets, readily available market quotations will not be obtainable and that such assets will be valued at fair value. A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation.
Under procedures established by the Board, we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available and deemed to represent fair value under GAAP, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market
 
14

quotation. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize
mid-market
pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates.
With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value under GAAP, the Board has approved a multi-step valuation process each quarter, as described below:
 
  (1)
our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment;
 
  (2)
preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser;
 
  (3)
independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets;
 
  (4)
the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and
 
  (5)
the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee.
The valuation principles set forth above may be modified from time to time, in whole or in part, as determined by the Board in its sole discretion.
Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC
820-10,
certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided
 
15

by pricing services are considered as an input in the valuation process. For the fiscal year ended December 31, 2023, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.
ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:
Level
 1
: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.
Level
 2
: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.
Level
 3
: Unobservable inputs for the asset or liability.
In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.
Competition
Our primary competitors provide financing to middle-market companies and include other business development companies, commercial and investment banks, commercial financing companies and, to the extent they provide an alternative form of financing, private equity funds. Additionally, alternative investment vehicles, such as hedge funds, frequently invest in middle-market companies. As a result, competition for investment opportunities at middle-market companies can be intense. While many middle-market companies were previously able to raise senior debt financing through traditional large financial institutions, we believe this approach to financing will become more difficult as implementation of U.S. and international financial reforms limits the capacity of large financial institutions to hold
non-investment
grade leveraged loans on their balance sheets. We believe that many of these financial institutions have
de-emphasized
their service and product offerings to middle-market companies in particular.
Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of funds and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments, which could allow them to consider a wider variety of investments and establish more relationships than us. Furthermore, many of our competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC. We use the industry information available to Messrs. Gross and Spohler and the other investment professionals of SLR Capital Partners to assess investment risks and determine appropriate pricing for our investments in portfolio companies. In addition, we believe that the relationships of Messrs. Gross and Spohler and the other investment professionals of our investment adviser enable us to learn about, and compete effectively for, financing opportunities with attractive leveraged companies in the industries in which we seek to invest.
Staffing
We do not currently have any employees. Mr. Gross, our Chairman and
Co-Chief
Executive Officer and President, and Mr. Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, SLR Capital Partners. In addition, Mr. Shiraz Kajee, our Chief Financial Officer and Treasurer, serves as the Chief Financial Officer for SLR Capital Partners. Guy Talarico, our Chief Compliance Officer and Secretary, serves as the Chief Compliance Officer and General Counsel for SLR Capital Partners.
 
16

Our
day-to-day
investment operations are managed by SLR Capital Partners. Based upon its needs, SLR Capital Partners may hire additional investment professionals. In addition, we will reimburse SLR Capital Management for the allocable portion of overhead and other expenses incurred by it in performing its obligations under the Administration Agreement, including rent, and the allocable portion of the cost of the company’s chief compliance officer and chief financial officer and their respective staffs.
Sarbanes-Oxley Act of 2002
The Sarbanes-Oxley Act of 2002 imposes a wide variety of regulatory requirements on publicly-held companies and their insiders. Many of these requirements affect us. For example:
 
   
pursuant to
Rule 13a-14
of the Securities Exchange Act of 1934, as amended (the “1934 Act”), our
Co-Chief
Executive Officers and Chief Financial Officer must certify as to the accuracy of the financial statements contained in our periodic reports;
 
   
pursuant to Item 307 of
Regulation S-K,
our periodic reports must disclose our conclusions about the effectiveness of our disclosure controls and procedures;
 
   
pursuant to Rule
13a-15
of the 1934 Act, our management is required to prepare an annual report regarding its assessment of our internal control over financial reporting and to obtain an audit of the effectiveness of internal control over financial reporting performed by our independent registered public accounting firm; and
 
   
pursuant to Item 308 of
Regulation S-K
and
Rule 13a-15
of the 1934 Act, our periodic reports must disclose whether there were significant changes in our internal controls over financial reporting or in other factors that could significantly affect these controls subsequent to the date of their evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.
The Sarbanes-Oxley Act of 2002 requires us to review our current policies and procedures to determine whether we comply with the Sarbanes-Oxley Act of 2002 and the regulations promulgated thereunder. We will continue to monitor our compliance with all regulations that are adopted under the Sarbanes-Oxley Act of 2002 and will take actions necessary to ensure that we are in compliance therewith.
Business Development Company Regulations
A BDC is regulated by the 1940 Act. A BDC must be organized in the United States for the purpose of investing in or lending to primarily private companies and making significant managerial assistance available to those investments that constitute qualifying assets (as discussed below). A BDC may use capital provided by public stockholders and from other sources to make long-term, private investments in businesses. A BDC provides stockholders the ability to retain the liquidity of a publicly-traded stock while sharing in the possible benefits, if any, of investing in primarily privately owned companies.
We may not change the nature of our business so as to cease to be, or withdraw our election as, a BDC unless authorized by vote of a majority of our outstanding voting securities, as required by the 1940 Act. A majority of the outstanding voting securities of a company is defined under the 1940 Act as the lesser of: (a) 67% or more of such company’s voting securities present at a meeting if more than 50% of the outstanding voting securities of such company are present or represented by proxy, or (b) more than 50% of the outstanding voting securities of such company. We do not anticipate any substantial change in the nature of our business.
As with other companies regulated by the 1940 Act, a BDC must adhere to certain substantive regulatory requirements. A majority of our directors must be persons who are not interested persons, as that term is defined in the 1940 Act. Additionally, we are required to provide and maintain a bond issued by a reputable fidelity insurance company to protect the BDC. Furthermore, as a BDC, we are prohibited from protecting any director or officer against any liability to us or our stockholders arising from willful misfeasance, bad faith, gross negligence or reckless disregard of the duties involved in the conduct of such person’s office.
 
17

As a BDC, we are required to meet an asset coverage ratio, reflecting the value of our total assets to our total senior securities, which include all of our borrowings and any preferred stock we may issue in the future, of at least 150%. We may also be prohibited under the 1940 Act from knowingly participating in certain transactions with our affiliates without the prior approval of our directors who are not interested persons and, in some cases, prior approval by the SEC.
We are generally not able to issue and sell our common stock at a price below net asset value per share without annual stockholder approval. We may, however, sell our common stock, or warrants, options or rights to acquire our common stock, at a price below the then-current net asset value of our common stock if the Board determines that such sale is in our best interests and the best interests of our stockholders, and our stockholders approve such sale. At this time, we do not have stockholder approval for such sales.
As a BDC, we were substantially limited in our ability to
co-invest
in privately negotiated transactions with affiliated funds until we obtained an exemptive order from the SEC. The Exemptive Order permits us to participate in negotiated
co-investment
transactions with certain affiliates, each of whose investment adviser is an investment adviser that controls, is controlled by or is under common control with SLR Capital Partners and is registered as an investment adviser under the Advisers Act, in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions to the Exemptive Order. If we are unable to rely on the Exemptive Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although our investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, we and our common stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of our investment adviser.
We will be periodically examined by the SEC for compliance with the federal securities laws, including the 1940 Act.
Qualifying Assets
Under the 1940 Act, a BDC may not acquire any asset other than assets of the type listed in Section 55(a) of the 1940 Act, which are referred to as qualifying assets, unless, at the time the acquisition is made, qualifying assets represent at least 70% of the BDC’s total assets. The principal categories of qualifying assets relevant to our business are the following:
(1) Securities purchased in transactions not involving any public offering from the issuer of such securities, which issuer (subject to certain limited exceptions) is an eligible portfolio company, or from any person who is, or has been during the preceding 13 months, an affiliated person of an eligible portfolio company, or from any other person, subject to such rules as may be prescribed by the SEC. An eligible portfolio company is defined in the 1940 Act as any issuer which:
(a) is organized under the laws of, and has its principal place of business in, the United States;
(b) is not an investment company (other than a small business investment company wholly owned by the BDC); and
(c) satisfies any of the following:
i. does not have any class of securities that is traded on a national securities exchange;
ii. has a class of securities listed on a national securities exchange, but has an aggregate market value of outstanding voting and
non-voting
common equity of less than $250 million;
 
18

iii. is controlled by a BDC or a group of companies including a BDC and the BDC has an affiliated person who is a director of the eligible portfolio company; or
iv. is a small and solvent company having total assets of not more than $4.0 million and capital and surplus of not less than $2.0 million.
(2) Securities of any eligible portfolio company which we control, which, as defined by the 1940 Act, is presumed to exist where a BDC beneficially owns more than 25% of the outstanding voting securities of the portfolio company.
(3) Securities purchased in a private transaction from a U.S. issuer that is not an investment company or from an affiliated person of the issuer, or in transactions incident thereto, if the issuer is in bankruptcy and subject to reorganization or if the issuer, immediately prior to the purchase of its securities, was unable to meet its obligations as they came due without material assistance other than conventional lending or financing arrangements.
(4) Securities of an eligible portfolio company purchased from any person in a private transaction if there is no ready market for such securities and we already own 60% of the outstanding equity of the eligible portfolio company.
(5) Securities received in exchange for or distributed on or with respect to securities described in (1) through (4) above, or pursuant to the exercise of warrants or rights relating to such securities.
(6) Cash, cash equivalents, U.S. government securities or high-quality debt securities maturing in one year or less from the time of investment.
(7) Office furniture and equipment, interests in real estate and leasehold improvements and facilities maintained to conduct the business operations of the BDC, deferred organization and operating expenses, and other noninvestment assets necessary and appropriate to its operations as a BDC, including notes of indebtedness of directors, officers, employees, and general partners held by a BDC as payment for securities of such company issued in connection with an executive compensation plan described in Section 57(j) of the 1940 Act.
Under Section 55(b) of the 1940 Act, the value of a BDC’s assets shall be determined as of the date of the most recent financial statements filed by such company with the SEC pursuant to Section 13 of the 1934 Act, and shall be determined no less frequently than annually.
Significant Managerial Assistance to Portfolio Companies
As a BDC, we offer, and must provide upon request, significant managerial assistance to our portfolio companies that constitute qualifying assets. This assistance could involve, among other things, monitoring the operations of our portfolio companies, participating in board and management meetings, consulting with and advising officers of portfolio companies and providing other organizational and financial guidance. We may also receive fees for these services. SLR Capital Management provides such managerial assistance, if any, on our behalf to portfolio companies that request this assistance.
Temporary Investments
Pending investment in other types of “qualifying assets,” as described above, our investments may consist of cash, cash equivalents, U.S. government securities or high-quality investment grade debt securities maturing in one year or less from the time of investment, which we refer to, collectively, as temporary investments, so that 70% of our assets are qualifying assets. Typically, we will invest in U.S. Treasury bills or in repurchase agreements, provided that such repurchase agreements are fully collateralized by cash or securities issued by the U.S. government or its agencies. A repurchase agreement involves the purchase by an investor, such as us, of a
 
19

specified security and the simultaneous agreement by the seller to repurchase it at an agreed-upon future date and at a price that is greater than the purchase price by an amount that reflects an agreed-upon interest rate. There is no percentage restriction on the proportion of our assets that may be invested in such repurchase agreements. However, if more than 25% of our total assets constitute repurchase agreements from a single counterparty, we would not meet the diversification tests in order to qualify as a RIC for U.S. federal income tax purposes. Thus, we do not intend to enter into repurchase agreements with a single counterparty in excess of this limit. SLR Capital Partners will monitor the creditworthiness of the counterparties with which we enter into repurchase agreement transactions.
Senior Securities
We are permitted, under specified conditions, to issue multiple classes of indebtedness and one class of stock senior to our common stock if our asset coverage, as defined in the 1940 Act, is at least equal to 150% immediately after each such issuance. In addition, while certain senior securities remain outstanding, we may be required to make provisions to prohibit any distribution to our stockholders or the repurchase of such securities or shares unless we meet the applicable asset coverage ratios at the time of the distribution or repurchase. We may also borrow amounts up to 5% of the value of our total assets for temporary purposes without regard to asset coverage. We may borrow money, which would magnify the potential for gain or loss on amounts invested and may increase the risk of investing in us.
Code of Ethics
We and SLR Capital Partners have each adopted a code of ethics pursuant to Rule
17j-1
under the 1940 Act and Rule
204A-1
under the Advisers Act, respectively, that establishes procedures for personal investments and restricts certain transactions by our personnel. Our codes of ethics generally do not permit investments by our employees in securities that may be purchased or held by us. Each code of ethics is available on the EDGAR Database on the SEC’s Internet site at http://www.sec.gov. You may also obtain copies of the codes of ethics, after paying a duplicating fee, by electronic request at the following Email address: publicinfo@sec.gov.
Compliance Policies and Procedures
We and our investment adviser have adopted and implemented written policies and procedures reasonably designed to detect and prevent violation of the federal securities laws. We are required to review these compliance policies and procedures annually for their adequacy and the effectiveness of their implementation and to designate a chief compliance officer to be responsible for their administration. Guy Talarico currently serves as our Chief Compliance Officer.
Proxy Voting Policies and Procedures
We have delegated our proxy voting responsibility to the Investment Adviser. A summary of the Proxy Voting Policies and Procedures of the Investment Adviser are set forth below. The guidelines are reviewed periodically by the Investment Adviser and our independent directors, and, accordingly, are subject to change.
As an investment adviser registered under the Advisers Act, SLR Capital Partners has a fiduciary duty to act solely in the best interests of its clients. As part of this duty, it recognizes that it must vote securities held by its clients in a timely manner free of conflicts of interest. These policies and procedures for voting proxies for investment advisory clients are intended to comply with Section 206 of, and Rule
206(4)-6
under, the Advisers Act.
Our investment adviser votes proxies relating to our portfolio securities in the best interest of our stockholders. SLR Capital Partners reviews on a
case-by-case
basis each proposal submitted for a proxy vote to determine its impact on our investments. Although it generally votes against proposals that may have a negative
 
20

impact on our investments, it may vote for such a proposal if there exists compelling long-term reasons to do so. The proxy voting decisions of our investment adviser are made by the senior investment professionals who are responsible for monitoring each of our investments. To ensure that our vote is not the product of a conflict of interest, it requires that: (i) anyone involved in the decision making process disclose to a managing member of SLR Capital Partners any potential conflict that he or she is aware of and any contact that he or she has had with any interested party regarding a proxy vote, and (ii) employees involved in the decision making process or vote administration are prohibited from revealing how we intend to vote on a proposal in order to reduce any attempted influence from interested parties.
You may obtain information about how we voted proxies by making a written request for proxy voting information to: SLR Capital Partners, LLC, 500 Park Avenue, New York, NY 10022.
Privacy Principles
We endeavor to maintain the privacy of our recordholders and to safeguard their
non-public
personal information. The following information is provided to help you understand what personal information we collect, how we protect that information and why, in certain cases, we may share such information with select other parties.
Generally, we will not receive any
non-public
personal information about the recordholders of the common stock of the Company, although certain of our recordholders’
non-public
information may become available to us. The
non-public
personal information that we may receive falls into the following categories:
 
   
Information we receive from recordholders, whether we receive it orally, in writing or electronically. This includes recordholders’ communications to us concerning their investment;
 
   
Information about recordholders’ transaction history with us; and
 
   
Other general information that we may obtain about recordholders, such as demographic and contact information such as address.
We disclose
non-public
person information about recordholders:
 
   
to our affiliates (such as SLR and our administrator) and their employees for everyday business purposes;
 
   
to our service providers (such as our accountants, attorneys, custodians, transfer agent, underwriter and proxy solicitors) and their employees as is necessary to service recordholder accounts or otherwise provide the applicable service;
 
   
to comply with court orders, subpoenas, lawful discovery requests, or other legal or regulatory requirements; or
 
   
as allowed or required by applicable law or regulation.
When the Company shares
non-public
recordholder personal information referred to above, the information is made available for limited business purposes and under controlled circumstances designed to protect our recordholders’ privacy. The Company does not permit use of recordholder information for any
non-
business or marketing purpose, nor does the Company permit third parties to rent, sell, trade or otherwise release or disclose information to any other party.
The Company’s service providers, such as SLR, its administrator, and its transfer agent, are required to maintain physical, electronic, and procedural safeguards to protect recordholder
non-public
personal information; to prevent unauthorized access or use; and to dispose of such information when it is no longer required.
 
21

Personnel of affiliates may access recordholder information only for business purposes. The degree of access is based on the sensitivity of the information and on personnel need for the information to service a recordholder’s account or comply with legal requirements.
If a recordholder ceases to be a recordholder, we will adhere to the privacy policies and practices as described above. We may choose to modify our privacy policies at any time. Before we do so, we will notify recordholders and provide a description of our privacy policy.
Taxation as a Regulated Investment Company
As a BDC, we elected to be treated, and intend to qualify annually, as a RIC under Subchapter M of the Code. As a RIC, we generally will not have to pay corporate-level U.S. federal income taxes on any ordinary income or capital gains that we timely distribute to our stockholders as dividends. To continue to qualify as a RIC, we must, among other things, meet certain
source-of-income
and asset diversification requirements (as described below). In addition, to qualify for RIC tax treatment we must distribute to our stockholders, for each taxable year, at least 90% of our “investment company taxable income,” which generally is our ordinary income plus the excess of our realized net short-term capital gains over our realized net long-term capital losses (the “Annual Distribution Requirement”). If we qualify as a RIC and satisfy the Annual Distribution Requirement, then we will not be subject to U.S. federal income tax on the portion of our investment company taxable income and net capital gain (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) we distribute (or are deemed to distribute) to stockholders. We will be subject to U.S. federal income tax at the regular corporate rates on any ordinary income or capital gain not distributed (or deemed not distributed) to our stockholders.
We will be subject to a 4% nondeductible U.S. federal excise tax on certain undistributed income unless we distribute in a timely manner an amount at least equal to the sum of (1) 98% of our ordinary income for each calendar year, (2) 98.2% of our capital gain net income for the
one-year
period ending October 31 in that calendar year and (3) any ordinary income and net capital gains that we recognized in preceding years, but were not distributed during such years, and on which we paid no U.S. federal income tax (the “Excise Tax Avoidance Requirement”).
In order to qualify as a RIC for U.S. federal income tax purposes, we must, among other things:
 
   
at all times during each taxable year, have in effect an election to be treated as a BDC under the 1940 Act;
 
   
derive in each taxable year at least 90% of our gross income from (a) dividends, interest, payments with respect to certain securities loans, gains from the sale of stock or other securities or currencies, or other income derived with respect to our business of investing in such stock, securities or currencies and (b) net income derived from an interest in a “qualified publicly traded partnership;” and
 
   
diversify our holdings so that at the end of each quarter of the taxable year:
 
   
at least 50% of the value of our assets consists of cash, cash equivalents, U.S. government securities, securities of other RICs, and other securities if such other securities of any one issuer do not represent more than 5% of the value of our assets or more than 10% of the outstanding voting securities of the issuer; and
 
   
no more than 25% of the value of our assets is invested in (i) the securities, other than U.S. government securities or securities of other RICs, of one issuer, (ii) the securities of two or more issuers that are controlled, as determined under applicable tax rules, by us and that are engaged in the same or similar or related trades or businesses or (iii) the securities of one or more “qualified publicly traded partnerships.”
We may be required to recognize taxable income in circumstances in which we do not receive cash. For example, if we hold debt obligations that are treated under applicable tax rules as having original issue discount
 
22

(such as debt instruments with
payment-in-kind
(“PIK”) income or, in certain cases, increasing interest rates or debt instruments issued with warrants), we must include in income each year a portion of the original issue discount that accrues over the life of the obligation, regardless of whether cash representing such income is received by us in the same taxable year. Because any original issue discount accrued will be included in our investment company taxable income for the year of accrual, we may be required to make a distribution to our stockholders in order to satisfy the Annual Distribution Requirement, even though we will not have received any corresponding cash amount.
Because we may use debt financing, we will be subject to certain asset coverage ratio requirements under the 1940 Act and financial covenants under loan and credit agreements that could, under certain circumstances, restrict us from making distributions necessary to satisfy the Annual Distribution Requirement. If we are unable to obtain cash from other sources or are otherwise limited in our ability to make distributions, we could fail to qualify for RIC tax treatment and thus become subject to corporate-level U.S. federal income tax.
Certain of our investment practices may be subject to special and complex U.S. federal income tax provisions that may, among other things: (i) disallow, suspend or otherwise limit the allowance of certain losses or deductions; (ii) convert lower taxed long-term capital gain into higher taxed short-term capital gain or ordinary income; (iii) convert an ordinary loss or a deduction into a capital loss (the deductibility of which is more limited); (iv) cause us to recognize income or gain without a corresponding receipt of cash; (v) adversely affect the time as to when a purchase or sale of securities is deemed to occur; (vi) adversely alter the characterization of certain complex financial transactions; and (vii) produce income that will not be qualifying income for purposes of the 90% gross income test described above. We will monitor our transactions and may make certain tax elections in order to mitigate the potential adverse effect of these provisions.
Gain or loss realized by us from the sale or exchange of warrants acquired by us as well as any loss attributable to the lapse of such warrants generally will be treated as capital gain or loss. The treatment of such gain or loss as long-term or short-term will depend on how long we have held a particular warrant. Upon the exercise of a warrant acquired by us, our tax basis in the stock purchased under the warrant will equal the sum of the amount paid for the warrant plus the strike price paid on the exercise of the warrant.
Failure to Qualify as a Regulated Investment Company
If we were unable to qualify for treatment as a RIC, we would be subject to U.S. federal income tax on all of our taxable income at regular corporate rates. We would not be able to deduct distributions to stockholders, nor would distributions be required. Such distributions would be taxable to our stockholders as dividends and, provided certain holding period and other requirements were met, could qualify for treatment as “qualified dividend income” in the hands of
non-corporate
stockholders (and thus eligible for the current 20% maximum rate) to the extent of our current and accumulated earnings and profits. Subject to certain limitations under the Code, corporate distributees would be eligible for the dividends received deduction. Distributions in excess of our current and accumulated earnings and profits would be treated first as a return of capital to the extent of the stockholder’s tax basis, and any remaining distributions would be treated as a capital gain. To requalify as a RIC in a subsequent taxable year, we would be required to satisfy the RIC qualification requirements for that year and dispose of any earnings and profits from any year in which we failed to qualify as a RIC. Subject to a limited exception applicable to RICs that qualified as such under Subchapter M of the Code for at least one year prior to disqualification and that requalify as a RIC no later than the second year following the
non-qualifying
year, we could be subject to tax on any unrealized net
built-in
gains in the assets held by us during the period in which we failed to qualify as a RIC that are recognized within the subsequent five years, unless we made a special election to pay corporate-level U.S. federal income tax on such
built-in
gain at the time of our requalification as a RIC.
 
23

Investment Advisory Fees
Pursuant to the Advisory Agreement, we have agreed to pay SLR Capital Partners a fee for investment advisory and management services consisting of two components — a base management fee and a performance-based incentive fee.
On April 1, 2022, in connection with the consummation of the Mergers, we entered into a letter agreement (the “Letter Agreement”) pursuant to which the Investment Adviser voluntarily agreed to a permanent 25 basis point reduction of the annual base management fee rate payable by us to the Investment Adviser pursuant to the Advisory Agreement. Following the Letter Agreement, the base management fee is now determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings.
The performance-based incentive fee has two parts, as follows: one is calculated and payable quarterly in arrears based on our
pre-incentive
fee net investment income for the immediately preceding calendar quarter. For this purpose,
pre-incentive
fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus our operating expenses for the quarter (including the base management fee, expenses payable under the Administration Agreement to SLR Capital Management, and any interest expense and dividend paid on any issued and outstanding preferred stock, but excluding the performance-based incentive fee).
Pre-incentive
fee net investment income includes, in the case of investments with a deferred interest feature (such as original issue discount, debt instruments with pay in kind income and zero coupon securities), accrued income that we have not yet received in cash.
Pre-incentive
fee net investment income does not include any realized capital gains, computed net of all realized capital losses or unrealized capital appreciation or depreciation.
Pre-incentive
fee net investment income, expressed as a rate of return on the value of our net assets at the end of the immediately preceding calendar quarter, is compared to a hurdle of 1.75% per quarter (7.00% annualized). Our net investment income used to calculate this part of the incentive fee is also included in the amount of our gross assets used to calculate the 1.50% base management fee. We pay SLR Capital Partners an incentive fee with respect to our
pre-incentive
fee net investment income in each calendar quarter as follows:
 
   
no performance-based incentive fee in any calendar quarter in which our
pre-incentive
fee net investment income does not exceed the hurdle of 1.75%;
 
   
100% of our
pre-incentive
fee net investment income with respect to that portion of such
pre-incentive
fee net investment income, if any, that exceeds the hurdle but is less than 2.1875% in any calendar quarter (8.75% annualized). We refer to this portion of our
pre-incentive
fee net investment income (which exceeds the hurdle but is less than 2.1875%) as the
“catch-up.”
The
“catch-up”
is meant to provide our investment adviser with 20% of our
pre-incentive
fee net investment income as if a hurdle did not apply if this net investment income exceeds 2.1875% in any calendar quarter; and
 
   
20% of the amount of our
pre-incentive
fee net investment income, if any, that exceeds 2.1875% in any calendar quarter (8.75% annualized) is payable to SLR Capital Partners (once the hurdle is reached and the
catch-up
is achieved, 20% of all
pre-incentive
fee investment income thereafter is allocated to SLR Capital Partners).
 
24

The following is a graphical representation of the calculation of the income-related portion of the performance-based incentive fee:
Quarterly Incentive Fee Based on Net Investment Income
Pre-incentive
fee net investment income
(expressed as a percentage of the value of net assets)
 

Percentage of
pre-incentive
fee net investment income
allocated to SLR Capital Partners
These calculations are appropriately
pro-rated
for any period of less than three months. You should be aware that a rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, an increase in interest rates would make it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase of the amount of incentive fees payable to our investment adviser with respect to
pre-incentive
fee net investment income.
The second part of the incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and equals 20% of our realized capital gains, if any, on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees with respect to each of the investments in our portfolio.
Examples of Quarterly Incentive Fee Calculation
Example 1: Income Related Portion of Incentive Fee
(*)
:
Alternative 1:
Assumptions
Investment income (including interest, dividends, fees, etc.) = 1.25%
Hurdle rate
(1)
 = 1.75%
Management fee
(2)
 = 0.375%
Other expenses (legal, accounting, custodian, transfer agent, etc.)
(3)
 = 0.20%
Pre-incentive
fee net investment income
(investment income – (management fee + other expenses)) = 0.675%
Pre-incentive
net investment income does not exceed hurdle rate, therefore there is no incentive fee.
Alternative 2:
Assumptions
Investment income (including interest, dividends, fees, etc.) = 2.70%
Hurdle rate
(1)
 = 1.75%
Management fee
(2)
 = 0.375%
Other expenses (legal, accounting, custodian, transfer agent, etc.)
(3)
 = 0.20%
Pre-incentive
fee net investment income
(investment income – (management fee + other expenses)) = 2.125%
 
(*)
The hypothetical amount of
pre-incentive
fee net investment income shown is based on a percentage of total net assets.
 
25

Incentive fee = 100% ×
pre-incentive
fee net investment income, subject to the
“catch-up”
(4)
= 100% × (2.125% – 1.75%)
= 0.375%
Alternative 3:
Assumptions
Investment income (including interest, dividends, fees, etc.) = 3.00%
Hurdle rate
(1)
 = 1.75%
Management fee
(2)
 = 0.375%
Other expenses (legal, accounting, custodian, transfer agent, etc.)
(3)
 = 0.20%
Pre-incentive
fee net investment income
(investment income – (management fee + other expenses)) = 2.425%
Incentive fee = 20% ×
pre-incentive
fee net investment income, subject to
“catch-up”
(4)
Incentive fee = 100% ×
“catch-up”
+ (20% ×
(pre-incentive
fee net investment income – 2.1875%))
Catch-up
= 2.1875% – 1.75%
= 0.4375%
Incentive fee = (100% × 0.4375%) + (20% × (2.425% – 2.1875%))
= 0.4375% + (20% × 0.2375%)
= 0.4375% + 0.0475%
= 0.485%
 
(1)
 
Represents 7% annualized hurdle rate.
(2)
 
Represents 1.50% annualized management fee.
(3)
 
Excludes organizational and offering expenses.
(4)
 
The
“catch-up”
provision is intended to provide our investment adviser with an incentive fee of 20% on all of our
pre-incentive
fee net investment income as if a hurdle rate did not apply when our net investment income exceeds 2.1875% in any calendar quarter.
Example 2: Capital Gains Portion of Incentive Fee:
Alternative 1:
Assumptions
 
   
Year 1: $20 million investment made in Company A (“Investment A”), and $30 million investment made in Company B (“Investment B”)
 
   
Year 2: Investment A sold for $50 million and fair market value (“FMV”) of Investment B was determined to be $32 million
 
   
Year 3: FMV of Investment B determined to be $25 million
 
   
Year 4: Investment B sold for $31 million
The capital gains portion of the incentive fee would be:
 
   
Year 1: None
 
   
Year 2: Capital gains incentive fee of $6 million ($30 million realized capital gains on the sale of Investment A multiplied by 20%)
 
   
Year 3: None
$5 million (20% multiplied by ($30 million cumulative capital gains less $5 million cumulative capital depreciation)) less $6 million (previous capital gains fee paid in Year 2)
 
   
Year 4: Capital gains incentive fee of $200,000
 
26

$6.2 million ($31 million cumulative realized capital gains multiplied by 20%) less $6 million (capital gains fee taken in Year 2)
Alternative 2:
Assumptions
 
   
Year 1: $20 million investment made in Company A (“Investment A”), $30 million investment made in Company B (“Investment B”) and $25 million investment made in Company C (“Investment C”)
 
   
Year 2: Investment A sold for $50 million, FMV of Investment B determined to be $25 million and FMV of Investment C determined to be $25 million
 
   
Year 3: FMV of Investment B determined to be $27 million and Investment C sold for $30 million
 
   
Year 4: FMV of Investment B determined to be $24 million
 
   
Year 5: Investment B sold for $20 million
The capital gains incentive fee, if any, would be:
 
   
Year 1: None
 
   
Year 2: $5 million capital gains incentive fee
20% multiplied by $25 million ($30 million realized capital gains on Investment A less unrealized capital depreciation on Investment B)
 
   
Year 3: $1.4 million capital gains incentive fee
(1)
$6.4 million (20% multiplied by $32 million ($35 million cumulative realized capital gains less $3 million unrealized capital depreciation)) less $5 million capital gains fee received in Year 2
 
   
Year 4: None
 
   
Year 5: None
$5 million (20% multiplied by $25 million (cumulative realized capital gains of $35 million less realized capital losses of $10 million)) less $6.4 million cumulative capital gains fee paid in Year 2 and Year 3
 
(1)
 
As illustrated in Year 3 of Alternative 2 above, if the Company were to be wound up on a date other than December 31 of any year, the Company may have paid aggregate capital gain incentive fees that are more than the amount of such fees that would be payable if the Company had been wound up on December 31 of such year.
Payment of Our Expenses
All investment professionals of the Investment Adviser and their respective staffs, when and to the extent engaged in providing investment advisory and management services, and the compensation and routine overhead expenses of such personnel allocable to such services, are provided and paid for by SLR Capital Partners. We bear all other costs and expenses of our operations and transactions, including (without limitation):
 
   
the cost of our organization and public offerings;
 
   
the cost of calculating our net asset value, including the cost of any third-party valuation services;
 
   
the cost of effecting sales and repurchases of our shares and other securities;
 
   
interest payable on debt, if any, to finance our investments;
 
27

   
fees payable to third parties relating to, or associated with, making investments, including fees and expenses associated with performing due diligence reviews of prospective investments and advisory fees;
 
   
transfer agent and custodial fees;
 
   
fees and expenses associated with marketing efforts;
 
   
federal and state registration fees, any stock exchange listing fees;
 
   
federal, state and local taxes;
 
   
independent directors’ fees and expenses;
 
   
brokerage commissions;
 
   
fidelity bond, directors and officers errors and omissions liability insurance and other insurance premiums;
 
   
direct costs and expenses of administration, including printing, mailing, long distance telephone and staff;
 
   
fees and expenses associated with independent audits and outside legal costs;
 
   
costs associated with our reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws; and
 
   
all other expenses incurred by either SLR Capital Management or us in connection with administering our business, including payments under the Administration Agreement that will be based upon our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the costs of compensation and related expenses of our chief compliance officer and our chief financial officer and their respective staffs.
Available Information
The SEC maintains an Internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC. The address of that site is
(http://www.sec.gov)
.
Our internet address is
www.slrinvestmentcorp.com
. We make available free of charge on our website our annual report on
Form 10-K,
quarterly reports on
Form 10-Q,
current reports on
Form 8-K
and amendments to those reports as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. Information contained on our website is not incorporated by reference into this annual report on
Form 10-K,
and you should not consider information contained on our website to be part of this annual report on
Form 10-K.
Summary Risk Factors
Risks Relating to Our Investments
 
   
We operate in a highly competitive market for investment opportunities.
 
   
Our investments are very risky and highly speculative.
 
   
The lack of liquidity in our investments may make it difficult for us to dispose of our investments at a favorable price, which may adversely affect our ability to meet our investment objectives.
 
28

   
Our portfolio may be concentrated in a limited number of portfolio companies and industries, which will subject us to a risk of significant loss if any of these companies performs poorly or defaults on its obligations under any of its debt instruments or if there is a downturn in a particular industry.
 
   
Economic sanction laws in the United States and other jurisdictions may prohibit us and our affiliates from transacting with certain countries, individuals and companies.
 
   
If we cannot obtain additional capital because of either regulatory or market price constraints, we could be forced to curtail or cease our new lending and investment activities, our net asset value could decrease and our level of distributions and liquidity could be affected adversely.
 
   
We may suffer a loss if a portfolio company defaults on a loan and the underlying collateral is not sufficient.
 
   
Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity.
 
   
We may be exposed to higher risks with respect to our investments that include original issue discount or PIK interest.
Risks Relating to an Investment in Our Securities
 
   
Our shares may trade at a substantial discount from net asset value and may continue to do so over the long term.
 
   
Our common stock price may be volatile and may decrease substantially.
 
   
Our business and operation could be negatively affected if we become subject to any securities litigation or stockholder activism, which could cause us to incur significant expense, hinder execution of investment strategy and impact our stock price.
 
   
If the current period of capital market disruption and instability continues for an extended period of time, there is a risk that investors in our equity securities may not receive distributions consistent with historical levels or at all or that our distributions may not grow over time and a portion of our distributions may be a return of capital.
 
   
Due to disruptions in the economy, we may reduce or defer our dividends and choose to incur U.S. federal excise tax in order to preserve cash and maintain flexibility.
 
   
We may choose to pay distributions in our own common stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive.
 
   
Sales of substantial amounts of our common stock in the public market may have an adverse effect on the market price of our common stock.
 
   
The net asset value per share of our common stock may be diluted if we issue or sell shares of our common stock at prices below the then current net asset value per share of our common stock or securities to subscribe for or convertible into shares of our common stock.
 
   
To the extent we use debt or preferred stock to finance our investments, changes in interest rates will affect our cost of capital and net investment income.
 
   
Our stock repurchase program could affect the price of our common stock and increase volatility and may be suspended or terminated at any time, which may result in a decrease in the trading price of our common stock.
Risks Relating to Our Business and Structure
 
   
We are dependent upon SLR Capital Partners’ key personnel for our future success.
 
29

   
Our business model depends to a significant extent upon strong referral relationships with financial sponsors, and the inability of the senior investment professionals of our Investment Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.
 
   
Our financial condition and results of operations will depend on SLR Capital Partners’ ability to manage our future growth effectively by identifying, investing in and monitoring companies that meet our investment criteria.
 
   
We may need to raise additional capital to grow because we must distribute most of our income.
 
   
Any failure on our part to maintain our status as a BDC would reduce our operating flexibility and we may be limited in our investment choices as a BDC.
 
   
Regulations governing our operation as a BDC affect our ability to, and the way in which we will, raise additional capital. As a BDC, the necessity of raising additional capital may expose us to risks, including the typical risks associated with leverage.
 
   
We have and will continue to borrow money, which would magnify the potential for loss on amounts invested and may increase the risk of investing in us.
 
   
It is likely that the terms of any current or future long-term or revolving credit or warehouse facility we may enter into in the future could constrain our ability to grow our business.
 
   
There will be uncertainty as to the value of our portfolio investments, which may impact our net asset value.
 
   
There are significant potential conflicts of interest, including SLR Capital Partners’ management of other investment funds such as SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC, which could impact our investment returns, and an investment in SLR Investment Corp. is not an investment in SCP Private Credit Income BDC LLC, SLR HC BDC LLC, or SLR Private Credit BDC II LLC.
 
   
We may be obligated to pay our Investment Adviser incentive compensation even if we incur a loss.
 
   
Our incentive fee may induce SLR Capital Partners to pursue speculative investments.
 
   
We may become subject to corporate-level U.S. federal income tax if we are unable to qualify and maintain our qualification for tax treatment as a regulated investment company under Subchapter M of the Code.
 
   
The failure in cyber security systems, as well as the occurrence of events unanticipated in our disaster recovery systems and management continuity planning could impair our ability to conduct business effectively.
 
   
Our business is subject to increasingly complex corporate governance, public disclosure and accounting requirements that could adversely affect our business and financial results.
 
30

Item 1A.
Risk Factors.
Before you invest in our securities, you should be aware of various risks, including those described below. You should carefully consider these risk factors, together with all of the other information included in this annual report on Form
10-K
before you decide whether to make an investment in our securities. The risks described in this document and set out below are not the only risks we face. If any of the following events occur, our business, financial condition and results of operations could be materially adversely affected. In such case, our net asset value and the trading price of our common stock could decline or the value of our preferred stock, debt securities, subscription rights or warrants may decline, and you may lose all or part of your investment.
Risks Relating to Our Investments
We operate in a highly competitive market for investment opportunities.
A number of entities compete with us to make the types of investments that we target in leveraged companies. We compete with other BDCs, public and private funds, commercial and investment banks, commercial financing companies and, to the extent they provide an alternative form of financing, private equity funds. Many of our competitors are substantially larger and have considerably greater financial, technical and marketing resources than we do. For example, some competitors may have a lower cost of funds and access to funding sources that are not available to us. In addition, some of our competitors may have higher risk tolerances or different risk assessments than we have, which could allow them to consider a wider variety of investments and establish more relationships and offer better pricing and a more flexible structure than we are able to do. Furthermore, many of our potential competitors are not subject to the regulatory restrictions that the 1940 Act imposes on us as a BDC. If we are unable to source attractive investments, we may hold a greater percentage of our assets in cash and cash equivalents than anticipated, which could impact potential returns on our portfolio. We cannot assure you that the competitive pressures we face will not have a material adverse effect on our business, financial condition and results of operations. Also, as a result of this competition, we may not be able to take advantage of attractive investment opportunities from time to time, and we can offer no assurance that we will be able to identify and make investments that are consistent with our investment objective.
Participants in our industry compete on several factors, including price, flexibility in transaction structure, customer service, reputation, market knowledge and speed in decision-making. We do not seek to compete primarily based on the interest rates we will offer, and we believe that some of our competitors may make loans with interest rates that will be comparable to or lower than the rates we offer. We may lose investment opportunities if we do not match our competitors’ pricing, terms and structure. However, if we match our competitors’ pricing, terms and structure, we may experience decreased net interest income and increased risk of credit loss.
Our investments are very risky and highly speculative.
We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities.
Senior Secured Loans.
When we make a senior secured term loan investment in a portfolio company, we generally take a security interest in the available assets of the portfolio company, including the equity interests of its subsidiaries, which we expect to help mitigate the risk that we will not be repaid. However, there is a risk that the collateral securing our loans may decrease in value over time, may be difficult to sell in a timely manner, may be difficult to appraise and may fluctuate in value based upon the success of the business and market conditions, including as a result of the inability of the portfolio company to raise additional capital, and, in some circumstances, our lien could be subordinated to claims of other creditors. In addition, deterioration in a portfolio company’s financial condition and prospects, including its inability to raise additional capital, may be accompanied by deterioration in the value of the collateral for the loan. Consequently, the fact that a loan is secured does not guarantee that we will receive principal and interest payments according to the loan’s terms, or at all, or that we will be able to collect on the loan should we be forced to enforce our remedies.
Unsecured
 
31

Loans and Preferred Securities.
Our unsecured and preferred investments are generally subordinated to senior loans and are generally unsecured. As such, other creditors may rank senior to us in the event of an insolvency. This may result in an above average amount of risk and loss of principal.
Equity Investments.
When we invest in senior secured loans, unitranche loans, unsecured loans or preferred securities, we may acquire common equity securities as well. In certain other unique circumstances we may also make equity investments in businesses that make senior loans and/or leases, such as our investments in Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment Finance, SLR Business Credit and SLR Healthcare ABL. In addition, we may invest directly in the equity securities of portfolio companies without limitation as to market capitalization. For instance, we may invest in thinly traded companies, the prices of which may be subject to erratic market movement. Our goal is ultimately to exit such equity interests and realize gains upon our disposition of such interests. However, the equity interests we receive may not appreciate in value and, in fact, may decline in value. Accordingly, we may not be able to realize gains from our equity interests, and any gains that we do realize on the disposition of any equity interests may not be sufficient to offset any other losses we experience.
In addition, investing in middle-market companies involves a number of significant risks, including:
 
   
these companies may have limited financial resources and may be unable to meet their obligations under their debt securities that we hold, which may be accompanied by a deterioration in the value of any collateral and a reduction in the likelihood of us realizing any guarantees we may have obtained in connection with our investment;
 
   
they typically have shorter operating histories, narrower product lines and smaller market shares than larger businesses, which tend to render them more vulnerable to competitors’ actions and market conditions, as well as general economic downturns;
 
   
they are more likely to depend on the management talents and efforts of a small group of persons; therefore, the death, disability, resignation or termination of one or more of these persons could have a material adverse impact on our portfolio company and, in turn, on us;
 
   
they generally have less predictable operating results, may from time to time be parties to litigation, may be engaged in rapidly changing businesses with products subject to a substantial risk of obsolescence, and may require substantial additional capital to support their operations, finance expansion or maintain their competitive position. In addition, our executive officers, directors and our Investment Adviser may, in the ordinary course of business, be named as defendants in litigation arising from our investments in the portfolio companies; and
 
   
they may have difficulty accessing the capital markets to meet future capital needs, which may limit their ability to grow or to repay their outstanding indebtedness upon maturity.
The lack of liquidity in our investments may make it difficult for us to dispose of our investments at a favorable price, which may adversely affect our ability to meet our investment objectives.
We generally make investments in private companies. We invest and expect to continue investing in companies whose securities have no established trading market and whose securities are and will be subject to legal and other restrictions on resale or whose securities are and will be less liquid than are publicly-traded securities. Investments purchased by us that are liquid at the time of purchase may subsequently become illiquid due to events relating to the issuer of the investments, market events, economic conditions or investor perceptions. The illiquidity of our investments may make it difficult for us to sell such investments if the need arises. In addition, if we are required to liquidate all or a portion of our portfolio quickly, we may realize significantly less than the value at which we have previously recorded our investments. As a result, we do not expect to achieve liquidity in our investments in the near-term. However, to maintain our qualification as a BDC and as a RIC, we may have to dispose of investments if we do not satisfy one or more of the applicable criteria under the respective regulatory frameworks. Domestic and foreign markets are complex and interrelated, so that events in one sector of the world
 
32

markets or economy, or in one geographical region, can reverberate and have materially negative consequences for other markets, economic or regional sectors in a manner that may not be foreseen and which may negatively impact the liquidity of our investments and materially harm our business. In addition, we may face other restrictions on our ability to liquidate an investment in a portfolio company to the extent that we have material
non-public
information regarding such portfolio company.
Our portfolio may be concentrated in a limited number of portfolio companies and industries, which will subject us to a risk of significant loss if any of these companies performs poorly or defaults on its obligations under any of its debt instruments or if there is a downturn in a particular industry.
Our portfolio may be concentrated in a limited number of portfolio companies and industries. For example, as of December 31, 2023, our investments in SLR Credit Solutions, Kingsbridge Holdings, LLC and SLR Equipment Finance comprised 11.3%, 9.4% and 4.9%, respectively, of our total assets and our investments in diversified financial services and multi-sector holdings industries comprised 18.7% and 14.8%, respectively, of our total assets. Beyond the asset diversification requirements associated with our qualification as a RIC under Subchapter M of the Code, we do not have fixed guidelines for diversification, and while we are not targeting any specific industries, our investments may be concentrated in relatively few industries or portfolio companies. As a result, the aggregate returns we realize may be significantly adversely affected if a small number of investments perform poorly or if we need to write down the value of any one investment. Additionally, a downturn in any particular industry in which we are invested could also significantly impact the aggregate returns we realize.
Our investments in securities rated below investment grade are speculative in nature and are subject to additional risk factors such as the increased possibility of default, illiquidity of the security, and changes in value based on changes in interest rates.
The securities that we invest in are typically rated below investment grade. Securities rated below investment grade are speculative and are often referred to as “leveraged loans,” “high yield” or “junk” securities, and may be considered “high risk” compared to debt instruments that are rated investment grade. High yield securities are regarded as having predominantly speculative characteristics with respect to the issuer’s capacity to pay interest and repay principal in accordance with the terms of the obligations and involve major risk exposure to adverse conditions. In addition, high yield securities generally offer a higher current yield than that available from higher grade issues, but typically involve greater risk. These securities are especially sensitive to adverse changes in general economic conditions, to changes in the financial condition of their issuers and to price fluctuation in response to changes in interest rates. During periods of economic downturn or rising interest rates, such as the recent economic period, issuers of below investment grade instruments may experience financial stress that could adversely affect their ability to make payments of principal and interest and increase the possibility of default. The secondary market for high yield securities may not be as liquid as the secondary market for more highly rated securities. In addition, many of our debt investments will not fully amortize during their lifetime, which means that a borrower may be unable to payoff its debt due to bankruptcy or other reasons and therefore we may
write-off
such debt investment prior to its scheduled maturity. Upon such an occurrence, we may realize a loss or a substantial amount of unpaid principal and interest due upon maturity.
Price declines and illiquidity in the corporate debt markets have adversely affected, and may continue to adversely affect, the fair value of our portfolio investments, reducing our net asset value through increased net unrealized depreciation. Any unrealized depreciation that we experience on our loan portfolio may be an indication of future realized losses, which could reduce our income available for distribution and could adversely affect our ability to service our outstanding borrowings.
As a BDC, we are required to carry our investments at market value or, if no market value is ascertainable, at fair value as determined in good faith by or under the direction of our board of directors. Decreases in the market values or fair values of our investments are recorded as unrealized depreciation. Any unrealized depreciation in our loan portfolio could be an indication of a portfolio company’s inability to meet its repayment obligations to us with respect to the affected loans. This could result in realized losses in the future and ultimately in reductions
 
33

of our income available for distribution in future periods and could materially adversely affect our ability to service our outstanding borrowings. Depending on market conditions, we could incur substantial losses in future periods, which could further reduce our net asset value and have a material adverse impact on our business, financial condition and results of operations.
Economic sanction laws in the United States and other jurisdictions may prohibit us and our affiliates from transacting with certain countries, individuals and companies.
Economic sanction laws in the United States and other jurisdictions may prohibit us or our affiliates from transacting with certain countries, individuals and companies. In the United States, the U.S. Department of the Treasury’s Office of Foreign Assets Control administers and enforces laws, executive orders and regulations establishing U.S. economic and trade sanctions, which prohibit, among other things, transactions with, and the provision of services to, certain
non-U.S.
countries, territories, entities and individuals. These types of sanctions may significantly restrict or completely prohibit investment activities in certain jurisdictions, and if we, our portfolio companies or other issuers in which we invest were to violate any such laws or regulations, we may face significant legal and monetary penalties.
The Foreign Corrupt Practices Act, or FCPA, and other anti-corruption laws and regulations, as well as anti-boycott regulations, may also apply to and restrict our activities, our portfolio companies and other issuers of our investments. If an issuer or we were to violate any such laws or regulations, such issuer or we may face significant legal and monetary penalties. The U.S. government has indicated that it is particularly focused on FCPA enforcement, which may increase the risk that an issuer or us becomes the subject of such actual or threatened enforcement. In addition, certain commentators have suggested that private investment firms and the funds that they manage may face increased scrutiny and/or liability with respect to the activities of their underlying portfolio companies. As such, a violation of the FCPA or other applicable regulations by us or an issuer of our portfolio investments could have a material adverse effect on us. We are committed to complying with the FCPA and other anti-corruption laws and regulations, as well as anti-boycott regulations, to which it is subject. As a result, we may be adversely affected because of our unwillingness to enter into transactions that violate any such laws or regulations.
If we cannot obtain additional capital because of either regulatory or market price constraints, we could be forced to curtail or cease our new lending and investment activities, our net asset value could decrease and our level of distributions and liquidity could be affected adversely.
Our ability to secure additional financing and satisfy our financial obligations under indebtedness outstanding from time to time will depend upon our future operating performance, which is subject to the prevailing general economic and credit market conditions, including interest rate levels and the availability of credit generally, and financial, business and other factors, many of which are beyond our control. The worsening of current economic and capital market conditions could have a material adverse effect on our ability to secure financing on favorable terms, if at all.
If we are unable to obtain debt capital, then our equity investors will not benefit from the potential for increased returns on equity resulting from leverage to the extent that our investment strategy is successful and we may be limited in our ability to make new commitments or fundings to our portfolio companies.
We may suffer a loss if a portfolio company defaults on a loan and the underlying collateral is not sufficient.
In the event of a default by a portfolio company on a secured loan, we will only have recourse to the assets collateralizing the loan. If the underlying collateral value is less than the loan amount, we will suffer a loss. In addition, we sometimes make loans that are unsecured, which are subject to the risk that other lenders may be directly secured by the assets of the portfolio company. In the event of a default, those collateralized lenders would have priority over us with respect to the proceeds of a sale of the underlying assets. In cases described
 
34

above, we may lack control over the underlying asset collateralizing our loan or the underlying assets of the portfolio company prior to a default, and as a result the value of the collateral may be reduced by acts or omissions by owners or managers of the assets.
In the event of bankruptcy of a portfolio company, we may not have full recourse to its assets in order to satisfy our loan, or our loan may be subject to equitable subordination. In addition, certain of our loans are subordinate to other debt of the portfolio company. If a portfolio company defaults on our loan or on debt senior to our loan, or in the event of a portfolio company bankruptcy, our loan will be satisfied only after the senior debt receives payment. Where debt senior to our loan exists, the presence of inter-creditor arrangements may limit our ability to amend our loan documents, assign our loans, accept prepayments, exercise our remedies (through “standstill” periods) and control decisions made in bankruptcy proceedings relating to the portfolio company. Bankruptcy and portfolio company litigation can significantly increase collection losses and the time needed for us to acquire the underlying collateral in the event of a default, during which time the collateral may decline in value, causing us to suffer further losses.
If the value of the collateral underlying our loan declines or interest rates increase during the term of our loan, a portfolio company may not be able to obtain the necessary funds to repay our loan at maturity through refinancing. Decreasing collateral value and/or periods of increasing interest rates, such as the recent economic period, may hinder a portfolio company’s ability to refinance our loan because the underlying collateral cannot satisfy the debt service coverage requirements necessary to obtain new financing. If a borrower is unable to repay our loan at maturity, we could suffer a loss which may adversely impact our financial performance.
The business, financial condition and results of operations of our portfolio companies could be adversely affected by worldwide economic conditions, as well as political and economic conditions in the countries in which they conduct business.
The business and operating results of our portfolio companies may be impacted by worldwide economic conditions, such as the economic impact that the
COVID-19
pandemic, certain regional bank failures, an inflationary economic environment, the Russian invasion of Ukraine and the ongoing war in the Middle East have imposed, and may continue to impose, on the U.S. and worldwide economy. Any deterioration of general economic conditions may lead to significant declines in corporate earnings or loan performance, and the ability of corporate borrowers to service their debt, any of which could trigger a period of global economic slowdown, and have an adverse impact on our performance and financial results, and the value and the liquidity of our investments. In an economic downturn, we could have
non-performing
assets or an increase in
non-performing
assets, and we would anticipate that the value of our portfolio would decrease during these periods. For instance, concerns of economic slowdown in China and other emerging markets and signs of deteriorating sovereign debt conditions in Europe could lead to disruption and instability in the global financial markets. The significant debt in the United States and European countries is expected to hinder growth in those countries for the foreseeable future. In the future, the U.S. government may not be able to meet its debt payments unless the federal debt ceiling is raised. If legislation increasing the debt ceiling is not enacted, as needed, and the debt ceiling is reached, the U.S. federal government may stop or delay making payments on its obligations. Any default by the U.S. government on its obligations or any prolonged U.S. government shutdown could negatively impact the U.S. economy and our portfolio companies. Multiple factors relating to the international operations of some of our portfolio companies and to particular countries in which they operate could negatively impact their business, financial condition and results of operations. In addition, concerns over the United States’ debt ceiling and budget-deficit have driven downgrades by rating agencies to the U.S. government’s credit rating. Downgrades by rating agencies to the U.S. government’s credit rating or concerns about its credit and deficit levels in general could cause interest rates and borrowing costs to rise, which may negatively impact both the perception of credit risk associated with our debt portfolio and our ability to access the debt markets on favorable terms. In addition, a decreased U.S. government credit rating, any default by the U.S. government on its obligations, or any prolonged U.S. government shutdown, could create broader financial turmoil and uncertainty, which may weigh heavily on our financial performance and the value of our common stock. U.S. debt ceiling and budget deficit concerns have increased the possibility of additional credit-rating downgrades and economic slowdowns or a recession in the U.S.
 
35

Some of the products of our portfolio companies are developed, manufactured, assembled, tested or marketed outside the United States. Any conflict or uncertainty in these countries, including due to natural disasters, public health concerns (including the global
COVID-19
pandemic), political unrest or safety concerns, could harm their business, financial condition and results of operations. In addition, if the government of any country in which their products are developed, manufactured or sold sets technical or regulatory standards for products developed or manufactured in or imported into their country that are not widely shared, it may lead some of their customers to suspend imports of their products into that country, require manufacturers or developers in that country to manufacture or develop products with different technical or regulatory standards and disrupt cross-border manufacturing, marketing or business relationships which, in each case, could harm their businesses.
Our failure to make
follow-on
investments in our portfolio companies could impair the value of our portfolio.
Following an initial investment in a portfolio company, we may make additional investments in that portfolio company as
“follow-on”
investments, in order to: (i) increase or maintain in whole or in part our ownership percentage; (ii) exercise warrants, options or convertible securities that were acquired in the original or subsequent financing; or (iii) attempt to preserve or enhance the value of our investment. We may elect not to make
follow-on
investments or otherwise lack sufficient funds to make those investments. We will have the discretion to make any
follow-on
investments, subject to the availability of capital resources. The failure to make
follow-on
investments may, in some circumstances, jeopardize the continued viability of a portfolio company and our initial investment, or may result in a missed opportunity for us to increase our participation in a successful operation. Even if we have sufficient capital to make a desired
follow-on
investment, we may elect not to make a
follow-on
investment because we may not want to increase our concentration of risk, either because we prefer other opportunities or because we are subject to BDC requirements that would prevent such
follow-on
investments or the desire to maintain our RIC tax treatment.
Where we do not hold controlling equity interests in our portfolio companies, we may not be in a position to exercise control over our portfolio companies or to prevent decisions by management of our portfolio companies that could decrease the value of our investments.
Although we hold controlling equity positions in some of our portfolio companies, we do not currently hold controlling equity positions in the majority of our portfolio companies. As a result, we are subject to the risk that a portfolio company in which we do not have a controlling interest may make business decisions with which we disagree, and that the management and/or stockholders of such portfolio company may take risks or otherwise act in ways that are adverse to our interests. Due to the lack of liquidity of the debt and equity investments that we typically hold in our portfolio companies, we may not be able to dispose of our investments in the event we disagree with the actions of a portfolio company and may therefore suffer a decrease in the value of our investments.
Prepayments of our debt investments by our portfolio companies could adversely impact our results of operations and reduce our return on equity.
We are subject to the risk that the investments we make in our portfolio companies may be prepaid prior to maturity. When this occurs, we may reduce our borrowings outstanding or reinvest these proceeds in temporary investments, pending their future investment in new portfolio companies. These temporary investments, if any, will typically have substantially lower yields than the debt investment being prepaid and we could experience significant delays in reinvesting these amounts. Any future investment in a new portfolio company may also be at lower yields than the debt investment that was prepaid. As a result, our results of operations could be materially adversely affected if one or more of our portfolio companies elect to prepay amounts owed to us. Additionally, prepayments could negatively impact our return on equity, which could result in a decline in the market price of our common stock.
We may choose to waive or defer enforcement of covenants in the debt securities held in our portfolio, which may cause us to lose all or part of our investment in these companies.
We structure the debt investments in our portfolio companies to include business and financial covenants placing affirmative and negative obligations on the operation of the company’s business and its financial condition.
 
36

However, from time to time we may elect to waive breaches of these covenants, including our right to payment, or waive or defer enforcement of remedies, such as acceleration of obligations or foreclosure on collateral, depending upon the financial condition and prospects of the particular portfolio company. These actions may reduce the likelihood of our receiving the full amount of future payments of interest or principal and be accompanied by a deterioration in the value of the underlying collateral as many of these companies may have limited financial resources, may be unable to meet future obligations and may go bankrupt. This could negatively impact our ability to pay distributions, could adversely affect our results of operation and financial condition and cause the loss of all or part of your investment.
In addition, some of the loans in which we may invest may be “covenant-lite” loans. We use the term “covenant-lite” loans to refer generally to loans that do not have a complete set of financial maintenance covenants.
Generally, “covenant-lite” loans provide borrower companies more freedom to negatively impact lenders because their covenants are incurrence-based, which means they are only tested and can only be breached following an affirmative action of the borrower, rather than by a deterioration in the borrower’s financial condition. Accordingly, to the extent we invest in “covenant-lite” loans, we may have fewer rights against a borrower and may have a greater risk of loss on such investments as compared to investments in or exposure to loans with financial maintenance covenants.
Our loans could be subject to equitable subordination by a court which would increase our risk of loss with respect to such loans.
Courts may apply the doctrine of equitable subordination to subordinate the claim or lien of a lender against a borrower to claims or liens of other creditors of the borrower, when the lender or its affiliates is found to have engaged in unfair, inequitable or fraudulent conduct. The courts have also applied the doctrine of equitable subordination when a lender or its affiliates is found to have exerted inappropriate control over a client, including control resulting from the ownership of equity interests in a client. We have made direct equity investments or received warrants in connection with loans. Payments on one or more of our loans, particularly a loan to a client in which we may also hold an equity interest, may be subject to claims of equitable subordination. If we were deemed to have the ability to control or otherwise exercise influence over the business and affairs of one or more of our portfolio companies resulting in economic hardship to other creditors of that company, this control or influence may constitute grounds for equitable subordination and a court may treat one or more of our loans as if it were unsecured or common equity in the portfolio company. In that case, if the portfolio company were to liquidate, we would be entitled to repayment of our loan on a
pro-rata
basis with other unsecured debt or, if the effect of subordination was to place us at the level of common equity, then on an equal basis with other holders of the portfolio company’s common equity only after all of its obligations relating to its debt and preferred securities had been satisfied.
An investment strategy focused primarily on privately held companies presents certain challenges, including the lack of available information about these companies, a dependence on the talents and efforts of only a few key portfolio company personnel and a greater vulnerability to economic downturns.
We invest primarily in privately held companies. Generally, little public information exists about these companies, and we are required to rely on the ability of SLR Capital Partners’ investment professionals to obtain adequate information to evaluate the potential returns from investing in these companies. If we are unable to uncover all material information about these companies, we may not make a fully informed investment decision, and we may lose money on our investments. Also, smaller privately held companies frequently have less diverse product lines and smaller market presence than larger competitors. These factors could adversely affect our investment returns as compared to companies investing primarily in the securities of public companies.
 
37

Our portfolio companies may incur debt that ranks equally with, or senior to, our investments in such companies.
We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. Our portfolio companies typically have, or may be permitted to incur, other debt that ranks equally with, or senior to, the debt securities in which we invest. By their terms, such debt instruments may provide that the holders are entitled to receive payment of interest or principal on or before the dates on which we are entitled to receive payments in respect of the debt securities in which we invest. Also, in the event of insolvency, liquidation, dissolution, reorganization or bankruptcy of a portfolio company, holders of debt instruments ranking senior to our investment in that portfolio company would typically be entitled to receive payment in full before we receive any distribution in respect of our investment. After repaying such senior creditors, such portfolio company may not have any remaining assets to use for repaying its obligation to us. In the case of debt ranking equally with debt securities in which we invest, we would have to share on an equal basis any distributions with other creditors holding such debt in the event of an insolvency, liquidation, dissolution, reorganization or bankruptcy of the relevant portfolio company. Any such limitations on the ability of our portfolio companies to make principal or interest payments to us, if at all, may reduce our net asset value and have a negative material adverse impact to our business, financial condition and results of operation.
Our investments in foreign securities may involve significant risks in addition to the risks inherent in U.S. investments.
Our investment strategy contemplates potential investments in debt securities of foreign companies, including emerging market companies. Investing in foreign companies may expose us to additional risks not typically associated with investing in U.S. companies. These risks include changes in exchange control regulations, political and social instability, expropriation, imposition of foreign taxes, less liquid markets and less available information than is generally the case in the United States, higher transaction costs, less government supervision of exchanges, brokers and issuers, less developed bankruptcy laws, difficulty in enforcing contractual obligations, lack of uniform accounting and auditing standards and greater price volatility. These risks may be more pronounced for portfolio companies located or operating primarily in emerging markets, whose economies, markets and legal systems may be less developed.
Although most of our investments will be U.S. dollar-denominated, any investments denominated in a foreign currency will be subject to the risk that the value of a particular currency will change in relation to one or more other currencies. Among the factors that may affect currency values are trade balances, the level of short-term interest rates, differences in relative values of similar assets in different currencies, long-term opportunities for investment and capital appreciation, and political developments. We may employ hedging techniques to minimize these risks, but we can offer no assurance that we will, in fact, hedge currency risk, or that if we do, such strategies will be effective.
We may expose ourselves to risks if we engage in hedging transactions.
If we engage in hedging transactions, we may expose ourselves to risks associated with such transactions. We may utilize instruments such as forward contracts, currency options and interest rate swaps, caps, collars and floors to seek to hedge against fluctuations in the relative values of our portfolio positions from changes in currency exchange rates and market interest rates. Hedging against a decline in the values of our portfolio positions does not eliminate the possibility of fluctuations in the values of such positions or prevent losses if the values of such positions decline. However, such hedging can establish other positions designed to gain from those same developments, thereby offsetting the decline in the value of such portfolio positions. Such hedging transactions may also limit the opportunity for gain if the values of the underlying portfolio positions should increase. It may not be possible to hedge against an exchange rate or interest rate fluctuation that is so generally anticipated that we are not able to enter into a hedging transaction at an acceptable price.
 
38

The success of our hedging transactions will depend on our ability to correctly predict movements in currencies and interest rates. Therefore, while we may enter into such transactions to seek to reduce currency exchange rate and interest rate risks, unanticipated changes in currency exchange rates or interest rates may result in poorer overall investment performance than if we had not engaged in any such hedging transactions. In addition, the degree of correlation between price movements of the instruments used in a hedging strategy and price movements in the portfolio positions being hedged may vary. Moreover, for a variety of reasons, we may not seek to establish a perfect correlation between such hedging instruments and the portfolio holdings being hedged. Any such imperfect correlation may prevent us from achieving the intended hedge and expose us to risk of loss. In addition, it may not be possible to hedge fully or perfectly against currency fluctuations affecting the value of securities denominated in
non-U.S.
currencies because the value of those securities is likely to fluctuate as a result of factors not related to currency fluctuations. To the extent we engage in hedging transactions, we also face the risk that counterparties to the derivative instruments we hold may default, which may expose us to unexpected losses from positions where we believed that our risk had been appropriately hedged.
Our Investment Adviser may not be able to achieve the same or similar returns as those achieved for other funds it currently manages or by our senior investment professionals while they were employed at prior positions.
Our Investment Adviser manages other funds, including other BDCs, and may manage other entities in the future. The track record and achievements of these other entities are not necessarily indicative of future results that will be achieved by our Investment Adviser because these other entities may have investment objectives and strategies that differ from ours. Additionally, although in the past our senior investment professionals held senior positions at a number of investment firms, their track record and achievements are not necessarily indicative of future results that will be achieved by our Investment Adviser. In their roles at such other firms, our senior investment professionals were part of investment teams, and they were not solely responsible for generating investment ideas. In addition, such investment teams arrived at investment decisions by consensus.
We may be exposed to higher risks with respect to our investments that include original issue discount or PIK interest.
Zero-coupon bonds pay interest only at maturity rather than at intervals during the life of the security. Deferred interest rate bonds generally provide for a period of delay before the regular payment of interest begins. PIK securities are debt obligations that pay “interest” in the form of other debt obligations, instead of in cash. Each of these instruments is normally issued and traded at a deep discount from face value. Zero-coupon bonds, deferred interest rate bonds and PIKs allow an issuer to avoid or delay the need to generate cash to meet current interest payments and, as a result, may involve greater credit risk than bonds that pay interest currently or in cash. In addition, such investments experience greater volatility in market value due to changes in interest rates than debt obligations that provide for regular payments of interest.
To the extent we invest in original issue discount instruments, including PIK, zero coupon bonds, and debt securities with attached warrants, investors will be exposed to the risks associated with the inclusion of such
non-cash
income in taxable and accounting income prior to receipt of cash, including the following:
 
   
The interest payments deferred on a PIK loan are subject to the risk that the borrower may default when the deferred payments are due in cash at the maturity of the loan;
 
   
The interest rates on PIK loans are higher to reflect the time-value of money on deferred interest payments and the higher credit risk of borrowers who may need to defer interest payments;
 
   
PIK instruments may have unreliable valuations because the accruals require judgments about ultimate collectability of the deferred payments and the value of the associated collateral;
 
   
An election to defer PIK income payments by adding them to principal increases our gross assets and, thus, increases future base fees to the Investment Adviser and, because income payments will then be
 
39

 
payable on a larger principal amount, the PIK election also increases the Investment Adviser’s future income incentive fees at a compounding rate;
 
   
Market prices of original issue discount instruments are more volatile because they are affected to a greater extent by interest rate changes than instruments that pay interest periodically in cash;
 
   
The deferral of interest on a PIK loan increases its
loan-to-value
ratio, which is a measure of the riskiness of a loan; and
 
   
Original issue discount creates the risk of
non-refundable
cash payments to the Investment Adviser based on
non-cash
accruals that may never be realized.
Risks Relating to an Investment in Our Securities
Our shares may trade at a substantial discount from net asset value and may continue to do so over the long term.
Shares of BDCs may trade at a market price that is less than the net asset value that is attributable to those shares. The possibility that our shares of common stock will trade at a substantial discount from net asset value over the long term is separate and distinct from the risk that our net asset value will decrease. We cannot predict whether shares of our common stock will trade above, at or below our net asset value in the future. If our common stock trades below its net asset value, we will generally not be able to issue additional shares or sell our common stock at its market price without first obtaining the approval for such issuance from our stockholders and our independent directors. If additional funds are not available to us, we could be forced to curtail or cease our new lending and investment activities, and our net asset value could decrease and our level of distributions could be impacted.
Our common stock price may be volatile and may decrease substantially.
The trading price of our common stock may fluctuate substantially. The price of our common stock that will prevail in the market may be higher or lower than the price you pay, depending on many factors, some of which are beyond our control and may not be directly related to our operating performance. These factors include, but are not limited to, the following:
 
   
price and volume fluctuations in the overall stock market from time to time;
 
   
investor demand for our shares;
 
   
significant volatility in the market price and trading volume of securities of BDCs or other companies in our sector, which are not necessarily related to the operating performance of these companies;
 
   
exclusion of our common stock from certain market indices, such as the Russell 2000 Financial Services Index, which could reduce the ability of certain investment funds to own our common stock and put short-term selling pressure on our common stock;
 
   
changes in regulatory policies or tax guidelines with respect to RICs or BDCs;
 
   
failure to qualify as a RIC, or the loss of RIC tax treatment;
 
   
any shortfall in revenue or net income or any increase in losses from levels expected by investors or securities analysts;
 
   
changes, or perceived changes, in the value of our portfolio investments;
 
   
departures of SLR Capital Partners’ key personnel;
 
   
operating performance of companies comparable to us;
 
   
changes in the prevailing interest rates;
 
40

   
loss of a major funding source; or
 
   
general economic conditions and trends and other external factors.
Our businesses may be adversely affected by litigation and regulatory proceedings.
From time to time, we may be subject to legal actions as well as various regulatory, governmental and law enforcement inquiries, investigations and subpoenas. In any such claims or actions, demands for substantial monetary damages may be asserted against us and may result in financial liability or an adverse effect on our reputation among investors. In connection with acquisitions of, and investments in, businesses complementary to our business, we have been and may be in the future subject to securities litigation or stockholder activism in connection with such acquisitions or investments. Securities litigation and stockholder activism, including potential proxy contests, could result in substantial costs and divert management’s and our board of directors’ attention and resources from our business. We may be unable to accurately estimate our exposure to litigation risk when we record balance sheet reserves for probable loss contingencies. As a result, any reserves we establish to cover any settlements or judgments may not be sufficient to cover our actual financial exposure, which may have a material impact on our results of operations or financial condition. In regulatory enforcement matters, claims for disgorgement, the imposition of penalties and the imposition of other remedial sanctions are possible.
If the current period of capital market disruption and instability continues for an extended period of time, there is a risk that investors in our equity securities may not receive distributions consistent with historical levels or at all or that our distributions may not grow over time and a portion of our distributions may be a return of capital.
We intend to make distributions on a quarterly basis to our stockholders out of assets legally available for distribution. We cannot assure you that we will achieve investment results that will allow us to make a specified level of cash distributions. Our ability to pay distributions might be adversely affected by the impact of one or more of the risk factors described in this annual report on Form
10-K.
If we violate certain covenants under our existing or future credit facilities or other leverage, we may be limited in our ability to make distributions. If we declare a distribution and if more stockholders opt to receive cash distributions rather than participate in our dividend reinvestment plan, we may be forced to sell some of our investments in order to make cash distribution payments. To the extent we make distributions to stockholders that include a return of capital, such portion of the distribution essentially constitutes a return of the stockholder’s investment. Although such return of capital may not be taxable, such distributions would generally decrease a stockholder’s basis in our common stock and may therefore increase such stockholder’s tax liability for capital gains upon the future sale of such stock. A return of capital distribution may cause a stockholder to recognize a capital gain from the sale of our common stock even if the stockholder sells its shares for less than the original purchase price.
As a RIC, if we do not distribute a certain percentage of our income annually, we may suffer adverse tax consequences, including possibly losing the U.S. federal income tax benefits allowable to RICs. We cannot assure you that you will receive distributions at a particular level or at all.
In certain cases, we may recognize income before or without receiving the accompanying cash. Depending on the amount of noncash income, this could result in difficulty satisfying the annual distribution requirement applicable to RICs. Accordingly, we may have to sell some portfolio investments at times it would not consider advantageous, raise additional debt or equity capital or reduce new investments to meet these distribution requirements.
Due to disruptions in the economy, we may reduce or defer our dividends and choose to incur U.S. federal excise tax in order to preserve cash and maintain flexibility.
In order to maintain our tax treatment as a RIC, we must distribute to stockholders for each taxable year at least 90% of our investment company taxable income (i.e., net ordinary income plus realized net short-term capital
 
41

gains in excess of realized net long-term capital losses). If we qualify for taxation as a RIC, we generally will not be subject to corporate-level US federal income tax on our investment company taxable income and net capital gains (i.e., realized net long-term capital gains in excess of realized net short-term capital losses) that we timely distribute to stockholders. We will be subject to a 4% U.S. federal excise tax on undistributed earnings of a RIC unless we distribute each calendar year at least the sum of (i) 98.0% of our ordinary income for the calendar year, (ii) 98.2% of our capital gains in excess of capital losses for the
one-year
period ending on October 31 of the calendar year, and (iii) any ordinary income and net capital gains that were recognized for preceding years, but were not distributed during such years and on which we paid no U.S. federal income tax. Any net operating losses that we incur in periods during which we qualify as a RIC will not offset net capital gains (i.e., net realized long-term capital gains in excess of net realized short-term capital losses) that we are otherwise required to distribute, and we cannot pass such net operating losses through to our stockholders. In addition, net operating losses that we carry over to a taxable year in which we qualify as a RIC normally cannot offset ordinary income or capital gains.
Under the Code, we may satisfy certain of our RIC distributions with dividends paid after the end of the current year. In particular, if we pay a distribution in January of the following year that was declared in October, November, or December of the current year and is payable to stockholders of record in the current year, the dividend will be treated for all US federal income tax purposes as if it were paid on December 31 of the current year. In addition, under the Code, we may pay dividends, referred to as “spillover dividends,” that are paid during the following taxable year that will allow us to maintain our qualification for taxation as a RIC and eliminate our liability for corporate-level U.S. federal income tax. Under these spillover dividend procedures, we may defer distribution of income earned during the current year until December of the following year. For example, we may defer distributions of income earned during 2024 until as late as December 31, 2025. If we choose to pay a spillover dividend, we will incur the 4% U.S. federal excise tax on some or all of the distribution.
Due to events such as the
COVID-19
pandemic, certain regional bank failures, the Russian invasion of Ukraine, the ongoing war in the Middle East or other disruptions in the economy, such as the recent inflationary environment, we may take certain actions with respect to the timing and amounts of our distributions in order to preserve cash and maintain flexibility. For example, we may reduce our dividends and/or defer dividends to the following taxable year. If we defer our dividends, we may choose to utilize the spillover dividend rules discussed above and incur the 4% U.S. federal excise tax on such amounts. To further preserve cash, we may combine these reductions or deferrals of dividends with one or more distributions that are payable partially in our stock as discussed below under “
We may choose to pay distributions in our own stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive.”
We may choose to pay distributions in our own common stock, in which case our stockholders may be required to pay U.S. federal income taxes in excess of the cash distributions they receive.
We may distribute taxable distributions that are payable in part in shares of our common stock. Under certain applicable provisions of the Code and the published guidance, distributions of a publicly offered RIC that are in cash or in shares of stock at the election of stockholders may be treated as taxable distributions. The Internal Revenue Service has issued a revenue procedure indicating that this rule will apply if the total amount of cash to be distributed is not less than 20% of the total distribution. Under this revenue procedure, if too many stockholders elect to receive their distributions in cash, the cash available for distribution must be allocated among the stockholders electing to receive cash (with the balance of distributions paid in stock). In no event will any stockholder electing to receive cash, receive less than the lesser of (a) the portion of the distribution such stockholder has elected to receive in cash or (b) an amount equal to his or her entire distribution times the percentage limitation on cash available for distribution. If we decide to make any distributions consistent with this revenue procedure that are payable in part in our stock, taxable stockholders receiving such distributions will be required to include the full amount of the distribution (whether received in cash, our stock, or a combination thereof) as ordinary income (or as long-term capital gain to the extent such distribution is properly reported as a capital gain distribution) to the extent of our current and accumulated earnings and profits for U.S. federal
 
42

income tax purposes. As a result, a U.S. stockholder may be required to pay tax with respect to such distributions in excess of any cash received. If a U.S. stockholder sells the stock it receives as a distribution in order to pay this tax, the sales proceeds may be less than the amount included in income with respect to the distribution, depending on the market price of our stock at the time of the sale. Furthermore, with respect to
non-U.S.
stockholders, we may be required to withhold U.S. tax with respect to such distributions, including in respect of all or a portion of such distribution that is payable in stock. If a significant number of our stockholders determine to sell shares of our stock in order to pay taxes owed on distributions, it may put downward pressure on the trading price of our stock.
Sales of substantial amounts of our common stock in the public market may have an adverse effect on the market price of our common stock.
The shares of our common stock beneficially owned by each of Messrs. Gross and Spohler immediately prior to completion of our initial public offering, including any shares that are attributable to such shares issued pursuant to our dividend reinvestment plan, are no longer subject to
lock-up
restrictions that each of Messrs. Gross and Spohler agreed to in connection with our initial public offering, and are generally available for resale without restriction, subject to the provisions of Rule 144 promulgated under the Securities Act of 1933, as amended (the “Securities Act”). In addition, on November 30, 2010, Messrs. Gross and Spohler jointly acquired 115,000 shares of our common stock in a private placement transaction conducted in accordance with Regulation D under the Securities Act. Such shares are generally available for resale without restriction, subject to the provisions of Rule 144 promulgated under the Securities Act. Sales of substantial amounts of our common stock, or the availability of such common stock for sale, could adversely affect the prevailing market prices for our common stock. If this occurs and continues, it could impair our ability to raise additional capital through the sale of securities should we desire to do so.
We may be unable to invest the net proceeds raised from any offerings on acceptable terms or allocate net proceeds from any offering of our securities in ways with which you may not agree.
We cannot assure you that we will be able to find enough appropriate investments that meet our investment criteria or that any investment we complete using the proceeds from any securities offering will produce a sufficient return. Until we identify new investment opportunities, we intend to either invest the net proceeds of future offerings in cash equivalents, U.S. government securities and other high-quality debt investments that mature in one year or less or use the net proceeds from such offerings to reduce then-outstanding obligations.
We have significant flexibility in investing the net proceeds of any offering of our securities and may use the net proceeds from an offering in ways with which you may not agree or for purposes other than those contemplated at the time of the offering.
The net asset value per share of our common stock may be diluted if we issue or sell shares of our common stock at prices below the then current net asset value per share of our common stock or securities to subscribe for or convertible into shares of our common stock.
We will generally not be able to issue additional shares or sell our common stock at its market price without first obtaining the approval for such issuance from our stockholders and our independent directors. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval. At our 2011 Annual Stockholders Meeting, our stockholders authorized us to sell or otherwise issue warrants or securities to subscribe for or convertible into shares of our common stock subject to certain limitations (including, without limitation, that the number of shares issuable does not exceed 25% of our then outstanding common stock and that the exercise or conversion price thereof is not, at the date of issuance, less than the market value per share of our common stock). Such authorization has no expiration.
We may also use newly issued shares to implement our dividend reinvestment plan, whether our shares are trading at a premium or at a discount to our then current net asset value per share. Any decision to issue or sell
 
43

shares of our common stock below our then current net asset value per share or securities to subscribe for or convertible into shares of our common stock would be subject to the determination by our board of directors that such issuance or sale is in our and our stockholders’ best interests.
If we were to issue or sell shares of our common stock below our then current net asset value per share, such issuances or sales would result in an immediate dilution to the net asset value per share of our common stock.
This dilution would occur as a result of the issuance or sale of shares at a price below the then current net asset value per share of our common stock and a proportionately greater decrease in the stockholders’ interest in our earnings and assets and their voting interest in us than the increase in our assets resulting from such issuance or sale. Because the number of shares of common stock that could be so issued and the timing of any issuance is not currently known, the actual dilutive effect cannot be predicted.
In addition, if we issue warrants or securities to subscribe for or convertible into shares of our common stock, subject to certain limitations, the exercise or conversion price per share could be less than net asset value per share at the time of exercise or conversion (including through the operation of anti-dilution protections).
Because we would incur expenses in connection with any issuance of such securities, such issuance could result in a dilution of the net asset value per share at the time of exercise or conversion. This dilution would include reduction in net asset value per share as a result of the proportionately greater decrease in the stockholders’ interest in our earnings and assets and their voting interest than the increase in our assets resulting from such issuance.
Further, if our current stockholders do not purchase any shares to maintain their percentage interest, regardless of whether such offering is above or below the then current net asset value per share, their voting power will be diluted. For example, if we sell an additional 10% of our common stock at a 5% discount from net asset value, a stockholder who does not participate in that offering for its proportionate interest will suffer net asset value dilution of up to 0.5% or $5 per $1,000 of net asset value.
Similarly, all distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are automatically reinvested in shares of our common stock. As a result, stockholders that opt out of the dividend reinvestment plan may experience dilution over time. Stockholders who do not elect to receive distributions in shares of common stock may experience accretion to the net asset value of their shares if our shares are trading at a premium and dilution if our shares are trading at a discount. The level of accretion or discount would depend on various factors, including the proportion of our stockholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to a stockholder.
If we issue preferred stock, the net asset value and market value of our common stock may become more volatile.
We cannot assure you that the issuance of preferred stock would result in a higher yield or return to the holders of the common stock. The issuance of preferred stock would likely cause the net asset value and market value of the common stock to become more volatile. If the distribution rate on the preferred stock were to approach the net rate of return on our investment portfolio, the benefit of leverage to the holders of the common stock would be reduced. If the distribution rate on the preferred stock were to exceed the net rate of return on our portfolio, the leverage would result in a lower rate of return to the holders of common stock than if we had not issued preferred stock. Any decline in the net asset value of our investments would be borne entirely by the holders of common stock. Therefore, if the market value of our portfolio were to decline, the leverage would result in a greater decrease in net asset value to the holders of common stock than if we were not leveraged through the issuance of preferred stock. This greater net asset value decrease would also tend to cause a greater decline in the market price for the common stock. We might be in danger of failing to maintain the required asset coverage of the preferred stock or of losing our ratings on the preferred stock or, in an extreme case, our current investment
 
44

income might not be sufficient to meet the distribution requirements on the preferred stock. In order to counteract such an event, we might need to liquidate investments in order to fund a redemption of some or all of the preferred stock. In addition, we would pay (and the holders of common stock would bear) all costs and expenses relating to the issuance and ongoing maintenance of the preferred stock, including higher advisory fees if our total return exceeds the distribution rate on the preferred stock. Holders of preferred stock may have different interests than holders of common stock and may at times have disproportionate influence over our affairs.
Our board of directors is authorized to reclassify any unissued shares of common stock into one or more classes of preferred stock, which could convey special rights and privileges to its owners.
Under Maryland General Corporation Law and our charter, our board of directors is authorized to classify and reclassify any authorized but unissued shares of stock into one or more classes of stock, including preferred stock. Prior to issuance of shares of each class or series, the board of directors is required by Maryland law and our charter to set the preferences, conversion or other rights, voting powers, restrictions, limitations as to other distributions, qualifications and terms or conditions of redemption for each class or series. Thus, the board of directors could authorize the issuance of shares of preferred stock with terms and conditions which could have the effect of delaying, deferring or preventing a transaction or a change in control that might involve a premium price for holders of our common stock or otherwise be in their best interest. The cost of any such reclassification would be borne by our existing common stockholders. The issuance of shares of preferred stock convertible into shares of common stock might also reduce the net income and net asset value per share of our common stock upon conversion, provided, that we will only be permitted to issue such convertible preferred stock to the extent we comply with the requirements of Section 61 of the 1940 Act, including obtaining common stockholder approval. These effects, among others, could have an adverse effect on your investment in our common stock.
Certain matters under the 1940 Act require the separate vote of the holders of any issued and outstanding preferred stock. For example, holders of preferred stock would vote separately from the holders of common stock on a proposal to cease operations as a BDC. In addition, the 1940 Act provides that holders of preferred stock are entitled to vote separately from holders of common stock to elect two preferred stock directors. In the event distributions become two full years in arrears, holders of any preferred stock would have the right to elect a majority of the directors until such arrearage is completely eliminated. Preferred stockholders also have class voting rights on certain matters, including changes in fundamental investment restrictions and conversion to
open-end
status, and accordingly can veto any such changes. Restrictions imposed on the declarations and payment of distributions to the holders of our common stock and preferred stock, both by the 1940 Act and by requirements imposed by rating agencies or the terms of our credit facilities, might impair our ability to maintain our qualification for tax treatment as a RIC for U.S. federal income tax purposes. While we would intend to redeem our preferred stock to the extent necessary to enable us to distribute our income as required to maintain our qualification as a RIC, there can be no assurance that such actions could be effected in time to meet the tax requirements.
To the extent we use debt or preferred stock to finance our investments, changes in interest rates will affect our cost of capital and net investment income.
To the extent we borrow money, or issue preferred stock, to make investments, our net investment income will depend, in part, upon the difference between the rate at which we borrow funds or pay distributions on preferred stock and the rate at which we invest those funds. In addition, many of our debt investments and borrowings have floating interest rates that reset on a periodic basis, and many of our investments are subject to interest rate floors. As a result, we can offer no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income in the event we use debt to finance our investments. In periods of rising interest rates, such as the recent economic period, our cost of funds have increased, and could continue to increase, because the interest rates on the amounts borrowed under our credit facilities or certain other financing arrangements are typically floating, except to the extent we issue fixed rate debt or preferred stock, which could reduce our net investment income, and the interest rate on investments with an interest rate
 
45

floor (such as a SOFR floor) above current levels will not increase until interest rates exceed the applicable floor. We expect that our long-term fixed-rate investments will generally be financed with equity and long-term debt.
We may use interest rate risk management techniques in an effort to limit our exposure to interest rate fluctuations. Such techniques may include various interest rate hedging activities to the extent permitted by the 1940 Act. These activities could limit our ability to participate in the benefits of lower interest rates with respect to the hedged borrowings. Adverse developments resulting from changes in interest rates or hedging transactions could have a material adverse effect on our business, financial condition and results of operations.
You should also be aware that the rise in the general level of interest rates can be expected to lead to higher interest rates applicable to our debt investments. Accordingly, such increase in interest rates makes it easier for us to meet or exceed the incentive fee hurdle rate and may result in a substantial increase of the amount of incentive fees payable to our Investment Adviser with respect to our
pre-incentive
fee net investment income. Also, an increase in interest rates available to investors could make an investment in our common stock less attractive if we are not able to increase our distribution rate, which could reduce the value of our common stock.
We may in the future determine to fund a portion of our investments with preferred stock, which would magnify the potential for loss and the risks of investing in us in a similar way as our borrowings.
Preferred stock, which is another form of leverage, has the same risks to our common stockholders as borrowings because the distributions on any preferred stock we issue must be cumulative. Payment of such distributions and repayment of the liquidation preference of such preferred stock must take preference over any distributions or other payments to our common stockholders, and preferred stockholders are not subject to any of our expenses or losses and are not entitled to participate in any income or appreciation in excess of their stated preference.
Our stock repurchase program could affect the price of our common stock and increase volatility and may be suspended or terminated at any time, which may result in a decrease in the trading price of our common stock.
On May 9, 2023, our board of directors most recently extended our share repurchase program (the “Program”), under which we can repurchase up to $50 million shares of our outstanding common stock. Under the Program, purchases can be made at management’s discretion from time to time in open-market transactions, in accordance with all applicable securities laws and regulations, at prices below the Company’s NAV as reported in its most recently published consolidated financial statements. We have in the past, and could in the future, enter into a plan to repurchase shares of our common stock pursuant to the Program in a manner intended to comply with the requirements of
Rule 10b5-1
under the 1934 Act.
The Program is discretionary and whether purchases will be made under the Program and how much will be purchased at any time is uncertain and dependent on prevailing market prices and trading volumes, all of which we cannot predict. These activities could have the effect of maintaining the market price of our common stock or retarding a decline in the market price of the common stock, and, as a result, the price of our common stock could be higher than the price that otherwise might exist in the open market. Repurchases pursuant to the Program could affect the price of our common stock and increase its volatility. The existence of the Program could also cause the price of our common stock to be higher than it would be in the absence of such a program and could potentially reduce the market liquidity for our common stock. There can be no assurance that any stock repurchases will enhance stockholder value because the market price of our common stock could decline below the levels at which we repurchased such shares. Any failure to repurchase shares after we have announced our intention to do so could negatively impact our reputation and investor confidence in us and could negatively impact our stock price. Although the Program is intended to enhance long-term stockholder value, short-term stock price fluctuations could reduce the Program’s effectiveness.
 
46

Risks Relating to Our Business and Structure
We are dependent upon SLR Capital Partners’ key personnel for our future success.
We depend on the diligence, skill and network of business contacts of Messrs. Gross and Spohler, who serve as the managing partners of SLR Capital Partners and who lead SLR Capital Partners’ investment team. Messrs. Gross and Spohler, together with the other dedicated investment professionals available to SLR Capital Partners, evaluate, negotiate, structure, close and monitor our investments. Our future success will depend on the diligence, skill, network of business contacts and continued service of Messrs. Gross and Spohler and the other investment professionals available to SLR Capital Partners. We cannot assure you that unforeseen business, medical, personal or other circumstances would not lead any such individual to terminate his relationship with us. The loss of Mr. Gross or Mr. Spohler, or any of the other senior investment professionals who serve on SLR Capital Partners’ investment team, could have a material adverse effect on our ability to achieve our investment objective as well as on our financial condition and results of operations. In addition, we can offer no assurance that SLR Capital Partners will remain our Investment Adviser.
The senior investment professionals of SLR Capital Partners are and may in the future become affiliated with entities engaged in business activities similar to those intended to be conducted by us, and may have conflicts of interest in allocating their time. We expect that Messrs. Gross and Spohler will dedicate a significant portion of their time to the activities of SLR Investment Corp.; however, they may be engaged in other business activities which could divert their time and attention in the future. Specifically, Mr. Gross serves as
Co-Chief
Executive Officer and President of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. In addition, Mr. Spohler serves as
Co-Chief
Executive Officer and Chief Operating Officer of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC.
Our business model depends to a significant extent upon strong referral relationships with financial sponsors, and the inability of the senior investment professionals of our Investment Adviser to maintain or develop these relationships, or the failure of these relationships to generate investment opportunities, could adversely affect our business.
We expect that the principals of our Investment Adviser will maintain and develop their relationships with financial sponsors, and we will rely to a significant extent upon these relationships to provide us with potential investment opportunities. If the senior investment professionals of our Investment Adviser fail to maintain their existing relationships or develop new relationships with other sponsors or sources of investment opportunities, we will not be able to grow our investment portfolio. In addition, individuals with whom the senior investment professionals of our Investment Adviser have relationships are not obligated to provide us with investment opportunities, and, therefore, there is no assurance that such relationships will generate investment opportunities for us. If our Investment Adviser is unable to source investment opportunities, we may hold a greater percentage of our assets in cash and cash equivalents than anticipated, which could impact potential returns on our portfolio.
A disruption in the capital markets and the credit markets could negatively affect our business.
As a BDC, we must maintain our ability to raise additional capital for investment purposes. Without sufficient access to the capital markets or credit markets, we may be forced to curtail our business operations or we may not be able to pursue new business opportunities. Disruptive conditions in the financial industry and the impact of new legislation in response to those conditions could restrict our business operations and could adversely impact our results of operations and financial condition.
If the fair value of our assets declines substantially, we may fail to maintain the asset coverage ratios imposed upon us by the 1940 Act and our existing credit facilities. Any such failure could result in an event of default and all of our debt being declared immediately due and payable and would affect our ability to issue senior securities, including borrowings, and pay distributions, which could materially impair our business operations. Our liquidity could be impaired further by an inability to access the capital markets or to draw on our credit facilities. For
 
47

example, we cannot be certain that we will be able to renew our existing credit facilities as they mature or to consummate new borrowing facilities to provide capital for normal operations, including new originations. Reflecting concern about the stability of the financial markets, many lenders and institutional investors have reduced or ceased providing funding to borrowers. This market turmoil and tightening of credit have led to increased market volatility and widespread reduction of business activity generally.
If we are unable to renew or replace our existing credit facilities and consummate new facilities on commercially reasonable terms, our liquidity will be reduced significantly. If we consummate new facilities but are then unable to repay amounts outstanding under such facilities and are declared in default or are unable to renew or refinance these facilities, we would not be able to initiate significant originations or to operate our business in the normal course. These situations may arise due to circumstances that we may be unable to control, such as inaccessibility to the credit markets, a severe decline in the value of the U.S. dollar, a further economic downturn or an operational problem that affects third parties or us, and could materially damage our business. Moreover, we are unable to predict when economic and market conditions may become more favorable. Even if such conditions improve broadly and significantly over the long term, adverse conditions in particular sectors of the financial markets could adversely impact our business.
Our financial condition and results of operations will depend on SLR Capital Partners’ ability to manage our future growth effectively by identifying, investing in and monitoring companies that meet our investment criteria.
Our ability to achieve our investment objective and to grow depends on SLR Capital Partners’ ability to identify, invest in and monitor companies that meet our investment criteria. Accomplishing this result on a cost-effective basis is largely a function of SLR Capital Partners’ structuring of the investment process, its ability to provide competent, attentive and efficient services to us and its ability to access financing for us on acceptable terms. The investment team of SLR Capital Partners has substantial responsibilities under the Advisory Agreement, and they may also be called upon to provide managerial assistance to our portfolio companies as the principals of our administrator. In addition, the members of SLR Capital Partners’ investment team have similar responsibilities with respect to the management of other investment portfolios, including the investment portfolios of SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. Such demands on their time may distract them or slow our rate of investment. In order to grow, we and SLR Capital Partners will need to retain, train, supervise and manage new investment professionals. However, we can offer no assurance that any such investment professionals will contribute effectively to the work of the Investment Adviser. Any failure to manage our future growth effectively could have a material adverse effect on our business, financial condition and results of operations.
We may need to raise additional capital to grow because we must distribute most of our income.
We may need additional capital to fund growth in our investments. We expect to issue equity securities and expect to borrow from financial institutions in the future. A reduction in the availability of new capital could limit our ability to grow. We must distribute at least 90% of our investment company taxable income to our stockholders to maintain our tax treatment as a RIC. As a result, any such cash earnings may not be available to fund investment originations. We expect to borrow from financial institutions and issue additional debt and equity securities. If we fail to obtain funds from such sources or from other sources to fund our investments, it could limit our ability to grow, which may have an adverse effect on the value of our securities. In addition, as a BDC, our ability to borrow or issue additional preferred stock may be restricted if our total assets are less than 150% of our total borrowings and preferred stock.
Any failure on our part to maintain our status as a BDC would reduce our operating flexibility and we may be limited in our investment choices as a BDC.
The 1940 Act imposes numerous constraints on the operations of BDCs. For example, BDCs are required to invest at least 70% of their total assets in specified types of securities, primarily in private companies or thinly-
 
48

traded U.S. public companies, cash, cash equivalents, U.S. government securities and other high quality debt investments that mature in one year or less. Furthermore, any failure to comply with the requirements imposed on BDCs by the 1940 Act could cause the SEC to bring an enforcement action against us and/or expose us to claims of private litigants. In addition, upon approval of a majority of our stockholders, we may elect to withdraw our status as a BDC. If we decide to withdraw our election, or if we otherwise fail to qualify, or maintain our qualification, as a BDC, we may be subject to the substantially greater regulation under the 1940 Act as a
closed-end
investment company. Compliance with such regulations would significantly decrease our operating flexibility, and could have a material adverse effect on our business, financial condition and results of operations.
Regulations governing our operation as a BDC affect our ability to, and the way in which we will, raise additional capital. As a BDC, the necessity of raising additional capital may expose us to risks, including the typical risks associated with leverage.
In order to satisfy the tax requirements applicable to a RIC, to avoid payment of excise taxes and to minimize or avoid payment of income taxes, we intend to distribute to our stockholders substantially all of our ordinary income and realized net capital gains except for certain realized net long-term capital gains, which we may retain, pay applicable income taxes with respect thereto and elect to treat as deemed distributions to our stockholders. We may issue debt securities or preferred stock and/or borrow money from banks or other financial institutions, which we refer to collectively as “senior securities,” up to the maximum amount permitted by the 1940 Act. Under the provisions of the 1940 Act, we had been permitted, as a BDC, to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 200% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. However, our stockholders have approved a resolution permitting us to be subject to a 150% asset coverage ratio effective as of October 12, 2018. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. Also, any amounts that we use to service our indebtedness would not be available for distributions to our common stockholders. Furthermore, as a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss. In addition, because our management fee is calculated as a percentage of our gross assets, which includes any borrowings for investment purposes, the management fee expenses will increase if we incur additional indebtedness.
As of December 31, 2023, we had $507.0 million outstanding under the Credit Facility, composed of $407.0 million of revolving credit and $100.0 million outstanding of term loans, and $206.3 million outstanding under our SPV Credit Facility. We also had $135.0 million outstanding of the Series F 2027 Unsecured Notes, $50.0 million outstanding of the 2027 Unsecured Notes, $75.0 million outstanding of the 2026 Unsecured Notes, $85.0 million outstanding of the 2025 Unsecured Notes, and $125.0 million outstanding of the 2024 Unsecured Notes. If we issue preferred stock, the preferred stock would rank “senior” to common stock in our capital structure, preferred stockholders would generally vote together with common stockholders but would have separate voting rights on certain matters and might have other rights, preferences, or privileges more favorable than those of our common stockholders, and the issuance of preferred stock could have the effect of delaying, deferring or preventing a transaction or a change of control that might involve a premium price for holders of our common stock or otherwise be in your best interest.
We are not generally able to issue and sell our common stock at a price below net asset value per share. We may, however, sell our common stock, or warrants, options or rights to acquire our common stock, at a price below the then-current net asset value per share of our common stock if our board of directors determines that such sale is in the best interests of SLR Investment Corp. and its stockholders, and our stockholders approve such sale. In any such case, the price at which our securities are to be issued and sold may not be less than a price that, in the determination of our board of directors, closely approximates the market value of such securities (less any distributing commission or discount). If we raise additional funds by issuing more common stock or senior
 
49

securities convertible into, or exchangeable for, our common stock, then the percentage ownership of our stockholders at that time will decrease, and you might experience dilution. This dilution would occur as a result of a proportionately greater decrease in a stockholder’s interest in our earnings and assets and voting interest in us than the increase in our assets resulting from such issuance. Because the number of future shares of common stock that may be issued below our net asset value per share and the price and timing of such issuances are not currently known, we cannot predict the actual dilutive effect of any such issuance. We cannot determine the resulting reduction in our net asset value per share of any such issuance. We also cannot predict whether shares of our common stock will trade above, at or below our net asset value.
Our credit ratings may not reflect all risks of an investment in our debt securities.
Our credit ratings are an assessment by third parties of our ability to pay our obligations. Consequently, real or anticipated changes in our credit ratings will generally affect the market value of our publicly issued debt securities. Our credit ratings, however, may not reflect the potential impact of risks related to market conditions generally or other factors discussed above on the market value of, or trading market for, any publicly issued debt securities.
Our stockholders may experience dilution in their ownership percentage if they opt out of our dividend reinvestment plan.
All distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are automatically reinvested in shares of our common stock. In the event we issue new shares in connection with our dividend reinvestment plan, our stockholders that do not elect to receive distributions in shares of common stock may experience dilution in their ownership percentage over time as a result of such issuance.
We have and will continue to borrow money, which would magnify the potential for loss on amounts invested and may increase the risk of investing in us.
We borrow money as part of our business plan. Borrowings, also known as leverage, magnify the potential for loss on amounts invested and, therefore, increase the risks associated with investing in our securities. As of December 31, 2023, we had $507.0 million outstanding under the Credit Facility, composed of $407.0 million of revolving credit and $100.0 million outstanding of term loans, and $206.3 million outstanding under our SPV Credit Facility. We also had $135.0 million outstanding of the Series F 2027 Unsecured Notes, $50.0 million outstanding of the 2027 Unsecured Notes, $75.0 million outstanding of the 2026 Unsecured Notes, $85.0 million outstanding of the 2025 Unsecured Notes, and $125.0 million outstanding of the 2024 Unsecured Notes. We may borrow from and issue senior debt securities to banks, insurance companies and other lenders in the future. Lenders of these senior securities, including the Credit Facility, the SPV Credit Facility, the Series F 2027 Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes, and the 2024 Unsecured Notes, will have fixed dollar claims on our assets that are superior to the claims of our common stockholders, and we would expect such lenders to seek recovery against our assets in the event of a default. If the value of our assets increases, then leveraging would cause the net asset value attributable to our common stock to increase more sharply than it would have had we not leveraged. Conversely, if the value of our assets decreases, leveraging would cause net asset value to decline more sharply than it otherwise would have had we not leveraged. Similarly, any decrease in our income would cause net income to decline more sharply than it would have had we not borrowed. Also, any increase in our income in excess of interest payable on the borrowed funds would cause our net investment income to increase more than it would without the leverage, while any decrease in our income would cause net investment income to decline more sharply than it would have had we not borrowed. Such a decline could also negatively affect our ability to make distribution payments on our common stock, scheduled debt payments or other payments related to our securities. Leverage is generally considered a speculative investment technique. Our ability to service any debt that we incur will depend largely on our financial performance and will be subject to prevailing economic conditions and competitive pressures. Moreover, as the management fee payable to our Investment Adviser, SLR Capital Partners, will be payable
 
50

based on our gross assets, including those assets acquired through the use of leverage, SLR Capital Partners will have a financial incentive to incur leverage which may not be consistent with our stockholders’ interests. In addition, our common stockholders will bear the burden of any increase in our expenses as a result of leverage, including any increase in the management fee payable to SLR Capital Partners.
As a BDC, we had generally been required to meet a coverage ratio of total assets to total borrowings and other senior securities, which include all of our borrowings and any preferred stock that we may issue in the future, of at least 200%. However, our stockholders have approved a resolution permitting us to be subject to a 150% asset coverage ratio effective as of October 12, 2018. Even though we are subject to a 150% asset coverage ratio effective as of October 12, 2018, contractual leverage limitations under our existing credit facilities or future borrowings may limit our ability to incur additional indebtedness. On August 28, 2019, we entered into the Credit Agreement, which was amended on December 28, 2021, which permits 150% asset coverage. Some of our wholly and/or substantially owned portfolio companies, including Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment Finance, SLR Business Credit and SLR Healthcare ABL, may incur significantly more leverage than we can but we do not consolidate Kingsbridge Holdings, LLC, SLR Credit Solutions, SLR Equipment Finance, SLR Business Credit and SLR Healthcare ABL and their leverage is
non-recourse
to us. Additionally, the Credit Facility and the SPV Credit Facility require us to comply with certain financial and other restrictive covenants including maintaining an asset coverage ratio of not less than 150% at any time. Failure to maintain compliance with these covenants could result in an event of default and all of our debt being declared immediately due and payable. If this ratio declines below 150%, we may not be able to incur additional debt and could be required by law to sell a portion of our investments to repay some debt when it is disadvantageous to do so, which could have a material adverse effect on our operations, and we may not be able to make distributions. The amount of leverage that we employ will depend on our Investment Adviser’s and our board of directors’ assessment of the market and other factors at the time of any proposed borrowing. We cannot assure you that we will be able to obtain credit at all or on terms acceptable to us.
In addition, our credit facilities impose, and any other debt facility into which we may enter would likely impose, financial and operating covenants that restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain RIC tax treatment under Subchapter M of the Code.
The debt securities that we may issue will be governed by an indenture or other instrument containing covenants restricting our operating flexibility. We, and indirectly our stockholders, bear the cost of issuing and servicing such debt securities. Any convertible or exchangeable securities that we issue in the future may have rights, preferences and privileges more favorable than those of our common stock.
Illustration.
The following table illustrates the effect of leverage on returns from an investment in our common stock assuming various annual returns on our portfolio, net of interest expense. The calculations in the table below are hypothetical and actual returns may be higher or lower than those appearing in the table below.
 
    
Assumed total return
(net of interest expense)
 
    
(10)%
   
(5)%
   
0%
   
5%
   
10%
 
Corresponding return to stockholder(1)
     (32.6 )%      (19.8 )%      (7.1 )%      5.7     18.5
 
(1)
Assumes $2.5 billion in total assets
(inclusive of temporary cash assets of $332 million)
 
and $1.2 billion in total debt outstanding, which reflects our total assets and total debt outstanding as of December 31, 2023, and a cost of funds of 5.88%. Excludes
non-leverage
related expenses.
In order for us to cover our annual interest payments on our outstanding indebtedness at December 31, 2023, we must achieve annual returns on our December 31, 2023 total assets of at least 2.8%.
 
51

It is likely that the terms of any current or future long-term or revolving credit or warehouse facility we may enter into in the future could constrain our ability to grow our business.
Our current lenders have, and any future lender or lenders may have, fixed dollar claims on our assets that are senior to the claims of our stockholders and, thus, will have a preference over our stockholders with respect to our assets in the collateral pool. Our current credit facilities and borrowings also subject us to various financial and operating covenants, including, but not limited to, maintaining certain financial ratios and minimum tangible net worth amounts. Future credit facilities and borrowings will likely subject us to similar or additional covenants. In addition, we may grant a security interest in our assets in connection with any such credit facilities and borrowings.
Our credit facilities generally contain customary default provisions such as a minimum net worth amount, a profitability test, and a restriction on changing our business and loan quality standards. In addition, our credit facilities require or are expected to require the repayment of all outstanding debt on the maturity, which may disrupt our business and potentially the business of our portfolio companies that are financed through our credit facilities. An event of default under our credit facilities would likely result, among other things, in termination of the availability of further funds under our credit facilities and accelerated maturity dates for all amounts outstanding under our credit facilities, which would likely disrupt our business and, potentially, the business of the portfolio companies whose loans we finance through our credit facilities. This could reduce our revenues and, by delaying any cash payment allowed to us under our credit facilities until the lender has been paid in full, reduce our liquidity and cash flow and impair our ability to grow our business and maintain RIC tax treatment.
The terms of future available financing may place limits on our financial and operational flexibility. If we are unable to obtain sufficient capital in the future, we may be forced to reduce or discontinue our operations, not be able to make new investments, or otherwise respond to changing business conditions or competitive pressures.
Our quarterly and annual operating results are subject to fluctuation as a result of the nature of our business, and if we fail to achieve our investment objective, the net asset value of our common stock may decline.
We could experience fluctuations in our quarterly and annual operating results due to a number of factors, some of which are beyond our control, including, but not limited to, the interest rate payable on the debt securities that we acquire, the default rate on such securities, the level of our expenses, variations in and the timing of the recognition of realized and unrealized gains or losses, changes in our portfolio composition, the degree to which we encounter competition in our markets, market volatility in our publicly traded securities and the securities of our portfolio companies, and general economic conditions. As a result of these factors, results for any period should not be relied upon as being indicative of performance in future periods. In addition, any of these factors could negatively impact our ability to achieve our investment objectives, which may cause our net asset value of our common stock to decline.
Our investments may be in portfolio companies that may have limited operating histories and financial resources.
We expect that our portfolio will continue to consist of investments that may have relatively limited operating histories. These companies may be particularly vulnerable to U.S. and foreign economic downturns such as the U.S. recession that began in
mid-2007,
the European financial crisis, and the
COVID-19
related economic downturn, may have more limited access to capital and higher funding costs, may have a weaker financial position and may need more capital to expand or compete. These businesses also may experience substantial variations in operating results. They may face intense competition, including from companies with greater financial, technical and marketing resources. Furthermore, some of these companies do business in regulated industries and could be affected by changes in government regulation. Accordingly, these factors could impair their cash flow or result in other events, such as bankruptcy, which could limit their ability to repay their obligations to us, and may adversely affect the return on, or the recovery of, our investment in these companies.
 
52

We cannot assure you that any of our investments in our portfolio companies will be successful. Our portfolio companies compete with larger, more established companies with greater access to, and resources for, further development in these new technologies. Therefore, we may lose our entire investment in any or all of our portfolio companies.
There will be uncertainty as to the value of our portfolio investments, which may impact our net asset value.
A large percentage of our portfolio investments are in the form of securities that are not publicly traded. The fair value of securities and other investments that are not publicly traded may not be readily determinable. We value these securities on a quarterly basis in accordance with our valuation policy, which is at all times consistent with GAAP. Our board of directors will (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
Our board of directors utilizes the services of third-party valuation firms to aid it in determining the fair value of material assets. The board of directors discusses valuations and determines the fair value in good faith based on the input of our Investment Adviser and, when utilized, the respective third-party valuation firms. The factors that may be considered in fair value pricing our investments include the nature and realizable value of any collateral, the portfolio company’s ability to make payments and its earnings, the markets in which the portfolio company does business, comparisons to publicly traded companies, discounted cash flow and other relevant factors. Because such valuations, and particularly valuations of private securities and private companies, are inherently uncertain, may fluctuate over short periods of time and may be based on estimates, our determinations of fair value may differ materially from the values that would have been used if a ready market for these securities existed. Our net asset value could be adversely affected if our determinations regarding the fair value of our investments were materially higher than the values that we ultimately realize upon the disposal of such securities.
Our equity ownership in a portfolio company may represent a control investment. Our ability to exit an investment in a timely manner because we are in a control position or have access to inside information in the portfolio company could result in a realized loss on the investment.
If we obtain a control investment in a portfolio company our ability to divest ourselves from a debt or equity investment could be restricted due to illiquidity in a private stock, limited trading volume on a public company’s stock, inside information on a company’s performance, insider blackout periods, or other factors that could prohibit us from disposing of the investment as we would if it were not a control investment. Additionally, we may choose not to take certain actions to protect a debt investment in a control investment portfolio company. As a result, we could experience a decrease in the value of our portfolio company holdings and potentially incur a realized loss on the investment.
There are significant potential conflicts of interest, including SLR Capital Partners’ management of other investment funds such as SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC, which could impact our investment returns, and an investment in SLR Investment Corp. is not an investment in SCP Private Credit Income BDC LLC, SLR HC BDC LLC, or SLR Private Credit BDC II LLC.
Our executive officers and directors, as well as the current and future partners of our Investment Adviser, SLR Capital Partners, may serve as officers, directors or principals of entities that operate in the same or a related line of business as we do. For example, SLR Capital Partners presently serves as the Investment Adviser to (i) SCP Private Credit Income BDC LLC, an unlisted BDC that focuses on investing primarily in senior secured loans, including
non-traditional
asset-based loans and first lien loans, (ii) SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry, and (iii) SLR Private Credit BDC II LLC, an unlisted BDC whose principal focus is to invest in first lien senior secured floating rate loans primarily to upper middle
 
53

market leveraged companies with EBITDA between approximately $25 million and $250 million that have significant free cash flow and are in
non-cyclical
industries in which the Investment Adviser has significant experience. In addition, Michael S. Gross, our Chairman,
Co-Chief
Executive Officer and President, Bruce Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer and board member, and Shiraz Y. Kajee, our Chief Financial Officer, serve in similar capacities for SCP Private Credit Income BDC LLC, SLR HC BDC LLC, and SLR Private Credit BDC II LLC. Accordingly, they may have obligations to investors in those entities, the fulfillment of which obligations might not be in the best interests of us or our stockholders. In addition, we note that any affiliated investment vehicle formed in the future and managed by our Investment Adviser or its affiliates may, notwithstanding different stated investment objectives, have overlapping investment objectives with our own and, accordingly, may invest in asset classes similar to those targeted by us. As a result, SLR Capital Partners may face conflicts in allocating investment opportunities between us and such other entities. Although SLR Capital Partners will endeavor to allocate investment opportunities in a fair and equitable manner, it is possible that, in the future, we may not be given the opportunity to participate in investments made by investment funds managed by our Investment Adviser or an investment manager affiliated with our Investment Adviser. In any such case, when SLR Capital Partners identifies an investment, it will be forced to choose which investment fund should make the investment.
As a BDC, we were substantially limited in our ability to
co-invest
in privately negotiated transactions with affiliated funds until we obtained an exemptive order from the SEC. The most recent exemptive order, received on June 13, 2017 (the “Exemptive Order”), permits us to participate in negotiated
co-investment
transactions with certain affiliates, each of whose investment adviser is an investment adviser that controls, is controlled by or is under common control with SLR Capital Partners and is registered as an Investment Adviser under the Advisers Act, in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions to the Exemptive Order. If we are unable to rely on the Exemptive Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although our investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, we and our common stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of our Investment Adviser.
SLR Capital Partners and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, SLR Capital Partners or its affiliates may determine that we should invest
side-by-side
with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with SLR Capital Partners’ allocation procedures. Related party transactions may occur among SLR Investment Corp., SLR Credit Solutions, Equipment Operating Leases LLC, Loyer Capital LLC, SLR Equipment Finance, SLR Business Credit, SLR Healthcare ABL, SLR Senior Lending Program LLC and SLR Senior Lending Program SPV LLC. These transactions may occur in the normal course of business. No administrative or other fees are paid to SLR Capital Partners by SLR Credit Solutions, Equipment Operating Leases LLC, Loyer Capital LLC, SLR Equipment Finance, SLR Business Credit, SLR Healthcare ABL, SLR Senior Lending Program LLC and SLR Senior Lending Program SPV LLC.
In the ordinary course of our investing activities, we pay management and incentive fees to SLR Capital Partners and reimburse SLR Capital Partners for certain expenses it incurs. As a result, investors in our common stock will invest on a “gross” basis and receive distributions on a “net” basis after expenses, resulting in a lower rate of return than an investor might achieve through direct investments. Accordingly, there may be times when the management team of SLR Capital Partners has interests that differ from those of our stockholders, giving rise to a conflict.
 
54

We entered into an amended and restated royalty-free license agreement on February 25, 2021 with our Investment Adviser, pursuant to which our Investment Adviser has granted us a
non-exclusive
license to use the marks “SOLAR” and “SLR.” Under the license agreement, we have the right to use the “SLR Investment” name for so long as SLR Capital Partners or one of its affiliates remains our Investment Adviser. In addition, we pay SLR Capital Management, an affiliate of SLR Capital Partners, our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the compensation of our chief compliance officer and our chief financial officer and their respective staffs. These arrangements create conflicts of interest that our board of directors must monitor.
Our ability to enter into transactions involving derivatives and financial commitment transactions may be limited.
Through comprehensive new global regulatory regimes impacting derivatives (
e.g.
, the Dodd-Frank Act, European Market Infrastructure Regulation (“EMIR”), Markets in Financial Investments Regulation (“MIFIR”)/Markets in Financial Instruments Directive (“MIFID II”)), certain
over-the-counter
derivatives transactions in which we may engage are either now or will soon be subject to various requirements, such as mandatory central clearing of transactions which include additional margin requirements and in certain cases trading on electronic platforms,
pre-and
post-trade transparency reporting requirements and mandatory
bi-lateral
exchange of initial margin for
non-cleared
swaps. The Dodd-Frank Act also created new categories of regulated market participants, such as “swap dealers,” “security-based swap dealers,” “major swap participants,” and “major security-based swap participants” who are subject to significant new capital, registration, recordkeeping, reporting, disclosure, business conduct and other regulatory requirements. The EU and some other jurisdictions are implementing similar requirements. Because these requirements are new and evolving (and some of the rules are not yet final), their ultimate impact remains unclear. However, even if we are not located in a particular jurisdiction or directly subject to the jurisdiction’s derivatives regulations, we may still be impacted to the extent we enter into a derivatives transaction with a regulated market participant or counterparty that is organized in that jurisdiction or otherwise subject to that jurisdiction’s derivatives regulations.
Based on information available as of the date of this annual report on Form
10-K,
the effect of such requirements will be likely to (directly or indirectly) increase our overall costs of entering into derivatives transactions. In particular, new margin requirements, position limits and significantly higher capital charges resulting from new global capital regulations, even if not directly applicable to us, may cause an increase in the pricing of derivatives transactions entered into by market participants to whom such requirements apply or affect our overall ability to enter into derivatives transactions with certain counterparties. Such new global capital regulations and the need to satisfy the various requirements by counterparties are resulting in increased funding costs and increased overall transaction costs and are significantly affecting balance sheets, thereby resulting in changes to financing terms and potentially impacting our ability to obtain financing. Administrative costs, due to new requirements such as registration, recordkeeping, reporting, and compliance, even if not directly applicable to us, may also be reflected in our derivatives transactions. New requirements to trade certain derivatives transactions on electronic trading platforms and trade reporting requirements may lead to (among other things) fragmentation of the markets, higher transaction costs or reduced availability of derivatives, and/or a reduced ability to hedge, all of which could adversely affect the performance of certain of our trading strategies. In addition, changes to derivatives regulations may impact the tax and/or accounting treatment of certain derivatives, which could adversely impact us.
In November 2020, the SEC adopted new rules regarding the ability of a BDC (or a registered investment company) to use derivatives and other transactions that create future payment or delivery obligations. BDCs that use derivatives would be subject to a
value-at-risk
leverage limit, certain other derivatives risk management program and testing requirements and requirements related to board reporting. These new requirements would apply unless the BDC qualified as a “limited derivatives user,” as defined in the SEC’s adopted rules. A BDC that enters into reverse repurchase agreements or similar financing transactions would need to aggregate the
 
55

amount of indebtedness associated with the reverse repurchase agreements or similar financing transactions and could either (i) comply with the asset coverage requirements of the Section 18 of the 1940 Act when engaging in reverse repurchase agreements or (ii) choose to treat such agreements as derivative transactions under the adopted rule. Under the adopted rule, a BDC may enter into an unfunded commitment agreement that is not a derivatives transaction, such as an agreement to provide financing to a portfolio company, if the BDC has a reasonable belief, at the time it enters into such an agreement, that it will have sufficient cash and cash equivalents to meet its obligations with respect to all of its unfunded commitment agreements, in each case as it becomes due. If the BDC cannot meet this test, it is required to treat unfunded commitments as a derivatives transaction subject to the requirements of the rule. Collectively, these requirements may limit our ability to use derivatives and/or enter into certain other financial contracts.
We may be obligated to pay our Investment Adviser incentive compensation even if we incur a loss.
Our Investment Adviser will be entitled to incentive compensation for each fiscal quarter in an amount equal to a percentage of the excess of our
pre-incentive
fee net investment income for that quarter (before deducting incentive compensation) above a performance threshold for that quarter. Accordingly, since the performance threshold is based on a percentage of our net asset value, decreases in our net asset value make it easier to achieve the performance threshold. Our
pre-incentive
fee net investment income for incentive compensation purposes excludes realized and unrealized capital losses or depreciation that we may incur in the fiscal quarter, even if such capital losses or depreciation result in a net loss on our statement of operations for that quarter.
Thus, we may be required to pay SLR Capital Partners incentive compensation for a fiscal quarter even if there is a decline in the value of our portfolio or we incur a net loss for that quarter.
Our incentive fee may induce SLR Capital Partners to pursue speculative investments.
The incentive fee payable by us to SLR Capital Partners may create an incentive for SLR Capital Partners to pursue investments on our behalf that are riskier or more speculative than would be the case in the absence of such compensation arrangement. The incentive fee payable to our Investment Adviser is calculated based on a percentage of our return on invested capital. This may encourage our Investment Adviser to use leverage to increase the return on our investments. Under certain circumstances, the use of leverage may increase the likelihood of default, which would impair the value of our common stock. In addition, our Investment Adviser receives the incentive fee based, in part, upon net capital gains realized on our investments. Unlike that portion of the incentive fee based on income, there is no hurdle rate applicable to the portion of the incentive fee based on net capital gains. As a result, our Investment Adviser may have a tendency to invest more capital in investments that are likely to result in capital gains as compared to income producing securities. Such a practice could result in our investing in more speculative securities than would otherwise be the case, which could result in higher investment losses, particularly during economic downturns.
The incentive fee payable by us to our Investment Adviser also may induce SLR Capital Partners to invest on our behalf in instruments that have a deferred interest feature, even if such deferred payments would not provide the cash necessary to enable us to pay current distributions to our stockholders. Under these investments, we would accrue interest over the life of the investment but would not receive the cash income from the investment until the end of the term. Our net investment income used to calculate the income portion of our investment fee, however, includes accrued interest. Thus, a portion of this incentive fee would be based on income that we have not received in cash. In addition, the
“catch-up”
portion of the incentive fee may encourage SLR Capital Partners to accelerate or defer interest payable by portfolio companies from one calendar quarter to another, potentially resulting in fluctuations in timing and distribution amounts.
We may invest, to the extent permitted by law, in the securities and instruments of other investment companies, including private funds, and, to the extent we so invest, will bear our ratable share of any such investment company’s expenses, including management and performance fees. We will also remain obligated to pay
 
56

management and incentive fees to SLR Capital Partners with respect to the assets invested in the securities and instruments of other investment companies. With respect to each of these investments, each of our stockholders will bear his or her share of the management and incentive fee of SLR Capital Partners as well as indirectly bearing the management and performance fees and other expenses of any investment companies in which we invest.
We may become subject to corporate-level U.S. federal income tax if we are unable to qualify and maintain our qualification for tax treatment as a regulated investment company under Subchapter M of the Code.
Although we have elected to be treated as a RIC under Subchapter M of the Code, no assurance can be given that we will continue to be able to qualify for and maintain RIC tax treatment. To maintain RIC tax treatment under the Code, we must meet the following annual distribution, income source and asset diversification requirements on an ongoing basis.
 
   
The Annual Distribution Requirement for a RIC will be satisfied if we distribute to our stockholders on an annual basis at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Because we may use debt financing, we are subject to certain asset coverage ratio requirements under the 1940 Act and financial covenants under loan and credit agreements that could, under certain circumstances, restrict us from making distributions necessary to satisfy the Annual Distribution Requirement. If we are unable to obtain cash from other sources, we could fail to qualify for RIC tax treatment and become subject to corporate-level U.S federal income tax.
 
   
The income source requirement will be satisfied if we obtain at least 90% of our income for each year from certain passive investments, including interest, dividends, gains from the sale of stock or securities, or similar sources.
 
   
The asset diversification requirement will be satisfied if we meet certain asset diversification requirements at the end of each quarter of our taxable year. Failure to meet those requirements may result in our having to dispose of certain investments quickly in order to prevent the loss of RIC tax treatment. Because most of our investments will be relatively illiquid, any such dispositions could be made at disadvantageous prices and could result in substantial losses.
If we fail to qualify for RIC tax treatment for any reason and become subject to corporate income tax, the resulting corporate taxes could substantially reduce our net assets, the amount of income available for distribution and the amount of our distributions. Such a failure could have a material adverse effect on us, the net asset value of our common stock and the total return, if any, obtainable from your investment in our common stock.
We may have difficulty satisfying the Annual Distribution Requirement in order to qualify and maintain RIC tax treatment if we recognize income before or without receiving cash representing such income.
In accordance with GAAP and tax requirements, we include in income certain amounts that we have not yet received in cash, such as contractual PIK interest, which represents contractual interest added to a loan balance and due at the end of such loan’s term. In addition to the cash yields received on our loans, in some instances, certain loans may also include any of the following:
end-of-term
payments, exit fees, balloon payment fees or prepayment fees. The increases in loan balances as a result of contractual PIK arrangements are included in income for the period in which such PIK interest was accrued, which is often in advance of receiving a cash payment, and are separately identified on our statements of cash flows. We also may be required to include in income certain other amounts prior to receiving the related cash.
Any warrants that we receive in connection with our debt investments will generally be valued as part of the negotiation process with the particular portfolio company. As a result, a portion of the aggregate purchase price
 
57

for the debt investments and warrants will be allocated to the warrants that we receive. This will generally result in “original issue discount” for U.S. federal income tax purposes, which we must recognize as ordinary income, increasing the amount that we are required to distribute to qualify for the U.S. federal income tax benefits applicable to RICs. Because these warrants generally will not produce distributable cash for us at the same time as we are required to make distributions in respect of the related original issue discount, we would need to obtain cash from other sources or to pay a portion of our distributions using shares of newly issued common stock, consistent with Internal Revenue Service requirements, to satisfy the Annual Distribution and Excise Tax Avoidance requirements.
Other features of the debt instruments that we hold may also cause such instruments to generate original issue discount, resulting in a distribution requirement in excess of current cash interest received. Since in certain cases we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the RIC tax requirement to distribute at least 90% of our net ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any. Under such circumstances, we may have to sell some of our investments at times we would not consider advantageous, raise additional debt or equity capital or reduce new investment originations to meet these distribution requirements. If we are unable to obtain cash from other sources and are otherwise unable to satisfy such distribution requirements, we may fail to qualify for the U.S. federal income tax benefits allowable to RICs and, thus, become subject to a corporate-level U.S. federal income tax on all our income.
Provisions of the Maryland General Corporation Law and of our charter and bylaws could deter takeover attempts and have an adverse impact on the price of our common stock.
The Maryland General Corporation Law and our charter and bylaws contain provisions that may discourage, delay or make more difficult a change in control of SLR Investment Corp. or the removal of our directors. We are subject to the Maryland Business Combination Act, subject to any applicable requirements of the 1940 Act. Our board of directors has adopted a resolution exempting from the Maryland Business Combination Act any business combination between us and any other person, subject to prior approval of such business combination by our board of directors, including approval by a majority of our disinterested directors. If the resolution exempting business combinations is repealed or our board of directors does not approve a business combination, the Maryland Business Combination Act may discourage third parties from trying to acquire control of us and increase the difficulty of consummating such an offer. Our bylaws exempt from the Maryland Control Share Acquisition Act (the “Control Share Act”) acquisitions of our stock by any person. If we amend our bylaws to repeal the exemption from the Control Share Act, the Control Share Act also may make it more difficult for a third party to obtain control of us and increase the difficulty of consummating such a transaction. The SEC staff has rescinded its position that, under the 1940 Act, an investment company may not avail itself of the Control Share Act. As a result, we will amend our bylaws to be subject to the Control Share Act only if our board of directors determines that it would be in our best interests.
We have also adopted measures that may make it difficult for a third party to obtain control of us, including provisions of our charter classifying our board of directors in three classes serving staggered three-year terms, and authorizing our board of directors to classify or reclassify shares of our stock in one or more classes or series, to cause the issuance of additional shares of our stock and to amend our charter without stockholder approval to increase or decrease the number of shares of stock that we have authority to issue. These provisions, as well as other provisions of our charter and bylaws, may delay, defer or prevent a transaction or a change in control that might otherwise be in the best interests of our stockholders.
The foregoing provisions are expected to discourage certain coercive takeover practices and inadequate takeover bids and to encourage persons seeking to acquire control of us to negotiate first with our board of directors. However, these provisions may deprive a stockholder of the opportunity to sell such stockholder’s shares at a premium to a potential acquirer. We believe that the benefits of these provisions outweigh the potential disadvantages of discouraging any such acquisition proposals because, among other things, the negotiation of
 
58

such proposals may improve their terms. Our board of directors has considered both the positive and negative effects of the foregoing provisions and determined that they are in the best interest of our stockholders.
Our bylaws designate the Circuit Court for Baltimore City, Maryland as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our stockholders and provide that claims relating to causes of action under the Securities Act may only be brought in federal district courts, which could limit our stockholders’ ability to obtain a favorable judicial forum for disputes with us or our directors, officers or agents, if any, and could discourage lawsuits against us and our directors, officers and agents, if any.
Our bylaws provide that, unless we consent in writing to the selection of an alternative forum, the Circuit Court for Baltimore City, Maryland, or, if that court does not have jurisdiction, the United States District Court for the District of Maryland, Northern Division, will be the sole and exclusive forum for (a) any Internal Corporate Claim, as such term is defined in the MGCL, (b) any derivative action or proceeding brought on our behalf (other than actions arising under federal securities laws), (c) any action asserting a claim of breach of any duty owed by any of our directors, officers or other agents to us or to our stockholders, (d) any action asserting a claim against us or any of our directors, officers or other agents arising pursuant to any provision of the MGCL or our charter or bylaws or (e) any other action asserting a claim against us or any of our directors, officers or other employees that is governed by the internal affairs doctrine. With respect to any proceeding described in the foregoing sentence that is in the Circuit Court for Baltimore City, Maryland, our stockholders consent to the assignment of the proceeding to the Business and Technology Case Management Program pursuant to Maryland Rule
16-308
or any successor thereof. None of the foregoing actions, claims or proceedings may be brought in any court sitting outside the State of Maryland unless we consent in writing to such court. Our bylaws do not apply to lawsuits asserting claims brought to enforce a duty or liability arising exclusively under the Securities Act, the 1934 Act, or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction.
Unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America shall, to the fullest extent permitted by law, be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act. This paragraph does not apply to claims arising exclusively under the 1934 Act or the 1940 Act, or any other claim for which the federal courts have exclusive jurisdiction. These exclusive forum provisions may limit the ability of our stockholders to bring a claim in a judicial forum that such stockholders find favorable for disputes with us or our directors, officers, or agents, if any, which may discourage such lawsuits against us and our directors, officers, and agents, if any. Alternatively, if a court were to find the choice of forum provisions contained in our bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition, and operating results. For example, under the Securities Act, federal courts have concurrent jurisdiction over all suits brought to enforce any duty or liability created by the Securities Act, and investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder.
The failure in cyber security systems, as well as the occurrence of events unanticipated in our disaster recovery systems and management continuity planning could impair our ability to conduct business effectively.
The occurrence of a disaster, such as a cyber-attack against us or against a third party that has access to our data or networks, a natural catastrophe, an industrial accident, failure of our disaster recovery systems, or consequential employee error, could have an adverse effect on our ability to communicate or conduct business, negatively impacting our operations and financial condition. This adverse effect can become particularly acute if those events affect our electronic data processing, transmission, storage, and retrieval systems, or impact the availability, integrity, or confidentiality of our data.
We depend heavily upon computer systems to perform necessary business functions. We rely on the Investment Adviser’s enterprise-wide cybersecurity program, to protect its information, including due oversight of the
 
59

cybersecurity programs of our key service providers and processes for the assessment, identification, and management of material risks from cybersecurity threats, including those associated with the use of third-party service providers. Despite the Investment Adviser’s implementation of a variety of security measures, our computer systems, networks, and data, like those of other companies, could be subject to cyber-attacks and unauthorized access, use, alteration, or destruction, such as from physical and electronic
break-ins
or unauthorized tampering. If one or more of these events occurs, it could potentially jeopardize the confidential, proprietary, and other information processed, stored in, and transmitted through our computer systems and networks. Such an attack could cause interruptions or malfunctions in our operations, which could result in financial losses, litigation, regulatory penalties, client dissatisfaction or loss, reputational damage, and increased costs associated with mitigation of damages and remediation. If unauthorized parties gain access to such information and technology systems, they may be able to steal, publish, delete or modify private and sensitive information, including nonpublic personal information related to stockholders (and their beneficial owners) and material nonpublic information. The systems the Investment Adviser has implemented to manage risks relating to these types of events could prove to be inadequate and, if compromised, could become inoperable for extended periods of time, cease to function properly or fail to adequately secure private information. Breaches such as those involving covertly introduced malware, impersonation of authorized users and industrial or other espionage may not be identified even with sophisticated prevention and detection systems, potentially resulting in further harm and preventing them from being addressed appropriately. The failure of these systems or of disaster recovery plans for any reason could cause significant interruptions in our and our Investment Adviser’s operations and result in a failure to maintain the security, confidentiality or privacy of sensitive data, including personal information relating to stockholders, material nonpublic information and other sensitive information in our possession.
A disaster or a disruption in the infrastructure that supports our business, including a disruption involving electronic communications or other services used by us or third parties with whom we conduct business, or directly affecting our headquarters, could have a material adverse impact on our ability to continue to operate our business without interruption and to protect us, insofar as is practicable, from the hazards of cybersecurity threats and vulnerabilities in accordance with applicable legal requirements and guidance. Our disaster recovery programs may not be sufficient to mitigate the harm that may result from such a disaster or disruption. In addition, insurance and other safeguards might only partially reimburse us for our losses, if at all.
Although we are not currently aware of any cyber-attacks or other incidents that, individually or in the aggregate, have materially affected, or would reasonably be expected to materially affect, its operations or financial condition, there has been an increase in the frequency and sophistication of the cyber and security threats faced in the marketplace. Cyber-attacks and other security threats could originate from a wide variety of sources, including cyber criminals, nation state hackers, hacktivists and other outside or inside parties. We may be a target for attacks because, as a specialty finance company, we hold confidential and other sensitive information, including price information, about existing and potential investments. Further, we are dependent on third-party vendors for hosting hardware, software and data processing systems that we do not control. We also rely on third-party service providers for certain aspects of its business, including for certain information systems, technology and administration of our portfolio companies and compliance matters. While we rely on the cybersecurity strategy and policies implemented by the Investment Adviser, our reliance on the Investment Adviser and third-party service providers removes certain cybersecurity functions from outside of the Company’s immediate control, and cyber-attacks on the Investment Adviser, on us or on third-party service providers could adversely affect us, our business, and our reputation. The costs related to cyber-attacks or other security threats or disruptions may not be fully insured or indemnified by others, including by our third-party providers.As our reliance on computer hardware and software systems, data processing systems, and other technology has increased, so have the risks posed to such systems, both those the Investment Adviser controls and those provided by third-party vendors. Cyber-attacks may originate from a wide variety of sources, and while the Investment Adviser has implemented processes, procedures, and internal controls designed to mitigate cybersecurity risks and cyber-attacks, these measures do not guarantee that a cyber-attack will not occur or that our financial results, operations, or confidential information, personal, or other sensitive information will not be
 
60

negatively impacted by such an incident, especially because the techniques of threat actors change frequently and are often not recognized until launched. The Investment Adviser relies on industry accepted security measures and technology to securely maintain confidential and proprietary information maintained on its information systems, as well as on policies and procedures to protect against the unauthorized or unlawful disclosure of confidential, personal, or other sensitive information. Although the Investment Adviser takes protective measures and endeavors to strengthen its computer systems, software, technology assets, and networks to prevent and address potential cyber-attacks, there can be no assurance that any of these measures prove effective. The Investment Adviser expects to be required to devote increasing levels of funding and resources, which may in part be allocated to us, to comply with evolving cybersecurity and privacy laws and regulations and to continually monitor and enhance its cybersecurity procedures and controls. In addition, we, the Investment Adviser, the Administrator, or their employees, if any, may also be the target of fraudulent emails or other targeted attempts to gain unauthorized access to confidential, personal, or other sensitive information. The result of any cyber-attack or other security incidents may include disrupted operations, misstated or unreliable financial data, fraudulent transfers or requests for transfers of money, liability for stolen information (including personal information), investigations, misappropriation of assets, increased cybersecurity protection and insurance costs, litigation and damage to our business relationships, regulatory fines or penalties, or other adverse effects on our business, financial condition or results of operations. The Invesment Adviser may be required to expend significant additional resources to modify its protective measures and to investigate and remediate vulnerabilities or other exposures arising from operational and security risks related to cyber-attacks. The rapid evolution and increasing prevalence of artificial intelligence technologies may also increase cybersecurity risks.
Third parties with which we do business may also be sources of cybersecurity or other technological risk. We outsource certain functions and these relationships allow for the storage and processing of our information, as well as client, counterparty, employee, and borrower information. While we engage in actions to reduce our exposure resulting from outsourcing, ongoing threats may result in unauthorized access, loss, exposure, destruction, or other cybersecurity incident that affects our data, resulting in increased costs and other consequences as described above.
In addition, cybersecurity has become a top priority for global lawmakers and regulators around the world, and some jurisdictions have proposed or enacted laws requiring companies to notify regulators and individuals of data security breaches involving certain types of personal data. In particular, state and federal laws and regulations related to cybersecurity compliance continue to evolve and change, which may require substantial investments in new technology, software and personnel, which could affect the Company’s profitability. These changes may also result in enhanced and unforeseen consequences for cyber-related breaches and incidents, which may further adversely affect the Company’s profitability. If we fail to comply with the relevant and increasing laws and regulations, we could suffer financial losses, a disruption of our businesses, liability to investors, regulatory intervention or reputational damage.
Policies of remote working, whether by the Investment Adviser, the Administrator, us or by our or their respective service providers, could strain technology resources, introduce operational risks and otherwise heighten the risks described above. Remote working environments may be less secure and more susceptible to hacking attacks, including phishing and social engineering attempts.
We, our Investment Adviser and our portfolio companies are subject to risks associated with cyber-attacks.
Cybersecurity risks are exacerbated by the rapidly increasing volume of highly sensitive data, including our proprietary business information, personal information of the Investment Adviser’s employees, our investors and others, and other sensitive information that the Investment Adviser collects, processes, and stores in its data centers and on its networks or those of third-party service providers. The secure processing, maintenance, and transmission of this information are critical to our operations.
There is a risk that encryption and other protective measures against cyber-attacks may be circumvented, particularly to the extent that new computing technologies increase the speed and computing power available.
 
61

Even the most well-protected information, networks, systems and facilities remain potentially vulnerable because the techniques used in such attempted security breaches evolve and generally are not recognized until launched against a target, and in some cases are designed not to be detected and, in fact, may not be detected. A significant actual or potential theft, loss, corruption, exposure, fraudulent use or misuse of investor or other personal information, proprietary business data or other sensitive information, whether by third parties or as a result of malfeasance by the Investment Adviser’s employees or otherwise,
non-compliance
with applicable contractual or other legal obligations regarding such data or intellectual property or a violation of applicable privacy and security policies with respect to such data could result in significant investigation, remediation and other costs, fines, penalties, litigation or regulatory actions against the Company and significant reputational harm, any of which could harm our business and results of operations.Cybersecurity risks require continuous and increasing attention and other resources from the Investment Adviser to, among other actions, identify and quantify these risks and upgrade and expand the Investment Adviser’s technologies, systems and processes to adequately address such risks. Such attention diverts time and other resources from other activities and there is no assurance that the Investment Adviser’s efforts will be effective.
Cybersecurity incidents may adversely impact us and our stockholders. There is no guarantee that we, the Investment Adviser, and/or their respective service providers will be successful in protecting against cybersecurity incidents.
We can be highly dependent on information systems and systems failures could significantly disrupt our business, which may, in turn, negatively affect the market price of our common stock and our ability to pay distributions.
Our business is highly dependent upon our and third parties’ communications and information systems. Any failure or interruption of those systems, including as a result of the termination of an agreement with any third-party service providers, could cause delays or other problems in our activities. Our financial, accounting, data processing, backup or other operating systems and facilities may fail to operate properly or become disabled or damaged as a result of a number of factors including events that are wholly or partially beyond our control and adversely affect our business.
There could be:
 
   
sudden electrical or telecommunications outages;
 
   
natural disasters such as earthquakes, tornadoes and hurricanes;
 
   
events arising from local or larger scale political or social matters, including terrorist acts; and
 
   
cyber-attacks.
These events, in turn, could have a material adverse effect on our operating results and negatively affect the market price of our common stock and our ability to pay distributions to our stockholders.
Communications with stockholders may be delivered electronically and there may be certain costs and possible risks associated with such electronic delivery. Moreover, the Investment Adviser cannot provide any assurance that these communication methods are secure and will not be responsible for any computer viruses, problems or malfunctions resulting from the use of such communication methods.
Our board of directors may change our investment objective, operating policies and strategies without prior notice or stockholder approval.
Our board of directors has the authority to modify or waive certain of our operating policies and strategies without prior notice (except as required by the 1940 Act) and without stockholder approval. However, absent stockholder approval, we may not change the nature of our business so as to cease to be, or withdraw our election as a BDC. We cannot predict the effect any changes to our current operating policies and strategies would have on our business, operating results and the value of our stock. Nevertheless, the effects may adversely affect our business and impact our ability to make distributions.
 
62

Our business is subject to increasingly complex corporate governance, public disclosure and accounting requirements that could adversely affect our business and financial results.
We are subject to changing rules and regulations of federal and state government as well as the stock exchange on which our common stock is listed. These entities, including the Public Company Accounting Oversight Board, the SEC and the NASDAQ Stock Market, have issued a significant number of new and increasingly complex requirements and regulations over the course of the last several years and continue to develop additional regulations and requirements in response to laws enacted by Congress. Our efforts to comply with these existing requirements, or any revised or amended requirements, have resulted in, and are likely to continue to result in, an increase in expenses and a diversion of management’s time from other business activities.
Changes in laws or regulations governing our operations may adversely affect our business.
Changes in the laws or regulations, or the interpretations of the laws and regulations, which govern BDCs, RICs or
non-depository
commercial lenders could significantly affect our operations and our cost of doing business. We are subject to federal, state and local laws and regulations and are subject to judicial and administrative decisions that affect our operations, including our loan originations, maximum interest rates, fees and other charges, disclosures to portfolio companies, the terms of secured transactions, collection and foreclosure procedures, and other trade practices. If these laws, regulations or decisions change, or if we expand our business into jurisdictions that have adopted more stringent requirements than those in which we currently conduct business, then we may have to incur significant expenses in order to comply or we may have to restrict our operations. In addition, if we do not comply with applicable laws, regulations and decisions, then we may lose licenses needed for the conduct of our business and be subject to civil fines and criminal penalties, any of which could have a material adverse effect upon our business results of operations or financial condition.
Changes to United States tariff and import/export regulations may have a negative effect on our portfolio companies and, in turn, harm us.
There has been ongoing discussion and commentary regarding potential significant changes to United States trade policies, treaties and tariffs. The current administration, along with Congress, has created significant uncertainty about the future relationship between the United States and other countries with respect to the trade policies, treaties and tariffs. These developments, or the perception that any of them could occur, may have a material adverse effect on global economic conditions and the stability of global financial markets, and may significantly reduce global trade and, in particular, trade between the impacted nations and the United States. Any of these factors could depress economic activity and restrict our portfolio companies’ access to suppliers or customers and have a material adverse effect on their business, financial condition and results of operations, which in turn would negatively impact us.
Our Investment Adviser can resign on 60 days’ notice, and we may not be able to find a suitable replacement within that time, resulting in a disruption in our operations that could adversely affect our financial condition, business and results of operations.
Our Investment Adviser has the right, under the Advisory Agreement, to resign at any time upon 60 days written notice, whether we have found a replacement or not. If our Investment Adviser resigns, we may not be able to find a new investment adviser or hire internal management with similar experience and ability to provide the same or equivalent services on acceptable terms within 60 days, or at all. If we are unable to do so quickly, our operations are likely to experience a disruption, our financial condition, business and results of operations as well as our ability to pay distributions are likely to be adversely affected and the market price of our shares may decline. In addition, the coordination of our internal management and investment activities is likely to suffer if we are unable to identify and reach an agreement with a single institution or group of executives having the experience possessed by our Investment Adviser and its affiliates. Even if we are able to retain comparable management, whether internal or external, the integration of such management and their lack of familiarity with
 
63

our investment objective may result in additional costs and time delays that may adversely affect our financial condition, business and results of operations.
General Risk Factors
Volatility or a prolonged disruption in the credit markets could materially damage our business.
We are required to record our assets at fair value, as determined in good faith by our board of directors, in accordance with our valuation policy. As a result, volatility in the capital markets may have a material adverse effect on our valuations and our net asset value, even if we hold investments to maturity. Volatility or dislocation in the capital markets may depress our stock price below our net asset value per share and create a challenging environment in which to raise equity and debt capital. These conditions could continue for a prolonged period of time or worsen in the future. While these conditions persist, we and other companies in the financial services sector may have to access, if available, alternative markets for debt and equity capital. Equity capital may be difficult to raise because, subject to some limited exceptions which apply to us, as a BDC we are generally not able to issue additional shares of our common stock at a price less than net asset value without first obtaining approval for such issuance from our stockholders and our independent directors. Any offering of our common stock that requires stockholder approval must occur, if at all, within one year after receiving such stockholder approval. In addition, our ability to incur indebtedness (including by issuing preferred stock) is limited by applicable regulations such that our asset coverage, as defined in the 1940 Act, must equal at least 150% immediately after each time we incur indebtedness. The debt capital that will be available, if at all, may be at a higher cost and on less favorable terms and conditions in the future. Any inability to raise capital could have a negative effect on our business, financial condition and results of operations.
Additionally, our ability to incur indebtedness is limited by the asset coverage ratio for a BDC, as defined under the 1940 Act. Declining portfolio values negatively impact our ability to borrow additional funds because our net asset value is reduced for purposes of the asset coverage ratio. If the fair value of our assets declines substantially, we may fail to maintain the asset coverage ratio stipulated by the 1940 Act, which could, in turn, cause us to lose our status as a BDC and materially impair our business operations. A lengthy disruption in the credit markets could also materially decrease demand for our investments.
The significant disruption in the capital markets experienced in the past, including the disruption caused by the
COVID-19
pandemic, certain regional bank failures, an inflationary economic environment, the Russian invasion of Ukraine and the ongoing war in the Middle East, have had, and may in the future have, a negative effect on the valuations of our investments and on the potential for liquidity events involving our investments. The debt capital that may be available to us in the future may be at a higher cost and have less favorable terms and conditions than those currently in effect. If our financing costs increase and we have no increase in interest income, then our net investment income will decrease. A prolonged inability to raise capital may require us to reduce the volume of investments we originate and could have a material adverse impact on our business, financial condition and results of operations. This may also increase the probability that other structural risks will negatively impact us. These situations may arise due to circumstances that we may be unable to control, such as a lengthy disruption in the credit markets, a severe decline in the value of the U.S. dollar, a sharp economic downturn or recession or an operational problem that affects third parties or us, and could materially damage our business, financial condition and results of operations.
Global economic, regulatory and market conditions may adversely affect our business, results of operations and financial condition, including our revenue growth and profitability.
We and our portfolio companies are subject to regulation by laws at the U.S. federal, state and local levels. These laws and regulations, as well as their interpretation, could change from time to time, including as the result of interpretive guidance or other directives from the U.S. President and others in the executive branch, and new laws, regulations and interpretations could also come into effect. Any such new or changed laws or regulations could have a material adverse effect on our business, and political uncertainty could increase regulatory uncertainty in the near term.
 
64

The effects of legislative and regulatory proposals directed at the financial services industry or affecting taxation, could negatively impact the operations, cash flows or financial condition of us and our portfolio companies, impose additional costs on us or our portfolio companies, intensify the regulatory supervision of us or our portfolio companies or otherwise adversely affect our business or the business of our portfolio companies. In addition, if we do not comply with applicable laws and regulations, we could lose any licenses that we then hold for the conduct of business and could be subject to civil fines and criminal penalties.
Over the last several years, there also has been an increase in regulatory attention to the extension of credit outside of the traditional banking sector, raising the possibility that some portion of the
non-bank
financial sector will be subject to new regulation. While it cannot be known at this time whether any regulation will be implemented or what form it will take, increased regulation of
non-bank
credit extension could negatively impact our operations, cash flows or financial condition, impose additional costs on us, intensify the regulatory supervision of us or otherwise adversely affect our business, financial condition and results of operations.
Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business, financial condition, operating results and cash flows. Until we know what policy changes are made and how those changes impact business and the business of our competitors over the long term, we will not know if, overall, it will benefit from them or be negatively affected by them.
Deterioration in the economic conditions in the Eurozone and other regions or countries globally and the resulting instability in global financial markets may pose a risk to our business. Financial markets have been affected at times by a number of global macroeconomic events, including the following: large sovereign debts and fiscal deficits of several countries in Europe and in emerging markets jurisdictions, levels of
non-performing
loans on the balance sheets of European banks, the effect of the United Kingdom leaving the European Union, instability in the Chinese capital markets and the
COVID-19
pandemic.
Various social and political circumstances in the U.S. and around the world (including wars and other forms of conflict, terrorist acts, security operations and catastrophic events such as fires, floods, earthquakes, tornadoes, hurricanes and global health epidemics), may also contribute to increased market volatility and economic uncertainties or deterioration in the U.S. and worldwide. Such events, including rising trade tensions between the United States and China, other uncertainties regarding actual and potential shifts in U.S. and foreign, trade, economic and other policies with other countries, the large-scale invasion of Ukraine by Russia that began in February 2022 and resulting sanctions or other restrictive actions that the United States and other countries have imposed against Russia, the
COVID-19
pandemic, certain regional bank failiures, an inflationary environment and the ongoing war in the Middle East, could adversely affect our business, financial condition or results of operations. These market and economic disruptions could negatively impact the operating results of our portfolio companies.
In addition, Russia’s invasion of Ukraine and corresponding events have had, and could continue to have, severe adverse effects on regional and global economic markets. Following Russia’s actions, various governments, including the United States, have issued broad-ranging economic sanctions against Russia, including, among other actions, a prohibition on doing business with certain Russian companies, large financial institutions, officials and oligarchs; a commitment by certain countries and the European Union to remove selected Russian banks from the Society for Worldwide Interbank Financial Telecommunications, the electronic banking network that connects banks globally; and restrictive measures to prevent the Russian Central Bank from undermining the impact of the sanctions. The duration of hostilities and the vast array of sanctions and related events (including cyberattacks and espionage) cannot be predicted. Furthermore, the conflict between the two nations and the varying involvement of the United States and other NATO countries could preclude prediction as to their ultimate adverse impact on global economic and market conditions, and, as a result, presents material uncertainty and risk with respect to markets globally, which pose potential adverse risks to us and the performance of our investments and operations, and our ability to achieve our investment objectives. Additionally, to the extent that third parties, investors, or related customer bases have material operations or assets in Russia or Ukraine, they
 
65

may have adverse consequences related to the ongoing conflict. Any such market disruptions could affect our portfolio companies’ operations and, as a result, could have a material adverse effect on our business, financial condition and results of operations.
Additionally, the Federal Reserve raised the Federal Funds Rate in 2022 and in 2023. Although the Federal Reserve left its benchmark rates steady in the fourth quarter of 2023, it has indicated that additional rate increases in the future may be necessary to mitigate inflationary pressures and there can be no assurance that the Federal Reserve will not make upward adjustments to the federal funds rate in 2024 the future. However, there are reports that the Federal Reserve may begin to cut the benchmark rates in 2024. These developments, along with the United States government’s credit and deficit concerns, global economic uncertainties and market volatility and the impacts of
COVID-19,
could cause interest rates to be volatile, which may negatively impact our ability to access the debt markets and capital markets on favorable terms.
Events outside of our control, including the
COVID-19
public health crises, could negatively affect our portfolio companies and our results of our operations.
Periods of market volatility have occurred and could continue to occur in response to pandemics or other events outside of our control. These types of events have adversely affected and could continue to adversely affect operating results for us and for our portfolio companies. For example, the
COVID-19
pandemic has adversely impacted global commercial activity and contributed to significant volatility in the equity and debt markets. The
COVID-19
pandemic and restrictive measures taken to contain or mitigate its spread have caused, and may continue to cause, business shutdowns, or the
re-introduction
of business shutdowns, cancellations of events and restrictions on travel, significant reductions in demand for certain goods and services, reductions in business activity and financial transactions, supply chain interruptions, labor shortages, increased inflationary pressure and overall economic and financial market instability both globally and in the United States. Many states, including those in which we and portfolio companies in which we invest may operate, have previously issued orders requiring the closure of, or certain restrictions on the operation of, certain businesses. The ultimate duration and severity of the
COVID-19
pandemic, including
COVID-19
variants, remain uncertain.
Despite actions of the U.S. federal government and foreign governments, the uncertainty surrounding the
COVID-19
pandemic, including uncertainty regarding existing or future variants and other factors, has contributed to significant volatility in the global public equity markets and global debt capital markets.
The continued uncertainty related to the sustainability and pace of economic recovery in the U.S. and globally could have a negative impact on our business.
Our business is directly influenced by the economic cycle, and could be negatively impacted by a downturn in economic activity in the U.S. as well as globally. Fiscal and monetary actions taken by U.S. and
non-U.S.
government and regulatory authorities could have a material adverse impact on our business. To the extent uncertainty regarding the U.S. or global economy, including as a result of the global
COVID-19
pandemic, negatively impacts consumer confidence and consumer credit factors, our business, financial condition and results of operations could be adversely affected. Moreover, Federal Reserve policy, including with respect to certain interest rates and the decision to end its quantitative easing policy, along with the general policies of the current Presidential administration, may also adversely affect the value, volatility and liquidity of dividend-and interest-paying securities. Market volatility, periods of rising interest rates, such as the recent economic period, and/or a return to unfavorable economic conditions could adversely affect our business.
There is uncertainty surrounding potential legal, regulatory and policy changes by new presidential administrations in the United States that may directly affect financial institutions and the global economy.
The current administration has called for significant changes to U.S. trade, healthcare, immigration, foreign and government regulatory policy. In this regard, there is significant uncertainty with respect to legislation, regulation
 
66

and government policy at the federal level, as well as the state and local levels. Recent events have created a climate of heightened uncertainty and introduced new and
difficult-to-quantify
macroeconomic and political risks with potentially
far-reaching
implications. There has been a corresponding meaningful increase in the uncertainty surrounding interest rates, inflation, foreign exchange rates, trade volumes and fiscal and monetary policy. To the extent the U.S. Congress or the current administration implements changes to U.S. policy, those changes may impact, among other things, the U.S. and global economy, international trade and relations, unemployment, immigration, corporate taxes, healthcare, the U.S. regulatory environment, inflation and other areas. Although we cannot predict the impact, if any, of these changes to our business, they could adversely affect our business, financial condition, operating results and cash flows. Until we know what policy changes are made and how those changes impact our business and the business of our competitors over the long term, we will not know if, overall, we will benefit from them or be negatively affected by them.
The alternative reference rates that have replaced LIBOR in our credit arrangements and other financial instruments may not yield the same or similar economic results as LIBOR over the life of such transactions.
The London Interbank Offered Rate (“LIBOR”) is an index rate that historically was widely used in lending transactions and was a common reference rate for setting the floating interest rate on private loans. LIBOR was typically the reference rate used in floating-rate loans extended to our portfolio companies.
The ICE Benchmark Administration (“IBA”) (the entity that is responsible for calculating LIBOR) ceased providing overnight, one, three, six and twelve months USD LIBOR tenors on June 30, 2023. In addition, the United Kingdom’s Financial Conduct Authority (“FCA”), which oversees the IBA, now prohibits entities supervised by the FCA from using LIBORs, including USD LIBOR, except in very limited circumstances.
In the United States, the Secured Overnight Financing Rate (“SOFR”) is the preferred alternative rate for LIBOR. SOFR is a measure of the cost of borrowing cash overnight, collateralized by U.S. Treasury securities, and is based on directly observable U.S. Treasury-backed repurchase transactions. SOFR is published by the Federal Reserve Bank of New York each U.S. Government Securities Business Day, for transactions made on the immediately preceding U.S. Government Securities Business Day. Alternative reference rates that may replace LIBOR, including SOFR for USD transactions, may not yield the same or similar economic results as LIBOR over the lives of such transactions.
As of the filing date of this Annual Report on Form
10-K,
many of our loans that referenced LIBOR have been amended to reference the forward-looking term rate published by CME Group Benchmark Administration Limited based on SOFR (“CME Term SOFR”) or CME Term SOFR plus a fixed spread adjustment. CME Term SOFR rates are forward-looking rates that are derived by compounding projected overnight SOFR rates over one, three, and six months taking into account the values of multiple consecutive, executed,
one-month
and three-month CME Group traded SOFR futures contracts and, in some cases,
over-the-counter
SOFR Overnight Indexed Swaps as an indicator of CME Term SOFR reference rate values. CME Term SOFR and the inputs on which it is based are derived from SOFR. Since CME Term SOFR is a relatively new market rate, there will likely be no established trading market for credit agreements or other financial instruments when they are issued, and an established market may never develop or may not be liquid. Market terms for instruments referencing CME Term SOFR rates may be lower than those of later-issued CME Term SOFR indexed instruments. Similarly, if CME Term SOFR does not prove to be widely used, the trading price of instruments referencing CME Term SOFR may be lower than those of instruments indexed to indices that are more widely used. Further, the composition and characteristics of SOFR and CME Term SOFR are not the same as those of LIBOR. Even with the application of a fixed spread adjustment, LIBOR and CME Term SOFR will not have the same composition and characteristics, and there can be no assurance that the replacement rate, as so adjusted, will be a direct substitute for LIBOR.
There can be no guarantee that SOFR will not be discontinued or fundamentally altered in a manner that is materially adverse to the interests of investors in loans referencing SOFR. If the manner in which SOFR or CME
 
67

Term SOFR is calculated is changed, that change may result in a reduction of the amount of interest payable on such loans and the trading prices of the SOFR Loans. In addition, there can be no guarantee that loans referencing SOFR or CME Term SOFR will continue to reference those rates until maturity or that, in the future, our loans will reference benchmark rates other than CME Term SOFR. Should any of these events occur, our loans, and the yield generated thereby, could be affected. Specifically, the anticipated yield on our loans may not be fully realized and our loans may be subject to increased pricing volatility and market risk.
Inflation and a rising interest rate environment may adversely affect the business, results of operations and financial condition of us and our portfolio companies.
The recent macroeconomic environment is characterized by record-high inflation, supply chain challenges, labor shortages, high interest rates, foreign currency exchange volatility, volatility in global capital markets and growing recession risk. The risks associated with the Company’s and our portfolio companies’ businesses are more severe during periods of economic slowdown or recession.
Any disruptions in the capital markets, as a result of inflation and a rising interest environment or otherwise, may increase the spread between the yields realized on risk-free and higher risk securities and can result in illiquidity in parts of the capital markets, significant write-offs in the financial sector and
re-pricing
of credit risk in the broadly syndicated market. These and any other unfavorable economic conditions could increase our funding costs, limit our access to the capital markets or result in a decision by lenders not to extend credit to us.
In addition, market conditions (including inflation, supply chain issues and decreased consumer demand) have adversely impacted, and could in the future further impact, the operations of certain of our portfolio companies. If the financial results of middle-market companies, like those in which we invest, experience deterioration, it could ultimately lead to difficulty in meeting debt service requirements and an increase in defaults, and further deterioration in market conditions will further depress the outlook for those companies. Further, adverse economic conditions decreased and may in the future decrease the value of collateral securing some of our loans and the value of our equity investments. Such conditions have required and may in the future require us to modify the payment terms of our investments, including changes in PIK interest provisions and/or cash interest rates. The performance of certain of our portfolio companies has been, and in the future may be, negatively impacted by these economic or other conditions, which can result in our receipt of reduced interest income from our portfolio companies and/or realized and unrealized losses related to our investments, and, in turn, may adversely affect distributable income and have a material adverse effect on our results of operations.
Inflation may cause the real value of our investments to decline.
Inflation risk results from the variation in the value of cash flows from a security due to inflation, as measured in terms of purchasing power. We are exposed to inflation risk with respect to any fixed rate investments that we make, if any, because the interest rate the issuer has to pay us is fixed for the life of the security. To the extent that interest rates reflect the expected inflation rate, floating rate loans have a lower level of inflation risk.
Adverse developments affecting the financial services industry, such as actual events or concerns involving liquidity, defaults
or non-performance
by financial institutions or transactional counterparties could have a material adverse effect on us, the Investment Adviser and our portfolio companies.
Cash not held in custody accounts and held by us, our Investment Adviser and by our portfolio companies
in non-interest-bearing
and interest-bearing operating accounts could, at times, exceed the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. If such banking institutions were to fail, we, our Investment Adviser, or our portfolio companies could lose all or a portion of those amounts held in excess of such insurance limits. In addition, actual events involving limited liquidity,
defaults, non-performance
or other adverse developments that affect financial institutions, transactional counterparties or other companies in the financial services industry or the financial services industry generally, or concerns or rumors about any events of these
 
68

kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems, which could adversely affect our, our Investment Adviser’s and our portfolio companies’ business, financial condition, results of operations, or prospects.
Although we and our Investment Adviser assess our and our portfolio companies’ banking and financing relationships as we believe necessary or appropriate, our and our portfolio companies’ access to funding sources and other credit arrangements in amounts adequate to finance or capitalize current and projected future business operations could be significantly impaired by factors that affect the financial institutions with which we, our Investment Adviser or our portfolio companies have arrangements directly or the financial services industry or economy in general. These factors could include, among others, events such as liquidity constraints or failures, the ability to perform obligations under various types of financial, credit or liquidity agreements or arrangements, disruptions or instability in the financial services industry or financial markets, or concerns or negative expectations about the prospects for companies in the financial services industry. These factors could involve financial institutions or financial services industry companies with which we, our Investment Adviser or our portfolio companies have financial or business relationships, but could also include factors involving financial markets or the financial services industry generally.
In addition, investor concerns regarding the U.S. or international financial systems could result in less favorable commercial financing terms, including higher interest rates or costs and tighter financial and operating covenants, or systemic limitations on access to credit and liquidity sources, thereby making it more difficult for us, our Investment Adviser, or our portfolio companies to acquire financing on acceptable terms or at all.
Technological innovations and industry disruptions may negatively impact us.
Technological innovations have disrupted traditional approaches in multiple industries and can permit younger companies to achieve success and in the process disrupt markets and market practices. We can provide no assurance that new businesses and approaches will not be created that would compete with us and/or our portfolio companies or alter the market practices in which SLR Capital Partners and its affiliates and us have been designed to function within and on which we depend on for our investment return. New approaches could damage our investments, disrupt the market in which we operate and subject us to increased competition, which could materially and adversely affect our business, financial condition and results of investments.
We are subject to risks associated with artificial intelligence and machine learning technology.
Recent technological advances in artificial intelligence and machine learning technology (“Machine Learning Technology”) pose risks to us and our portfolio companies. We and our portfolio companies could be exposed to the risks of Machine Learning Technology if third-party service providers or any counterparties use Machine Learning Technology in their business activities. We and the Investment Adviser are not in a position to control the use of Machine Learning Technology in third-party products or services. Use of Machine Learning Technology could include the input of confidential information in contravention of applicable policies, contractual or other obligations or restrictions, resulting in such confidential information becoming part accessible by other third-party Machine Learning Technology applications and users. Machine Learning Technology and its applications continue to develop rapidly, and we cannot predict the risks that may arise from such developments.
Machine Learning Technology is generally highly reliant on the collection and analysis of large amounts of data, and it is not possible or practicable to incorporate all relevant data into the model that Machine Learning Technology utilizes to operate. Certain data in such models will inevitably contain a degree of inaccuracy and error and could otherwise be inadequate or flawed, which would be likely to degrade the effectiveness of Machine Learning Technology. To the extent we or our portfolio companies are exposed to the risks of Machine Learning Technology use, any such inaccuracies or errors could adversely impact us or our portfolio companies.
 
69

We are subject to risks related to corporate social responsibility.
Our business (including that of our portfolio companies) faces increasing public scrutiny related to environmental, social and governance (“ESG”) activities, which are increasingly considered to contribute to reducing a company’s operational risk, market risk and reputational risk, which may in turn impact the long-term sustainability of a company’s performance. A variety of organizations measure the performance of companies on ESG topics, and the results of these assessments are widely publicized. In addition, investment in funds that specialize in companies that perform well in such assessments are increasingly popular, and major institutional investors have publicly emphasized the importance of such ESG ratings and measures to their investment decisions. We risk damage to our brand and reputation if we fail to act responsibly in a number of areas, including, but not limited to, diversity, equity and inclusion, human rights, climate change, environmental stewardship, support for local communities, corporate governance, transparency and consideration of ESG factors in our investment processes. Adverse incidents with respect to ESG activities could impact the value of our brand, our relationship with existing and future portfolio companies, the cost of our operations and relationships with investors, all of which could adversely affect our business and results of operations.
However, regional and investor specific sentiment may differ in what constitutes a material positive or negative ESG corporate practice. There is no guarantee that the Company’s ESG and sustainability practices will uniformly fit every investor’s definition of best practices for all environmental, social and governance considerations across geographies and investor types. If we do not successfully manage expectations across varied stakeholder interests, it could erode stakeholder trust, impact our reputation and constrain our investment opportunities.
There is also a growing regulatory interest across jurisdictions in improving transparency regarding the definition, measurement and disclosure of ESG factors in order to allow investors to validate and better understand sustainability claims. For example, the SEC has proposed, or has announced that it is working on proposals for, rules that, among other matters, would establish a framework for reporting of climate-related risks, corporate and fund carbon emissions, broad diversity and capital management. At this time, there is uncertainty regarding the scope of such proposals or when they would become effective (if at all). In 2021, the SEC established an enforcement task force to look into ESG practices and disclosures by public companies and investment managers and has started to bring enforcement actions based on ESG disclosures not matching actual investment processes. Further, in 2022 the SEC issued a proposed rule regarding the enhancement and standardization of mandatory climate-related disclosures for investors that would mandate extensive disclosure of climate-related data, risks and opportunities for certain public companies.
We and our portfolio companies are subject to the risk that similar measures might be introduced in other jurisdictions in the future. Additionally, compliance with any new laws or regulations increases our regulatory burden and could make compliance more difficult and expensive, affect the manner in which we or our portfolio companies conduct our businesses and adversely affect our profitability.
The effect of global climate change may impact the operations of our portfolio companies.
There may be evidence of global climate change. Climate change creates physical and financial risk and some of our portfolio companies may be adversely affected by climate change. For example, the needs of customers of energy companies vary with weather conditions, primarily temperature and humidity. To the extent weather conditions are affected by climate change, energy use could increase or decrease depending on the duration and magnitude of any changes. Increases in the cost of energy could adversely affect the cost of operations of our portfolio companies if the use of energy products or services is material to their business. A decrease in energy use due to weather changes may affect some of our portfolio companies’ financial condition, through decreased revenues. Extreme weather conditions in general require more system backup, adding to costs, and can contribute to increased system stresses, including service interruptions. Energy companies could also be affected by the potential for lawsuits against or taxes or other regulatory costs imposed on greenhouse gas emitters, based on links drawn between greenhouse gas emissions and climate change.
 
70

In December 2015, the United Nations, of which the U.S. is a member, adopted a climate accord with the long-term goal of limiting global warming and the short-term goal of significantly reducing greenhouse gas emissions. As a result, some of our portfolio companies may become subject to new or strengthened regulations or legislation, which could increase their operating costs and/or decrease their revenues.
We cannot predict how changes in tax law will affect us, our investments, or our stockholders, and any such legislation could adversely affect our business.
Legislative or other actions relating to taxes could have a negative effect on us. The rules dealing with U.S. federal income taxation are constantly under review by persons involved in the legislative process and by the Internal Revenue Service and the U.S. Treasury Department. New legislation and any other tax law developments, including new or revised U.S. Treasury regulations, administrative interpretations or court decisions, could negatively and perhaps retroactively affect our ability to qualify for tax treatment as a RIC or the U.S. federal income tax consequences to us and our stockholders, or could have other adverse consequences. Investors are urged to consult with their tax advisor regarding tax legislative, regulatory, or administrative developments and proposals and their potential effect on an investment in our common stock.
Uncertainty about U.S. government initiatives could negatively impact our business, financial condition and results of operations.
The U.S. government has recently called for significant changes to U.S. trade, healthcare, immigration, foreign and government regulatory policy. In this regard, there is significant uncertainty with respect to legislation, regulation and government policy at the federal level, as well as the state and local levels. Recent events have created a climate of heightened uncertainty and introduced new and
difficult-to-quantify
macroeconomic and political risks with potentially
far-reaching
implications. There has been a corresponding meaningful increase in the uncertainty surrounding interest rates, inflation, foreign exchange rates, trade volumes and fiscal and monetary policy. To the extent the U.S. Congress or the current administration implements changes to U.S. policy, those changes may impact, among other things, the U.S. and global economy, international trade and relations, unemployment, immigration, corporate taxes, healthcare, the U.S. regulatory environment, inflation and other areas.
A particular area identified as subject to potential change, amendment or repeal includes the Dodd-Frank Wall Street Reform and Consumer Protection Act, or the “Dodd-Frank Act,” including the Volcker Rule and various swaps and derivatives regulations, credit risk retention requirements and the authorities of the Federal Reserve, the Financial Stability Oversight Council and the SEC. Given the uncertainty associated with the manner in which and whether the provisions of the Dodd-Frank Act will be implemented, repealed, amended, or replaced, the full impact such requirements will have on our business, results of operations or financial condition is unclear. The changes resulting from the Dodd-Frank Act or any changes to the regulations already implemented thereunder may require us to invest significant management attention and resources to evaluate and make necessary changes in order to comply with new statutory and regulatory requirements. Failure to comply with any such laws, regulations or principles, or changes thereto, may negatively impact our business, results of operations or financial condition. While we cannot predict what effect any changes in the laws or regulations or their interpretations would have on us as a result of recent financial reform legislation, these changes could be materially adverse to us and our stockholders.
 
Item 1B.
Unresolved Staff Comments
None.
 
71

Item 1C.
Cybersecurity
Risk Management and Strategy
We recognize the importance of assessing, identifying, and managing material risks from cybersecurity threats, as such term is defined in Item 106(a) of Regulation
S-K.
These risks include, among other things, operational risks, financial loss, intellectual property theft, fraud, extortion, loss of sensitive data, harm to individuals including stockholders, violation of privacy or security laws, increased costs associated with mitigation of damages and remediation, and other legal and reputational risks. We have implemented several cybersecurity processes and controls to aid in our efforts to assess, identify, and manage such material risks.
We rely on the Investment Adviser’s enterprise-wide cybersecurity program to protect our information, including due oversight of the cybersecurity programs of our key service providers and processes for the assessment, identification, and management of material risks from cybersecurity threats, including those associated with the use of third-party service providers. The Investment Adviser considers such cybersecurity threats as part of its broader risk management framework, and its cybersecurity program is designed to, among other things, protect us, insofar as is practicable, from the hazards of cybersecurity threats and vulnerabilities in accordance with applicable legal requirements and guidance. The Investment Adviser collaborates with third-party subject-matter experts, as necessary, to identify and assess material cybersecurity threat risks and evaluate and test its cybersecurity protections, including through continuous network and endpoint monitoring, employee anti-phishing training, vulnerability assessments, and penetration testing to inform the Investment Adviser’s risk identification and assessment. The Investment Adviser also performs due diligence reviews on third-parties that have access to our systems, data, or facilities that house such systems or data and continually monitors cybersecurity threat risks identified through such diligence.
Together with management, the Board has designated an Information Security Group (“ISG”) to monitor issues relating to cybersecurity and work with the Investment Adviser’s third-party Information Technology (“IT”) service provider to evaluate potential cyber risk vulnerabilities. While its composition may change over time, the ISG currently consists of our Chief Financial Officer and Chief Compliance Officer. The ISG, together with the Investment Adviser’s third-party IT service provider, annually reviews the cyber risks applicable to our business and the measures established by the Investment Adviser and other service providers to protect against those risks and recommends changes or enhancements, as necessary. The Investment Adviser’s management and the third-party IT service provider also monitor the Investment Adviser’s network to identify internal and external cybersecurity threats and vulnerabilities in order to determine any steps that should be taken to protect information stored on the Investment Adviser’s network and promptly inform the ISG of any identified cybersecurity threats or vulnerabilities. The ISG also makes inquiries of the Investment Adviser’s management and the third-party IT service provider regarding such efforts.
Material Impact of Cybersecurity Risks
The potential impact of risks from cybersecurity threats on us are assessed on an ongoing basis, and how such risks could materially affect our business strategy, operational results, or financial condition are regularly evaluated. During the reporting period, we did not identify any risks from cybersecurity threats, including as a result of previous cybersecurity incidents, that we believe have materially affected, or are reasonably likely to materially affect, our business strategy, operational results, or financial condition. We further describe cybersecurity risks that we face in “The failure in cyber security systems, as well as the occurrence of events unanticipated in our disaster recovery systems and management continuity planning could impair our ability to conduct business effectively” and “We, our Investment Adviser and our portfolio companies are subject to risks associated with cyber-attacks” under “Item 1A. Risk Factors” of this annual report on Form
10-K.
 
72

Governance
The Board has overall responsibility for risk oversight, including risks related to cybersecurity threats. The Board is aware of the critical nature of managing these risks and has sought to establish oversight mechanisms to ensure effective governance in managing risks associated with cybersecurity and appropriate review of the protections provided to us by the Investment Adviser.
In conducting its duties, the ISG relies on the experience and expertise of the Investment Adviser’s third-party IT service provider, which includes, among other things, over two decades of managing network security for companies, a track record of collaborating with management teams on incident response and threat mitigation, and, through various partnerships, vetting and implementing cutting-edge cybersecurity technologies. The ISG will provide a report, at least annually, to the entire Board regarding our cybersecurity threat risk management and strategy processes covering topics such as data security posture, results from third-party assessments, progress towards
pre-determined
risk mitigation-related goals, the Investment Adviser’s incident response plan, and cybersecurity threat risks or incidents and developments, as well as the steps the Investment Adviser’s management has taken to respond to and mitigate such risks. The Investment Adviser’s incident response plan provides guidelines for responding to cyber incidents and facilitates coordination across multiple operational functions of the Investment Adviser. The incident response plan includes notification to the ISG and, depending on its nature, escalation to the Board, if appropriate. The Board is also encouraged to engage with the ISG on cybersecurity topics at other times, and material cybersecurity threats and risks are also considered by the Board in relation to other important matters that come before it.
 
Item 2.
Properties
Our offices are located at 500 Park Avenue, New York, New York 10022, and are provided by SLR Capital Management in accordance with the terms of the Administration Agreement. We believe that our office facilities are suitable and adequate for our business as it is presently conducted.
 
Item 3.
Legal Proceedings
We and our consolidated subsidiaries are not currently subject to any material legal proceedings, nor, to our knowledge, is any material legal proceeding threatened against us or our consolidated subsidiaries. From time to time, we and our consolidated subsidiaries may be a party to certain legal proceedings in the ordinary course of business, including proceedings relating to the enforcement of our rights under contracts with our portfolio companies. While the outcome of these legal proceedings cannot be predicted with certainty, we do not expect that these proceedings will have a material effect upon our financial condition or results of operations.
 
Item 4.
Mine Safety Disclosures
Not applicable.
 
73

PART II
 
Item 5.
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Common Stock
Our common stock is traded on the NASDAQ Global Select Market under the symbol “SLRC”. The following table sets forth, for each fiscal quarter during the last two fiscal years, the net asset value (“NAV”) per share of our common stock, the high and low closing sales prices for our common stock, such sales prices as a percentage of NAV per share and distributions per share.
 
           
Price Range
    
Premium or
(Discount)
of High Closing
   
Premium or
(Discount)
of
Low Closing
Price to
   
Declared
 
    
NAV
(1)
    
High
    
Low
    
Price to NAV
(2)
   
NAV
(2)
   
Distributions
(3)
 
Fiscal 2023
               
Fourth Quarter
   $ 18.09      $ 15.43      $ 14.14        (14.7 )%      (21.8 )%    $ 0.41  
Third Quarter
     18.06        15.60        14.22        (13.6     (21.3     0.41  
Second Quarter
     17.98        15.20        13.59        (15.5     (24.4     0.41  
First Quarter
     18.04        16.00        14.12        (11.3     (21.7     0.41  
Fiscal 2022
               
Fourth Quarter
   $ 18.33      $ 15.03      $ 12.50        (18.0 )%      (31.8 )%    $ 0.41  
Third Quarter
     18.37        15.76        12.32        (14.2     (32.9     0.41  
Second Quarter
     18.53        18.19        14.17        (1.8     (23.5     0.41  
First Quarter
     19.56        19.26        17.68        (1.5     (9.6     0.41  
 
(1)
 
NAV per share is determined as of the last day in the relevant quarter and therefore may not reflect the NAV per share on the date of the high and low sales prices. The net asset values shown are based on outstanding shares at the end of each period.
(2)
 
Calculated as of the respective high or low closing price divided by NAV and subtracting 1.
(3)
 
Represents the cash distribution for the specified quarter.
On February 23, 2024, the last reported sales price of our common stock was $14.89 per share. As of February 23, 2024, we had 19 stockholders of record.
Shares of BDCs may trade at a market price that is less than the value of the net assets attributable to those shares. The possibility that our shares of common stock will trade at a discount from net asset value or at premiums that are unsustainable over the long term is separate and distinct from the risk that our net asset value will decrease. Since our IPO on February 9, 2010, our shares of common stock have traded at both a discount and a premium to the net assets attributable to those shares. As of February 23, 2024, our shares of common stock traded at a discount equal to approximately 17.7% of the net assets attributable to those shares based upon our net asset value as of December 31, 2023. It is not possible to predict whether the shares offered hereby will trade at, above, or below net asset value.
DISTRIBUTIONS
Tax characteristics of all distributions will be reported to stockholders on Form 1099 after the end of the calendar year. Future quarterly distributions, if any, will be determined by the Board. We expect that our distributions to stockholders will generally be from accumulated net investment income, from net realized capital gains or
non-taxable
return of capital, if any, as applicable.
 
74

We have elected to be taxed as a RIC under Subchapter M of the Code. To maintain our RIC tax treatment, we must distribute at least 90% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, out of the assets legally available for distribution. In addition, although we currently intend to distribute realized net capital gains (
i.e.
, net long-term capital gains in excess of short-term capital losses), if any, at least annually, out of the assets legally available for such distributions, we may in the future decide to retain such capital gains for investment.
We maintain an “opt out” dividend reinvestment plan for our common stockholders. As a result, if we declare a distribution, then stockholders’ cash distributions will be automatically reinvested in additional shares of our common stock, unless they specifically “opt out” of the dividend reinvestment plan so as to receive cash distributions.
We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, due to the asset coverage test applicable to us as a business development company, we may in the future be limited in our ability to make distributions. Also, our revolving credit facility may limit our ability to declare distributions if we default under certain provisions. If we do not distribute a certain percentage of our income annually, we will suffer adverse tax consequences, including possible loss of the tax benefits available to us as a regulated investment company. In addition, in accordance with GAAP and tax regulations, we include in income certain amounts that we have not yet received in cash, such as contractual
payment-in-kind
income, which represents contractual income added to the loan balance that becomes due at the end of the loan term, or the accrual of original issue or market discount. Since we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the requirement to distribute at least 90% of our investment company taxable income to obtain tax benefits as a regulated investment company.
With respect to the distributions to stockholders, income from origination, structuring, closing and certain other upfront fees associated with investments in portfolio companies are treated as taxable income and accordingly, distributed to stockholders.
We cannot assure stockholders that they will receive any distributions at a particular level.
All distributions declared in cash payable to stockholders that are participants in our dividend reinvestment plan are generally automatically reinvested in shares of our common stock. As a result, stockholders that do not participate in the dividend reinvestment plan may experience dilution over time. Stockholders who do not elect to receive distributions in shares of common stock may experience accretion to the net asset value of their shares if our shares are trading at a premium and dilution if our shares are trading at a discount. The level of accretion or discount would depend on various factors, including the proportion of our stockholders who participate in the plan, the level of premium or discount at which our shares are trading and the amount of the distribution payable to a stockholder.
Recent Sales of Unregistered Securities
None.
Issuer Purchases of Equity Securities
None.
 
75

STOCK PERFORMANCE GRAPH
This graph compares the cumulative total return on our common stock with that of the Standard & Poor’s BDC Index, Standard & Poor’s 500 Stock Index and the Russell 2000 Financial Services Index, for the period from December 31, 2018 through December 31, 2023. The graph assumes that a person invested $10,000 in each of the following: our common stock (SLRC), the S&P BDC Index, the S&P 500 Index, and the Russell 2000 Financial Services Index. The graph measures total stockholder return, which takes into account both changes in stock price and dividends. It assumes that dividends paid are invested in additional shares of the same class of equity securities at the frequency with which dividends are paid of such securities during the applicable fiscal year.
 
The graph and other information furnished under this Part II Item 5 of this Form
10-K
shall not be deemed to be “soliciting material” or to be “filed” with the SEC or subject to Regulation 14A or 14C, or to the liabilities of Section 18 of the 1934 Act. The stock price performance included in the above graph is not necessarily indicative of future stock price performance.
 
76

FEES AND EXPENSES
The following table is intended to assist an investor in understanding the costs and expenses that you will bear directly or indirectly. We caution you that some of the percentages indicated in the table below are estimates and may vary. Except where the context suggests otherwise, whenever this report contains a reference to fees or expenses paid by “us” or “SLRC,” or that “we” will pay fees or expenses, you will indirectly bear such fees or expenses as an investor in SLR Investment Corp.
 
Stockholder transaction expenses:
  
Sales load (as a percentage of offering price)
     %
(1)
 
Offering expenses (as a percentage of offering price)
     %
(2)
 
Dividend reinvestment plan expenses
     %
(3)
 
Total stockholder transaction expenses (as a percentage of offering price)
     %
(2)
 
Annual expenses (as a percentage of net assets attributable to common stock)
(4)
:
  
Base management fee
     3.21 %
(5)
 
Incentive fees payable under the Advisory Agreement (up to 20%)
     2.27 %
(6)
 
Interest payments on borrowed funds
     7.35 %
(7)
 
Acquired fund fees and expenses
     0.35 %
(8)
 
Other expenses (estimated)
     1.08 %
(9)
 
Total annual expenses
     14.26
 
(1)
 
In the event that the shares of common stock are sold to or through underwriters, a corresponding prospectus supplement will disclose the applicable sales load and the “Example” will be updated accordingly.
(2)
 
The prospectus supplement corresponding to each offering will disclose the applicable offering expenses and total stockholder transaction expenses.
(3)
 
The expenses of the dividend reinvestment plan are included in “other expenses.”
(4)
 
Annual Expenses are presented in this manner because common stockholders will bear all costs of running the Company.
(5)
 
Our 1.50% base management fee under the Advisory Agreement (giving effect to the Letter Agreement) is based on our gross assets, which is defined as all the assets of SLRC, excluding temporary assets, including those acquired using borrowings for investment purposes, and assumes our gross assets remain consistent with gross assets for the fiscal year ended December 31, 2023. The base management fee is reduced to 1.00% on gross assets that exceed 200% of total net assets as of the immediately preceding quarter.
(6)
Assumes that annual incentive fees earned by our investment adviser, SLR Capital Partners, remain consistent with the incentive fees earned by SLR Capital Partners for the fiscal year ended December 31, 2023. The incentive fee consists of two parts:
The first part, which is payable quarterly in arrears, equals 20% of the excess, if any, of our
“Pre-Incentive
Fee Net Investment Income” that exceeds a 1.75% quarterly (7.00% annualized) hurdle rate, which we refer to as the Hurdle, subject to a
“catch-up”
provision measured at the end of each calendar quarter. The first part of the incentive fee is computed and paid on income that may include interest that is accrued but not yet received in cash. The operation of the first part of the incentive fee for each quarter is as follows:
 
   
no incentive fee is payable to our investment adviser in any calendar quarter in which our
Pre-Incentive
Fee Net Investment Income does not exceed the Hurdle of 1.75%;
 
   
100% of our
Pre-Incentive
Fee Net Investment Income with respect to that portion of such
Pre-Incentive
Fee Net Investment Income, if any, that exceeds the Hurdle but is less than 2.1875% in any calendar quarter (8.75% annualized) is payable to our investment adviser. We refer to this portion of our
Pre-Incentive
Fee Net Investment Income (which exceeds the Hurdle but is less than 2.1875%) as the
“catch-up.”
The
“catch-up”
is meant to provide our investment adviser with 20% of our
 
77

 
Pre-Incentive
Fee Net Investment Income, as if a Hurdle did not apply when our
Pre-Incentive
Fee Net Investment Income exceeds 2.1875% in any calendar quarter; and
 
   
20% of the amount of our
Pre-Incentive
Fee Net Investment Income, if any, that exceeds 2.1875% in any calendar quarter (8.75% annualized) is payable to our investment adviser (once the Hurdle is reached and the
catch-up
is achieved, 20% of all
Pre-Incentive
Fee Investment Income thereafter is allocated to our investment adviser).
The second part of the incentive fee equals 20% of our “Incentive Fee Capital Gains,” if any, which equals our realized capital gains on a cumulative basis from inception through the end of each calendar year, computed net of all realized capital losses and unrealized capital depreciation on a cumulative basis, less the aggregate amount of any previously paid capital gain incentive fees. The second part of the incentive fee is payable, in arrears, at the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date).
 
(7)
 
We have historically and will in the future borrow funds from time to time to make investments to the extent we determine that the economic situation is conducive to doing so. The costs associated with our outstanding borrowings are indirectly borne by our investors. For purposes of this section, we have computed interest expense using the average consolidated balance outstanding for borrowings during the fiscal year ended December 31, 2023. We used SOFR or a similar base rate on December 31, 2023 and the interest rate on the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes and the 2024 Unsecured Notes on December 31, 2023. We have also included, as applicable, the estimated market discount or amortization of fees incurred in establishing the Credit Facility, the SPV Credit Facility, the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes and the 2024 Unsecured Notes as of December 31, 2023. Additionally, we included the estimated cost of commitment fees for unused balances on the Credit Facility and the SPV Credit Facility. As of December 31, 2023, we had $507.0 million outstanding under the Credit Facility, $206.3 million outstanding under the SPV Credit Facility and $135 million, $50 million, $75 million, $125 million and $85 million outstanding under the 2027 Series F Unsecured Notes, the 2027 Unsecured Notes, the 2026 Unsecured Notes, the 2025 Unsecured Notes and the 2024 Unsecured Notes, respectively. We may also issue preferred stock, subject to our compliance with applicable requirements under the 1940 Act, although we have no immediate intention to do so.
(8)
 
The holders of shares of our common stock indirectly bear the expenses of our investment in SLR Senior Lending Program LLC (“SSLP”). No management fee is charged on our investments in SSLP in connection with the administrative services provided to SSLP. Future expenses for SSLP may be substantially higher or lower because certain expenses may fluctuate over time.
(9)
 
“Other expenses” are based on estimated amounts for the current fiscal year, which considers the amounts incurred for the fiscal year ended December 31, 2023 and include our overhead expenses, including payments under our Administration Agreement based on our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement.
Example
The following example demonstrates the projected dollar amount of total cumulative expenses that would be incurred over various periods with respect to a hypothetical investment in our common stock. In calculating the following expense amounts, we have assumed that our annual operating expenses would remain at the levels set forth in the table above and have excluded performance-based incentive fees. As such, the below example is based on an annual expense ratio of 11.99%. See Note 7 above for additional information regarding certain
 
78

assumptions regarding our level of leverage. In the event that shares are sold to or through underwriters, a corresponding prospectus supplement will restate this example to reflect the applicable sales load.
 
    
1 Year
    
3 Years
    
5 Years
    
10 Years
 
You would pay the following expenses on a $1,000 investment, assuming a 5% annual return
   $ 120      $ 335      $ 521      $ 884  
The example and the expenses in the tables above should not be considered a representation of our future expenses, and actual expenses may be greater or less than those shown.
While the example assumes, as required by the SEC, a 5% annual return, our performance will vary and may result in a return greater or less than 5%. The incentive fee under the Advisory Agreement, which, assuming a 5% annual return, would either not be payable or would have an insignificant impact on the expense amounts shown above, is not included in the example. This illustration assumes that we will not realize any capital gains (computed net of all realized capital losses and unrealized capital depreciation) in any of the indicated time periods. If we achieve sufficient returns on our investments, including through the realization of capital gains, to trigger an incentive fee of a material amount, our expenses and returns to our investors would be higher. For example, if we assumed that we received our 5% annual return completely in the form of net realized capital gains on our investments, computed net of all cumulative unrealized depreciation on our investments, the projected dollar amount of total cumulative expenses set forth in the above illustration would be as follows:
 
    
1 Year
    
3 Years
    
5 Years
    
10 Years
 
You would pay the following expenses on a $1,000 investment, assuming a 5% annual return
   $ 130      $ 359      $ 554      $ 919  
In addition, the example assumes no sales load. Also, while the example assumes reinvestment of all distributions at net asset value, participants in our dividend reinvestment plan will receive a number of shares of our common stock, determined by dividing the total dollar amount of the distribution payable to a participant by the market price per share of our common stock at the close of trading on the distribution payment date, which may be at, above or below net asset value unless the company makes open market purchases and the shares received will be determined based on the average price paid by our agent, plus commissions.
 
Item 6.
Reserved
 
Item 7.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
The information contained in this section should be read in conjunction with our Consolidated Financial Statements and notes thereto appearing elsewhere in this report.
Some of the statements in this report constitute forward-looking statements, which relate to future events or our future performance or financial condition. The forward-looking statements contained herein involve risks and uncertainties, including statements as to:
 
   
our future operating results, including our ability to achieve objectives;
 
   
our business prospects and the prospects of our portfolio companies;
 
   
the impact of investments that we expect to make;
 
   
our contractual arrangements and relationships with third parties;
 
   
the dependence of our future success on the general economy and its impact on the industries in which we invest;
 
   
the impact of any protracted decline in the liquidity of credit markets on our business;
 
79

   
the ability of our portfolio companies to achieve their objectives;
 
   
the valuation of our investments in portfolio companies, particularly those having no liquid trading market;
 
   
market conditions and our ability to access alternative debt markets and additional debt and equity capital;
 
   
our expected financings and investments;
 
   
the adequacy of our cash resources and working capital;
 
   
the timing of cash flows, if any, from the operations of our portfolio companies;
 
   
the ability of the Investment Adviser to locate suitable investments for us and to monitor and administer our investments;
 
   
the ability of the Investment Adviser to attract and retain highly talented professionals;
 
   
the ability of the Investment Adviser to adequately allocate investment opportunities among the Company and its other advisory clients;
 
   
any conflicts of interest posed by the structure of the management fee and incentive fee to be paid to the Investment Adviser;
 
   
changes in political, economic or industry conditions, relations between the United States, Russia, Ukraine and other nations, the interest rate environment, certain regional bank failures or conditions affecting the financial and capital markets;
 
   
the escalating conflict in the Middle East;
 
   
changes in the general economy, slowing economy, rising inflation, risk of recession and risks in respect of a failure to increase the U.S. debt ceiling; and
 
   
our ability to anticipate and identify evolving market expectations with respect to environmental, social and governance matters, including the environmental impacts of our portfolio companies’ supply chains and operations.
These statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements, including without limitation:
 
   
an economic downturn could impair our portfolio companies’ ability to continue to operate, which could lead to the loss of some or all of our investments in such portfolio companies;
 
   
a contraction of available credit and/or an inability to access the equity markets could impair our lending and investment activities;
 
   
interest rate volatility could adversely affect our results, particularly because we use leverage as part of our investment strategy;
 
   
currency fluctuations could adversely affect the results of our investments in foreign companies, particularly to the extent that we receive payments denominated in foreign currency rather than U.S. dollars; and
 
   
the risks, uncertainties and other factors we identify in Item 1A. — Risk Factors contained in this Annual Report on Form
10-K
for the year ended December 31, 2023 and in our other filings with the SEC.
We generally use words such as “anticipates,” “believes,” “expects,” “intends” and similar expressions to identify forward-looking statements. Our actual results could differ materially from those projected in the forward-looking statements for any reason, including any factors set forth in “Risk Factors” and elsewhere in this report.
 
80

We have based the forward-looking statements included in this report on information available to us on the date of this report, and we assume no obligation to update any such forward-looking statements. Although we undertake no obligation to revise or update any forward-looking statements, whether as a result of new information, future events or otherwise, you are advised to consult any additional disclosures that we may make directly to you or through reports that we in the future may file with the SEC, including any annual reports on Form
10-K,
quarterly reports on Form
10-Q
and current reports on Form
8-K.
Overview
SLR Investment Corp. (the “Company”, “SLRC”, “we” or “our”), a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S federal income tax purposes, the Company has elected to be treated as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
On February 9, 2010, we priced our initial public offering, selling 5.68 million shares of our common stock. Concurrent with our initial public offering, Michael S. Gross, our Chairman,
Co-Chief
Executive Officer and President, and Bruce Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer, collectively purchased an additional 0.6 million shares of our common stock through a private placement transaction exempt from registration under the Securities Act of 1933, as amended.
We invest primarily in privately held U.S. middle-market companies, where we believe the supply of primary capital is limited and the investment opportunities are most attractive. Our investment objective is to generate both current income and capital appreciation through debt and equity investments. We invest primarily in leveraged middle-market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded. Our business is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. Our investments generally range between $5 million and $100 million each, although we expect that this investment size will vary proportionately with the size of our capital base and/or with strategic initiatives. Our investment activities are managed by SLR Capital Partners, LLC (the “Investment Adviser”) and supervised by our board of directors (the “Board”), a majority of whom are
non-interested,
as such term is defined in the 1940 Act. SLR Capital Management, LLC (the “Administrator”) provides the administrative services necessary for us to operate.
In addition, we may invest a portion of our portfolio in other types of investments, which we refer to as opportunistic investments, which are not our primary focus but are intended to enhance our overall returns. These investments may include, but are not limited to, direct investments in public companies that are not thinly traded and securities of leveraged companies located in select countries outside of the United States.
Recent Developments
On February 27, 2024, the Board declared a quarterly distribution of $0.41 per share payable on March 28, 2024 to holders of record as of March 14, 2024.
Investments
Our level of investment activity can and does vary substantially from period to period depending on many factors, including the amount of debt and equity capital available to middle market companies, the level of merger and acquisition activity for such companies, the general economic environment and the competitive
 
81

environment for the types of investments we make. As a BDC, we must not acquire any assets other than “qualifying assets” specified in the 1940 Act unless, at the time the acquisition is made, at least 70% of our total assets are qualifying assets (with certain limited exceptions). Qualifying assets include investments in “eligible portfolio companies.” The definition of “eligible portfolio company” includes certain public companies that do not have any securities listed on a national securities exchange and companies whose securities are listed on a national securities exchange but whose market capitalization is less than $250 million.
Revenue
We generate revenue primarily in the form of interest and dividend income from the securities we hold and capital gains, if any, on investment securities that we may sell. Our debt investments generally have a stated term of three to seven years and typically bear interest at a floating rate usually determined on the basis of a benchmark Secured Overnight Financing Rate (“SOFR”), commercial paper rate, or the prime rate. Interest on our debt investments is generally payable monthly or quarterly but may be
bi-monthly
or semi-annually. In addition, our investments may provide
payment-in-kind
(“PIK”) income. Such amounts of accrued PIK income are added to the cost of the investment on the respective capitalization dates and generally become due at maturity of the investment or upon the investment being called by the issuer. We may also generate revenue in the form of commitment, origination, structuring fees, fees for providing managerial assistance and, if applicable, consulting fees, etc.
Expenses
All investment professionals of the Investment Adviser and their respective staffs, when and to the extent engaged in providing investment advisory and management services, and the compensation and routine overhead expenses of such personnel allocable to such services, are provided and paid for by the Investment Adviser. We bear all other costs and expenses of our operations and transactions, including (without limitation):
 
   
the cost of our organization and public offerings;
 
   
the cost of calculating our net asset value, including the cost of any third-party valuation services;
 
   
the cost of effecting sales and repurchases of our shares and other securities;
 
   
interest payable on debt, if any, to finance our investments;
 
   
fees payable to third parties relating to, or associated with, making investments, including fees and expenses associated with performing due diligence reviews of prospective investments and advisory fees;
 
   
transfer agent and custodial fees;
 
   
fees and expenses associated with marketing efforts;
 
   
federal and state registration fees, any stock exchange listing fees;
 
   
federal, state and local taxes;
 
   
independent directors’ fees and expenses;
 
   
brokerage commissions;
 
   
fidelity bond, directors and officers errors and omissions liability insurance and other insurance premiums;
 
   
direct costs and expenses of administration, including printing, mailing, long distance telephone and staff;
 
   
fees and expenses associated with independent audits and outside legal costs;
 
82

   
costs associated with our reporting and compliance obligations under the 1940 Act and applicable federal and state securities laws; and
 
   
all other expenses incurred by either SLR Capital Management or us in connection with administering our business, including payments under the Administration Agreement that will be based upon our allocable portion of overhead and other expenses incurred by SLR Capital Management in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and our allocable portion of the costs of compensation and related expenses of our chief compliance officer and our chief financial officer and their respective staffs.
We expect our general and administrative operating expenses related to our ongoing operations to increase moderately in dollar terms. During periods of asset growth, we generally expect our general and administrative operating expenses to decline as a percentage of our total assets and increase during periods of asset declines. Incentive fees, interest expense and costs relating to future offerings of securities, among others, may also increase or reduce overall operating expenses based on portfolio performance, interest rate benchmarks, and offerings of our securities relative to comparative periods, among other factors.
Macroeconomic Environment
Credit markets showed resilience in 2023 in the face of persistent but declining inflationary pressures and higher interest rates. The U.S. economy grew during the year and central banks have postured toward lower interest rates. The year ended with uncertainties around the economy and geopolitical issues.
Portfolio and Investment Activity
During the year ended December 31, 2023, we invested approximately $812 million across over 85 portfolio companies. This compares to investing approximately $610 million across over 75 portfolio companies for the year ended December 31, 2022. Investments sold, prepaid or repaid during the year ended December 31, 2023 totaled approximately $750 million versus approximately $532 million for the year ended December 31, 2022.
At December 31, 2023, our portfolio consisted of 151 portfolio companies and was invested 32.5% in cash flow senior secured loans, 27.8% in asset-based senior secured loans / SLR Credit Solutions (“SLR Credit”) / SLR Healthcare ABL / SLR Business Credit, 23.0% in equipment senior secured financings / SLR Equipment Finance (“SLR Equipment”) / Kingsbridge Holdings, LLC (“KBH”) and 16.7% in life science senior secured loans, in each case, measured at fair value, versus 139 portfolio companies invested 30.8% in cash flow senior secured loans, 30.0% in asset-based senior secured loans / SLR Credit, 23.7% in equipment senior secured financings / SLR Equipment / KBH, and 15.5% in life science senior secured loans, in each case, measured at fair value, at December 31, 2022.
At December 31, 2023, 78.7% or $1.67 billion of our income producing investment portfolio
*
is floating rate and 21.3% or $450.6 million is fixed rate, measured at fair value. At December 31, 2022, 77.7% or $1.61 billion of our income producing investment portfolio
*
is floating rate and 22.3% or $464.5 million is fixed rate, measured at fair value. As of December 31, 2023 and 2022, we had one and two issuers on
non-accrual
status, respectively.
 
*
 
We have included SLR Credit Solutions, SLR Equipment Finance, SLR Healthcare ABL, SLR Business Credit and Kingsbridge Holdings, LLC within our income producing investment portfolio.
SLR Credit Solutions
On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275 million in cash. Crystal Financial owned approximately 98% of the outstanding ownership
 
83

interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400 million at November 30, 2012 and a $275 million committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5.7 million. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of December 31, 2023, total commitments to the revolving credit facility are $300 million.
As of December 31, 2023, SLR Credit had 31 funded commitments to 26 different issuers with total funded loans of approximately $406.6 million on total assets of $438.4 million. As of December 31, 2022, SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $439.5 million on total assets of $460.7 million. As of December 31, 2023 and December 31, 2022, the largest loan outstanding totaled $30.0 million and $33.4 million, respectively. For the same periods, the average exposure per issuer was $15.6 million and $17.6 million, respectively. SLR Credit’s credit facility, which is
non-recourse
to the Company, had approximately $218.9 million and $224.3 million of borrowings outstanding at December 31, 2023 and December 31, 2022, respectively. For the years ended December 31, 2023 and 2022, SLR Credit had net income of $6.5 million and $7.5 million, respectively, on gross income of $57.8 million and $30.3 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Credit will be able to maintain consistent dividend payments to us. SLR Credit’s consolidated financial statements for the fiscal years ended December 31, 2023 and December 31, 2022 are attached as an exhibit to this annual report on Form
10-K.
SLR Equipment Finance
On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209.9 million in cash to effect the transaction, of which $145.0 million was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64.9 million was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150.0 million
non-recourse
facility with an accordion feature to expand up to $250.0 million. In September 2019, SLR Equipment amended the facility, increasing commitments to $214.0 million with an accordion feature to expand up to $314.0, million and extended the maturity date of the facility to July 31, 2023. In June 2023, the facility was amended to extend the maturity date to January 31, 2024, with updated commitments totaling $152.1 million, effective August 1, 2023.
As of December 31, 2023, SLR Equipment had 150 funded equipment-backed leases and loans to 62 different customers with a total net investment in leases and loans of approximately $203.7 million on total assets of $254.7 million. As of December 31, 2022, SLR Equipment had 131 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $190.8 million on total assets of $241.8 million. As of December 31, 2023 and December 31, 2022, the largest position outstanding totaled $17.9 million and $19.3 million, respectively. For the same periods, the average exposure per customer was $3.3 million and $3.2 million, respectively. SLR Equipment’s credit facility, which is
non-recourse
to the Company, had approximately $137.2 million and $115.0 million of borrowings outstanding at December 31, 2023 and December 31, 2022, respectively. For the years ended December 31, 2023 and 2022, SLR Equipment had net losses of $6.4 million and $2.9 million, respectively, on gross income of $19.6 million and $20.4 million,
 
84

respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Equipment’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Equipment will be able to maintain consistent dividend payments to us. SLR Equipment’s consolidated financial statements for the fiscal years ended December 31, 2023 and December 31, 2022 are attached as an exhibit to this annual report on Form
10-K.
Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216.6 million to effect the transaction, of which $136.6 million was invested to acquire 87.5% of KBHT’s equity and $80.0 million in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of December 31, 2023 and 2022, KBHT had total assets of $857.3 million and $777.2 million, respectively. For the same periods, debt recourse to KBHT totaled $249.8 million and $222.1 million, respectively, and
non-recourse
debt totaled $367.1 million and $353.1 million, respectively. None of the debt is recourse to the Company. For the years ended December 31, 2023 and December 31, 2022, KBHT had net income of $9.1 million and $13.3 million, respectively, on gross income of $327.4 million and $298.8 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us. KBHT’s consolidated financial statements for the years ended December 31, 2023 and December 31, 2022 are attached as an exhibit to this annual report on Form
10-K.
SLR Healthcare ABL
SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”) on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and
mid-sized
companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was approximately $32.8 million. The management team of SLR Healthcare
co-invested
in the transaction and continues to lead SLR Healthcare. As of December 31, 2023, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers on April 1, 2022. Effective with an amendment dated August 24, 2023, SLR Healthcare has a $150 million
non-recourse
credit facility, which is expandable to $200 million under its accordion facility. The maturity date of this facility is March 31, 2026.
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2023, the portfolio totaled approximately $255.0 million of commitments with a total net investment in loans of $111.3 million on total assets of $118.6 million. As of December 31, 2022, the portfolio totaled approximately $242.1 million of commitments with a total net investment in loans of $92.4 million on total assets of $108.7 million. At December 31, 2023, the portfolio consisted of 42 issuers with an average balance of approximately $2.6 million versus 41 issuers with an average balance of approximately $2.3 million at December 31, 2022. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured,
cash-pay
loans. SLR Healthcare’s credit facility, which is
non-recourse
to us, had approximately $84.7 million and $77.0 million of borrowings outstanding at December 31, 2023 and December 31, 2022, respectively. For the years ended December 31, 2023 and 2022, SLR Healthcare had net income of $5.5 million and $3.5 million, respectively, on gross income of $17.9 million and $11.6 million,
 
85

respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. SLR Healthcare’s consolidated financial statements for the fiscal years ended December 31, 2023 and December 31, 2022 are attached as an exhibit to this annual report on Form
10-K.
SLR Business Credit
SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based
small-to-medium-sized
businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51.0 million to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and 1% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and
medium-sized
businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15.5 million transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of approximately $66.7 million was financed with equity from SUNS of $19.0 million and borrowings on NMC’s credit facility of $47.7 million. SLRC acquired SLR Business Credit in connection with the Mergers on April 1, 2022.
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2023, the portfolio totaled approximately $610.9 million of commitments, of which $273.5 million were funded, on total assets of $315.3 million. As of December 31, 2022, the portfolio totaled approximately $603.4 million of commitments, of which $286.0 million were funded, on total assets of $332.2 million. At December 31, 2023, the portfolio consisted of 102 issuers with an average balance of approximately $2.7 million versus 108 issuers with an average balance of approximately $2.6 million at December 31, 2022. NMC has a senior credit facility with a bank lending group for $285.3 million which expires on November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is
non-recourse
to us, had approximately $222.9 million and $214.4 million of borrowings outstanding at December 31, 2023 and December 31, 2022, respectively. For the years ended December 31, 2023, 2022 and 2021, SLR Business Credit had net income (loss) of ($9.5) million, $3.9 million, and $7.3 million, respectively, on gross income of $38.1 million, $29.4 million, and $24.0 million, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us. SLR Business Credit’s consolidated financial statements for the fiscal years ended December 31, 2023 and December 31, 2022 are attached as an exhibit to this annual report on Form
10-K.
Stock Repurchase Program
On May 9, 2023, our Board authorized an extension of a program for the purpose of repurchasing up to $50 million of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule
10b-18
of the 1934 Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless further amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 10, 2024 or until $50 million of our outstanding shares of common
 
86

stock have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. For the fiscal year ended December 31, 2023, the Company repurchased 746 shares at an average price of approximately $14.02 per share, inclusive of commissions. The total dollar amount of shares repurchased for the fiscal year ended December 31, 2023 was $0.01 million. During the fiscal year ended December 31, 2022, the Company repurchased 217,271 shares at an average price of approximately $13.98 per share, inclusive of commissions. The total dollar amount of shares repurchased for the fiscal year ended December 31, 2022 was $3.0 million.
SLR Senior Lending Program LLC
On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50 million, resulting in a total equity commitment of $100 million. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.
On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP as servicer and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $100 million senior secured revolving credit facility (the “SSLP Facility”) with Goldman Sachs Bank USA acting as administrative agent. On October 20, 2023, the SSLP Facility was expanded to $150 million. The SSLP Facility is scheduled to mature on December 12, 2027. The SSLP Facility generally bears interest at a rate of SOFR plus 3.25%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. As of December 31, 2023 and December 31, 2022, borrowings outstanding on the SSLP Facility totaled $106.9 million and $0, respectively.
As of December 31, 2023 and December 31, 2022, the Company and the Investor had contributed combined equity capital in the amount of $85.8 million and $19.0 million, respectively. As of December 31, 2023 and December 31, 2022, the Company and the Investor’s combined remaining commitments to SSLP totaled $14.2 million and $81.0 million, respectively. The Company, along with the Investor, controls the funding of SSLP, and SSLP may not call the unfunded commitments of the Company or the Investor without approval of both the Company and the Investor.
As of December 31, 2023 and December 31, 2022, SSLP had total assets of $195.9 million and $19.1 million, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 32 and 7 different borrowers, respectively. For the year ended December 31, 2023 and the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $188.7 million in 32 portfolio companies and $18.1 million in 7 portfolio companies, respectively. For the same periods, investments prepaid totaled $21.1 million and $0.1 million, respectively.
 
87

SSLP Portfolio as of December 31, 2023 (dollar amounts in thousands)
 
Description
 
Industry
 
Spread
Above
Index
(1)
   
Floor
   
Interest
Rate
(2)
   
Maturity
Date
   
Par
Amount
   
Cost
   
Fair
Value
(3)
 
Aegis Toxicology Sciences Corporation
(4)
  Health Care Providers & Services     S+550       1.00     11.13     5/9/25     $ 2,947     $ 2,947     $ 2,947  
Alkeme Intermediary Holdings, LLC
 (4)
  Insurance     S+650       1.00     11.96     10/28/26       3,017       2,934       3,017  
All States Ag Parts, LLC
(4)
  Trading Companies & Distributors     S+600       1.00     11.61     9/1/26       2,133       2,133       2,133  
Apex Service Partners, LLC
  Diversified Consumer Services     S+700       1.00     11.87     10/24/30       4,905       4,784       4,783  
Atria Wealth Solutions, Inc.
(4)
  Diversified Financial Services     S+650       1.00     11.97     5/31/24       2,468       2,468       2,468  
BayMark Health Services, Inc.
 (4)
  Health Care Providers & Services     S+500       1.00     10.61     6/11/27       4,033       4,033       4,033  
CC SAG Holdings Corp.
(4)
  Diversified Consumer Services     S+575       0.75     11.22     6/29/28       8,969       8,969       8,969  
CVAUSA Management, LLC
 (4)
  Health Care Providers & Services     S+650       1.00     11.74     5/22/29       5,412       5,251       5,412  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
  Trading Companies & Distributors     S+475       1.00     10.20     12/31/25       1,086       1,086       1,086  
Erie Construction
Mid-west,
LLC
  Building Products     S+475       1.00     10.20     7/30/27       8,457       8,457       8,457  
Fertility (ITC) Investment Holdco, LLC
(4)
  Health Care Providers & Services     S+650       1.00     11.97     1/3/29       5,955       5,791       5,955  
Foundation Consumer Brands, LLC 
(4)
  Personal Products     S+625       1.00     11.79     2/12/27       8,641       8,641       8,641  
GSM Acquisition Corp.
(4)
  Leisure Equipment & Products     S+500       1.00     10.47     11/16/26       8,541       8,541       8,541  
Higginbotham Insurance Agency, Inc.
(4)
  Insurance     S+550       1.00     10.96     11/25/28       7,573       7,573       7,573  
High Street Buyer, Inc.
  Insurance     S+575       0.75     11.25     4/16/28       7,604       7,604       7,604  
iCIMS, Inc.
(4)
  Software     S+725       0.75     12.62     8/18/28       3,089       3,066       3,089  
Kaseya, Inc.
(4)
  Software     S+600       0.75     11.38     6/23/29       9,058       9,058       9,058  
Kid Distro Holdings, LLC
(4)
  Software     S+550       1.00     11.00     10/1/27       8,939       8,939       8,939  
Maxor Acquisition, Inc.
(4)
  Health Care Providers & Services     S+675       1.00     12.48     3/1/29       6,120       5,940       6,120  
ONS MSO, LLC
(4)
  Health Care Providers & Services     S+625       1.00     11.62     7/8/26       5,922       5,784       5,922  
Pinnacle Treatment Centers, Inc.
(4)
  Health Care Providers & Services     S+650       1.00     11.95     1/2/26       6,951       6,951       6,951  
Plastics Management, LLC
(4)
  Health Care Providers & Services     S+500       1.00     10.45     8/18/27       5,637       5,471       5,637  
RQM+ Corp.
(4)
  Life Sciences Tools & Services     S+575       1.00     11.36     8/12/26       5,955       5,955       5,955  
RxSense Holdings LLC
(4)
  Diversified Consumer Services     S+500       1.00     10.48     3/13/26       8,968       8,968       8,968  
SunMed Group Holdings, LLC
(4)
  Health Care Equipment & Supplies     S+550       0.75     10.96     6/16/28       8,948       8,948       8,948  
The Townsend Company, LLC
(4)
  Commercial Services & Supplies     S+625       1.00     11.61     8/15/29       3,642       3,555       3,642  
Tilley Distribution, Inc.
(4)
  Trading Companies & Distributors     S+600       1.00     11.50     12/31/26       5,850       5,850       5,850  
Ultimate Baked Goods Midco LLC
(4)
  Packaged Foods & Meats     S+625       1.00     11.71     8/13/27       8,954       8,954       8,865  
United Digestive MSO Parent, LLC
(4)
  Health Care Providers & Services     S+675       1.00     12.25     3/30/29       3,411       3,311       3,411  
Urology Management Holdings, Inc.
(4)
  Health Care Providers & Services     S+650       1.00     11.93     6/15/26       3,179       3,102       3,155  
Vessco Midco Holdings, LLC
(4)
  Water Utilities     S+450       1.00     9.96     11/2/26       4,304       4,304       4,304  
West-NR
Parent, Inc.
(4)
  Insurance     S+625       1.00     11.70     12/27/27       6,822       6,691       6,822  
             
 
 
   
 
 
 
              $ 186,059     $ 187,255  
             
 
 
   
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2023.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
 
 
88

SSLP Portfolio as of December 31, 2022 (dollar amounts in thousands)
 
Description
 
Industry
 
Spread
Above
Index
(1)
   
Floor
   
Interest
Rate
(2)
   
Maturity
Date
   
Par
Amount
   
Cost
   
Fair
Value
(3)
 
Atria Wealth Solutions, Inc.
(4)
  Diversified Financial Services     S+600       1.00     10.84     2/29/24     $ 2,494     $ 2,494     $ 2,494  
BayMark Health Services, Inc.
(4)
  Health Care Providers & Services     L+500       1.00     9.73     6/11/27       2,992       2,992       2,992  
ENS Holdings III Corp. & ES Opco USA LLC
(4)
  Trading Companies & Distributors     L+475       1.00     9.43     12/31/25       1,097       1,097       1,097  
Foundation Consumer Brands, LLC 
(4)
  Personal Products     L+550       1.00     10.15     2/12/27       2,963       2,963       2,963  
High Street Buyer, Inc.
(4)
  Insurance     L+600       0.75     10.73     4/16/28       2,494       2,494       2,494  
Ivy Fertility Services, LLC
(4)
  Health Care Providers & Services     L+625       1.00     10.39     2/25/26       3,000       3,000       3,030  
Kid Distro Holdings, LLC
(4)
  Software     L+575       1.00     10.48     10/1/27       2,992       2,992       2,992  
             
 
 
   
 
 
 
              $ 18,032     $ 18,062  
             
 
 
   
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
Below is certain summarized financial information for SSLP as of December 31, 2023 and December 31, 2022, for the year ended December 31, 2023 and for the period December 1, 2022 (commencement of operations) through December 31, 2022:
 
   
December 31,
2023
   
December 31,
2022
 
Selected Balance Sheet Information for SSLP
(in thousands):
   
Investments at fair value (cost $186,059 and $18,032, respectively)
  $ 187,255     $ 18,062  
Cash and other assets.
    8,613       1,043  
 
 
 
   
 
 
 
Total assets
  $ 195,868     $ 19,105  
 
 
 
   
 
 
 
Debt outstanding ($106,900 and $0 face amounts, respectively, reported net of unamortized debt issuance costs of $1,697 and $0, respectively)
  $ 105,203     $ —   
Distributions payable
    1,900       —   
Interest payable and other credit facility related expenses
    551       165  
Accrued expenses and other payables
    416       89  
 
 
 
   
 
 
 
Total liabilities
  $ 108,070     $ 254  
 
 
 
   
 
 
 
Members’ equity
  $ 87,798     $ 18,851  
 
 
 
   
 
 
 
Total liabilities and members’ equity
  $ 195,868     $ 19,105  
 
 
 
   
 
 
 
 
 
89

   
Year ended
December 31,
2023
   
For the Period
December 1, 2022
(commencement of
operations)
through
December 31, 2022
 
Selected Income Statement Information for SSLP (in thousands):
   
Interest income
  $ 10,209     $ 152  
 
 
 
   
 
 
 
Service fees*
  $ 224     $ 4  
Interest and other credit facility expenses
    6,517       166  
Organizational costs
    —        73  
Other general and administrative expenses
    195       88  
 
 
 
   
 
 
 
Total expenses
  $ 6,936     $ 331  
 
 
 
   
 
 
 
Net investment income (loss).
  $ 3,273     $ (179
 
 
 
   
 
 
 
Realized gain on investments
    30       —   
Net change in unrealized gain on investments
    1,166       30  
 
 
 
   
 
 
 
Net realized and unrealized gain on investments
    1,196       30  
 
 
 
   
 
 
 
Net income (loss).
  $ 4,469     $ (149
 
 
 
   
 
 
 
 
*
Service fees are included within the Company’s Consolidated Statements of Operations as other income.
Critical Accounting Policies
The preparation of consolidated financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and revenues and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following items as critical accounting policies. Within the context of these critical accounting policies and disclosed subsequent events herein, we are not currently aware of any other reasonably likely events or circumstances that would result in materially different amounts being reported.
Valuation of Portfolio Investments
In December 2020, the SEC adopted Rule
2a-5
under the 1940 Act addressing fair valuation of fund investments. The rule sets forth requirements for good faith determinations of fair value, as well as for the performance of fair value determinations, including related oversight and reporting obligations. The rule also defines “readily available market quotations” for purposes of the definition of “value” under the 1940 Act, and the SEC noted that this definition will apply in all contexts under the 1940 Act. The Company complies with Rule
2a-5’s
valuation requirements.
We conduct the valuation of our assets, pursuant to which our net asset value is determined, at all times consistent with GAAP and the 1940 Act. The Board will (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
It is anticipated that in respect of many of the Company’s assets, readily available market quotations will not be obtainable and that such assets will be valued at fair value. A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that
 
90

the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation.
Our valuation procedures are set forth in more detail in Note 2(b) to the Company’s Consolidated Financial Statements. Determination of fair value involves subjective judgments and estimates. Accordingly, the notes to our consolidated financial statements express the uncertainty with respect to the possible effect of such valuations, and any change in such valuations, on our consolidated financial statements.
Revenue Recognition
The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Investments that are expected to pay regularly scheduled interest and/or dividends in cash are generally placed on
non-accrual
status when principal or interest/dividend cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest/dividend cash payments will be collected. Such
non-accrual
investments are restored to accrual status if past due principal and interest or dividends are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining interest or dividend obligations. Interest or dividend cash payments received on investments may be recognized as income or applied to principal depending upon management’s judgment. Some of our investments may have contractual PIK income. PIK income computed at the contractual rate, as applicable, is accrued and reflected as a receivable up to the capitalization date. PIK investments offer issuers the option at each payment date of making payments in cash or in additional securities. When additional securities are received, they typically have the same terms, including maturity dates and interest rates as the original securities issued. On these payment dates, the Company capitalizes the accrued interest or dividends receivable (reflecting such amounts as the basis in the additional securities received). PIK generally becomes due at the maturity of the investment or upon the investment being called by the issuer. At the point the Company believes PIK is not expected to be realized, the PIK investment will be placed on
non-accrual
status. When a PIK investment is placed on
non-accrual
status, the accrued, uncapitalized interest or dividends is reversed from the related receivable through interest or dividend income, respectively. The Company does not reverse previously capitalized PIK income. Upon capitalization, PIK is subject to the fair value estimates associated with their related investments. PIK investments on
non-accrual
status are restored to accrual status if the Company again believes that PIK is expected to be realized. Loan origination fees, original issue discount, and market discounts are capitalized and amortized into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record prepayment premiums on loans and other investments as interest income when we receive such amounts. Capital structuring fees are recorded as other income when earned.
The typically higher yields and interest rates on PIK securities, to the extent we invested, reflects the payment deferral and increased credit risk associated with such instruments and that such investments may represent a significantly higher credit risk than coupon loans. PIK securities may have unreliable valuations because their continuing accruals require continuing judgments about the collectability of the deferred payments and the value of any associated collateral. PIK income has the effect of generating investment income and increasing the incentive fees payable at a compounding rate. In addition, the deferral of PIK income also increases the
loan-to-value
ratio at a compounding rate. PIK securities create the risk that incentive fees will be paid to the Investment Adviser based on
non-cash
accruals that ultimately may not be realized, but the Investment Adviser will be under no obligation to reimburse the Company for these fees. For the fiscal years ended December 31, 2023 and 2022, capitalized PIK income totaled $11.1 million and $4.3 million, respectively.
Net Realized Gain or Loss and Net Change in Unrealized Gain or Loss
We generally measure realized gain or loss by the difference between the net proceeds from the repayment or sale and the amortized cost basis of the investment, without regard to unrealized appreciation or depreciation
 
91

previously recognized, but considering unamortized origination or commitment fees and prepayment penalties. The net change in unrealized gain or loss reflects the change in portfolio investment values during the reporting period, including the reversal of previously recorded unrealized gain or loss, when gains or losses are realized. Gains or losses on investments are calculated by using the specific identification method.
Income Taxes
SLRC, a U.S. corporation, has elected to be treated, and intends to qualify annually, as a RIC under Subchapter M of the Code. In order to qualify for U.S. federal income taxation as a RIC, the Company is required, among other things, to timely distribute to its stockholders at least 90% of investment company taxable income, as defined by the Code, for each year. Depending on the level of taxable income earned in a given tax year, we may choose to carry forward taxable income in excess of current year distributions into the next tax year and pay a nondeductible 4% U.S. federal excise tax on such income, as required. To the extent that the Company determines that its estimated current year annual taxable income will be in excess of estimated current year distributions, the Company accrues an estimated excise tax, if any, on estimated excess taxable income.
Recent Accounting Pronouncements
None.
RESULTS OF OPERATIONS
Results comparisons are for the fiscal years ended December 31, 2023 and December 31, 2022. Results for the fiscal year ended December 31, 2021 can be found in Item 7 of the Company’s report on Form
10-K
filed on February 28, 2023, which is incorporated by reference herein.
Investment Income
For the fiscal years ended December 31, 2023 and 2022, gross investment income totaled $229.3 million and $177.5 million, respectively. The increase in gross investment income for the year over year period was primarily due to net growth of the income producing portfolio as well as an increase in index rates.
Expenses
Net expenses totaled $137.2 million and $101.1 million, respectively, for the fiscal years ended December 31, 2023 and 2022, of which $54.6 million and $45.1 million, respectively, were base management fees and performance-based incentive fees and $72.5 million and $46.1 million, respectively, were interest and other credit facility expenses. Other general and administrative expenses totaled $10.6 million and $11.5 million, respectively, for the fiscal years ended December 31, 2023 and 2022. Over the same periods, $0.5 million and $1.5 million of performance-based incentive fees were waived. Expenses generally consist of management and performance-based incentive fees, interest and other credit facility expenses, administrative services fees, insurance expenses, legal fees, directors’ fees, transfer agency fees, printing and proxy expenses, audit and tax services expenses, and other general and administrative expenses. Interest and other credit facility expenses generally consist of interest, unused fees, agency fees and loan origination fees, if any, among others. The increase in expenses for the year over year period was primarily due to higher management fees, incentive fees and interest expense on a larger portfolio. Additionally, there was an increase in index rates on borrowings.
Net Investment Income
The Company’s net investment income totaled $92.1 million and $76.4 million, or $1.69 and $1.48, per average share, respectively, for the fiscal years ended December 31, 2023 and 2022.
 
92

Net Realized Loss
The Company had investment sales and prepayments totaling approximately $750 million and $532 million, respectively, for the fiscal years ended December 31, 2023 and 2022. Net realized losses over the same periods were $28.0 million and $36.5 million, respectively. Net realized losses for fiscal year 2023 were primarily related to our investment in American Teleconferencing Services, Ltd. Net realized losses for fiscal year 2022 were primarily related to the exit of our investment in PhyMed Management, LLC.
Net Change in Unrealized Gain (Loss)
For the fiscal years ended December 31, 2023 and 2022, net change in unrealized gain (loss) on the Company’s assets and liabilities totaled $12.3 million and ($21.5) million, respectively. Net unrealized gain for the fiscal year ended December 31, 2023 is primarily due to the reversal of previously recognized unrealized depreciation on our investment in American Teleconferencing Services, Ltd. as well as appreciation in the value of our investments in Alimera Sciences, Inc., SLR Healthcare ABL and SLR Senior Lending Program LLC, among others, partially offset by depreciation in the value of our investments in
SLR-AMI
Topco Blocker, LLC (f/k/a AmeriMark), KBH Topco, LLC and SLR Credit Solutions, among others. Net unrealized loss for the fiscal year ended December 31, 2022 is primarily due to depreciation in the value of our investments in American Teleconferencing Services, Ltd., RD Holdco, Inc., SLR Credit Solutions and SLR Equipment Finance, among others, partially offset by the reversal of previously recognized unrealized depreciation on our investment in PhyMed Management LLC as well as appreciation on the value of our investments in SLR Business Credit and KBH Topco, LLC in addition to unrealized appreciation on assets acquired in the Mergers due to the accounting treatment of the purchase discount.
Net Increase in Net Assets From Operations
For the fiscal years ended December 31, 2023 and 2022, the Company had a net increase in net assets resulting from operations of $76.4 million and $18.3 million, respectively. For the fiscal years ended December 31, 2023 and 2022, earnings per average share were $1.40 and $0.35, respectively.
LIQUIDITY AND CAPITAL RESOURCES
The Company’s liquidity and capital resources are generated and generally available through its Credit Facility and SPV Credit Facility (as defined below), the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes (collectively the “Debt Instruments”), through cash flows from operations, investment sales, prepayments of senior and subordinated loans, income earned on investments and cash equivalents, and periodic
follow-on
equity and/or debt offerings. As of December 31, 2023, we had a total of $246.8 million of unused borrowing capacity under the Credit Facility and SPV Credit Facility, subject to borrowing base limits.
We may from time to time issue equity and/or debt securities in either public or private offerings. The issuance of such securities will depend on future market conditions, funding needs and other factors and there can be no assurance that any such issuance will occur or be successful. The primary uses of existing funds and any funds raised in the future is expected to be for investments in portfolio companies, repayment of indebtedness, cash distributions to our stockholders, or for other general corporate purposes.
Debt
On April 1, 2022, we entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to our assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently,
 
93

subsequent to an August 29, 2023 amendment, the commitment under the SPV Credit Facility is $275 million; however, the commitment can also be expanded up to $600 million. The stated interest rate on the SPV Credit Facility is SOFR plus
2.00%-2.50%
with no SOFR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, we as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties, and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At December 31, 2023, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $206.3 million.
On April 1, 2022, we entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to our assumption of $85 million in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, we expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
On January 6, 2022, the Company closed a private offering of $135 million of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment, a $25 million November 2022 upsizing and a $40 million August 2023 commitment expiration, the Credit Facility is composed of $585 million of revolving credit and $100 million of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor and matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800 million with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that among other things, require the Company to maintain a minimum stockholder’s equity and a minimum asset coverage ratio. At December 31, 2023, outstanding USD equivalent borrowings under the Credit Facility totaled $507.0 million, composed of $407.0 million of revolving credit and $100.0 million of term loans.
On September 14, 2021, the Company closed a private offering of $50 million of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125 million of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $75 million of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
 
94

On November 22, 2017, we issued $75 million in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73.8 million. Interest on the 2023 Unsecured Notes was paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes were repaid in full at maturity on January 20, 2023.
Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code. At December 31, 2023, the Company was in compliance with all financial and operational covenants required by the Debt Instruments.
Cash Equivalents
We deem certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities as cash equivalents. The Company makes purchases that are consistent with its purpose of making investments in securities described in paragraphs 1 through 3 of Section 55(a) of the 1940 Act. From time to time, including at or near the end of each fiscal quarter, we consider using various temporary investment strategies for our business. One strategy includes taking proactive steps by utilizing cash equivalents as temporary assets with the objective of enhancing our investment flexibility pursuant to Section 55 of the 1940 Act. More specifically, from time to time we may purchase U.S. Treasury bills or other high-quality, short-term debt securities at or near the end of the quarter and typically close out the position on a net cash basis subsequent to quarter end. We may also utilize repurchase agreements or other balance sheet transactions, including drawing down on the Credit Facility, as deemed appropriate. The amount of these transactions or such drawn cash for this purpose is excluded from total assets for purposes of computing the asset base upon which the management fee is determined. We held a face amount of $335 million in cash equivalents as of December 31, 2023.
Contractual Obligations
A summary of our significant contractual payment obligations is as follows as of December 31, 2023:
Payments Due by Period (in millions)
 
    
Total
    
Less than
1 Year
    
1-3 Years
    
3-5 Years
    
More Than
5 Years
 
Revolving credit facilities (1)
   $ 613.3      $ —     $ 613.3      $ —       $ —   
Unsecured senior notes
     470.0        125.0        160.0      185.0      —   
Term loans
     100.0        —         100.0        —         —   
 
(1)
As of December 31, 2023, we had a total of $246.8 million of unused borrowing capacity under our revolving credit facilities, subject to borrowing base limits.
Under the provisions of the 1940 Act, we are permitted, as a BDC, to issue senior securities in amounts such that our asset coverage ratio, as defined in the 1940 Act, equals at least 150% of gross assets less all liabilities and indebtedness not represented by senior securities, after each issuance of senior securities. If the value of our assets declines, we may be unable to satisfy the asset coverage test. If that happens, we may be required to sell a portion of our investments and, depending on the nature of our leverage, repay a portion of our indebtedness at a time when such sales may be disadvantageous. Also, any amounts that we use to service our indebtedness would not be available for distributions to our common stockholders. Furthermore, as a result of issuing senior securities, we would also be exposed to typical risks associated with leverage, including an increased risk of loss.
We have also entered into two contracts under which we have future commitments: the Advisory Agreement, pursuant to which the Investment Adviser has agreed to serve as our investment adviser, and the Administration Agreement, pursuant to which the Administrator has agreed to furnish us with the facilities and administrative services necessary to conduct our
day-to-day
operations and provide on our behalf managerial
 
95

assistance to those portfolio companies to which we are required to provide such assistance. Payments under the Advisory Agreement are equal to (1) a percentage of the value of our average gross assets and (2) a
two-part
incentive fee. Payments under the Administration Agreement are equal to an amount based upon our allocable portion of the Administrator’s overhead in performing its obligations under the Administration Agreement, including rent, technology systems, insurance and our allocable portion of the costs of our chief financial officer and chief compliance officer and their respective staffs. Either party may terminate each of the Advisory Agreement and Administration Agreement without penalty upon 60 days written notice to the other. See note 3 to our Consolidated Financial Statements.
On July 31, 2017, the Company, NEFPASS LLC and NEFCORP LLC entered into a servicing agreement. NEFCORP LLC was engaged to provide NEFPASS LLC with administrative services related to the loans and capital leases held by NEFPASS LLC. NEFPASS LLC may terminate this agreement upon 30 days written notice to NEFCORP LLC.
On October 7, 2022, the Company committed $50 million to SSLP and entered into a servicing agreement. SSLP engaged and retained the Company to provide certain administrative services relating to the facilities, supplies and necessary ongoing overhead support services for the operation of SSLP’s ongoing business affairs in exchange for a fee.
Senior Securities
Information about our senior securities is shown in the following table (in thousands) as of each year ended December 31 for the past ten years, unless otherwise noted. The “—” indicates information which the SEC expressly does not require to be disclosed for certain types of senior securities.
 
Class and Year
  
Total Amount
Outstanding(1)
    
Asset
Coverage
Per Unit(2)
    
Involuntary
Liquidating
Preference
Per Unit(3)
    
Average
Market Value
Per Unit(4)
 
Credit Facility
           
Fiscal 2023
   $ 407,000      $ 631               N/A  
Fiscal 2022
     293,000        513               N/A  
Fiscal 2021
     222,500        552               N/A  
Fiscal 2020
     126,000        421               N/A  
Fiscal 2019
     42,900        182               N/A  
Fiscal 2018
     96,400        593               N/A  
Fiscal 2017
     245,600        1,225               N/A  
Fiscal 2016
     115,200        990               N/A  
Fiscal 2015
     207,900        1,459               N/A  
Fiscal 2014
                          N/A  
Fiscal 2013
                          N/A  
SPV Credit Facility
           
Fiscal 2023
     206,250        320               N/A  
Fiscal 2022
     155,200        272               N/A  
2022 Unsecured Notes
           
Fiscal 2022
                          N/A  
Fiscal 2021
     150,000        372               N/A  
Fiscal 2020
     150,000        501               N/A  
Fiscal 2019
     150,000        638               N/A  
Fiscal 2018
     150,000        923               N/A  
Fiscal 2017
     150,000        748               N/A  
Fiscal 2016
     50,000        430               N/A  
 
96

Class and Year
  
Total Amount
Outstanding(1)
    
Asset
Coverage
Per Unit(2)
    
Involuntary
Liquidating
Preference
Per Unit(3)
    
Average
Market Value
Per Unit(4)
 
2022 Tranche C Notes
           
Fiscal 2022
                          N/A  
Fiscal 2021
     21,000        52               N/A  
Fiscal 2020
     21,000        70               N/A  
Fiscal 2019
     21,000        89               N/A  
Fiscal 2018
     21,000        129               N/A  
Fiscal 2017
     21,000        105               N/A  
2023 Unsecured Notes
           
Fiscal 2023
                          N/A  
Fiscal 2022
     75,000        131               N/A  
Fiscal 2021
     75,000        186               N/A  
Fiscal 2020
     75,000        250               N/A  
Fiscal 2019
     75,000        319               N/A  
Fiscal 2018
     75,000        461               N/A  
Fiscal 2017
     75,000        374               N/A  
2024 Unsecured Notes
           
Fiscal 2023
     125,000        194               N/A  
Fiscal 2022
     125,000        219               N/A  
Fiscal 2021
     125,000        309               N/A  
Fiscal 2020
     125,000        417               N/A  
Fiscal 2019
     125,000        531               N/A  
2025 Unsecured Notes
           
Fiscal 2023
     85,000        132               N/A  
Fiscal 2022
     85,000        149               N/A  
2026 Unsecured Notes
           
Fiscal 2023
     75,000        116               N/A  
Fiscal 2022
     75,000        131               N/A  
Fiscal 2021
     75,000        186               N/A  
Fiscal 2020
     75,000        250               N/A  
Fiscal 2019
     75,000        319               N/A  
2027 Unsecured Notes
           
Fiscal 2023
     50,000        77               N/A  
Fiscal 2022
     50,000        88               N/A  
Fiscal 2021
     50,000        124               N/A  
2027 Series F Unsecured Notes
           
Fiscal 2023
     135,000        209               N/A  
Fiscal 2022
     135,000        237               N/A  
2042 Unsecured Notes
           
Fiscal 2017
                          N/A  
Fiscal 2016
     100,000        859             $ 1,002  
Fiscal 2015
     100,000        702               982  
Fiscal 2014
     100,000        2,294               943  
Fiscal 2013
     100,000        2,411               934  
Senior Secured Notes
           
Fiscal 2017
                          N/A  
Fiscal 2016
     75,000        645               N/A  
Fiscal 2015
     75,000        527               N/A  
Fiscal 2014
     75,000        1,721               N/A  
Fiscal 2013
     75,000        1,808               N/A  
 
97

Class and Year
  
Total Amount
Outstanding(1)
    
Asset
Coverage
Per Unit(2)
    
Involuntary
Liquidating
Preference
Per Unit(3)
    
Average
Market Value
Per Unit(4)
 
Term Loans
           
Fiscal 2023
     100,000        155               N/A  
Fiscal 2022
     100,000        175               N/A  
Fiscal 2021
     100,000        248               N/A  
Fiscal 2020
     75,000        250               N/A  
Fiscal 2019
     75,000        319               N/A  
Fiscal 2018
     50,000        308               N/A  
Fiscal 2017
     50,000        250               N/A  
Fiscal 2016
     50,000        430               N/A  
Fiscal 2015
     50,000        351               N/A  
Fiscal 2014
     50,000        1,147               N/A  
Fiscal 2013
     50,000        1,206               N/A  
NEFPASS Facility
           
Fiscal 2021
                          N/A  
Fiscal 2020
     30,000        100               N/A  
Fiscal 2019
     30,000        128               N/A  
Fiscal 2018
     30,000        185               N/A  
SSLP Facility
           
Fiscal 2019
                          N/A  
Fiscal 2018
     53,785        331               N/A  
Total Senior Securities
           
Fiscal 2023
   $ 1,183,250      $ 1,834               N/A  
Fiscal 2022
     1,093,200        1,915               N/A  
Fiscal 2021
     818,500        2,029               N/A  
Fiscal 2020
     677,000        2,259               N/A  
Fiscal 2019
     593,900        2,525               N/A  
Fiscal 2018
     476,185        2,930               N/A  
Fiscal 2017
     541,600        2,702               N/A  
Fiscal 2016
     390,200        3,354               N/A  
Fiscal 2015
     432,900        3,039               N/A  
Fiscal 2014
     225,000        5,162               N/A  
Fiscal 2013
     225,000        5,425               N/A  
 
(1)
Total amount of each class of senior securities outstanding (in thousands) at the end of the period presented.
(2)
The asset coverage ratio for a class of senior securities representing indebtedness is calculated as our consolidated total assets, less all liabilities and indebtedness not represented by senior securities, divided by all senior securities representing indebtedness. This asset coverage ratio is multiplied by one thousand to determine the Asset Coverage Per Unit. In order to determine the specific Asset Coverage Per Unit for each class of debt, the total Asset Coverage Per Unit is allocated based on the amount outstanding in each class of debt at the end of the period. As of December 31, 2023, asset coverage was 183.4%.
(3)
The amount to which such class of senior security would be entitled upon the involuntary liquidation of the issuer in preference to any security junior to it.
(4)
Not applicable except for the 2042 Unsecured Notes which were publicly traded. The Average Market Value Per Unit is calculated by taking the daily average closing price during the period and dividing it by twenty-five dollars per share and multiplying the result by one thousand to determine a unit price per thousand consistent with Asset Coverage Per Unit. The average market value for the fiscal 2016, 2015, 2014 and 2013 periods was $100,175, $98,196, $94,301 and $93,392, respectively.
 
98

The following is a schedule of financial highlights for the respective years:
 
   
Year ended
December 31,
2018
   
Year ended
December 31,
2017
   
Year ended
December 31,
2016
   
Year ended
December 31,
2015
   
Year ended
December 31,
2014
 
Per Share Data: (a)
         
Net asset value, beginning of year
  $ 21.81     $ 21.74     $ 20.79     $ 22.05     $ 22.50  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net investment income
    1.77       1.62       1.68       1.52       1.56  
Net realized and unrealized gain (loss)
    (0.19     0.05       0.84       (1.18     (0.43
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net increase in net assets resulting from operations
    1.58       1.67       2.52       0.34       1.13  
Distributions to stockholders (see note 8a):
    —           
From net investment income
    —        (1.60     (1.60     (1.60     (1.55
From net realized gains
      —        —        —        —   
From return of capital
    (1.64     —        —        —        (0.05
Anti-dilution
    —        —        0.03       —        0.02
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net asset value, end of year
  $ 21.75     $ 21.81     $ 21.74     $ 20.79     $ 22.05  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Per share market value, end of year
  $ 19.19     $ 20.21     $ 20.82     $ 16.43     $ 18.01  
Total Return(b)
    2.77     4.47     37.49     (0.29 )%      (13.58 )% 
Net assets, end of year
  $ 919,171     $ 921,605     $ 918,507     $ 882,698     $ 936,568  
Shares outstanding, end of year
    42,260,826       42,260,826       42,248,525       42,464,762       42,465,162  
Ratios to average net assets:
         
Net investment income
    8.10     7.43     7.91     6.94     6.93
Operating expenses
    5.83     5.80     6.25     3.84 %*      4.24
Interest and other credit facility expenses**
    2.67     2.35     2.73     1.68     1.50
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total expenses
    8.50     8.15     8.98     5.52 %*      5.74
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Average debt outstanding
  $ 508,445     $ 414,264     $ 495,795     $ 262,341     $ 225,000  
Portfolio turnover ratio
    39.3     24.9     31.0     13.0     53.7
 
(a)
Calculated using the average shares outstanding method.
(b)
Total return is based on the change in market price per share during the year and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. Total return does not include a sales load.
*
The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of a voluntary incentive fee waiver (see note 3). For the year ended December 31, 2015, the ratios of operating expenses to average net assets and total expenses to average net assets would be 4.02% and 5.70%, respectively, without the voluntary incentive fee waiver.
**
Ratios shown without the
non-recurring
costs associated with the amendments and establishment of the Credit Facility and 2022 Unsecured Notes would be 2.67%, 2.29%, 2.39%, 1.68% and 1.50%, respectively for the years shown.
 
99

Off-Balance
Sheet Arrangements
From time to time and in the normal course of business, the Company may make unfunded capital commitments to current or prospective portfolio companies. Typically, the Company may agree to provide delayed-draw term loans or, to a lesser extent, revolving loan or equity commitments. These unfunded capital commitments always take into account the Company’s liquidity and cash available for investment, portfolio and issuer diversification, and other considerations. Accordingly, the Company had the following unfunded capital commitments at December 31, 2023 and December 31, 2022, respectively:
 
 
  
December 31,
2023
 
  
December 31,
2022
 
(in millions)
  
 
 
  
 
 
SLR Credit Solutions*
  
$
44.3
 
  
$
44.3
 
Orthopedic Care Partners Management, LLC
  
 
20.8
 
  
 
1.6
 
Southern Orthodontic Partners Management, LLC
  
 
17.9
 
  
 
1.9
 
Ardelyx, Inc.
  
 
15.9
 
  
 
7.8
 
CVAUSA Management, LLC
  
 
10.2
 
  
 
— 
 
BDG Media, Inc.
  
 
10.1
 
  
 
3.5
 
iCIMS, Inc.
  
 
9.8
 
  
 
11.4
 
Retina Midco, Inc.
  
 
9.4
 
  
 
— 
 
Alkeme Intermediate Holdings, LLC
  
 
8.5
 
  
 
— 
 
SPAR Marketing Force, Inc.
  
 
8.3
 
  
 
1.3
 
SLR Senior Lending Program LLC*
  
 
7.1
 
  
 
40.5
 
Copper River Seafoods, Inc.
  
 
7.1
 
  
 
3.6
 
Legacy Service Partners, LLC
  
 
5.4
 
  
 
— 
 
Peter C. Foy & Associates Insurance Services, LLC
  
 
5.1
 
  
 
1.1
 
West-NR
Parent, Inc.
  
 
5.0
 
  
 
— 
 
Luxury Asset Capital, LLC
  
 
4.5
 
  
 
7.5
 
One Touch Direct, LLC
  
 
4.1
 
  
 
3.1
 
DeepIntent, Inc.
  
 
3.9
 
  
 
3.1
 
United Digestive MSO Parent, LLC
  
 
3.9
 
  
 
— 
 
Kaseya, Inc.
  
 
3.8
 
  
 
3.9
 
The Townsend Company, LLC
  
 
3.3
 
  
 
— 
 
Vertos Medical, Inc.
  
 
3.3
 
  
 
— 
 
AMF Levered II, LLC
  
 
3.2
 
  
 
— 
 
Foundation Consumer Brands, LLC
  
 
3.0
 
  
 
3.0
 
UVP Management, LLC.
  
 
2.9
 
  
 
— 
 
Kid Distro Holdings, LLC
  
 
2.7
 
  
 
2.7
 
Erie Construction
Mid-west,
LLC
  
 
2.4
 
  
 
1.3
 
Ultimate Baked Goods Midco LLC
  
 
2.4
 
  
 
1.6
 
Basic Fun, Inc
  
 
2.1
 
  
 
2.7
 
SLR Equipment Finance*
  
 
2.1
 
  
 
1.0
 
Bayside Opco, LLC
  
 
2.1
 
  
 
— 
 
SunMed Group Holdings, LLC
  
 
1.6
 
  
 
0.8
 
Urology Management Holdings, Inc.
  
 
1.5
 
  
 
— 
 
SLR Healthcare ABL*
  
 
1.4
 
  
 
1.4
 
RxSense Holdings LLC
  
 
1.3
 
  
 
1.3
 
Tilley Distribution, Inc.
  
 
1.2
 
  
 
0.5
 
SCP Eye Care, LLC
  
 
1.0
 
  
 
2.8
 
GSM Acquisition Corp.
  
 
0.9
 
  
 
0.8
 
Medrina, LLC
  
 
0.8
 
  
 
— 
 
Pinnacle Treatment Centers, Inc.
  
 
0.6
 
  
 
1.7
 
High Street Buyer, Inc.
  
 
0.6
 
  
 
0.3
 
 
100

    
December 31,
2023
    
December 31,
2022
 
(in millions)
             
ENS Holdings III Corp, LLC
     0.6        0.1  
CC SAG Holdings Corp. (Spectrum Automotive)
     0.5        20.7  
Crewline Buyer, Inc.
     0.5        —   
Exactcare Parent, Inc.
     0.4        —   
WCI-BXC
Purchaser, LLC
     0.3        —   
All States Ag Parts, LLC
     0.3        0.1  
Vessco Midco Holdings, LLC
     0.3        3.9  
TAUC Management, LLC
     0.3        0.3  
Outset Medical, Inc.
     —         35.1  
Apeel Technology, Inc.
     —         32.8  
Human Interest, Inc.
     —         20.1  
Glooko, Inc.
     —         17.9  
World Insurance Associates, LLC
     —         17.1  
Spectrum Pharmaceuticals, Inc.
     —         8.8  
Arcutis Biotherapeutics, Inc.
     —         8.4  
Atria Wealth Solutions, Inc.
     —         8.2  
Accession Risk Management Group, Inc.
     —         7.5  
Cerapedics, Inc.
     —         6.7  
Maurices, Incorporated
     —         4.3  
Meditrina, Inc.
     —         3.4  
Plastics Management, LLC
     —         2.4  
Pediatric Home Respiratory Services, LLC
     —         1.8  
Ivy Fertility Services, LLC
     —         1.6  
Composite Technology Acquisition Corp.
     —         1.5  
NAC Holdings Corporation
     —         1.5  
Montefiore Nyack Hospital
     —         1.0  
Enverus Holdings, Inc.
     —         1.0  
American Teleconferencing Services, Ltd.
     —         1.1  
BayMark Health Services, Inc.
     —         0.4  
  
 
 
    
 
 
 
Total Commitments
   $ 248.7      $ 364.2  
  
 
 
    
 
 
 
 
*
The Company controls the funding of these commitments and may cancel them at its discretion
The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the respective portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of December 31, 2023 and December 31, 2022, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.
In the normal course of business, we invest or trade in various financial instruments and may enter into various investment activities with
off-balance
sheet risk, which may include forward foreign currency contracts. Generally, these financial instruments represent future commitments to purchase or sell other financial instruments at specific terms at future dates. These financial instruments contain varying degrees of
off-balance
sheet risk whereby changes in the market value or our satisfaction of the obligations may exceed the amount recognized in our Consolidated Statements of Assets and Liabilities.
 
101

Distributions
The following table reflects the cash distributions per share on our common stock for the two most recent fiscal years and the current fiscal year to date:
 
Date Declared
  
Record Date
    
Payment Date
    
Amount
 
Fiscal 2024
        
February 27, 2024
     March 14, 2024        March 28, 2024      $ 0.41  
        
 
 
 
Total 2024
         $ 0.41  
        
 
 
 
Fiscal 2023
        
November 7, 2023
     December 14, 2023        December 28, 2023      $ 0.41  
September 5, 2023
     September 20, 2023        September 28, 2023        0.136667  
August 8, 2023
     August 18, 2023        August 30, 2023        0.136667  
July 5, 2023
     July 20, 2023        August 1, 2023        0.136667  
June 1, 2023
     June 20, 2023        June 29, 2023        0.136667  
May 10, 2023
     May 24, 2023        June 1, 2023        0.136667  
April 4, 2023
     April 20, 2023        May 2, 2023        0.136667  
February 28, 2023
     March 23, 2023        April 4, 2023        0.136667  
February 2, 2023
     February 16, 2023        March 1, 2023        0.136667  
January 10, 2023.
     January 26, 2023        February 2, 2023        0.136667  
        
 
 
 
Total 2023
         $ 1.64  
        
 
 
 
Fiscal 2022
        
December 6, 2022
     December 22, 2022        January 5, 2023      $ 0.136667  
November 2, 2022
     November 17, 2022        December 1, 2022        0.136667  
October 5, 2022
     October 20, 2022        November 2, 2022        0.136667  
September 2, 2022
     September 20, 2022        October 4, 2022        0.136667  
August 2, 2022
     August 18, 2022        September 1, 2022        0.136667  
July 6, 2022
     July 21, 2022        August 2, 2022        0.136667  
June 3, 2022
     June 23, 2022        July 5, 2022        0.136667  
May 3, 2022
     May 19, 2022        June 2, 2022        0.136667  
April 4, 2022
     April 21, 2022        May 3, 2022        0.136667  
March 1, 2022
     March 18, 2022        April 1, 2022        0.41  
        
 
 
 
Total 2022
         $ 1.64  
        
 
 
 
Tax characteristics of all distributions will be reported to stockholders on Form 1099 after the end of the calendar year. Future quarterly distributions, if any, will be determined by the Board. We expect that our distributions to stockholders will generally be from accumulated net investment income, from net realized capital gains or
non-taxable
return of capital, if any, as applicable.
We have elected to be taxed as a RIC under Subchapter M of the Code. To maintain our RIC tax treatment, we must distribute at least 90% of our ordinary income and realized net short-term capital gains in excess of realized net long-term capital losses, if any, out of the assets legally available for distribution. In addition, although we currently intend to distribute realized net capital gains (
i.e.
, net long-term capital gains in excess of short-term capital losses), if any, at least annually, out of the assets legally available for such distributions, we may in the future decide to retain such capital gains for investment.
We maintain an “opt out” dividend reinvestment plan for our common stockholders. As a result, if we declare a distribution, then stockholders’ cash distributions will be automatically reinvested in additional shares of our common stock, unless they specifically “opt out” of the dividend reinvestment plan so as to receive cash distributions.
 
102

We may not be able to achieve operating results that will allow us to make distributions at a specific level or to increase the amount of these distributions from time to time. In addition, due to the asset coverage test applicable to us as a business development company, we may in the future be limited in our ability to make distributions. Also, the Credit Facility may limit our ability to declare distributions if we default under certain provisions. If we do not distribute a certain percentage of our income annually, we will suffer adverse tax consequences, including possible loss of the tax benefits available to us as a RIC. In addition, in accordance with GAAP and tax regulations, we include in income certain amounts that we have not yet received in cash, such as contractual
payment-in-kind
income, which represents contractual income added to the loan balance that becomes due at the end of the loan term, or the accrual of original issue or market discount. Since we may recognize income before or without receiving cash representing such income, we may have difficulty meeting the requirement to distribute at least 90% of our investment company taxable income to obtain tax benefits as a RIC.
With respect to the distributions to stockholders, income from origination, structuring, closing and certain other upfront fees associated with investments in portfolio companies are treated as taxable income and accordingly, distributed to stockholders.
Related Parties
We have entered into a number of business relationships with affiliated or related parties, including the following:
 
   
We have entered into the Advisory Agreement with the Investment Adviser. Mr. Gross, our Chairman,
Co-Chief
Executive Officer and President, and Mr. Spohler, our
Co-Chief
Executive Officer, Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, the Investment Adviser. In addition, Mr. Kajee, our Chief Financial Officer and Treasurer, serves as the Chief Financial Officer for the Investment Adviser and Mr. Talarico, our Chief Compliance Officer and Secretary, serves as Partner, General Counsel and Chief Compliance Officer for the Investment Adviser.
 
   
The Administrator provides us with the office facilities and administrative services necessary to conduct
day-to-day
operations pursuant to our Administration Agreement. We reimburse the Administrator for the allocable portion of overhead and other expenses incurred by it in performing its obligations under the Administration Agreement, including rent, the fees and expenses associated with performing compliance functions, and the compensation of our chief compliance officer, our chief financial officer and their respective staffs.
 
   
We have entered into a license agreement with the Investment Adviser, pursuant to which the Investment Adviser has granted us a
non-exclusive,
royalty-free license to use the licensed marks “SOLAR” and “SLR”.
The Investment Adviser may also manage other funds in the future that may have investment mandates that are similar, in whole and in part, with ours. For example, the Investment Adviser presently serves as investment adviser to SCP Private Credit Income BDC LLC, an unlisted BDC that focuses on investing primarily in senior secured loans, including
non-traditional
asset-based loans and first lien loans, SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry, and SLR Private Credit BDC II LLC, an unlisted BDC focused on first lien senior secured floating rate loans. In addition, Michael S. Gross, our Chairman,
Co-Chief
Executive Officer and President, Bruce Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer, Shiraz Kajee, our Chief Financial Officer and Treasurer, and Guy F. Talarico, our Chief Compliance Officer and Secretary, serve in similar capacities for SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC. The Investment Adviser and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, the Investment Adviser or
 
103

its affiliates may determine that we should invest
side-by-side
with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with the Investment Adviser’s allocation procedures. On June 13, 2017, the Investment Adviser received an exemptive order that permits the Company to participate in negotiated
co-investment
transactions with certain affiliates, in a manner consistent with the Company’s investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to various conditions (the “Exemptive Order”). If the Company is unable to rely on the Exemptive Order for a particular opportunity, such opportunity will be allocated first to the entity whose investment strategy is the most consistent with the opportunity being allocated, and second, if the terms of the opportunity are consistent with more than one entity’s investment strategy, on an alternating basis. Although the Investment Adviser’s investment professionals will endeavor to allocate investment opportunities in a fair and equitable manner, the Company and its stockholders could be adversely affected to the extent investment opportunities are allocated among us and other investment vehicles managed or sponsored by, or affiliated with, our executive officers, directors and members of the Investment Adviser.
Related party transactions may occur among us, SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL and SLR Equipment. These transactions may occur in the normal course of business. No administrative or other fees are paid to the Investment Adviser by SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL or SLR Equipment.
In addition, we have adopted a formal code of ethics that governs the conduct of our officers and directors. Our officers and directors also remain subject to the duties imposed by both the 1940 Act and the Maryland General Corporation Law.
 
Item 7A.
Quantitative and Qualitative Disclosure About Market Risk
We are subject to financial market risks, including changes in interest rates. Uncertainty with respect to interest rates, inflationary pressures, risks in respect of a failure to increase the U.S. debt ceiling or a downgrade in the U.S. credit rating, the war between Ukraine and Russia, certain regional bank failures, an inflationary environment, the ongoing war in the Middle East and health epidemics and pandemics introduced significant volatility in the financial markets, and the effects of this volatility have materially impacted and could continue to materially impact our market risks. Because we fund a portion of our investments with borrowings, our net investment income is affected by the difference between the rate at which we invest and the rate at which we borrow. As a result, there can be no assurance that a significant change in market interest rates will not have a material adverse effect on our net investment income. In a low interest rate environment, including a reduction of SOFR to zero, the difference between the total interest income earned on interest earning assets and the total interest expense incurred on interest bearing liabilities may be compressed, reducing our net interest income and potentially adversely affecting our operating results. Conversely, in a rising interest rate environment, such as the recent economic environment, such difference could potentially increase thereby increasing our net investment income. During the fiscal year ended December 31, 2023, certain investments in our comprehensive investment portfolio had floating interest rates. These floating rate investments were primarily based on floating SOFR and typically have durations of one to three months after which they reset to current market interest rates. Additionally, some of these investments have floors. The Company also has revolving credit facilities that are generally based on floating SOFR. Assuming no changes to our balance sheet as of December 31, 2023 and no new defaults by portfolio companies, a hypothetical one percent decrease in SOFR on our comprehensive floating rate assets and liabilities would decrease our net investment income by six cents per average share over the next twelve months. Assuming no changes to our balance sheet as of December 31, 2023 and no new defaults by portfolio companies, a hypothetical one percent increase in SOFR on our comprehensive floating rate assets and liabilities would increase our net investment income by approximately six cents per average share over the next twelve months. However, we may hedge against interest rate fluctuations from time to time by using
 
104

standard hedging instruments such as futures, options, swaps and forward contracts subject to the requirements of the 1940 Act. While hedging activities may insulate us against adverse changes in interest rates, they may also limit our ability to participate in any benefits of certain changes in interest rates with respect to our portfolio of investments. At December 31, 2023, we had no interest rate hedging instruments outstanding on our balance sheet.
 
Increase (Decrease) in SOFR
    (1.00 %)      1.00
Increase (Decrease) in Net Investment Income Per Share Per Year
  $ (0.06   $ 0.06  
We may also have exposure to foreign currencies through various investments. These investments are converted into U.S. dollars at the balance sheet date, exposing us to movements in foreign exchange rates. In order to reduce our exposure to fluctuations in foreign exchange rates, we may borrow from time to time in such currencies under our multi-currency revolving credit facility or enter into forward currency or similar contracts.
 
105

Item 8.
Financial Statements and Supplementary Data
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
 
    
Page
 
     107  
     108  
     111  
     112  
     113  
     114  
     115  
     136  
 
106

MANAGEMENT’S REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING
Management is responsible for establishing and maintaining adequate internal control over financial reporting, and for performing an assessment of the effectiveness of internal control over financial reporting as of December 31, 2023. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. The Company’s internal control over financial reporting includes those policies and procedures that (i) pertain to assets of the Company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of consolidated financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the consolidated financial statements.
Management performed an assessment of the effectiveness of the Company’s internal control over financial reporting as of December 31, 2023 based upon criteria in
Internal Control – Integrated Framework (2013)
 issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on our assessment, management determined that the Company’s internal control over financial reporting was effective as of December 31, 2023 based upon criteria in
Internal Control – Integrated Framework (2013)
 issued by COSO.
The effectiveness of the Company’s internal control over financial reporting as of December 31, 2023 has been audited by KPMG LLP, an independent registered public accounting firm, as stated in their report which appears herein.
 
107

Report of Independent Registered Public Accounting Firm
To the Stockholders and Board of Directors
SLR Investment Corp.:
Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting
We have audited the accompanying consolidated statements of assets and liabilities, including the consolidated schedules of investments, of SLR Investment Corp. (and subsidiaries) (the Company), as of December 31, 2023 and 2022, the related consolidated statements of operations, changes in net assets, and cash flows for each of the years in the three-year period ended December 31, 2023, and the related notes (collectively, the consolidated financial statements). We also have audited the Company’s internal control over financial reporting as of December 31, 2023, based on criteria established in
Internal Control – Integrated Framework (2013)
 issued by the Committee of Sponsoring Organizations of the Treadway Commission.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2023 and 2022, and the results of its operations and its cash flows for each of the years in the three-year period ended December 31, 2023, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2023 based on criteria established in
Internal Control – Integrated Framework (2013)
 issued by the Committee of Sponsoring Organizations of the Treadway Commission.
Basis for Opinions
The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying management’s report on internal control over financial reporting. Our responsibility is to express an opinion on the Company’s consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our procedures included confirmation of securities owned as of December 31, 2023 and 2022, by correspondence with the custodian, portfolio companies or agents. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
 
108

Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matter
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of a critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Fair value of investments
As described in Notes 2 and 6 to the consolidated financial statements, the Company measures its investments at fair value. Investments are valued using a market approach, an income approach, or both approaches, as applicable. In determining the fair value of investments classified as Level 3, the Company makes subjective judgments and estimates using unobservable inputs.
We identified the assessment of the fair value of such investments as a critical audit matter. A high degree of auditor judgment was required to assess the Company’s fair value assumptions. Specifically, subjective auditor judgment was required to assess the (1) credit risk associated with the borrower and its ability to make interest and principal payments for debt investments and (2) selection of comparable companies and the financial performance multiples of such comparable companies used in the market approach for equity investments. Additionally, the involvement of valuation professionals with specialized skills and knowledge was required to assist in evaluating the Company’s fair value estimates.
The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls over the Company’s process to measure the fair value of investments, including controls related to the development of the above assumptions. For recently purchased investments we evaluated changes in the borrowers assessed credit risk and market yields from the purchase date to the fair value measurement date. We evaluated the Company’s ability to estimate fair value by comparing dispositions to the Company’s most recent fair value estimate prior to the disposition. We also involved valuation professionals with specialized skills and knowledge, who for certain investments, developed estimates of fair value by assessing available market information using market yields of comparable companies of similar credit risk for debt investments fair valued using an income approach, and financial performance multiples of comparable companies for equity investments fair valued using a market approach, and compared the results to the Company’s fair value estimates.
 
109

/s/ KPMG LLP
We have served as the Company’s auditor since 2007.
New York, New York
February 27, 2024
 
110

SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF ASSETS AND LIABILITIES
(in thousands, except share amounts)
 
    
December 31,
2023
   
December 31,
2022
 
Assets
    
Investments at fair value:
    
Companies less than 5% owned (cost: $1,260,205 and $1,312,701, respectively)
   $ 1,271,442     $ 1,289,082  
Companies 5% to 25% owned (cost: $60,064 and $0, respectively)
     44,250        
Companies more than 25% owned (cost: $870,128 and $821,886, respectively)
     839,074       797,594  
Cash
     11,864       10,743  
Cash equivalents (cost: $332,290 and $417,590, respectively)
     332,290       417,590  
Dividends receivable
     11,768       11,192  
Interest receivable
     11,034       9,706  
Receivable for investments sold
     1,538       1,124  
Prepaid expenses and other assets
     608       664  
  
 
 
   
 
 
 
Total assets
   $ 2,523,868     $ 2,537,695  
  
 
 
   
 
 
 
Liabilities
    
Debt ($1,183,250 and $1,093,200 face amounts, respectively, reported net of unamortized debt issuance costs of $5,473 and $7,202, respectively. See notes 6 and 7)
   $ 1,177,777     $ 1,085,998  
Payable for investments and cash equivalents purchased
     332,290       417,611  
Distributions payable
           7,481  
Management fee payable (see note 3)
     8,027       7,964  
Performance-based incentive fee payable (see note 3)
     5,864       5,422  
Interest payable (see note 7)
     7,535       7,943  
Administrative services payable (see note 3)
     1,969       1,488  
Other liabilities and accrued expenses
     3,767       4,057  
  
 
 
   
 
 
 
Total liabilities
   $ 1,537,229     $ 1,537,964  
  
 
 
   
 
 
 
Commitments and contingencies (see note 15)
    
Net Assets
    
Common stock, par value $0.01 per share, 200,000,000 and 200,000,000 common shares authorized, respectively, and 54,554,634 and 54,555,380 shares issued and outstanding, respectively
   $ 546     $ 546  
Paid-in
capital in excess of par (see note 2f)
     1,117,930       1,162,569  
Accumulated distributable net loss (see note 2f)
     (131,837 )     (163,384
  
 
 
   
 
 
 
Total net assets
   $ 986,639     $ 999,731  
  
 
 
   
 
 
 
Net Asset Value Per Share
   $ 18.09     $ 18.33  
  
 
 
   
 
 
 
See notes to consolidated financial statements.
 
11
1

SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except share amounts)
 
    
Year ended December 31,
 
    
2023
   
2022
   
2021
 
INVESTMENT INCOME:
      
Interest:
      
Companies less than 5% owned
   $ 163,589     $ 121,491     $ 86,122  
Companies 5% to 25% owned
     2,058              
Companies more than 25% owned
     11,627       9,515       11,354  
Dividends:
      
Companies less than 5% owned
                 133  
Companies more than 25% owned
     45,986       44,383       37,564  
Other income:
      
Companies less than 5% owned
     5,802       2,116       4,157  
Companies 5% to 25% owned
     26              
Companies more than 25% owned
     224             24  
  
 
 
   
 
 
   
 
 
 
Total investment income
     229,312       177,505       139,354  
  
 
 
   
 
 
   
 
 
 
EXPENSES:
      
Management fees (see note 3)
     31,661       29,982       28,277  
Performance-based incentive fees (see note 3)
     22,898       15,097       10,309  
Interest and other credit facility expenses (see note 7)
     72,507       46,087       29,876  
Administrative services expense (see note 3)
     5,899       5,401       5,575  
Other general and administrative expenses
     4,756       6,099       4,390  
  
 
 
   
 
 
   
 
 
 
Total expenses
     137,721       102,666       78,427  
  
 
 
   
 
 
   
 
 
 
Performance-based incentive fees waived (see note 3)
     (500     (1,527      
  
 
 
   
 
 
   
 
 
 
Net expenses
     137,221       101,139       78,427  
  
 
 
   
 
 
   
 
 
 
Net investment income
   $ 92,091     $ 76,366     $ 60,927  
  
 
 
   
 
 
   
 
 
 
REALIZED AND UNREALIZED GAIN (LOSS) ON INVESTMENTS AND CASH EQUIVALENTS:
      
Net realized gain (loss) on investments and cash equivalents:
      
Companies less than 5% owned
   $ (27,602   $ (36,485   $ 26  
Companies more than 25% owned
     (381            
  
 
 
   
 
 
   
 
 
 
Net realized gain (loss) on investments and cash equivalents
     (27,983     (36,485     26  
  
 
 
   
 
 
   
 
 
 
Net change in unrealized gain (loss) on investments:
      
Companies less than 5% owned
     20,425       (2,909     (10,500
Companies 5% to 25% owned
     (1,384            
Companies more than 25% owned
     (6,761     (18,630     9,113  
  
 
 
   
 
 
   
 
 
 
Net change in unrealized gain (loss) on investments
     12,280       (21,539     (1,387
  
 
 
   
 
 
   
 
 
 
Net realized and unrealized loss on investments and cash equivalents
     (15,703     (58,024     (1,361
  
 
 
   
 
 
   
 
 
 
NET INCREASE IN NET ASSETS RESULTING FROM OPERATIONS
   $ 76,388     $ 18,342     $ 59,566  
  
 
 
   
 
 
   
 
 
 
EARNINGS PER SHARE (see note 5)
   $ 1.40     $ 0.35     $ 1.41  
  
 
 
   
 
 
   
 
 
 
See notes to consolidated financial statements.
 
11
2
SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF CHANGES IN NET ASSETS
(in thousands, except share amounts)
 
    
Year ended December 31,
 
    
2023
   
2022
   
2021
 
Increase (decrease) in net assets resulting from operations:
      
Net investment income
   $ 92,091     $ 76,366     $ 60,927  
Net realized gain (loss)
     (27,983     (36,485     26  
Net change in unrealized gain (loss)
     12,280       (21,539     (1,387
  
 
 
   
 
 
   
 
 
 
Net increase in net assets resulting from operations
     76,388       18,342       59,566  
  
 
 
   
 
 
   
 
 
 
Distributions to stockholders (see note 8a):
      
From distributable earnings
     (89,470     (57,594     (41,221
From return of capital
           (27,099     (28,087
  
 
 
   
 
 
   
 
 
 
Net distributions to stockholders
     (89,470     (84,693     (69,308
  
 
 
   
 
 
   
 
 
 
Capital transactions (see note 16):
      
Issuance of common stock
           226,839        
Repurchases of common stock
     (10     (3,038      
  
 
 
   
 
 
   
 
 
 
Net increase (decrease) in net assets resulting from capital transactions
     (10     223,801        
  
 
 
   
 
 
   
 
 
 
Total increase (decrease) in net assets
     (13,092     157,450       (9,742
Net assets at beginning of year
     999,731       842,281       852,023  
  
 
 
   
 
 
   
 
 
 
Net assets at end of year
   $ 986,639     $ 999,731     $ 842,281  
  
 
 
   
 
 
   
 
 
 
Capital share activity (see note 16):
      
Issuance of common stock
           12,511,825        
Repurchases of common stock
     (746     (217,271      
  
 
 
   
 
 
   
 
 
 
Net increase (decrease) from capital share activity
     (746     12,294,554        
  
 
 
   
 
 
   
 
 
 
See notes to consolidated financial statements.
 
11
3

SLR INVESTMENT CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
 
    
Year ended December 31,
 
    
2023
   
2022
   
2021
 
Cash Flows from Operating Activities:
      
Net increase in net assets resulting from operations
   $ 76,388     $ 18,342     $ 59,566  
Adjustments to reconcile net increase in net assets resulting from operations to net cash provided by (used in) operating activities:
      
Net realized (gain) loss on investments and cash equivalents
     27,983       36,485       (26
Net change in unrealized (gain) loss on investments
     (12,280     21,539       1,387  
Deferred financing costs/market discount
     2,114       2,227       2,019  
(Increase) decrease in operating assets:
      
Purchase of investments
     (774,888 )     (609,645     (596,256
Proceeds from disposition of investments
     713,643       531,389       468,532  
Net accretion of discount on investments
     (11,932     (9,850     (6,087
Capitalization of
payment-in-kind
income
     (11,113     (4,282     (7,592
Collections of
payment-in-kind
income
     497       1,286       1,411  
Receivable for investments sold
     (414     254       (1,123
Interest receivable
     (1,328     (3,185     (43
Dividends receivable
     (576     (2,164     (1,101
Prepaid expenses and other assets
     56       (97     4  
Cash and other net assets acquired in Mergers
           3,640        
Increase (decrease) in operating liabilities:
      
Payable for investments and cash equivalents purchased
     (85,321     97,570       (59,997
Management fee payable
     63       529       900  
Performance-based incentive fee payable
     442       3,558       1,072  
Administrative services expense payable
     481       (1,201     743  
Interest payable
     (408     3,451       1,076  
Other liabilities and accrued expenses
     (290     1,213       414  
  
 
 
   
 
 
   
 
 
 
Net Cash Provided by (Used in) Operating Activities
     (76,883     91,059       (135,101
  
 
 
   
 
 
   
 
 
 
Cash Flows from Financing Activities:
      
Cash distributions paid
     (96,951     (94,539     (69,308
Proceeds from unsecured borrowings
           134,914       49,936  
Repayment of unsecured borrowings
     (75,000     (171,000      
Proceeds from secured borrowings
     1,059,665       844,002       812,132  
Repayments of secured borrowings
     (895,000     (696,000     (723,500
Repurchase of common stock
     (10     (3,038      
  
 
 
   
 
 
   
 
 
 
Net Cash Provided by (Used in) Financing Activities
     (7,296     14,339       69,260  
  
 
 
   
 
 
   
 
 
 
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
     (84,179     105,398       (65,841
CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR
     428,333       322,935       388,776  
  
 
 
   
 
 
   
 
 
 
CASH AND CASH EQUIVALENTS AT END OF YEAR
   $ 344,154     $ 428,333     $ 322,935  
  
 
 
   
 
 
   
 
 
 
Supplemental disclosure of cash flow information:
      
Cash paid for interest
   $ 72,915     $ 42,636     $ 28,800  
Issuance of shares in connection with the Mergers
(1)
           226,839        
  
 
 
   
 
 
   
 
 
 
 
(1)
On April 1, 2022, in connection with the Mergers (as defined in Note 1 “Organization”), the Company acquired net assets of $244,691 for the total stock consideration of $226,839.
See notes to consolidated financial statements.
 
11
4

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2023
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Spread
Above
Index
(7)
   
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
   
Maturity

Date
   
Par Amount
   
Cost
   
Fair
Value
 
Senior Secured Loans — 129.5%
 
First Lien Bank Debt/Senior Secured Loans
                 
Accession Risk Management Group, Inc. (f/k/a RSC Acquisition, Inc.)
  Insurance     S+550       0.75     11.00     4/1/2022       11/1/2029     $ 6,958     $ 6,932     $ 6,932  
Aegis Toxicology Sciences Corporation(16)
  Health Care Providers & Services     S+550       1.00     11.13     5/7/2018       5/9/2025       13,360       13,188       13,360  
Alkeme Intermediary Holdings, LLC
  Insurance     S+650       1.00     11.96     9/20/2023       10/28/2026       8,514       8,277       8,514  
All States Ag Parts, LLC(16)
  Trading Companies & Distributors     S+600       1.00     11.61     4/1/2022       9/1/2026       2,063       2,036       2,063  
Atria Wealth Solutions, Inc.(16)
  Diversified Financial Services     S+650       1.00     11.97     9/14/2018       5/31/2024       16,243       16,159       16,243  
Basic Fun, Inc.(16)
  Specialty Retail     S+650       1.00     12.14     10/30/2020       7/2/2024       2,150       2,145       2,150  
BayMark Health Services, Inc.(16)
  Health Care Providers & Services     S+500       1.00     10.61     4/1/2022       6/11/2027       8,265       8,016       8,265  
Bayside Opco, LLC(27)
  Healthcare Providers & Services     S+725
(11)
 
    1.00     12.75     5/31/2023       5/31/2026       19,415       19,415       19,415  
Bayside Parent, LLC(27)
  Healthcare Providers & Services     S+1000
(11)
 
    1.00     15.50     5/31/2023       5/31/2026       5,153       5,153       5,153  
BDG Media, Inc.
  Media     P+525       5.50     13.75     7/18/2022       7/31/2025       7,854       7,854       7,854  
CC SAG Holdings Corp. (Spectrum Automotive)(16)
  Diversified Consumer Services     S+575       0.75     11.22     6/29/2021       6/29/2028       30,510       30,031       30,510  
Copper River Seafoods, Inc.
  Food Products     P+275             11.25     12/1/2023       4/23/2025       4,949       4,949       4,949  
Crewline Buyer, Inc.
  IT Services     S+675       1.00     12.10     11/8/2023       11/8/2030       5,084       4,958       4,957  
CVAUSA Management, LLC(16)
  Health Care Providers & Services     S+650       1.00     11.74     5/22/2023       5/22/2029       17,366       16,873       17,366  
DeepIntent, Inc.
  Media     P+175             10.25     12/1/2023       3/25/2025       21,067       21,067       21,067  
Enhanced Permanent Capital, LLC(3)
  Capital Markets     S+700       1.00     12.44     12/29/2020       12/29/2025       42,521       41,864       42,521  
ENS Holdings III Corp. & ES Opco USA LLC (Bluefin)(16)
  Trading Companies & Distributors     S+475       1.00     10.20     4/1/2022       12/31/2025       4,505       4,398       4,505  
Exactcare Parent, Inc.
  Health Care Providers & Services     S+650       1.00     11.89     11/3/2023       11/5/2029       3,228       3,140       3,139  
Fertility (ITC) Investment Holdco, LLC
  Health Care Providers & Services     S+650       1.00     11.97     1/4/2023       1/3/2029       22,596       22,000       22,596  
Foundation Consumer Brands, LLC(16)
  Personal Products     S+625       1.00     11.79     2/12/2021       2/12/2027       26,726       26,181       26,726  
GSM Acquisition Corp.
  Leisure Equipment & Products     S+500       1.00     10.47     4/1/2022       11/16/2026       2,371       2,296       2,371  
 
See notes to consolidated financial statements.
 
11
5

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2023
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Spread
Above
Index
(7)
   
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
   
Maturity

Date
   
Par Amount
   
Cost
   
Fair
Value
 
Senior Secured Loans (continued)
 
             
Higginbotham Insurance Agency, Inc.(16)
  Insurance     S+550       1.00     10.96     4/1/2022       11/25/2028     $ 21,210     $ 21,210     $ 21,210  
Human Interest Inc
  Internet Software & Services     S+785       1.00     13.19     6/30/2022       7/1/2027       20,104       19,943       20,104  
iCIMS, Inc.
  Software     S+725       0.75     12.10 %
(26)
 
    8/18/2022       8/18/2028       31,059       30,642       31,059  
Kaseya, Inc.(16)
  Software     S+600       0.75     10.86 %
(14)
 
    6/22/2022       6/23/2029       24,519       24,215       24,519  
Kid Distro Holdings, LLC (Distro Kid)(16)
  Software     S+550       1.00     11.00     9/24/2021       10/1/2027       20,207       19,934       20,207  
Kingsbridge Holdings, LLC(2) .
  Multi-Sector Holdings     S+700       1.00     12.52     12/21/2018       12/21/2024       96,000       95,897       96,000  
Logix Holding Company, LLC(16)
  Communications Equipment     P+475       1.00     13.25     9/14/2018       12/22/2024       14,009       13,613       13,729  
Luxury Asset Capital, LLC(16)
  Thrifts & Mortgage Finance     S+675       1.00     12.21     7/15/2022       7/15/2027       30,500       30,032       30,500  
Maxor Acquisition, Inc.(16)
  Health Care Providers & Services     S+675       1.00     12.48     3/1/2023       3/1/2029       17,604       17,128       17,604  
Medrina, LLC
  Health Care Providers & Services     S+625       1.00     11.67     10/20/2023       10/20/2029       2,410       2,351       2,350  
NSPC Intermediate Corp. (National Spine)
  Health Care Providers & Services     S+800       1.00     13.53     4/1/2022       2/13/2026       2,216       2,143       2,216  
One Touch Direct, LLC.
  Commercial Services & Supplies     P+75             9.25     12/1/2023       3/31/2025       4,915       4,915       4,915  
ONS MSO, LLC
  Health Care Providers & Services     S+625       1.00     11.62     2/10/2023       7/8/2026       28,110       27,454       28,110  
Orthopedic Care Partners Management, LLC
  Health Care Providers & Services     S+650       1.00     12.11     8/17/2022       5/16/2024       5,488       5,470       5,488  
Peter C. Foy & Associates Insurance Services, LLC(16)
  Insurance     S+600       0.75     11.47     4/1/2022       11/1/2028       16,877       16,636       16,539  
Pinnacle Treatment Centers, Inc.(16)
  Health Care Providers & Services     S+650       1.00     11.86     1/22/2020       1/2/2026       22,687       22,405       22,687  
Plastics Management, LLC(16)
  Health Care Providers & Services     S+500       1.00     10.45     4/1/2022       8/18/2027       17,140       16,488       17,140  
Retina Midco, Inc.(16)
  Health Care Providers & Services     S+575       1.00     11.38     12/18/2023       1/31/2026       28,146       27,592       27,583  
RQM+ Corp.(16)
  Life Sciences Tools & Services     S+575       1.00     11.36     8/20/2021       8/12/2026       23,636       23,327       23,636  
RxSense Holdings LLC(16)
  Diversified Consumer Services     S+500       1.00     10.48     4/1/2022       3/13/2026       2,656       2,573       2,656  
SCP Eye Care, LLC
  Health Care Providers & Services     S+575       1.00     11.17     10/6/2022       10/5/2029       10,015       9,728       10,015  
SHO Holding I Corporation (Shoes for Crews)(16)
  Footwear     S+523       1.00     10.87     4/1/2022       4/27/2024       5,658       5,557       5,092  
 
See notes to consolidated financial statements.
 
11
6

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2023
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Spread
Above
Index
(7)
   
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
   
Maturity

Date
   
Par Amount
   
Cost
   
Fair
Value
 
Senior Secured Loans (continued)
 
             
Southern Orthodontic Partners Management, LLC(16)
  Health Care Providers & Services     S+625       1.00     11.72     6/3/2022       1/27/2026     $ 15,545     $ 15,300     $ 15,545  
SPAR Marketing Force, Inc
  Media     P+190             10.40     12/1/2023       10/10/2024       8,461       8,461       8,461  
Stryten Resources LLC
  Auto Parts & Equipment     S+800       1.00     13.47     8/11/2021       10/12/2026       25,659       25,341       26,044  
SunMed Group Holdings, LLC(16)
  Health Care Equipment & Supplies     S+550       0.75     10.96     6/16/2021       6/16/2028       14,982       14,676       14,982  
TAUC Management, LLC(16)
  Health Care Providers & Services     P+450       1.00     13.00     4/1/2022       2/12/2027       6,891       6,646       6,409  
The Townsend Company, LLC(16)
  Commercial Services & Supplies     S+625       1.00     11.61     8/17/2023       8/15/2029       10,276       10,030       10,276  
Tilley Distribution, Inc.(16)
  Trading Companies & Distributors     S+600       1.00     11.50     4/1/2022       12/31/2026       3,808       3,663       3,808  
Ultimate Baked Goods Midco LLC (Rise Baking)(16)
  Packaged Foods & Meats     S+625       1.00     10.96     8/12/2021       8/13/2027       26,359       25,811       26,095  
United Digestive MSO Parent, LLC
  Health Care Providers & Services     S+675       1.00     12.25     3/30/2023       3/30/2029       9,812       9,544       9,812  
Urology Management Holdings, Inc
  Health Care Providers & Services     S+650       1.00     11.93     2/7/2023       6/15/2026       9,205       8,983       9,136  
UVP Management, LLC
  Health Care Providers & Services     S+625       1.00     11.75     9/18/2023       9/15/2025       16,922       16,550       16,499  
Vessco Midco Holdings, LLC
  Water Utilities     P+350       1.00     12.00     4/1/2022       11/2/2026       15       15       15  
WCI-BXC
Purchaser, LLC
  Distributors     S+625       1.00     11.64     11/6/2023       11/6/2030       2,904       2,833       2,832  
West-NR
Parent, Inc.(16)
  Insurance     S+625       1.00     11.70     8/1/2023       12/27/2027       9,015       8,848       9,015  
 
 
 
   
 
 
 
Total First Lien Bank Debt/Senior Secured Loans
 
  $ 862,886     $ 872,944  
 
 
 
   
 
 
 
Second Lien Asset-Based Senior Secured Loans
                 
AMF Levered II, LLC
  Diversified Financial Services     S+705       1.00     12.52     12/24/2021       8/21/2028       29,925     $ 29,474     $ 29,326  
FGI Worldwide LLC
  Diversified Financial Services     S+650       1.00     11.86     4/17/2023       4/17/2028       8,206       8,023       8,206  
 
 
 
   
 
 
 
                $ 37,497     $ 37,532  
 
 
 
   
 
 
 
Second Lien Bank Debt/Senior Secured Loans
                 
RD Holdco, Inc.** (2)
  Diversified Consumer Services     S+975
(11)
 
    1.00           12/23/2013       10/12/2026       15,654     $ 12,297     $ 7,827  
 
 
 
   
 
 
 
 
See notes to consolidated financial statements.
 
11
7

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2023
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Spread
Above
Index
(7)
   
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
   
Maturity

Date
   
Par Amount
   
Cost
   
Fair
Value
 
Senior Secured Loans (continued)
 
             
First Lien Life Science Senior Secured Loans
                 
Alimera Sciences, Inc.(16)
  Pharmaceuticals     S+515       4.60     10.50     12/31/2019       5/1/2028     $ 34,738     $ 34,945     $ 37,274  
Arcutis Biotherapeutics, Inc.(3)
  Pharamceuticals     S+745       0.10     12.90     12/22/2021       1/1/2027       66,849       68,169       68,186  
Ardelyx, Inc.(3)
  Pharmaceuticals     S+795       1.00     13.32     2/23/2022       3/1/2027       17,228       17,306       17,766  
BridgeBio Pharma, Inc.(3)
  Biotechnology                 9.00 %
(22)
 
    11/17/2021       11/17/2026       40,753       40,567       40,854  
Cerapedics, Inc.
  Biotechnology     S+620       2.75     11.55     12/27/2022       1/1/2028       36,156       36,260       36,156  
Glooko, Inc.(16)
  Health Care Technology     S+790       0.10     13.35     9/30/2021       10/1/2026       9,927       10,010       10,373  
Meditrina, Inc.
  Health Care Equipment & Supplies     S+550       3.45     10.85     12/20/2022       12/1/2027       3,367       3,374       3,401  
Neuronetics, Inc.(16)
  Health Care Equipment & Supplies     S+565       3.95     11.00     3/2/2020       3/29/2028       30,878       30,921       30,878  
OmniGuide Holdings, Inc. (13)
  Health Care Equipment & Supplies     S+580       5.31     11.25     7/30/2018       11/1/2025       24,500       24,874       24,623  
Outset Medical, Inc.(3)(16)
  Health Care Equipment & Supplies     S+515       2.75     10.50     11/3/2022       11/1/2027       44,727       44,837       44,839  
Vapotherm, Inc.
  Health Care Equipment & Supplies     S+930       1.00     14.75 %
(24)
 
    2/18/2022       2/1/2027       37,670       38,094       38,235  
Vertos Medical, Inc.
  Health Care Equipment & Supplies     S+515       4.75     10.50     6/14/2023       7/1/2028       6,651       6,604       6,651  
 
 
 
   
 
 
 
Total First Lien Life Science Senior Secured Loans
 
  $ 355,961     $ 359,236  
 
 
 
   
 
 
 
Total Senior Secured Loans
 
 
$
1,268,641
 
 
$
1,277,539
 
 
 
 
   
 
 
 
 
Description
 
Industry
 
Interest
Rate
(1)
 
Acquisition
Date
 
Maturity

Date
 
Par Amount
   
Cost
   
Fair
Value
 
Equipment Financing — 26.0%
     
A&A Crane and Rigging, LLC (10)
  Commercial Services & Supplies   7.78%   3/27/2023   3/27/2028   $ 69     $ 69     $ 69  
Aero Operating LLC (10)
  Commercial Services & Supplies  
8.47-9.64%
  2/12/2021  
3/1/2025-11/1/2026
    1,345       1,343       1,343  
AFG Dallas III, LLC (10)
  Diversified Consumer Services  
10.00-11.29%
  8/11/2022  
8/11/2026-3/1/2027
    1,099       1,099       1,099  
Air Methods Corporation (10)
  Airlines  
7.08-7.13%
  11/3/2021  
11/3/2026-11/23/2026
    3,103       3,142       3,103  
AmeraMex International, Inc. (10)
  Commercial Services & Supplies   10.00%   3/29/2019   10/15/2024     381       381       385  
Bazzini, LLC (10)
  Food & Staples Retailing   10.46%   12/23/2022   1/1/2028     1,985       2,043       1,985  
Boart Longyear Company (10)
  Metals & Mining  
8.31-10.44%
  5/28/2020  
7/1/2024-10/7/2026
    2,447       2,447       2,447  
Bowman Energy Solutions, LLC (10)
  Commercial Services & Supplies   7.42%   7/1/2022   7/1/2026     114       114       114  
C-Port/Stone
LLC (10)
  Oil, Gas & Consumable Fuels   8.54%   10/7/2022   11/1/2027     6,247       6,098       6,060  
 
See notes to consolidated financial
statements
.
 
11
8

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2023
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Interest
Rate
(1)
 
Acquisition
Date
 
Maturity

Date
 
Par Amount
   
Cost
   
Fair
Value
 
Equipment Financing (continued)
     
Capital City Jet Center, Inc. (10)
  Airlines   10.00%   4/4/2018   6/22/2026   $ 1,242     $ 1,242     $ 1,242  
Carolina’s Contracting, LLC (10)
  Diversified Consumer Services  
8.40-8.72%
  3/7/2023  
3/7/2028-5/18/2028
    3,523       3,554       3,523  
CKD Holdings, Inc. (10)
  Road & Rail  
8.10-8.60%
  9/22/2022  
3/22/2026-9/22/2027
    2,863       2,863       2,863  
Clubcorp Holdings, Inc. (10)
  Hotels, Restaurants & Leisure  
9.36-13.01%
  5/27/2021  
4/1/2025-5/1/2028
    6,461       6,461       6,461  
Complete Equipment Rentals, LLC (10)
  Commercial Services & Supplies  
6.75-7.15%
  3/23/2023  
4/1/2028-6/1/2028
    1,837       1,810       1,806  
Dongwon Autopart Technology Inc. (10)
  Auto Components   7.96%   2/2/2021   1/1/2026     1,266       1,277       1,266  
Double S Industrial Contractors, Inc. (10)
  Commercial Services & Supplies   8.60%   7/28/2023   8/1/2027     112       112       112  
Drillers Choice, Inc. (10)
  Commercial Services & Supplies  
8.00-10.08%
  10/31/2022  
11/1/2027-6/1/2029
    1,873       1,875       1,873  
Energy Drilling Services, LLC (10)
  Diversified Consumer Services  
6.58-9.16%
  8/26/2022  
11/9/2025-9/1/2027
    1,076       1,076       1,076  
Environmental Protection & Improvement Company, LLC (10)
  Road & Rail   8.25%   9/30/2020   10/1/2027     4,564       4,585       4,564  
Equipment Operating Leases, LLC (2)(12)
  Multi-Sector Holdings   8.37%   4/27/2018   4/27/2025     3,381       3,381       3,296  
Extreme Steel Crane & Rigging, LLC (10)
  Commercial Services & Supplies   9.52%   3/3/2023   3/3/2027     847       854       847  
First American Commercial Bancorp, Inc. (10)
  Diversified Financial Services  
7.50-9.02%
  10/28/2021  
10/1/2026-3/1/2027
    2,279       2,281       2,279  
First National Capital, LLC (10)
  Diversified Financial Services   9.00%   11/5/2021   7/1/2026     5,290       5,290       5,290  
Georgia Jet, Inc. (10)
  Airlines   8.00%   12/4/2017   1/4/2024     25       25       25  
GMT Corporation (10)
  Machinery   10.71%   10/23/2018   1/1/2026     3,813       3,816       3,813  
Hawkeye Contracting Company, LLC (10)
  Construction & Engineering   10.50%   10/8/2021   11/1/2025     689       689       689  
HTI Logistics Corporation (10)
  Commercial Services & Supplies  
9.69-9.94%
  11/15/2018  
5/1/2024-9/1/2025
    153       153       149  
International Automotive Components Group, North America, Inc. (10)
  Auto Components   7.95%   6/23/2021   6/23/2025     3,787       3,801       3,711  
Kool Pak, LLC (10)
  Road & Rail   8.58%   2/5/2018   3/1/2024     29       29       29  
Loc Performance Products, LLC (10)
  Machinery   10.50%   12/29/2022   6/1/2027     636       636       636  
Loyer Capital LLC (2)(12)
  Multi-Sector Holdings  
8.73-11.52%
  5/16/2019  
5/16/2024-9/25/2024
    7,500       7,500       7,361  
Lux Credit Consultants, LLC (10)
  Road & Rail  
8.28-12.09%
  6/17/2021  
12/1/2024-12/1/2026
    10,911       10,911       10,911  
Lux Vending, LLC (10)
  Consumer Finance  
12.46-13.26%
  8/20/2021  
8/20/2024-11/1/2024
    632       636       632  
 
See notes to consolidated financial statements.
 
11
9

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2023
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Interest
Rate
(1)
 
Acquisition
Date
 
Maturity

Date
 
Par Amount
   
Cost
   
Fair
Value
 
Equipment Financing (continued)
     
Miranda Logistics Enterprise, Inc. (10)
  Construction & Engineering   7.69%   4/14/2023   4/14/2028   $ 787     $ 787     $ 787  
Mountain Air Helicopters, Inc. (10)
  Commercial Services & Supplies   10.00%   7/31/2017   2/28/2025     248       247       248  
Nimble Crane LLC (10)
  Commercial Services & Supplies   9.18%   7/13/2023   7/13/2028     934       934       934  
No Limit Construction Services, LLC (10)
  Commercial Services & Supplies   7.73%   5/5/2023   6/1/2028     118       118       118  
Ozzies, Inc. (10)
  Commercial Services & Supplies   10.72%   12/23/2022   1/1/2027     1,621       1,668       1,621  
PCX Aerostructures LLC (10)
  Aerospace & Defense   9.32%   11/23/2022   12/1/2028     2,311       2,311       2,311  
Rane Light Metal Castings Inc. (10)
  Machinery   10.00%   6/1/2020   6/1/2024     56       56       56  
Rango, Inc. (10)
  Commercial Services & Supplies   9.33%   9/24/2019   11/1/2024     573       583       563  
Rayzor’s Edge LLC (10)
  Diversified Consumer Services  
7.69-8.27%
  5/19/2023  
5/18/2030-6/30/2030
    711       711       711  
RH Land Construction, LLC & Harbor Dredging LA, Inc. (10)
  Construction & Engineering   8.08%   5/10/2023   5/10/2026     114       114       114  
Royal Express Inc. (10)
  Road & Rail   9.53%   1/17/2019   2/1/2024     148       148       148  
Rotten Rock Hardscaping & Tree Service (10)
  Diversified Consumer Services   8.21%   12/6/2022   12/6/2027     204       204       204  
Rutt Services, LLC (10)
  Commercial Services & Supplies   8.95%   8/11/2023   8/11/2030     1,176       1,179       1,176  
Signet Marine Corporation (10)
  Transportation Infrastructure   8.50%   10/31/2022   10/1/2029     12,272       12,310       12,272  
SLR Equipment Finance(2)
  Multi-Sector Holdings   8.50%   1/24/2022   1/27/2024     3,850       3,850       3,850  
Smiley Lifting Solutions, LLC(10)
  Commercial Services & Supplies  
7.82-8.61%
  6/30/2022  
9/15/2026-6/27/2030
    5,945       5,945       5,945  
ST Coaches, LLC (10)
  Road & Rail   8.50%   7/31/2017   1/25/2025     583       583       583  
Star Coaches Inc. (10)
  Road & Rail   8.42%   3/9/2018   4/1/2025     2,327       2,327       2,211  
Superior Transportation, Inc. (10)
  Road & Rail  
10.22-10.63%
  7/31/2017   1/1/2026     2,279       2,279       2,279  
The Smedley Company & Smedley Services, Inc. (10)..
  Commercial Services & Supplies   4.07%   7/31/2017   1/15/2028     1,397       1,397       1,270  
Trinity Equipment, Inc. (10)
  Commercial Services & Supplies  
8.78-8.93%
  5/4/2023  
5/4/2028-5/19/2028
    1,345       1,345       1,345  
Trinity Equipment Rentals, Inc. (10)
  Commercial Services & Supplies  
7.94-8.75%
  10/8/2021  
11/1/2024-12/1/2026
    361       361       361  
U.S. Crane & Rigging, LLC (10)
  Commercial Services & Supplies  
8.73%-10.92%
  12/23/2022  
3/1/2027-9/1/2028
    2,574       2,574       2,574  
Up Trucking Services, LLC (10)
  Road & Rail   11.21%   3/23/2018   8/1/2024     208       209       208  
 
See notes to consolidated financial statements.
 
1
20
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2023
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Interest
Rate
(1)
 
Acquisition
Date
 
Maturity

Date
   
Par Amount
   
Cost
   
Fair
Value
 
Equipment Financing (continued)
 
     
Waste Pro of Florida, Inc. & Waste Pro USA, Inc. (10)
  Commercial Services & Supplies   9.17%   4/18/2023     4/18/2028     $ 8,915     $ 9,057     $ 8,915  
Wind River Environmental, LLC (10)
  Diversified Consumer Services  
8.43-10.00%
  7/31/2019    
8/1/2024-10/5/2025
      311       311       311  
Womble Company, Inc. (10)
  Energy Equipment & Services   9.11%   12/27/2019     1/1/2025       210       210       206  
Worldwide Flight Services, Inc. (10)
  Transportation Infrastructure  
8.32-9.93%
  9/23/2022    
9/23/2027-8/16/2028
      3,053       3,097       3,053  
Zamborelli Enterprises Pacific Souther
n
Foundation (10)
  Diversified Consumer Services   8.91%   12/7/2022     1/1/2027       566       570       566  
 
 
Shares/Units
 
   
SLR Equipment Finance Equity Interests (2)(9)(17)*
  Multi-Sector Holdings   7/31/2017       200       145,000       120,820  
       
 
 
   
 
 
 
Total Equipment Financing
 
 
$
282,078
 
 
$
256,819
 
                
 
 
   
 
 
 
                              
Par Amount
             
Preferred Equity – 0.4%
 
     
SOINT, LLC (2)(3)(4)
  Aerospace & Defense   5.00%
(11)
  6/8/2012     6/30/2025       —      $ 5,178     $ 3,801  
                
 
 
   
 
 
 
 
Description
 
Industry
 
Acquisition
Date
   
Shares/
Units
   
Cost
   
Fair
Value
 
Common Equity/Equity Interests/Warrants—62.5%
       
Assertio Holdings, Inc. (8)*
  Pharmaceuticals     7/31/2023       12,510     $ 51     $ 13  
aTyr Pharma, Inc. Warrants *
  Pharmaceuticals     11/18/2016       2,932       36        
Bayside Parent, LLC (27)*
  Health Care Providers & Services     5/31/2023       6,526       11,411       3,815  
CardioFocus, Inc. Warrants *
  Health Care Equipment & Supplies     3/31/2017       90       51        
Centrexion Therapeutics, Inc. Warrants *
  Pharmaceuticals     6/28/2019       289,102       136       45  
Conventus Orthopaedics, Inc. Warrants *
  Health Care Equipment & Supplies     6/15/2016       157,500       65        
Delphinus Medical Technologies, Inc. Warrants *
  Health Care Equipment & Supplies     8/18/2017       444,388       74       80  
Essence Group Holdings Corporation (Lumeris) Warrants *
  Health Care Technology     3/22/2017       260,000       129       327  
KBH Topco LLC (Kingsbridge) (2)(5)(18).
  Multi-Sector Holdings     11/3/2020       73,500,000       136,596       142,000  
Meditrina, Inc. Warrants *
  Health Care Equipment & Supplies     12/20/2022       29,366       23       19  
NSPC Holdings, LLC (National Spine) *
  Health Care Providers & Services     2/13/2023       207,043       657        
RD Holdco, Inc. (Rug Doctor) (2)*
  Diversified Consumer Services     12/23/2013       231,177       15,683        
RD Holdco, Inc. (Rug Doctor) Class B (2)*
  Diversified Consumer Services     12/23/2013       522       5,216        
Senseonics Holdings, Inc. (3)(8)*
  Health Care Equipment & Supplies     7/25/2019       469,353       235       268  
SLR-AMI
Topco Blocker, LLC (15)(27)*
  Internet & Catalog Retail     6/16/2023             24,085       15,867  
SLR Business Credit (2)(3)(19)
  Diversified Financial Services     4/1/2022       100       81,583       90,370  
SLR Credit Solutions (2)(3)(20)
  Diversified Financial Services     12/28/2012       280,303       80,737       284,000  
 
See notes to consolidated financial statements.
 
12
1

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2023
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Acquisition
Date
   
Shares/
Units
   
Cost
   
Fair
Value
 
Common Equity/Equity Interests/Warrants (continued)
       
SLR Healthcare ABL (2)(3)(21)
  Diversified Financial Services     4/1/2022       32,839     $ 34,335     $ 35,850  
SLR Senior Lending Program LLC (2)(3)(25)
  Asset Management     12/1/2022             42,875       43,899  
SLR Healthcare ABL (2)(3)(21)
  Diversified Financial Services     4/1/2022       32,839       34,335       35,850  
Vapotherm, Inc. Warrants*
  Health Care Equipment & Supplies     2/18/2022       78,287       319       3  
Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics)
  Health Care Equipment & Supplies     5/10/2018       2,230       152        
Vertos Medical, Inc. Warrants*
  Health Care Equipment & Supplies     6/14/2023       161,761       51       51  
       
 
 
   
 
 
 
Total Common Equity/Equity Interests/Warrants
 
   
$
634,500
 
 
$
616,607
 
       
 
 
   
 
 
 
Total Investments (6) — 218.4%
     
$
2,190,397
 
 
$
2,154,766
 
       
 
 
   
 
 
 
 
Description
  
Industry
    
Acquisition
Date
    
Maturity

Date
    
Par Amount
               
Cash Equivalents —
33.7
%
 
              
U.S. Treasury Bill
     Government        12/29/2023        2/27/2024      $ 335,000      $ 332,290      $ 332,290  
              
 
 
    
 
 
 
Total Investments & Cash Equivalents —
252.1
%
 
  
$
2,522,687
 
  
$
2,487,056
 
Liabilities in Excess of Other Assets —
(152.1
%)
 
        (1,500,417
     
 
 
 
Net Assets —
100.0
%
 
  
$
986,639
 
                 
 
 
 
 
(1)
Floating rate debt investments typically bear interest at a rate determined by reference to the Secured Overnight Financing Rate (“SOFR” or “S”) or the prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2023.
(2)
Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (the “1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2023 in these controlled investments are as follows:
 
Name of Issuer
 
Fair Value at
December 31,
2022
   
Gross
Additions
   
Gross
Reductions
   
Realized
Loss
   
Change in
Unrealized
Gain
(Loss)
   
Fair Value at
December 31,
2023
    
Interest/
Dividend/
Other

Income
 
Equipment Operating Leases, LLC
  $ 3,741     $     $ (456   $     $ 11     $ 3,296      $ 304  
Kingsbridge Holdings, LLC
    80,000       16,000                   (96     96,000        10,320  
KBH Topco, LLC (Kingsbridge)
    148,444                         (6,444     142,000        13,125  
Loyer Capital LLC
    7,361                               7,361        755  
RD Holdco, Inc. (Rug Doctor, common equity)
                                          
RD Holdco, Inc. (Rug Doctor, class B)..
                                          
RD Holdco, Inc. (Rug Doctor, warrants)..
                      (381     381               
RD Holdco, Inc. (debt)
    6,521       506                   800       7,827         
SLR Business Credit
    89,370                         1,000       90,370        7,000  
 
See notes to consolidated financial statements.
 
12
2

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2023
(in thousands, except share/unit amounts)
 
Name of Issuer
 
Fair Value at
December 31,
2022
   
Gross
Additions
   
Gross
Reductions
   
Realized
Loss
   
Change in
Unrealized
Gain
(Loss)
   
Fair Value at
December 31,
2023
    
Interest/
Dividend/
Other

Income
 
SLR Credit Solutions
    288,760                         (4,760     284,000        20,000  
SLR Equipment Finance (equity)
    120,820                               120,820         
SLR Equipment Finance (debt)
    5,000       3,850       (5,000                 3,850        248  
SLR Healthcare ABL
    34,350                         1,500       35,850        4,360  
SLR Senior Lending Program LLC
    9,426       33,375                   1,098       43,899        1,474  
SOINT, LLC
    3,801       251                   (251     3,801        251  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
    
 
 
 
  $ 797,594     $ 53,982     $ (5,456   $ (381   $ (6,761   $ 839,074      $ 57,837  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
    
 
 
 
 
(3)
Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making
follow-on
investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2023, on a fair value basis,
non-qualifying
assets in the portfolio represented 26.6% of the total assets of the Company.
(4)
The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.
(5)
Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.
(6)
Aggregate net unrealized appreciation for U.S. federal income tax purposes is $2,567; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $97,678 and $95,111, respectively, based on a tax cost of $2,152,199. Unless otherwise noted, all of the Company’s investments are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
(7)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR or PRIME rate. These instruments are often subject to a SOFR or PRIME rate floor.
(8)
Denotes a Level 1 investment.
(9)
SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.
(10)
Indicates an investment that is wholly held by the Company through NEFPASS LLC.
(11)
Interest is paid in kind (“PIK”).
(12)
Denotes a subsidiary of SLR Equipment Finance.
(13)
OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are
co-borrowers.
(14)
Kaseya, Inc. may elect to defer up to 2.50% of the coupon as PIK.
(15)
Through this entity and other intermediate entities, the Company owns approximately 7.3% of the underlying common units of ASC Holdco, LLC, a joint venture which owns certain assets of the former Amerimark Interactive, LLC.
(16)
Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.
(17)
See note 11 to the consolidated financial statements.
 
See notes to consolidated financial statements.
 
12
3

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2023
(in thousands, except share/unit amounts)
 
(18)
See note 12 to the consolidated financial statements.
(19)
See note 14 to the consolidated financial statements.
(20)
See note 10 to the consolidated financial statements.
(21)
See note 13 to the consolidated financial statements.
(22)
BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.
(23)
The Company became an Affiliated Person to Bayside Opco, LLC and Bayside Parent, LLC on May 31, 2023 and to Amerimark Intermediate Holdings, LLC and SLR- AMI Topco Blocker, LLC on June 16, 2023.
(24)
Vapotherm, Inc. may elect to defer up to 9.00% of the coupon as PIK.
(25)
See note 18 to the consolidated financial statements.
(26)
iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK.
(27)
Denotes investments in which we are an “Affiliated Person” but do not exercise a controlling influence, as defined in the 1940 Act, due to beneficially owning, either directly or through one or more controlled companies, more than 5% but less than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2023 (beginning with the date at which the Company became an Affiliated Person) in these affiliated investments are as follows:
 
Name of Issuer
 
Fair Value at
Date of
Affiliation(23)
   
Gross
Additions
   
Gross
Reductions
   
Realized
Gain
(Loss)
   
Change in
Unrealized
Gain
(Loss)
   
Fair Value at
December 31,
2023
   
Interest
Income
 
Oldco AI, LLC (f/k/a AmeriMark)
  $     $ 1,270     $ (1,270   $       $     $     $ 194  
Oldco AI, LLC (f/k/a AmeriMark)
    9,371             (17,070 )
          7,699              
Bayside Opco, LLC
    846       21       (867                       44  
Bayside Opco, LLC
    18,224       1,191                         19,415       1,399  
Bayside Parent, LLC (loan)
    4,773       380                         5,153       447  
Bayside Parent, LLC (equity)
    4,681                         (866     3,815        
SLR-AMI
Topco Blocker, LLC
    7,014       17,070
a

                (8,217     15,867        
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
    $44,909     $19,932     $(19,207)     $     $(1,384)     $44,250     $2,084  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
a
Includes contribution of basis from Oldco AI, LLC to SLR-AMI Topco Blocker, LLC.
*
Non-income
producing security.
**
Investment is on
non-accrual
status.
 
See notes to consolidated financial statements.
 
12
4

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2023
(in thousands)
 
Industry Classification
  
Percentage of Total
Investments (at fair value) as
of December 31, 2023
 
Diversified Financial Services (includes SLR Credit Solutions, SLR Business Credit and SLR Healthcare ABL)
     21.9
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC)
     17.3
Health Care Providers & Services
     13.2
Health Care Equipment & Supplies
     7.6
Pharmaceuticals
     5.7
Biotechnology
     3.6
Software
     3.5
Insurance
     2.9
Diversified Consumer Services
     2.3
Commercial Services & Supplies
     2.2
Asset Management
     2.1
Capital Markets
     2.0
Media
     1.7
Thrifts & Mortgage Finance
     1.4
Personal Products
     1.3
Packaged Foods & Meats
     1.2
Auto Parts & Equipment
     1.2
Road & Rail
     1.1
Life Sciences Tools & Services
     1.1
Internet Software & Services
     0.9
Internet & Catalog Retail
     0.7
Transportation Infrastructure
     0.7
Communications Equipment
     0.7
Health Care Technology
     0.5
Trading Companies & Distributors
     0.5
Hotels, Restaurants & Leisure .
     0.3
Aerospace & Defense
     0.3
Oil, Gas & Consumable Fuels.
     0.3
Footwear
     0.2
Auto Components
     0.2
IT Services
     0.2
Food Products
     0.2
Machinery
     0.2
Airlines
     0.2
Distributors
     0.1
Metals & Mining
     0.1
Leisure Equipment & Products
     0.1
Specialty Retail
     0.1
Food & Staples Retailing
     0.1
Construction & Engineering
     0.1
Consumer Finance
     0.0
Energy Equipment & Services
     0.0
Water Utilities
     0.0
  
 
 
 
Total Investments
     100.0
  
 
 
 
 
See notes to consolidated financial statements.
 
12
5

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS
December 31, 2022
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Spread
Above
Index
(7)
 
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
 
Maturity

Date
 
Par Amount
   
Cost
   
Fair
Value
 
Senior Secured Loans —124.6%
             
First Lien Bank Debt/Senior Secured Loans
                 
Aegis Toxicology Sciences Corporation(16)
  Health Care Providers & Services   L+550     1.00     10.09   5/7/2018   5/9/2025   $ 17,103     $ 16,793     $ 17,103  
All State Ag Parts, LLC(16)
  Trading Companies & Distributors   S+575     1.00     10.19   4/1/2022   9/1/2026     4,197       4,081       4,197  
American Teleconferencing Services, Ltd.**
  Communications Equipment   L+650     1.00         5/5/2016   9/9/2021     36,135       25,926        
American Teleconferencing Services, Ltd.**
  Communications Equipment   L+650     1.00         9/17/2021   1/31/2023     6,405       6,254       224  
AmeriMark Intermediate Holdings, LLC(14)
  Internet & Catalog Retail   L+800     1.00     14.77   7/28/2021   10/15/2026     24,087       23,711       22,882  
Apex Services Partners, LLC(16)
  Diversified Consumer Services   S+525     1.00     9.80   8/31/2022   7/31/2025     14,021       13,644       14,021  
Atria Wealth Solutions, Inc.(16)
  Diversified Financial Services   S+600     1.00     10.84   9/14/2018   2/29/2024     8,149       8,107       8,149  
Basic Fun, Inc.(16)
  Specialty Retail   L+550     1.00     10.27   10/30/2020   10/30/2023     2,162       2,152       2,162  
BayMark Health Services, Inc.(16)
  Health Care Providers & Services   L+500     1.00     9.73   4/1/2022   6/11/2027     9,432       9,078       9,432  
BDG Media, Inc
  Media   L+900     0.25     13.17   7/18/2022   4/27/2023     14,454       14,454       14,454  
CC SAG Holdings Corp. (Spectrum Automotive)(16)
  Diversified Consumer Services   L+575     0.75     10.48   6/29/2021   6/29/2028     20,427       20,057       20,427  
Composite Technology Acquisition Corp.(16)
  Building Products   L+475     1.00     9.73   4/1/2022   2/1/2025     10,386       9,983       10,386  
Copper River Seafoods, Inc.
  Food Products   P+275           10.25   8/31/2022   4/23/2025     8,405       8,405       8,405  
DeepIntent, Inc
  Media   P+175           9.25   10/12/2022   3/25/2025     16,951       16,951       16,951  
Enhanced Permanent Capital, LLC(3)
  Capital Markets   L+700     1.00     10.13   12/29/2020   12/29/2025     35,205       34,496       35,205  
ENS Holdings III Corp. & ES Opco USA LLC (Bluefin)(16)..
  Trading Companies & Distributors   S+475     1.00     9.43   4/1/2022   12/31/2025     4,978       4,804       4,978  
Enverus Holdings, Inc. (fka Drilling Info Holdings)(16)
  IT Services   L+450           8.88   4/1/2022   7/30/2025     11,598       11,129       11,598  
Erie Construction
Mid-west,
LLC(16)
  Building Products   S+475     1.00     9.79   4/1/2022   7/30/2027     8,915       8,580       8,915  
Foundation Consumer Brands, LLC(16)
  Personal Products   L+550     1.00     10.15   2/12/2021   2/12/2027     35,273       34,421       35,273  
GSM Acquisition Corp.(16)
  Leisure Equipment & Products   S+500     1.00     9.03   4/1/2022   11/16/2026     11,022       10,562       10,912  
Higginbotham Insurance Agency, Inc.(16)
  Insurance   L+525     0.75     9.63   4/1/2022   11/25/2026     6,223       5,994       6,223  
High Street Buyer, Inc.(16)
  Insurance   L+600     0.75     10.73   4/1/2022   4/16/2028     5,188       4,900       5,188  
 
See notes to consolidated financial statements.
 
12
6
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Spread
Above
Index
(7)
 
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
   
Maturity

Date
   
Par Amount
   
Cost
   
Fair
Value
 
Senior Secured Loans (continued)
             
Human Interest Inc
  Internet Software & Services   S+785     1.00    
11.97
    6/30/2022       7/1/2027     $ 20,104     $ 19,783     $ 20,104  
iCIMS, Inc.
  Software   S+725     0.75     11.52 %
(26)
 
    8/18/2022       8/18/2028       32,084       31,548       31,522  
Ivy Fertility Services, LLC
  Health Care Providers & Services   L+625     1.00     10.39     12/22/2021       2/25/2026       30,092       29,415       30,393  
Kaseya, Inc.(16)
  Software   S+575     0.75     10.33     6/22/2022       6/23/2029       32,426       31,966       32,426  
Kid Distro Holdings, LLC (Distro Kid)(16)
  Software   L+575     1.00     10.48     9/24/2021       10/1/2027       26,452       26,015       26,452  
Kingsbridge Holdings, LLC(2)
  Multi-Sector Holdings   L+700     1.00     10.75     12/21/2018       12/21/2024       80,000       79,800       80,000  
KORE Wireless Group, Inc.(16)
  Wireless Telecommunication Services   S+550           10.08     12/21/2018       12/21/2024       23,588       23,123       23,588  
Logix Holding Company, LLC(16)
  Communications Equipment   L+575     1.00     10.13     9/14/2018       12/22/2024       14,009       13,246       13,449  
Luxury Asset Capital, LLC(16)
  Thrifts & Mortgage Finance   S+675     1.00     10.99     7/15/2022       7/15/2027       27,500       26,991       27,500  
Maurices, Incorporated(16)
  Specialty Retail   S+675     1.00     8.74     8/27/2021       6/1/2024       7,808       7,678       7,808  
Montefiore Nyack Hospital
  Health Care Providers & Services   L+495           9.72     8/9/2022       11/15/2024       3,966       3,966       3,966  
NAC Holdings Corporation (Jaguar)(16)
  Insurance   S+525     1.00     9.45     7/30/2021       9/28/2024       28,603       28,214       28,603  
National Spine and Pain Centers, LLC
  Health Care Providers & Services   L+500     1.00     7.31     4/1/2022       6/2/2024       2,681       2,564       2,547  
One Touch Direct, LLC
  Commercial Services & Supplies   P+75           8.25     4/3/2020       3/30/2024       4,431       4,431       4,431  
Orthopedic Care Partners Management, LLC
  Health Care Providers & Services   S+650     1.00     10.91     8/17/2022       5/16/2024       3,111       3,092       3,111  
Pediatric Home Respiratory Services, LLC
  Health Care Providers & Services   S+625     1.00     10.67     8/19/2022       12/4/2024       1,327       1,309       1,313  
Peter C. Foy & Associates Insurance Services, LLC
  Insurance   S+600     0.75     10.44     4/1/2022       11/1/2028       10,854       10,699       10,854  
PhyNet Dermatology LLC
  Health Care Providers & Services   S+625
(15)
    1.00     9.81     9/5/2018       8/16/2024       14,458       14,420       14,458  
Pinnacle Treatment Centers, Inc.(16)
  Health Care Providers & Services   S+650     1.00     10.57     1/22/2020       1/2/2026       27,997       27,528       27,367  
Plastics Management, LLC(16)
  Health Care Providers & Services   S+500     1.00     9.89     4/1/2022       8/18/2027       9,491       9,161       9,491  
PPT Management Holdings, LLC(16)
  Health Care Providers & Services   L+850
(11)
    1.00     12.83     9/14/2018       1/30/2023       32,163       31,987       25,827  
RQM+ Corp.(16)
  Life Sciences Tools & Services   S+575     1.00     10.97     8/20/2021       8/12/2026       26,823       26,455       26,823  
RSC Acquisition, Inc.(16)
  Insurance   S+550     0.75     9.26     4/1/2022       11/1/2026       6,985       6,813       6,985  
RxSense Holdings LLC(16)
  Diversified Consumer Services   L+500     1.00     9.41     4/1/2022       3/13/2026       11,775       11,357       11,775  
 
See notes to consolidated financial statements.
 
12
7

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Spread
Above
Index
(7)
 
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
   
Maturity

Date
   
Par Amount
   
Cost
   
Fair
Value
 
Senior Secured Loans (continued)
             
SCP Eye Care, LLC
  Health Care Providers & Services   S+575     1.00     9.46     10/6/2022       10/5/2029     $ 8,314     $ 8,050     $ 8,044  
SHO Holding I Corporation (Shoes for Crews)(16)
  Footwear   L+523     1.00     9.66     4/1/2022       4/27/2024       5,704       5,361       5,419  
Southern Orthodontic Partners Management, LLC(16)
  Health Care Providers & Services   S+600     1.00     10.77     6/3/2022       1/27/2026       1,399       1,387       1,399  
SPAR Marketing Force, Inc
  Media   P+95           8.45     7/18/2022       10/10/2024       9,162       9,162       9,162  
Stryten Resources LLC
  Auto Parts & Equipment   S+800     1.00     12.44     8/11/2021       10/12/2026       25,922       25,506       25,922  
SunMed Group Holdings, LLC(16)
  Health Care Equipment & Supplies   L+575     0.75     10.48     6/16/2021       6/16/2028       24,953       24,446       24,953  
TAUC Management, LLC(16)
  Health Care Providers & Services   L+525     1.00     9.98     4/1/2022       2/12/2027       6,899       6,585       6,864  
Tilley Distribution, Inc.(16)
  Trading Companies & Distributors   S+550     1.00     10.14     4/1/2022       12/31/2026       9,996       9,527       9,996  
Ultimate Baked Goods Midco LLC (Rise Baking)(16)
  Packaged Foods & Meats   L+650     1.00     10.88     8/12/2021       8/13/2027       24,789       24,038       24,789  
Vessco Midco Holdings, LLC(16)
  Water Utilities   L+450     1.00     7.87     4/1/2022       11/2/2026       1,728       1,668       1,728  
World Insurance Associates, LLC(16)
  Insurance   S+575     1.00     9.31     4/1/2022       4/1/2026       31,624       30,785       30,359  
               
 
 
   
 
 
 
Total First Lien Bank Debt/Senior Secured Loans
 
  $ 912,558     $ 886,513  
 
 
 
   
 
 
 
Second Lien Asset-Based Senior Secured Loans
                 
ACRES Commercial Mortgage, LLC
  Diversified Financial Services   S+705     1.00     11.38     12/24/2021       8/21/2028       29,925     $ 29,398     $ 29,925  
               
 
 
   
 
 
 
Second Lien Bank Debt/Senior Secured Loans
                 
RD Holdco, Inc.** (2)
  Diversified Consumer Services   S+975
(11)
    1.00           12/23/2013       10/12/2026       13,043     $ 11,791     $ 6,521  
               
 
 
   
 
 
 
 
See notes to consolidated financial statements.
 
12
8
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Spread
Above
Index
(7)
 
Floor
   
Interest
Rate
(1)
   
Acquisition
Date
   
Maturity

Date
   
Par Amount
   
Cost
   
Fair
Value
 
Senior Secured Loans (continued)
             
First Lien Life Science Senior Secured Loans
                 
Alimera Sciences, Inc.(16)
  Pharmaceuticals   L+765     1.78     11.82     12/31/2019       7/1/2024     $ 23,159     $ 23,894     $ 24,433  
Apeel Technology, Inc.
  Biotechnology   S+625     1.00     8.75%       6/29/2022       6/1/2027       3,643       3,620       3,643  
Arcutis Biotherapeutics, Inc.(3)
  Pharamceuticals   L+745     0.10     11.62%       12/22/2021       1/1/2027       66,849       67,077       67,685  
Ardelyx, Inc.(3)
  Pharmaceuticals   L+795     0.10     12.12%       2/23/2022       3/1/2027       9,475       9,437       9,499  
BridgeBio Pharma, Inc.(3)
  Biotechnology             9.00%
(22)
      11/17/2021       11/17/2026       39,839       39,340       39,839  
Centrexion Therapeutics, Inc.
  Pharmaceuticals   L+725     2.45     11.42%       6/28/2019       1/1/2024       11,844       12,372       12,555  
Cerapedics, Inc.
  Biotechnology   S+620     2.75     10.52%       12/27/2022       1/1/2028       26,939       26,874       26,872  
Glooko, Inc.(16)
  Health Care Technology   L+790     0.10     12.07%       9/30/2021       10/1/2026       15,883       15,867       15,922  
Meditrina, Inc.
  Health Care Equipment & Supplies   S+550     3.45     9.82%       12/20/2022       12/1/2027       3,367       3,338       3,359  
Neuronetics, Inc.(16)
  Health Care Equipment & Supplies   L+765     1.66     11.82%       3/2/2020       2/28/2025       18,012       18,450       19,003  
OmniGuide Holdings, Inc. (13).
  Health Care Equipment & Supplies   L+1405     0.10     18.22%
(23)
      7/30/2018       7/1/2023       19,201       19,380       19,777  
Outset Medical, Inc.(3)
  Health Care Equipment & Supplies   S+515     2.75     9.33%       11/3/2022       11/1/2027       35,084       34,880       34,820  
Spectrum Pharmaceuticals, Inc.(16)
  Biotechnology   S+570     2.30     9.88%       9/21/2022       9/1/2027       10,525       10,406       10,420  
Vapotherm, Inc.
  Health Care Equipment & Supplies   S+830     1.00     12.58%
(24)
      2/18/2022       2/1/2027       34,455       34,270       34,628  
               
 
 
   
 
 
 
Total First Lien Life Science Senior Secured Loans
 
  $ 319,205     $ 322,455  
 
 
 
   
 
 
 
Total Senior Secured Loans
 
  $ 1,272,952     $ 1,245,414  
 
 
 
   
 
 
 
 
Description
 
Industry
 
Interest
Rate
(1)
 
Acquisition
Date
 
Maturity

Date
 
Par Amount
   
Cost
   
Fair
Value
 
Equipment Financing — 26.6%
     
Aero Operating LLC (10)
  Commercial Services & Supplies  
8.47-9.64%
  2/12/2021  
3/1/2025-12/1/2026
  $ 2,264     $ 2,262     $ 2,262  
AFG Dallas III, LLC (10)
  Diversified Consumer Services   10.00%   8/11/2022  
8/11/2026-8/29/2026
    1,036       1,036       1,036  
Air Methods Corporation (10)
  Airlines  
7.08-7.13%
  11/3/2021  
11/3/2026-11/23/2026
    3,600       3,660       3,600  
 
See notes to consolidated financial statements.
 
12
9

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Interest
Rate
(1)
 
Acquisition
Date
 
Maturity

Date
 
Par Amount
   
Cost
   
Fair
Value
 
Equipment Financing (continued)
     
AmeraMex International, Inc. (10)
  Commercial Services & Supplies   10.00%   3/29/2019   9/15/2024   $ 1,059     $ 1,059     $ 1,069  
Bazzini, LLC (10)
  Food & Staples Retailing   10.46%   12/23/2022   1/1/2028     2,365       2,440       2,365  
Boart Longyear Company (10)
  Metals & Mining  
8.31-10.44%
  5/28/2020  
7/1/2024-10/7/2026
    4,568       4,568       4,568  
Bowman Energy Solutions, LLC (10)
  Commercial Services & Supplies   7.42%   7/1/2022   8/1/2026     153       153       153  
C-Port/Stone
LLC (10)
  Oil, Gas & Consumable Fuels   8.54%   10/7/2022   11/1/2027     6,708       6,514       6,507  
Capital City Jet Center, Inc. (10)
  Airlines   10.00%   4/4/2018  
10/4/2023-6/22/2026
    2,241       2,241       2,214  
Champion Air, LLC (10)
  Airlines   10.00%   3/19/2018   1/1/2023     1,055       1,055       1,055  
CKD Holdings, Inc. (10)
  Road & Rail  
8.10-8.60%
  9/22/2022  
3/22/2026-9/22/2027
    3,690       3,690       3,690  
Clubcorp Holdings, Inc. (10)
  Hotels, Restaurants & Leisure  
9.36-13.01%
  5/27/2021  
4/1/2025-1/1/2028
    6,539       6,539       6,539  
Dongwon Autopart Technology Inc. (10)
  Auto Components   7.96%   2/2/2021   1/1/2026     1,828       1,849       1,828  
Drillers Choice, Inc. (10)
  Commercial Services & Supplies   8.00%   10/31/2022   11/1/2027     1,589       1,589       1,589  
EasyPak, LLC (10)
  Containers & Packaging   9.01%   1/6/2021   1/1/2024     276       276       276  
Energy Drilling Services, LLC (10)
  Diversified Consumer Services  
6.58-9.16%
  8/26/2022  
12/9/2025-9/1/2027
    1,321       1,321       1,295  
Environmental Protection & Improvement Company, LLC (10)
  Road & Rail   8.25%   9/30/2020   10/1/2027     5,270       5,300       5,270  
Equipment Operating Leases, LLC (2)(12)
  Multi-Sector Holdings   8.37%   4/27/2018   4/27/2025     3,837       3,837       3,741  
First American Commercial Bancorp, Inc. (10)
  Diversified Financial Services  
7.50-9.02%
  10/28/2021  
10/1/2026-3/1/2027
    2,938       2,941       2,938  
First National Capital, LLC. (10)
  Diversified Financial Services   9.00%   11/5/2021   8/1/2026     7,116       7,116       7,116  
Freightsol LLC (10)
  Road & Rail  
12.51-12.89%
  4/9/2019   11/1/2023     779       784       779  
Garda CL Technical Services, Inc. (10)
  Commercial Services & Supplies  
8.30-8.77%
  3/22/2018  
6/5/2023-10/5/2023
    469       469       468  
Georgia Jet, Inc. (10)
  Airlines   8.00%   12/4/2017   1/4/2024     425       425       425  
GMT Corporation (10)
  Machinery   10.71%   10/23/2018   1/1/2026     4,801       4,806       4,801  
Hawkeye Contracting Company, LLC (10)
  Construction & Engineering   10.50%   10/8/2021   11/1/2025     997       997       997  
HTI Logistics Corporation. (10)
  Commercial Services & Supplies  
9.69-9.94%
  11/15/2018  
5/1/2024-9/1/2025
    290       290       283  
International Automotive Components Group, North America, Inc. (10)
  Auto Components   7.95%   6/23/2021   6/23/2025     6,072       6,109       5,951  
Kool Pak, LLC (10)
  Road & Rail   8.58%   2/5/2018   3/1/2024     194       194       194  
Loc Performance Products, LLC (10)
  Machinery   10.50%   12/29/2022   6/1/2027     767       767       767  
Loyer Capital LLC (2)(12)
  Multi-Sector Holdings  
8.73-11.52%
  5/16/2019  
5/16/2024-9/25/2024
    7,500       7,500       7,361  
Lux Credit Consultants, LLC (10)
  Road & Rail  
8.28-12.09%
  6/17/2021  
12/1/2024-12/1/2026
    16,411       16,411       16,411  
 
See notes to consolidated financial statements.
 
1
30

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Interest
Rate
(1)
 
Acquisition
Date
 
Maturity

Date
 
Par Amount
   
Cost
   
Fair
Value
 
Equipment Financing (continued)
     
Lux Vending, LLC (10)
  Consumer Finance  
12.46-13.26%
  8/20/2021  
8/20/2024-10/1/2024
  $ 1,638     $ 1,663     $ 1,638  
Mountain Air Helicopters, Inc. (10)
  Commercial Services & Supplies   10.00%   7/31/2017   2/28/2025     369       368       369  
Ozzies, Inc. (10)
  Commercial Services & Supplies   10.72%   12/23/2022   1/1/2027     2,005       2,072       2,005  
PCX Aerostructures LLC (10)
  Aerospace & Defense   9.32%   11/23/2022   12/1/2028     2,658       2,658       2,658  
Rane Light Metal Castings Inc. (10)
  Machinery   10.00%   6/1/2020   6/1/2024     159       159       159  
Rango, Inc. (10)
  Commercial Services & Supplies  
9.33-9.79%
  9/24/2019  
4/1/2023-11/1/2024
    1,940       1,960       1,904  
Royal Coach Lines, Inc.(10)
  Road & Rail   9.56%   11/21/2019   8/1/2025     849       849       775  
Royal Express Inc. (10)
  Road & Rail   9.53%   1/17/2019   2/1/2024     428       431       428  
Rotten Rock Hardscaping & Tree Service (10)
  Diversified Consumer Services   8.21%   12/6/2022   12/6/2027     245       245       245  
Signet Marine Corporation (10)
  Transportation Infrastructure   8.50%   10/31/2022   7/1/2029     14,102       14,152       14,102  
SLR Equipment Finance(2)
  Multi-Sector Holdings   8.50%   1/24/2022   1/24/2023     5,000       5,000       5,000  
Smiley Lifting Solutions, LLC(10)
  Commercial Services & Supplies  
7.82-8.28%
  6/30/2022  
9/15/2026-12/29/2029
    4,139       4,139       4,139  
ST Coaches, LLC (10)
  Road & Rail  
8.47-8.58%
  7/31/2017  
7/1/2023-1/25/2025
    1,521       1,521       1,459  
Star Coaches Inc. (10)
  Road & Rail   8.42%   3/9/2018   4/1/2025     2,887       2,887       2,591  
Superior Transportation, Inc. (10)
  Road & Rail  
10.22-10.63%
  7/31/2017   1/1/2026     3,369       3,369       3,369  
The Smedley Company & Smedley Services, Inc. (10)..
  Commercial Services & Supplies   4.07%   7/31/2017   1/15/2028     1,706       1,706       1,706  
Trinity Equipment Rentals, Inc. (10)
  Commercial Services & Supplies  
7.94-8.75%
  10/8/2021  
11/1/2024-12/1/2026
    577       577       577  
U.S. Crane & Rigging, LLC (10)
  Commercial Services & Supplies   10.92%   12/23/2022   3/1/2027     2,005       2,005       2,005  
Up Trucking Services, LLC (10)
  Road & Rail   11.21%   3/23/2018   8/1/2024     469       473       469  
Wind River Environmental, LLC (10)
  Diversified Consumer Services  
8.43-10.00%
  7/31/2019  
8/1/2024-10/5/2025
    604       605       604  
Womble Company, Inc. (10)
  Energy Equipment & Services   9.11%   12/27/2019   1/1/2025     386       386       371  
Worldwide Flight Services, Inc. (10)
  Transportation Infrastructure  
8.32-9.36%
 
9/23/2022
 
9/23/2027-10/28/2027
    304       308       304  
Zamborelli Enterprises Pacific Souther
n
Foundation (10)
  Diversified Consumer Services   8.91%  
12/7/2022
  1/1/2027     707       714       707  
   
Shares/Units
             
SLR Equipment Finance Equity Interests (2)(9)(17)*Multi-Sector Holdings
  7/31/2017     200       145,000       120,820  
     
 
 
   
 
 
 
Total Equipment Financing
     
$
291,445
   
$
265,952
 
           
 
 
   
 
 
 
 
See notes to consolidated financial statements.
 
13
1
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands, except share/unit amounts)
 
Description
 
Industry
 
Interest
Rate
(1)
 
Acquisition
Date
 
Maturity

Date
 
Par Amount
   
Cost
   
Fair
Value
 
Preferred Equity – 0.4%
           
SOINT, LLC (2)(3)(4)
  Aerospace & Defense   5.00%
(11)
  6/8/2012   6/30/2023     49,273     $ 4,927     $ 3,801  
           
 
 
   
 
 
 
 
Description
  
Industry
  
Acquisition
Date
    
Shares/
Units
    
Cost
    
Fair
Value
 
Common Equity/Equity Interests/Warrants—57.1%
 
aTyr Pharma, Inc. Warrants *
   Pharmaceuticals      11/18/2016        6,347      $ 106      $  
CardioFocus, Inc. Warrants *
   Health Care Equipment & Supplies      3/31/2017        90        51         
Centrexion Therapeutics, Inc. Warrants *
   Pharmaceuticals      6/28/2019        289,102        136        82  
Conventus Orthopaedics, Inc. Warrants *
   Health Care Equipment & Supplies      6/15/2016        157,500        65         
Delphinus Medical Technologies, Inc. Warrants *
   Health Care Equipment & Supplies      8/18/2017        444,388        74        103  
Essence Group Holdings Corporation (Lumeris) Warrants *
   Health Care Technology      3/22/2017        260,000        129        366  
KBH Topco LLC (Kingsbridge) (2)(5)(18).
   Multi-Sector Holdings      11/3/2020        73,500,000        136,596        148,444  
Meditrina, Inc. Warrants *
   Health Care Equipment & Supplies      12/20/2022        29,366        23        23  
RD Holdco, Inc. (Rug Doctor) (2)*
   Diversified Consumer Services      12/23/2013        231,177        15,683         
RD Holdco, Inc. (Rug Doctor) Class B (2)*
   Diversified Consumer Services      12/23/2013        522        5,216         
RD Holdco, Inc. (Rug Doctor) Warrants (2)*
   Diversified Consumer Services      12/23/2013        30,370        381         
Senseonics Holdings, Inc. (3)(8)*
   Health Care Equipment & Supplies      7/25/2019        469,353        235        483  
SLR Business Credit (2)(3)(19)
   Diversified Financial Services      4/1/2022        100        81,583        89,370  
SLR Credit Solutions (2)(3)(20)
   Diversified Financial Services      12/28/2012        280,303        280,737        288,760  
SLR Healthcare ABL (2)(3)(21)
   Diversified Financial Services      4/1/2022        32,839        34,335        34,350  
SLR Senior Lending Program LLC (2)(3)(25)
   Asset Management      12/1/2022               9,500        9,426  
Spectrum Pharmaceuticals, Inc. Warrants *
   Biotechnology      9/21/2022        159,470        51        15  
Vapotherm, Inc. Warrants*
   Health Care Equipment & Supplies      2/18/2022        36,996        210        87  
Venus Concept Ltd. Warrants* (f/k/a Restoration Robotics)
   Health Care Equipment & Supplies      5/10/2018        33,430        152         
           
 
 
    
 
 
 
Total Common Equity/Equity Interests/Warrants
 
   $ 565,263      $ 571,509  
  
 
 
    
 
 
 
Total Investments (6) — 208.7%
 
  
$
2,134,587
 
  
$
2,086,676
 
                 
 
 
    
 
 
 
 
Description
  
Industry
    
Acquisition
Date
    
Maturity

Date
    
Par Amount
               
Cash Equivalents — 41.8%
 
              
U.S. Treasury Bill
     Government        12/30/2022        2/23/2023      $ 420,000      $ 417,590      $ 417,590  
              
 
 
    
 
 
 
Total Investments & Cash Equivalents —250.5%
 
  
$
2,552,177
    
$
2,504,266
 
Liabilities in Excess of Other Assets — (150.5%)
 
        (1,504,535
                 
 
 
 
Net Assets — 100.0%
 
     
$
999,731
 
                 
 
 
 
 
(1)
Floating rate debt investments typically bear interest at a rate determined by reference to the London Interbank Offered Rate (“LIBOR” or “L”), the Secured Overnight Financing Rate (“SOFR” or “S”) or the
 
See notes to consolidated financial statements.
 
13
2

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands, except share/unit amounts)
 
  prime index rate (“PRIME” or “P”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current rate of interest, or in the case of leases the current implied yield, in effect as of December 31, 2022.
(2)
Denotes investments in which we are deemed to exercise a controlling influence over the management or policies of a company, as defined in the Investment Company Act of 1940, as amended (“1940 Act”), due to beneficially owning, either directly or through one or more controlled companies, more than 25% of the outstanding voting securities of the investment. Transactions during the year ended December 31, 2022 in these controlled investments are as follows:
 
Name of Issuer
 
Fair Value at
December 31,
2021
   
Gross
Additions
   
Gross
Reductions
   
Realized
Gain
(Loss)
   
Change in
Unrealized
Gain
(Loss)
   
Interest/
Dividend
Income
   
Fair Value at
December 31,
2022
 
Equipment Operating Leases, LLC
  $ 18,939     $     $ 15,833     $     $ 635     $ 749     $ 3,741  
Kingsbridge Holdings, LLC
    80,000                         (87     7,402       80,000  
KBH Topco, LLC (Kingsbridge)
    145,996                         2,448       15,225       148,444  
Loyer Capital LLC
    10,725             3,500             136       1,003       7,361  
RD Holdco, Inc. (Rug Doctor, common equity)
                                         
RD Holdco, Inc. (Rug Doctor, class B)..
    5,216                         (5,216            
RD Holdco, Inc. (Rug Doctor, warrants)..
                                         
RD Holdco, Inc. (debt)
    11,829       685                   (5,280     (18     6,521  
SLR Business Credit
          81,583                   7,787       5,150       89,370  
SLR Credit Solutions
    298,766                         (10,006     20,500       288,760  
SLR Equipment Finance (equity)
    129,102                         (8,282           120,820  
SLR Equipment Finance (debt)
          5,000                         379       5,000  
SLR Healthcare ABL
          34,335                   15       2,595       34,350  
SLR Senior Lending Program LLC
          9,500                   (74           9,426  
SOAGG LLC
    1,121             447             (674     647        
SOINT, LLC
    4,509       266       942             (32     266       3,801  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
  $ 706,203     $ 131,369     $ 20,722     $     $ (18,630   $ 53,898     $ 797,594  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(3)
Indicates assets that the Company believes may not represent “qualifying assets” under Section 55(a) of the 1940 Act. If we fail to invest a sufficient portion of our assets in qualifying assets, we could be prevented from making
follow-on
investments in existing portfolio companies or could be required to dispose of investments at inappropriate times in order to comply with the 1940 Act. As of December 31, 2022, on a fair value basis,
non-qualifying
assets in the portfolio represented 24.2% of the total assets of the Company.
(4)
The Company’s investment in SOINT, LLC includes a one dollar investment in common shares.
(5)
Kingsbridge Holdings, LLC is held through KBH Topco LLC, a Delaware corporation.
(6)
Aggregate net unrealized appreciation for U.S. federal income tax purposes is $17,187; aggregate gross unrealized appreciation and depreciation for U.S. federal tax purposes is $161,053 and $143,866, respectively, based on a tax cost of $2,069,489. Unless otherwise noted, all of the Company’s investments
 
See notes to consolidated financial statements.
 
13
3

SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands)
 
  are pledged as collateral against the borrowings outstanding on the senior secured credit facility. The Company generally acquires its investments in private transactions exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”). These investments are generally subject to certain limitations on resale, and may be deemed to be “restricted securities” under the Securities Act. All investments are Level 3 unless otherwise indicated.
(7)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR, SOFR or PRIME rate. These instruments are often subject to a LIBOR, SOFR or PRIME rate floor.
(8)
Denotes a Level 1 investment.
(9)
SLR Equipment Finance is held through NEFCORP LLC, a wholly-owned consolidated taxable subsidiary and NEFPASS LLC, a wholly-owned consolidated subsidiary.
(10)
Indicates an investment that is wholly held by the Company through NEFPASS LLC.
(11)
Interest is paid in kind (“PIK”).
(12)
Denotes a subsidiary of SLR Equipment Finance.
(13)
OmniGuide Holdings, Inc., Domain Surgical, Inc. and OmniGuide, Inc. are
co-borrowers.
(14)
AmeriMark Interactive, LLC, AmeriMark Direct LLC, AmeriMark Intermediate Sub, Inc., L.T.D. Commodities LLC, Dr. Leonard’s Healthcare Corp. and Amerimark Intermediate Holdings, LLC are each
co-Borrowers.
Amerimark may elect to defer up to 8.00% of the coupon as PIK.
(15)
Spread is 5.75% Cash / 0.50% PIK.
(16)
Indicates an investment that is wholly or partially held by the Company through its wholly-owned financing subsidiary SUNS SPV LLC (the “SUNS SPV”). Such investments are pledged as collateral under the Senior Secured Revolving SPV Credit Facility (the “SPV Credit Facility”) (see Note 7 to the consolidated financial statements) and are not generally available to creditors, if any, of the Company.
(17)
See note 11 to the consolidated financial statements.
(18)
See note 12 to the consolidated financial statements.
(19)
See note 14 to the consolidated financial statements.
(20)
See note 10 to the consolidated financial statements.
(21)
See note 13 to the consolidated financial statements.
(22)
BridgeBio Pharma, Inc. may elect to defer up to 3.00% of the coupon as PIK.
(23)
OmniGuide Holdings, Inc. may elect to defer up to 10.00% of the coupon as PIK.
(24)
Vapotherm, Inc. may elect to defer up to 8.00% of the coupon as PIK.
(25)
See note 18 to the consolidated financial statements.
(26)
iCIMS, Inc. may elect to defer up to 3.875% of the coupon as PIK.
*
Non-income
producing security.
**
Investment is on
non-accrual
status.
 
See notes to consolidated financial statements.
 
13
4
SLR INVESTMENT CORP.
CONSOLIDATED SCHEDULE OF INVESTMENTS (continued)
December 31, 2022
(in thousands)
 
 
Industry Classification
 
Percentage of Total
Investments (at fair value) as
of December 31, 2022
 
Diversified Financial Services (includes SLR Credit Solutions, SLR Business Credit and SLR Healthcare ABL)
    22.1
Multi-Sector Holdings (includes Kingsbridge Holdings, LLC, SLR Equipment Finance, Equipment Operating Leases, LLC and Loyer Capital LLC)
    17.5
Health Care Providers & Services
    7.7
Health Care Equipment & Supplies
    6.6
Pharmaceuticals
    5.5
Software
    4.3
Insurance
    4.2
Biotechnology
    3.9
Diversified Consumer Services
    2.7
Media
    1.9
Road & Rail
    1.7
Personal Products
    1.7
Capital Markets
    1.7
Thrifts & Mortgage Finance
    1.3
Life Sciences Tools & Services
    1.3
Auto Parts & Equipment
    1.2
Packaged Foods & Meats
    1.2
Wireless Telecommunication Services
    1.1
Commercial Services & Supplies
    1.1
Internet & Catalog Retail
    1.1
Internet Software & Services
    1.0
Building Products
    0.9
Trading Companies & Distributors
    0.9
Health Care Technology
    0.8
Transportation Infrastructure
    0.7
Communications Equipment
    0.7
IT Services
    0.6
Leisure Equipment & Products
    0.5
Specialty Retail
    0.5
Asset Management
    0.5
Food Products
    0.4
Auto Components
    0.4
Airlines
    0.3
Hotels, Restaurants & Leisure .
    0.3
Oil, Gas & Consumable Fuels
    0.3
Aerospace & Defense
    0.3
Machinery
    0.3
Footwear
    0.3
Metals & Mining
    0.2
Food & Staples Retailing
    0.1
Water Utilities
    0.1
Consumer Finance
    0.1
Construction & Engineering
    0.0
Energy Equipment & Services
    0.0
Containers & Packaging
    0.0
 
 
 
 
Total Investments
    100.0
 
 
 
 
 
See notes to consolidated financial statements.
 
13
5

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
December 31, 2023
(in thousands, except share amounts)
Note 1. Organization
SLR Investment Corp. (the “Company”, “SLRC”, “we”, “us” or “our”), a Maryland corporation formed in November 2007, is a
closed-end,
externally managed,
non-diversified
management investment company that has elected to be regulated as a business development company (“BDC”) under the Investment Company Act of 1940, as amended (the “1940 Act”). Furthermore, as the Company is an investment company, it continues to apply the guidance in FASB Accounting Standards Codification (“ASC”) Topic 946. In addition, for U.S. federal income tax purposes, the Company has elected to be treated, and intends to qualify annually, as a regulated investment company (“RIC”) under Subchapter M of the Internal Revenue Code of 1986, as amended (the “Code”).
On February 9, 2010, the Company priced its initial public offering, selling 5.68 million shares of common stock, including the underwriters’ over-allotment, at a price of $18.50 per share. Concurrent with this offering, the Company’s senior management purchased an additional 600,000 shares through a private placement, also at $18.50 per share.
The Company’s investment objective is to maximize both current income and capital appreciation through debt and equity investments. The Company directly and indirectly invests primarily in leveraged middle market companies in the form of senior secured loans, financing leases and to a lesser extent, unsecured loans and equity securities. From time to time, we may also invest in public companies that are thinly traded.
On April 1, 2022, we acquired SLR Senior Investment Corp., a Maryland corporation (“SUNS”), pursuant to that certain Agreement and Plan of Merger (the “Merger Agreement”), dated as of December 1, 2021, by and among us, SUNS, Solstice Merger Sub, Inc., a Maryland corporation and our wholly-owned subsidiary (“Merger Sub”), and, solely for the limited purposes set forth therein, SLR Capital Partners, LLC (the “Investment Adviser”). Pursuant to the Merger Agreement, Merger Sub merged with and into SUNS, with SUNS continuing as the surviving company and as SUNS’s wholly-owned subsidiary (the “Merger”) and, immediately thereafter, SUNS merged with and into us, with us continuing as the surviving company (together with the Merger, the “Mergers”). In accordance with the terms of the Merger Agreement, at the effective time of the Merger, each outstanding share of SUNS’s common stock was converted into the right to receive 0.7796 shares of our common stock (with SUNS’s stockholders receiving cash in lieu of fractional shares of our common stock). As a result of the Mergers, we issued an aggregate of 12,511,825 shares of our common stock to former SUNS stockholders.
Note 2. Significant Accounting Policies
The accompanying consolidated financial statements have been prepared on the accrual basis of accounting in conformity with U.S. generally accepted accounting principles (“GAAP”), and include the accounts of the Company and certain wholly-owned subsidiaries. The consolidated financial statements reflect all adjustments and reclassifications which, in the opinion of management, are necessary for the fair presentation of the results of the operations and financial condition for the periods presented. All significant intercompany balances and transactions have been eliminated. Certain prior period amounts may have been reclassified to conform to the current period presentation.
The preparation of consolidated financial statements in conformity with GAAP and pursuant to the requirements for reporting on Form
10-K
and Regulation
S-X,
as appropriate, also requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reported periods. Changes in the economic environment, financial markets and any other parameters used in determining these estimates could cause actual results to differ materially.
 
13
6

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
 
In the opinion of management, all adjustments, which are of a normal recurring nature, considered necessary for the fair presentation of financial statements, have been included.
The significant accounting policies consistently followed by the Company are:
 
  (a)
Investment transactions are accounted for on the trade date.
 
  (b)
Under procedures established by the board of directors (the “Board”), we value investments, including certain senior secured debt, subordinated debt and other debt securities with maturities greater than 60 days, for which market quotations are readily available and deemed to represent fair value under GAAP, at such market quotations (unless they are deemed not to represent fair value). A market quotation is readily available for a security only when that quotation is a quoted price (unadjusted) in active markets for identical investments that the Company can access at the measurement date, provided that a quotation will not be readily available if it is not reliable. If the Company anticipates using a market quotation for a security, it will also monitor for circumstances that may necessitate the use of fair value, such as significant events that may cause concern over the reliability of a market quotation. We attempt to obtain market quotations from at least two brokers or dealers (if available, otherwise from a principal market maker or a primary market dealer or other independent pricing service). We utilize
mid-market
pricing as a practical expedient for fair value unless a different point within the range is more representative. If and when market quotations are deemed not to represent fair value, we may utilize independent third-party valuation firms to assist us in determining the fair value of material assets. Accordingly, such investments go through our multi-step valuation process as described below. In each such case, independent valuation firms, that may from time to time be engaged by the Board, consider observable market inputs together with significant unobservable inputs in arriving at their valuation recommendations. Debt investments with maturities of 60 days or less shall each be valued at cost plus accreted discount, or minus amortized premium, which is expected to approximate fair value, unless such valuation, in the judgment of the Investment Adviser, does not represent fair value, in which case such investments shall be valued at fair value as determined in good faith by or under the direction of the Board. Investments that are not publicly traded or whose market quotations are not readily available are valued at fair value as determined in good faith by or under the direction of the Board. Such determination of fair values involves subjective judgments and estimates.
With respect to investments for which market quotations are not readily available or when such market quotations are deemed not to represent fair value under GAAP, the Board has approved a multi-step valuation process each quarter, as described below:
 
  (1)
our quarterly valuation process begins with each portfolio company or investment being initially valued by the investment professionals of the Investment Adviser responsible for the portfolio investment;
 
  (2)
preliminary valuation conclusions are then documented and discussed with senior management of the Investment Adviser;
 
  (3)
independent valuation firms engaged by the Board conduct independent appraisals and review the Investment Adviser’s preliminary valuations and make their own independent assessment for all material assets;
 
  (4)
the audit committee of the Board reviews the preliminary valuation of the Investment Adviser and that of the independent valuation firm and responds to the valuation recommendation of the independent valuation firm, if any, to reflect any comments; and
 
13
7

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
  (5)
the Board discusses valuations and determines the fair value of each investment in our portfolio in good faith based on the input of the Investment Adviser, the respective independent valuation firm, if any, and the audit committee.
The valuation principles set forth above may be modified from time to time, in whole or in part, as determined by the Board in its sole discretion. The Board will also (1) periodically assess and manage valuation risks; (2) establish and apply fair value methodologies; (3) test fair value methodologies; (4) oversee and evaluate third-party pricing services, as applicable; (5) oversee the reporting required by Rule
2a-5
under the 1940 Act; and (6) maintain recordkeeping requirements under Rule
2a-5.
Investments in all asset classes are valued utilizing a market approach, an income approach, or both approaches, as appropriate. However, in accordance with ASC
820-10,
certain investments that qualify as investment companies in accordance with ASC 946 may be valued using net asset value as a practical expedient for fair value. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities (including a business). The income approach uses valuation approaches to convert future amounts (for example, cash flows or earnings) to a single present amount (discounted). The measurement is based on the value indicated by current market expectations about those future amounts. In following these approaches, the types of factors that we may take into account in fair value pricing our investments include, as relevant: available current market data, including relevant and applicable market trading and transaction comparables, applicable market yields and multiples, security covenants, call protection provisions, the nature and realizable value of any collateral, the portfolio company’s ability to make payments, its earnings and discounted cash flows, the markets in which the portfolio company does business, comparisons of financial ratios of peer companies that are public, M&A comparables, our principal market (as the reporting entity) and enterprise values, among other factors. When available, broker quotations and/or quotations provided by pricing services are considered as an input in the valuation process. For the fiscal year ended December 31, 2023, there has been no change to the Company’s valuation approaches or techniques and the nature of the related inputs considered in the valuation process.
ASC Topic 820 classifies the inputs used to measure these fair values into the following hierarchy:
Level
 1
: Unadjusted quoted prices in active markets for identical assets or liabilities, accessible by the Company at the measurement date.
Level
 2
: Quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in markets that are not active, or other observable inputs other than quoted prices.
Level
 3
: Unobservable inputs for the asset or liability.
In all cases, the level in the fair value hierarchy within which the fair value measurement in its entirety falls is determined based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to each investment. The exercise of judgment is based in part on our knowledge of the asset class and our prior experience.
 
  (c)
Gains or losses on investments are calculated by using the specific identification method.
 
  (d)
The Company records dividend income and interest, adjusted for amortization of premium and accretion of discount, on an accrual basis. Loan origination fees, original issue discount, and market
 
13
8

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
  discounts are capitalized and we amortize such amounts into income using the effective interest method. Upon the prepayment of a loan, any unamortized loan origination fees are recorded as interest income. We record call premiums received on loans repaid as interest income when we receive such amounts. Capital structuring fees, amendment fees, consent fees, and any other
non-recurring
fee income as well as a management fee and other fee income for services rendered, if any, are recorded as other income when earned.
 
  (e)
The Company intends to comply with the applicable provisions of the Code pertaining to RICs to make distributions of taxable income sufficient to relieve it of substantially all U.S. federal income taxes. The Company, at its discretion, may carry forward taxable income in excess of calendar year distributions and pay a 4% excise tax on this income. The Company will accrue excise tax on such estimated excess taxable income as appropriate.
 
  (f)
Book and tax basis differences relating to stockholder distributions and other permanent book and tax differences are typically reclassified among the Company’s capital accounts. In addition, the character of income and gains to be distributed is determined in accordance with income tax regulations that may differ from GAAP; accordingly, at December 31, 2023, $44,629 was reclassified on our balance sheet between accumulated distributable net loss and
paid-in
capital in excess of par. Total earnings and net asset value are not affected.
 
  (g)
Distributions to common stockholders are recorded as of the record date. The amount to be paid out as a distribution is determined by the Board. Net realized capital gains, if any, are generally distributed or deemed distributed at least annually.
 
  (h)
In accordance with Regulation
S-X
and ASC Topic 810—
Consolidation
, the Company consolidates its interest in controlled investment company subsidiaries, financing subsidiaries and certain wholly-owned holding companies that serve to facilitate investment in portfolio companies. In addition, the Company may also consolidate any controlled operating companies substantially all of whose business consists of providing services to the Company.
 
  (i)
The accounting records of the Company are maintained in U.S. dollars. Any assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the rate of exchange of such currencies against U.S. dollars on the date of valuation. The Company will not isolate that portion of the results of operations resulting from changes in foreign exchange rates on investments from the fluctuations arising from changes in market prices of securities held. Such fluctuations would be included with the net unrealized gain or loss from investments. The Company’s investments in foreign securities, if any, may involve certain risks, including without limitation: foreign exchange restrictions, expropriation, taxation or other political, social or economic risks, all of which could affect the market and/or credit risk of the investment. In addition, changes in the relationship of foreign currencies to the U.S. dollar can significantly affect the value of these investments in terms of U.S. dollars and therefore the earnings of the Company.
 
  (j)
In accordance with ASC
835-30,
the Company reports origination and other expenses related to certain debt issuances as a direct deduction from the carrying amount of the debt liability. Applicable expenses are deferred and amortized using either the effective interest method or the straight-line method over the stated life. The straight-line method may be used on revolving facilities and/or when it approximates the effective yield method.
 
  (k)
The Company may enter into forward exchange contracts in order to hedge against foreign currency risk. These contracts are
marked-to-market
by recognizing the difference between the contract
 
13
9

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
  exchange rate and the current market rate as unrealized appreciation or depreciation. Realized gains or losses are recognized when contracts are settled.
 
  (l)
The Company records expenses related to shelf registration statements and applicable equity offering costs as prepaid assets. These expenses are typically charged as a reduction of capital upon the sale of shares or expensed, in accordance with ASC
946-20-25.
 
  (m)
Investments that are expected to pay regularly scheduled interest in cash are generally placed on
non-accrual
status when principal or interest cash payments are past due 30 days or more (90 days or more for equipment financing) and/or when it is no longer probable that principal or interest cash payments will be collected. Such
non-accrual
investments are restored to accrual status if past due principal and interest are paid in cash, and in management’s judgment, are likely to continue timely payment of their remaining principal and interest obligations. Cash interest payments received on such investments may be recognized as income or applied to principal depending on management’s judgment.
 
  (n)
The Company defines cash equivalents as securities that are readily convertible into known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Generally, only securities with a maturity of three months or less would qualify, with limited exceptions. The Company believes that certain U.S. Treasury bills, repurchase agreements and other high-quality, short-term debt securities would qualify as cash equivalents.
Note 3. Agreements
The Company has entered into the Third Amended and Restated Investment Advisory and Management Agreement (the “Advisory Agreement”) with the Investment Adviser, under which the Investment Adviser manages the
day-to-day
operations of, and provides investment advisory services to the Company. For providing these services, the Investment Adviser receives a fee from the Company, consisting of two components—a base management fee and a performance-based incentive fee. On April 1, 2022, in connection with the consummation of the Mergers, the Company entered into a letter agreement (the “Letter Agreement”) pursuant to which the Investment Adviser voluntarily agreed to a permanent 25 basis point reduction of the annual base management fee rate payable by the Company to the Investment Adviser pursuant to the Advisory Agreement. Following the Letter Agreement, the base management fee is determined by taking the average value of the Company’s gross assets at the end of the two most recently completed calendar quarters calculated at an annual rate of 1.50% on gross assets up to 200% of the Company’s total net assets as of the immediately preceding quarter end and 1.00% on gross assets that exceed 200% of the Company’s total net assets as of the immediately preceding quarter end. For purposes of computing the base management fee, gross assets exclude temporary assets acquired at the end of each fiscal quarter for purposes of preserving investment flexibility in the next fiscal quarter. Temporary assets include, but are not limited to, U.S. Treasury bills, other short-term U.S. government or government agency securities, repurchase agreements or cash borrowings.
The performance-based incentive fee has two parts, as follows: one part is calculated and payable quarterly in arrears based on the Company’s
pre-incentive
fee net investment income for the immediately preceding calendar quarter. For this purpose,
pre-incentive
fee net investment income means interest income, dividend income and any other income (including any other fees (other than fees for providing managerial assistance), such as commitment, origination, structuring, diligence and consulting fees or other fees that we receive from portfolio companies) accrued during the calendar quarter, minus the Company’s operating expenses for the quarter (including the base management fee, any expenses payable under the Administration Agreement, and any interest expense and distributions paid on any issued and outstanding preferred stock, but excluding the
 
1
40

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
performance-based incentive fee).
Pre-incentive
fee net investment income does not include any realized capital gains or losses, or unrealized capital appreciation or depreciation.
Pre-incentive
fee net investment income, expressed as a rate of return on the value of the Company’s net assets at the end of the immediately preceding calendar quarter, is compared to the hurdle rate of 1.75% per quarter (7% annualized). The Company pays the Investment Adviser a performance-based incentive fee with respect to the Company’s
pre-incentive
fee net investment income in each calendar quarter as follows: (1) no performance-based incentive fee in any calendar quarter in which the Company’s
pre-incentive
fee net investment income does not exceed the hurdle rate; (2) 100% of the Company’s
pre-incentive
fee net investment income with respect to that portion of such
pre-incentive
fee net investment income, if any, that exceeds the hurdle rate but is less than 2.1875% in any calendar quarter; and (3) 20% of the amount of the Company’s
pre-incentive
fee net investment income, if any, that exceeds 2.1875% in any calendar quarter. These calculations are appropriately
pro-rated
for any period of less than three months.
The second part of the performance-based incentive fee is determined and payable in arrears as of the end of each calendar year (or upon termination of the Advisory Agreement, as of the termination date), and will equal 20% of the Company’s cumulative realized capital gains less cumulative realized capital losses, unrealized capital depreciation (unrealized depreciation on a gross
investment-by-investment
basis at the end of each calendar year) and all net capital gains upon which prior performance-based capital gains incentive fee payments were previously made to the Investment Adviser. For financial statement purposes, the second part of the performance-based incentive fee is accrued based upon 20% of cumulative net realized gains and net unrealized capital appreciation. No accrual was required for the fiscal years ended December 31, 2023, 2022 and 2021.
For the fiscal years ended December 31, 2023, 2022 and 2021, the Company recognized $31,661, $29,982 and $28,277, respectively, in base management fees and $22,898, $15,097 and $10,309, respectively, in performance-based incentive fees. For the fiscal years ended December 31, 2023, 2022 and 2021, $500, $1,527 and $0, respectively, of such performance-based incentive fees were waived. The Investment Adviser has agreed to waive incentive fees resulting from income earned due to the accretion of purchase discount allocated to investments acquired as a result of the Mergers. Fees waived pursuant to the above are not subject to recoupment by the Investment Adviser. 
The Company has also entered into an Administration Agreement with SLR Capital Management, LLC (the “Administrator”) under which the Administrator provides administrative services to the Company. For providing these services, facilities and personnel, the Company reimburses the Administrator for the Company’s allocable portion of overhead and other expenses incurred by the Administrator in performing its obligations under the Administration Agreement, including rent. The Administrator will also provide, on the Company’s behalf, managerial assistance to those portfolio companies to which the Company is required to provide such assistance. The Company typically reimburses the Administrator on a quarterly basis.
For the fiscal years ended December 31, 2023, 2022 and 2021, the Company recognized expenses under the Administration Agreement of $5,899, $5,401 and $5,575, respectively. No managerial assistance fees were accrued or collected for the fiscal years ended December 31, 2023, 2022 and 2021.
Note 4. Net Asset Value Per Share
At December 31, 2023, the Company’s total net assets and net asset value per share were $986,639 and $18.09, respectively. This compares to total net assets and net asset value per share at December 31, 2022 of $999,731 and $18.33, respectively.
 
14
1

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
Note 5. Earnings Per Share
The following table sets forth the computation of basic and diluted net increase in net assets per share resulting from operations, pursuant to ASC
260-10,
for the years ended December 31, 2023, 2022 and 2021:
 
   
Year ended
December 31, 2023
   
Year ended
December 31, 2022
   
Year ended
December 31, 2021
 
Earnings per share (basic & diluted)
     
Numerator—net increase in net assets resulting from operations:
  $ 76,388     $ 18,342     $ 59,566  
Denominator—weighted average shares:
    54,554,638       51,680,522       42,260,826  
Earnings per share:
  $ 1.40     $ 0.35     $ 1.41  
Note 6. Fair Value
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a framework for measuring fair value that includes a hierarchy used to classify the inputs used in measuring fair value. The hierarchy prioritizes the inputs to valuations used to measure fair value into three levels. The level in the fair value hierarchy within which the fair value measurement falls is determined based on the lowest level input that is significant to the fair value measurement. The levels of the fair value hierarchy are as follows:
Level
 1.
 Financial assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market that the Company has the ability to access.
Level
 2.
 Financial assets and liabilities whose values are based on quoted prices in markets that are not active or model inputs that are observable either directly or indirectly for substantially the full term of the asset or liability. Level 2 inputs include the following:
 
  a)
Quoted prices for similar assets or liabilities in active markets;
 
  b)
Quoted prices for identical or similar assets or liabilities in
non-active
markets;
 
  c)
Pricing models whose inputs are observable for substantially the full term of the asset or liability; and
 
  d)
Pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or other means for substantially the full term of the asset or liability.
Level
 3.
Financial assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and significant to the overall fair value measurement. These inputs reflect management’s and, if applicable, an independent third-party valuation firm’s own assumptions about the assumptions a market participant would use in pricing the asset or liability.
When the inputs used to measure fair value fall within different levels of the hierarchy, the level within which the fair value measurement is categorized is based on the lowest level input that is significant to the fair value measurement in its entirety. For example, a Level 3 fair value measurement may include inputs that are observable (Levels 1 and 2) and unobservable (Level 3).
Gains and losses for assets and liabilities categorized within the Level 3 table below may include changes in fair value that are attributable to both observable inputs (Levels 1 and 2) and unobservable inputs (Level 3).
 
14
2

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
A review of fair value hierarchy classifications is conducted on a quarterly basis. Changes in the observability of valuation inputs may result in a reclassification for certain financial assets or liabilities. Such reclassifications involving Level 3 assets and liabilities are reported as transfers in/out of Level 3 as of the end of the quarter in which the reclassifications occur. Within the fair value hierarchy tables below, cash and cash equivalents are excluded but could be classified as Level 1.
The following tables present the balances of assets and liabilities measured at fair value on a recurring basis, as of December 31, 2023 and December 31, 2022:
Fair Value Measurements
As of December 31, 2023
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
              
Senior Secured Loans
   $    $      $ 1,277,539      $      $ 1,277,539  
Equipment Financing
                   256,819               256,819  
Preferred Equity
                   3,801               3,801  
Common Equity/Equity Interests/Warrants
     281               572,427        43,899        616,607  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 281    $      $ 2,110,586      $ 43,899      $ 2,154,766  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Fair Value Measurements
As of December 31, 2022
 
    
Level 1
    
Level 2
    
Level 3
    
Measured at
Net Asset Value*
    
Total
 
Assets:
              
Senior Secured Loans
   $    $      $ 1,245,414      $      $ 1,245,414  
Equipment Financing
                   265,952               265,952  
Preferred Equity
                   3,801               3,801  
Common Equity/Equity Interests/Warrants
     483               561,600        9,426        571,509  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
Total Investments
   $ 483    $      $ 2,076,767      $ 9,426      $ 2,086,676  
  
 
 
    
 
 
    
 
 
    
 
 
    
 
 
 
 
*
In accordance with ASC
820-10,
certain investments that are measured using the net asset value per share (or its equivalent) as a practical expedient for fair value have not been classified in the fair value hierarchy. The fair value amounts presented in this table are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the Consolidated Statements of Assets and Liabilities. The portfolio investment in this category is SSLP. See Note 18 for more information on this investment, including its investment strategy and the Company’s unfunded equity commitment to SSLP. This investment is not redeemable by the Company absent an election by the members of the entity to liquidate all investments and distribute the proceeds to the members.
 
14
3
SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2023, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2023:
Fair Value Measurements Using Level 3 Inputs
 
   
Senior Secured
Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/
Equity
Interests/
Warrants
   
Total
 
Fair value, December
 31, 2022
  $ 1,245,414     $ 265,952     $ 3,801     $ 561,600     $ 2,076,767  
Total gains or losses included in earnings:
         
Net realized loss
    (26,108                 (451     (26,559
Net change in unrealized gain (loss)
    36,436       234       (251     (24,985     11,434  
Purchase of investment securities
*
    729,964       35,585       251       36,314       802,114  
Proceeds from dispositions of investment securities
    (708,167     (44,952           (51     (753,170
Transfers in/out of Level 3
                             
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, December
 31, 2023
  $ 1,277,539     $ 256,819     $ 3,801     $ 572,427     $ 2,110,586  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized gains (losses) for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
         
Net change in unrealized gain (loss)
  $ 31,484     $ 234     $ (251   $ (24,985   $ 6,482  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
*
Includes PIK capitalization and accretion of discount.
While the Company has not made an election to apply the fair value option of accounting to any of its current debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2023, the fair value of the Credit Facility, SPV Credit Facility, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $507,000, $206,250, $122,813, $82,663, $71,438, $45,500 and $124,875, respectively.
 
14
4

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
The following table provides a summary of the changes in fair value of Level 3 assets for the year ended December 31, 2022, as well as the portion of gains or losses included in income attributable to unrealized gains or losses related to those assets still held at December 31, 2022:
Fair Value Measurements Using Level 3 Inputs
 
    
Senior Secured
Loans
   
Equipment

Financing
   
Preferred Equity
   
Common Equity/
Equity
Interests/
Warrants
   
Total
 
Fair value, December
 31, 2021
   $ 939,690     $ 273,795     $ 5,630     $ 450,381     $ 1,669,496  
Total gains or losses included in earnings:
          
Net realized gain (loss)
     (36,244                 6       (36,238
Net
change in unrealized loss
     (8,065     (6,924     (706     (5,048     (20,743
Purchase of investment securities(1)
(2)
     796,389       84,168       266       116,272       997,095  
Proceeds from dispositions of investment securities
     (446,356     (85,087     (1,389     (11     (532,843
Transfers in/out of Level 3
                              
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Fair value, December
 31, 2022
   $ 1,245,414     $ 265,952     $ 3,801     $ 561,600     $ 2,076,767  
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Unrealized losses for the period relating to those Level 3 assets that were still held by the Company at the end of the period:
          
Net
change in unrealized loss
   $ (8,920   $ (6,924   $ (706   $ (5,048   $ (21,598
  
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
 
(1)
Includes positions acquired from SUNS as a result of the Mergers.
(2)
Includes PIK capitalization and accretion of discount.
The following table shows a reconciliation of the beginning and ending balances for fair valued liabilities measured using significant unobservable inputs (Level 3) for the year ended December 31, 2022:
 
2022 Unsecured Notes
  
For the year ended
December 31, 2022
 
Beginning fair value
   $ 150,000  
Net realized (gain) loss
      
Net change in unrealized (gain) loss
      
Borrowings
      
Repayments
     (150,000
Transfers in/out of Level 3
      
  
 
 
 
Ending fair value
   $  
  
 
 
 
The Company made an election to apply the fair value option of accounting to the 2022 Unsecured Notes, in accordance with ASC
825-10.
On May 8, 2022, the borrowings were repaid in full. While the Company has not made an election to apply the fair value option of accounting to any of its other debt obligations, if the Company’s debt obligations were carried at fair value at December 31, 2022, the fair value of the Credit Facility, SPV Credit Facility, 2023 Unsecured Notes, 2024 Unsecured Notes, 2025 Unsecured Notes, 2026 Unsecured
 
14
5

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
Notes, 2027 Unsecured Notes and 2027 Series F Unsecured Notes would be $393,000, $155,200, $75,000, $118,750, $79,688, $68,250, $42,875 and $118,125, respectively.
Quantitative Information about Level 3 Fair Value Measurements
The Company typically determines the fair value of its performing debt investments utilizing a yield analysis. In a yield analysis, a price is ascribed for each investment based upon an assessment of current and expected market yields for similar investments and risk profiles. Additional consideration is given to current contractual interest rates, relative maturities and other key terms and risks associated with an investment. Among other factors, a significant determinant of risk is the amount of leverage used by the portfolio company relative to the total enterprise value of the company, and the rights and remedies of our investment within each portfolio company.
Significant unobservable quantitative inputs typically used in the fair value measurement of the Company’s Level 3 assets and liabilities primarily reflect current market yields, including indices, and readily available quotes from brokers, dealers, and pricing services as indicated by comparable assets and liabilities, as well as enterprise values, returns on equity and earnings before income taxes, depreciation and amortization (“EBITDA”) multiples of similar companies, and comparable market transactions for equity securities.
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2023 is summarized in the table below:
 
   
Asset or
Liability
   
Fair Value at
December 31, 2023
   
Principal Valuation
Technique/Methodology
 
Unobservable Input
 
Range (Weighted
Average)
Senior Secured Loans
    Asset     $ 1,269,712     Income Approach   Market Yield   10.0% – 45.5% (13.2%)
    $ 7,827     Recovery Analysis   Recoverable Amount   N/A
Equipment Financing
    Asset     $ 135,999     Income Approach   Market Yield   8.5% –9.3% (9.3%)
    $ 120,820     Market Multiple
(1)
  Comparable Multiple  
1.2x-1.5x
(1.4x)
Preferred Equity
    Asset     $ 3,801     Income Approach   Market Yield   5.0% –5.0% (5.0%)
Common Equity/Equity Interests/Warrants
    Asset     $ 162,207     Market Multiple
(2)
  Comparable Multiple   5.5x –11.3x (9.5x)
    $ 410,220     Market Approach   Return on Equity   7.1% –34.8% (10.6%)
 
(1)
Includes $120,820 of investments valued using an implied multiple.
(2)
Includes $525 of investments valued using a Black-Scholes model and $161,682 of investments valued using an EBITDA multiple.
 
14
6

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
Quantitative information about the Company’s Level 3 asset and liability fair value measurements as of December 31, 2022 is summarized in the table below:
 
   
Asset or
Liability
   
Fair Value at
December 31, 2022
   
Principal Valuation
Technique/Methodology
   
Unobservable Input
   
Range (Weighted
Average)
Senior Secured Loans
    Asset     $ 1,212,842       Income Approach       Market Yield     9.4% – 18.2% (12.0%)
    $ 32,572       Market Multiple
(1)
      Comparable Multiple    
0.1x-21.4x
(12.4x)
Equipment Financing
    Asset     $ 145,132       Income Approach       Market Yield     8.5% –9.7% (9.7%)
    $ 120,820       Market Multiple
(2)
      Comparable Multiple    
1.1x-1.4x
(1.2x)
Preferred Equity
    Asset     $ 3,801       Income Approach       Market Yield     5.0% – 5.0% (5.0%)
Common Equity/Equity Interests/Warrants
    Asset     $ 149,120       Market Multiple
(3)
      Comparable Multiple     7.8x – 9.8x (8.8x)
    $ 412,480       Market Approach       Return on Equity     6.6% – 35.2% (9.2%)
 
(1)
Investments are valued using a
sum-of-the
parts analysis, using expected revenue multiples for certain segments of the businesses and expected EBITDA multiples for certain segments of the businesses.
(2)
Includes $120,820 of investments valued using an implied multiple.
(3)
Includes $676 of investments valued using a Black-Scholes model and $148,444 of investments valued using an EBITDA multiple.
Significant increases or decreases in any of the above unobservable inputs in isolation, including unobservable inputs used in deriving
bid-ask
spreads, if applicable, could result in significantly lower or higher fair value measurements for such assets and liabilities. Generally, an increase in market yields or decrease in EBITDA multiples may result in a decrease in the fair value of certain of the Company’s
investments.
Note 7. Debt
Our debt obligations consisted of the following as of December 31, 2023 and December 31, 2022:
 
    
December 31, 2023
   
December 31, 2022
 
Facility
  
Face Amount
    
Carrying Value
   
Face Amount
    
Carrying Value
 
Credit Facility
   $ 507,000    $ 503,358
(1)
 
  $ 393,000    $ 388,254
(1)
 
SPV Credit Facility
     206,250        205,357
(2)
 
    155,200        154,302
(2)
 
2023 Unsecured Notes
                  75,000        74,979
(3)
 
2024 Unsecured Notes
     125,000        124,711
(4)
 
    125,000        124,421
(4)
 
2025 Unsecured Notes
     85,000        84,781
(5)
 
    85,000        84,613
(5)
 
2026 Unsecured Notes
     75,000        74,616
(6)
 
    75,000        74,498
(6)
 
2027 Unsecured Notes
     50,000        49,966
(7)
 
    50,000        49,953
(7)
 
2027 Series F Unsecured Notes
     135,000        134,988
(8)
 
    135,000        134,978
(8)
 
  
 
 
    
 
 
   
 
 
    
 
 
 
   $ 1,183,250      $ 1,177,777     $ 1,093,200      $ 1,085,998  
  
 
 
    
 
 
   
 
 
    
 
 
 
 
(1)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $3,642 and $4,746 as of December 31, 2023 and December 31, 2022, respectively.
 
14
7

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
(2)
Carrying Value equals the Face Amount net of unamortized market discount of $893 and $898 as of December 31, 2023 and December 31, 2022, respectively.
(3)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $21 as of December 31, 2022.
(4)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $289 and $579 as of December 31, 2023 and December 31, 2022, respectively.
(5)
Carrying Value equals the Face Amount net of unamortized market discount of $219 and $387 as of December 31, 2023 and December 31, 2022, respectively.
(6)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $384 and $502 as of December 31, 2023 and December 31, 2022, respectively.
(7)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $34 and $47 as of December 31, 2023 and December 31, 2022, respectively.
(8)
Carrying Value equals the Face Amount net of unamortized debt issuance costs of $12 and $22 as of December 31, 2023 and December 31, 2022, respectively.
Unsecured Notes
On April 1, 2022, the Company entered into an assumption agreement (the “Note Assumption Agreement”), effective as of the closing of the Mergers. The Note Assumption Agreement relates to the Company’s assumption of $85,000 in aggregate principal amount of five-year, 3.90% senior unsecured notes, due March 31, 2025 (the “2025 Unsecured Notes”) and other obligations of SUNS under the Note Purchase Agreement, dated as of March 31, 2020 (the “Note Purchase Agreement”), among SUNS and certain institutional investors. Interest on the 2025 Unsecured Notes is due semi-annually on March 31 and September 30. Pursuant to the Note Assumption Agreement, the Company expressly assumed on behalf of SUNS the due and punctual payment of the principal of (and premium, if any) and interest on all the 2025 Unsecured Notes outstanding, and the due and punctual performance and observance of every covenant and every condition of the Note Purchase Agreement, to be performed or observed by SUNS.
On January 6, 2022, the Company closed a private offering of $135,000 of the 2027 Series F Unsecured Notes with a fixed interest rate of 3.33% and a maturity date of January 6, 2027. Interest on the 2027 Series F Unsecured Notes is due semi-annually on January 6 and July 6. The 2027 Series F Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On September 14, 2021, the Company closed a private offering of $50,000 of the 2027 Unsecured Notes with a fixed interest rate of 2.95% and a maturity date of March 14, 2027. Interest on the 2027 Unsecured Notes is due semi-annually on March 14 and September 14. The 2027 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $125,000 of the 2024 Unsecured Notes with a fixed interest rate of 4.20% and a maturity date of December 15, 2024. Interest on the 2024 Unsecured Notes is due semi-annually on June 15 and December 15. The 2024 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
On December 18, 2019, the Company closed a private offering of $75,000 of the 2026 Unsecured Notes with a fixed interest rate of 4.375% and a maturity date of December 15, 2026. Interest on the 2026 Unsecured Notes is due semi-annually on June 15 and December 15. The 2026 Unsecured Notes were issued in a private placement only to qualified institutional buyers.
 
14
8

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
On November 22, 2017, the Company issued $75,000 in aggregate principal amount of publicly registered 2023 Unsecured Notes for net proceeds of $73,846. Interest on the 2023 Unsecured Notes was paid semi-annually on January 20 and July 20, at a fixed rate of 4.50% per year, commencing on January 20, 2018. The 2023 Unsecured Notes were repaid in full on the maturity date, January 20, 2023. 
Revolving and Term Loan Facilities
On April 1, 2022, the Company entered into an assumption agreement (the “CF Assumption Agreement”), effective as of the closing of the Mergers. The CF Assumption Agreement relates to the Company’s assumption of the Revolving Credit Facility, originally entered into on August 26, 2011 (as amended from time to time, the “SPV Credit Facility”), by and among SUNS SPV LLC (the “SUNS SPV”), a wholly-owned subsidiary of SUNS, acting as borrower, Citibank, N.A., acting as administrative agent and collateral agent, and the other parties thereto. Currently, subsequent to an August 29, 2023 amendment, the commitment under the SPV Credit Facility is $275,000; however, the commitment can also be expanded up to $600,000. The stated interest rate on the SPV Credit Facility is SOFR plus
2.00%-2.50%
with no SOFR floor requirement and the current final maturity date is June 1, 2026. The SPV Credit Facility is secured by all of the assets held by SUNS SPV. Under the terms of the SPV Credit Facility and related transaction documents, the Company as successor to SUNS, and SUNS SPV, as applicable, have made certain customary representations and warranties and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SPV Credit Facility also includes usual and customary events of default for credit facilities of this nature. At December 31, 2023, outstanding USD equivalent borrowings under the SPV Credit Facility totaled $206,250.
On December 28, 2021, the Company closed on Amendment No. 1 to its August 28, 2019 senior secured credit agreement (the “Credit Facility”). Following the amendment, a $25,000 November 2022 upsizing and a $40,000 August 2023 commitment expiration, the Credit Facility is now composed of $585,000 of revolving credit and $100,000 of term loans. Borrowings generally bear interest at a rate per annum equal to the base rate plus a range of
1.75%-2.00%
or the alternate base rate plus
0.75%-1.00%.
The Credit Facility has a 0% floor, matures in December 2026 and includes ratable amortization in the final year. The Credit Facility may be increased up to $800,000 with additional new lenders or an increase in commitments from current lenders. The Credit Facility contains certain customary affirmative and negative covenants and events of default. In addition, the Credit Facility contains certain financial covenants that, among other things, require the Company to maintain a minimum stockholder’s equity and a minimum asset coverage ratio. At December 31, 2023, outstanding USD equivalent borrowings under the Credit Facility totaled $507,000, composed of $407,000 of revolving credit and $100,000 of term loans.
Certain covenants on our issued debt may restrict our business activities, including limitations that could hinder our ability to finance additional loans and investments or to make the distributions required to maintain our status as a RIC under Subchapter M of the Code.
The average annualized interest cost for all borrowings for the years ended December 31, 2023 and December 31, 2022 was 5.88% and 4.09%, respectively. These costs are exclusive of other credit facility expenses such as unused fees, agency fees and other prepaid expenses related to establishing and/or amending the Credit Facility, the SPV Credit Facility, the 2023 Unsecured Notes, the 2024 Unsecured Notes, the 2025 Unsecured Notes, the 2026 Unsecured Notes, the 2027 Unsecured Notes and the 2027 Series F Unsecured Notes (collectively the “Debt Instruments”), if any. The maximum amounts borrowed on the Debt Instruments during the year ended December 31, 2023 and December 31, 2022 were $1,273,200 and $1,164,200, respectively.
 
14
9

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
Note 8(a). Income Tax Information and Distributions to Stockholders
The tax character of distributions for the fiscal years ended December 31, 2023, 2022 and 2021 were as follows (1):
 
    
2023
   
2022
   
2021
 
Ordinary income
   $ 89,470        100.0   $ 50,113        59.2   $ 41,221        59.5
Capital gains
            0.0            0.0            0.0
Return of capital
            0.0     27,099        32.0     28,087        40.5
Distributions recognized in subsequent year
            0.0     7,481        8.8            0.0
  
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
Total distributions
   $ 89,470        100.0   $ 84,693        100.0   $ 69,308        100.0
  
 
 
    
 
 
   
 
 
    
 
 
   
 
 
    
 
 
 
As of December 31, 2023, 2022 and 2021 the total accumulated earnings (loss) on a tax basis were as follows (1):
 
 
  
2023
 
 
2022
 
 
2021
 
Undistributed ordinary income
   $ 1,793      $     $  
Undistributed long-term net capital gains
                   
  
 
 
    
 
 
   
 
 
 
Total undistributed net earnings
     1,793               
Post-October capital losses
                   
Capital loss carryforward
     (138,561 )
2
 
     (127,348 )
2
 
    (68,857
Other book/tax temporary differences
     2,364        (53,223     2,332  
Net unrealized appreciation
     2,567        17,187       19,495  
  
 
 
    
 
 
   
 
 
 
Total tax accumulated loss
   $ (131,837 )    $ (163,384   $ (47,030
  
 
 
    
 
 
   
 
 
 
 
(1)
Tax information for the fiscal years ended December 31, 2023, 2022 and 2021 are/were estimates and are not final until the Company files its tax returns, typically in September or October each year.
(2)
Includes capital loss carryforward acquired from the Mergers which is subject to limitations under IRC Sections
381-384.
The Company recognizes in its consolidated financial statements the tax effect of a tax position when it is more likely than not, based on the technical merits, that the position will be sustained upon examination. To the best of our knowledge, we did not have any uncertain tax positions that met the recognition or measurement criteria of ASC
740-10-25
nor did we have any unrecognized tax benefits as of the periods presented herein. Although we file federal and state tax returns, our major tax jurisdiction is federal. Our tax returns for each of our federal tax years since 2020 remain subject to examination by the Internal Revenue Service and the state department of revenue. The capital loss carryforwards shown above do not expire. 
Note 8(b). Other Tax Information (unaudited)
For the fiscal years ended December 31, 2023, 2022 and 2021, 0.00%, 0.00% and 0.32%, respectively, of the ordinary distributions paid during the year were eligible for qualified dividend income treatment and the dividends received deduction for corporate stockholders. For the fiscal years ended December 31, 2023, 2022, and 2021, 90.05%, 88.05% and 93.05%, respectively, of each of the ordinary distributions paid during the year represent interest-related dividends. For the fiscal years ended December 31, 2023, 2022 and 2021, none of the distributions represent short-term capital gains dividends.
 
1
5
0

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
Note 9. Financial Highlights
The following is a schedule of financial highlights for the respective years:
 
   
Year ended
December 31,
2023
   
Year ended
December 31,
2022
   
Year ended
December 31,
2021
   
Year ended
December 31,
2020
   
Year ended
December 31,
2019
 
Per Share Data: (a)
         
Net asset value, beginning of year
  $ 18.33     $ 19.93     $ 20.16     $ 21.44     $ 21.75  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net investment income
    1.69       1.48       1.44       1.40       1.71  
Net realized and unrealized loss
    (0.29     (1.13 )*      (0.03     (1.04     (0.38
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net increase in net assets resulting from operations
    1.40       0.35       1.41       0.36       1.33  
Issuance of common stock in connection with the Mergers
          (0.33                  
Anti-dilution
          0.02                    
Distributions to stockholders (see note 8a):
         
From distributable earnings
    (1.64     (1.12     (0.98     (1.15     (1.55
From return of capital
          (0.52     (0.66     (0.49     (0.09
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Net asset value, end of year
  $ 18.09     $ 18.33     $ 19.93     $ 20.16     $ 21.44  
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Per share market value, end of year
  $ 15.03     $ 13.91     $ 18.43     $ 17.51     $ 20.62  
Total Return(b)
    19.42     (16.09 %)      14.66     (5.72 %)      16.22
Net assets, end of year
  $ 986,639     $ 999,731     $ 842,281     $ 852,023     $ 905,880  
Shares outstanding, end of year
    54,554,634       54,555,380       42,260,826       42,260,826       42,260,826  
Ratios to average net assets:
         
Net investment income
    9.33     7.76     7.13     6.93     7.83
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Operating expenses
    6.56 %**      5.60 %**      5.68     4.14     5.76
Interest and other credit facility expenses
    7.34     4.68     3.50     3.18     3.13
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Total expenses
    13.90 %**      10.28 %**      9.18     7.32     8.89
 
 
 
   
 
 
   
 
 
   
 
 
   
 
 
 
Average debt outstanding
  $ 1,171,816     $ 994,578     $ 703,670     $ 556,104     $ 561,249  
Portfolio turnover ratio
    35.1     27.4     29.9     26.0     24.1
 
(a)
Calculated using the average shares outstanding method, except for the issuance of common stock in connection with the Mergers, which reflects the actual amount per share for the applicable period.
(b)
Total return is based on the change in market price per share during the year and takes into account distributions, if any, reinvested in accordance with the dividend reinvestment plan. Total return does not include a sales load.
*
The amount shown may not correspond with the aggregate amount for the period as it includes the effect of the timing of the Mergers.
**
The ratio of operating expenses to average net assets and the ratio of total expenses to average net assets is shown net of the performance-based incentive fee waiver (see note 3). For the years ended December 31, 2023 and December 31, 2022, the ratios of operating expenses to average net assets would be 6.60% and 5.75%, respectively, and the ratios of total expenses to average net assets would be and 13.95% and 10.43%, respectively, without the performance-based incentive fee waiver.
 
 
15
1

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
Note 10. SLR Credit Solutions
On December 28, 2012, we acquired an equity interest in Crystal Capital Financial Holdings LLC (“Crystal Financial”) for $275,000 in cash. Crystal Financial owned approximately 98% of the outstanding ownership interest in SLR Credit Solutions (“SLR Credit”), f/k/a Crystal Financial LLC. The remaining financial interest was held by various employees of SLR Credit, through their investment in Crystal Management LP. SLR Credit had a diversified portfolio of 23 loans having a total par value of approximately $400,000 at November 30, 2012 and a $275,000 committed revolving credit facility. On July 28, 2016, the Company purchased Crystal Management LP’s approximately 2% equity interest in SLR Credit for approximately $5,737. Upon the closing of this transaction, the Company holds 100% of the equity interest in SLR Credit. On September 30, 2016, Crystal Capital Financial Holdings LLC was dissolved. As of December 31, 2023, total commitments to the revolving credit facility are $300,000.
As of December 31, 2023, SLR Credit had 31 funded commitments to 26 different issuers with total funded loans of approximately $406,554 on total assets of $438,422. As of December 31, 2022, SLR Credit had 29 funded commitments to 25 different issuers with total funded loans of approximately $439,484 on total assets of $460,683. As of December 31, 2023 and December 31, 2022, the largest loan outstanding totaled $30,000 and $33,420, respectively. For the same periods, the average exposure per issuer was $15,637 and $17,579, respectively. SLR Credit’s credit facility, which is
non-recourse
to the Company, had approximately $218,878 and $224,325 of borrowings outstanding at December 31, 2023 and December 31, 2022, respectively. For the years ended December 31, 2023, 2022 and 2021 SLR Credit had net income of $6,476, $7,521 and $14,164, respectively, on gross income of $57,800, $30,324 and $33,993, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. SLR Credit’s consolidated financial statements for the fiscal years ended December 31, 2023 and December 31, 2022 are attached as an exhibit to this annual report on Form
10-K.
Note 11. SLR Equipment Finance
On July 31, 2017, we acquired a 100% equity interest in NEF Holdings, LLC, which conducts its business through its wholly-owned subsidiary Nations Equipment Finance, LLC. Effective February 25, 2021, Nations Equipment Finance, LLC and its related companies are doing business as SLR Equipment Finance (“SLR Equipment”). SLR Equipment is an independent equipment finance company that provides senior secured loans and leases primarily to U.S. based companies. We invested $209,866 in cash to effect the transaction, of which $145,000 was invested in the equity of SLR Equipment through our wholly-owned consolidated taxable subsidiary NEFCORP LLC and our wholly-owned consolidated subsidiary NEFPASS LLC and $64,866 was used to purchase certain leases and loans held by SLR Equipment through NEFPASS LLC. Concurrent with the transaction, SLR Equipment refinanced its existing senior secured credit facility into a $150,000
non-recourse
facility with an accordion feature to expand up to $250,000. In September 2019, SLR Equipment amended the facility, increasing commitments to $213,957 with an accordion feature to expand up to $313,957 and extended the maturity date of the facility to July 31, 2023. In June 2023, the facility was amended to extend the maturity date to January 31, 2024, with updated commitments totaling $152,147, effective August 1, 2023.
As of December 31, 2023, SLR Equipment had 150 funded equipment-backed leases and loans to 62 different customers with a total net investment in leases and loans of approximately $203,674 on total assets of $254,656. As of December 31, 2022, SLR Equipment had 131 funded equipment-backed leases and loans to 59 different customers with a total net investment in leases and loans of approximately $190,830 on total assets of $241,813. As of December 31, 2023 and December 31, 2022, the largest position outstanding totaled $17,943 and
 
15
2

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
$19,259, respectively. For the same periods, the average exposure per customer was $3,285 and $3,234, respectively. SLR Equipment’s credit facility, which is
non-recourse
to the Company, had approximately $137,178 and $114,977 of borrowings outstanding at December 31, 2023 and December 31, 2022, respectively. For the years ended December 31, 2023, 2022 and 2021, SLR Equipment had net losses of $6,385, $2,867 and $9,729, respectively on gross income of $19,608, $20,380 and $22,931, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. SLR Equipment’s consolidated financial statements for the fiscal years ended December 31, 2023 and December 31, 2022 are attached as an exhibit to this annual report on Form
10-K.
Note 12. Kingsbridge Holdings, LLC
On November 3, 2020, the Company acquired 87.5% of the equity securities of Kingsbridge Holdings, LLC (“KBH”) through KBH Topco LLC (“KBHT”), a Delaware corporation. KBH is a residual focused independent
mid-ticket
lessor of equipment primarily to U.S. investment grade companies. The Company invested $216,596 to effect the transaction, of which $136,596 was invested to acquire 87.5% of KBHT’s equity and $80,000 in KBH’s debt. The existing management team of KBH committed to continuing to lead KBH after the transaction. Following the transaction, the Company owns 87.5% of KBHT equity and the KBH management team owns the remaining 12.5% of KBHT’s equity.
As of December 31, 2023 and December 31, 2022, KBHT had total assets of $857,346 and $777,151, respectively. For the same periods, debt recourse to KBHT totaled $249,807 and $222,094, respectively, and
non-recourse
debt totaled $367,082 and $353,128, respectively. None of the debt is recourse to the Company. For the years ended December 31, 2023, 2022 and 2021, KBHT had net income of $9,065, $13,287 and $12,151, respectively, on gross income of $327,363, $298,760 and $245,889, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in KBHT’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that KBHT will be able to maintain consistent dividend payments to us. KBHT’s consolidated financial statements for the fiscal years ended December 31, 2023 and December 31, 2022 are attached as an exhibit to this annual report on Form
10-K.
Note 13. SLR Healthcare ABL
SUNS acquired an equity interest in SLR Healthcare ABL, f/k/a Gemino Healthcare Finance, LLC (“SLR Healthcare”), on September 30, 2013. SLR Healthcare is a commercial finance company that originates, underwrites, and manages primarily secured, asset-based loans for small and
mid-sized
companies operating in the healthcare industry. SUNS initial investment in SLR Healthcare ABL was $32,839. The management team of SLR Healthcare
co-invested
in the transaction and continues to lead SLR Healthcare. As of December 31, 2023, SLR Healthcare’s management team and the Company own approximately 7% and 93% of the equity in SLR Healthcare, respectively. SLRC acquired SLR Healthcare in connection with the Mergers on April 1, 2022. Effective upon an amendment dated August 24, 2023, SLR Healthcare has a $150,000
non-recourse
credit facility, which is expandable to $200,000 under its accordion facility. The maturity date of this facility is March 31, 2026.
SLR Healthcare currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2023, the portfolio totaled approximately $255,000 of commitments with a total net investment in loans of $111,264 on total assets of $118,563. As of December 31, 2022, the portfolio totaled approximately $242,106 of commitments with a total net investment in loans of $92,383 on total
 
15
3

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
assets of $108,705. At December 31, 2023, the portfolio consisted of 42 issuers with an average balance of approximately $2,649 versus 41 issuers with an average balance of approximately $2,253 at December 31, 2022. All of the commitments in SLR Healthcare’s portfolio are floating-rate, senior-secured,
cash-pay
loans. SLR Healthcare’s credit facility, which is
non-recourse
to us, had approximately $84,700 and $77,000 of borrowings outstanding at December 31, 2023 and December 31, 2022, respectively. For the years ended December 31, 2023, 2022 and 2021, SLR Healthcare had net income of $5,458, $3,475 and $662, respectively, on gross income of $17,886, $11,593 and $10,052, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. SLR Healthcare’s consolidated financial statements for the fiscal years ended December 31, 2023 and December 31, 2022 are attached as an exhibit to this annual report on Form
10-K.
Note 14. SLR Business Credit
SUNS acquired 100% of the equity interests of North Mill Capital LLC (“NMC”) on October 20, 2017. NMC is a leading asset-backed lending commercial finance company that provides senior secured asset-backed financings to U.S. based
small-to-medium-sized
businesses primarily in the manufacturing, services and distribution industries. SUNS invested approximately $51,000 to effect the transaction. Subsequently, SUNS contributed 1% of its equity interest in NMC to ESP SSC Corporation. Immediately thereafter, SUNS and ESP SSC Corporation contributed their equity interests to NorthMill LLC (“North Mill”). On May 1, 2018, North Mill merged with and into NMC, with NMC being the surviving company. SUNS and ESP SSC Corporation then owned 99% and
1
% of the equity interests of NMC, respectively. The management team of NMC continues to lead NMC. On June 28, 2019, North Mill Holdco LLC (“NM Holdco”), a newly formed entity and ESP SSC Corporation acquired 100% of Summit Financial Resources, a Salt Lake City-based provider of asset-backed financing to small and
medium-sized
businesses. As part of this transaction, SUNS 99% interest in the equity of NMC was contributed to NM Holdco. This approximately $15,500 transaction was financed with borrowings on NMC’s credit facility. Effective February 25, 2021, NMC and its related companies are doing business as SLR Business Credit. On June 3, 2021, NMC acquired 100% of Fast Pay Partners LLC, a Los Angeles-based provider of asset-backed financing to digital media companies. The transaction purchase price of $66,671 was financed with equity from SUNS of $19,000 and borrowings on NMC’s credit facility of $47,671.
 
SLRC acquired SLR Business Credit in connection with the Mergers on April 1, 2022.
SLR Business Credit currently manages a highly diverse portfolio of directly-originated and underwritten senior-secured commitments. As of December 31, 2023, the portfolio totaled approximately $610,949 of commitments, of which $273,541 were funded, on total assets of $315,335. As of December 31, 2022, the portfolio totaled approximately $603,432 of commitments, of which $286,006 were funded, on total assets of $332,247. At December 31, 2023, the portfolio consisted of 102 issuers with an average balance of approximately $2,681 versus 108 issuers with an average balance of approximately $2,648 at December 31, 2022. NMC has a senior credit facility with a bank lending group for $285,307 which expires on November 13, 2025. Borrowings are secured by substantially all of NMC’s assets. NMC’s credit facility, which is
non-recourse
to us, had approximately $222,917 and $214,425 of borrowings outstanding at December 31, 2023 and December 31, 2022, respectively. For the years ended December 31, 2023, 2022 and 2021, SLR Business Credit had net income
(
loss
)
 
of ($9,488), $3,940, and $7,295, respectively, on gross income of $38,143, $29,433, and $24,021, respectively. Due to timing and
non-cash
items, there may be material differences between GAAP net income and cash available for distributions. As such, and subject to fluctuations in SLR Business Credit’s funded commitments, the timing of originations, and the repayments of financings, the Company cannot guarantee that SLR Business Credit will be able to maintain consistent dividend payments to us. SLR Business Credit’s consolidated financial statements for the fiscal years ended December 31, 2023 and December 31, 2022 are attached as an exhibit to this annual report on Form
10-K.
 
15
4

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
Note 15. Commitments and Contingencies
Off-Balance
Sheet Arrangements
The Company had unfunded debt and equity commitments to various revolving and delayed-draw term loans as well as to SLR Credit and SLR Healthcare. The total amount of these unfunded commitments as of December 31, 2023 and December 31, 2022 is $248,692 and $364,163, respectively, comprised of the following:
 
    
December 31,
2023
    
December 31,
2022
 
SLR Credit Solutions*
   $ 44,263      $ 44,263  
Orthopedic Care Partners Management, LLC
     20,770        1,620  
Southern Orthodontic Partners Management, LLC
     17,861        1,918  
Ardelyx, Inc.
     15,875        7,752  
CVAUSA Management, LLC
     10,164         
BDG Media, Inc.
     10,146        3,546  
iCIMS, Inc.
     9,858        11,435  
Retina Midco, Inc.
     9,382         
Alkeme Intermediate Holdings, LLC
     8,531         
SPAR Marketing Force, Inc.
     8,339        1,338  
SLR Senior Lending Program LLC*
     7,125        40,500  
Copper River Seafoods, Inc.
     7,051        3,595  
Legacy Service Partners, LLC
     5,368         
Peter C. Foy & Associates Insurance Services, LLC
     5,062        1,094  
West-NR
Parent, Inc.
     5,043         
Luxury Asset Capital, LLC
     4,500        7,500  
One Touch Direct, LLC
     4,085        3,069  
DeepIntent, Inc.
     3,933        3,049  
United Digestive MSO Parent, LLC
     3,909         
Kaseya, Inc.
     3,768        3,936  
The Townsend Company, LLC
     3,330         
Vertos Medical, Inc.
     3,325         
AMF Levered II, LLC
     3,177         
Foundation Consumer Brands, LLC
     3,009        3,009  
UVP Management, LLC
     2,869         
Kid Distro Holdings, LLC
     2,650        2,650  
Erie Construction
Mid-west,
LLC
     2,403        1,248  
Ultimate Baked Goods Midco LLC
     2,356        1,636  
Basic Fun, Inc.
     2,150        2,675  
SLR Equipment Finance
*
     2,150        1,000  
Bayside Opco, LLC
     2,093         
SunMed Group Holdings, LLC
     1,621        843  
Urology Management Holdings, Inc.
     1,510         
SLR Healthcare ABL*
     1,400        1,400  
RxSense Holdings LLC
     1,250        1,250  
Tilley Distribution, Inc.
     1,158        525  
SCP Eye Care, LLC
     983        2,771  
GSM Acquisition Corp
     862        784  
 
15
5

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
    
December 31,
2023
    
December 31,
2022
 
Medrina, LLC
     826         
Pinnacle Treatment Centers, Inc.
     643        1,745  
High Street Buyer, Inc.
     631        327  
ENS Holdings III Corp, LLC
     576        144  
CC SAG Holdings Corp. (Spectrum Automotive)
     548        20,670  
Crewline Buyer, Inc.
     530         
Exactcare Parent, Inc.
     352         
WCI-BXC
Purchaser, LLC
     332         
All States Ag Parts, LLC
     321        135  
Vessco Midco Holdings, LLC
     310        3,892  
TAUC Management, LLC
     294        294  
Outset Medical, Inc.
            35,084  
Apeel Technology, Inc.
            32,786  
Human Interest, Inc.
            20,104  
Glooko, Inc.
            17,868  
World Insurance Associates, LLC
            17,117  
Spectrum Pharmaceuticals, Inc.
            8,771  
Arcutis Biotherapeutics, Inc.
            8,356  
Atria Wealth Solutions, Inc.
            8,215  
Accession Risk Management Group, Inc.
            7,498  
Cerapedics, Inc.
            6,735  
Maurices, Incorporated
            4,314  
Meditrina, Inc.
            3,367  
Plastics Management, LLC
            2,424  
Pediatric Home Respiratory Services, LLC
            1,805  
Ivy Fertility Services, LLC
            1,571  
Composite Technology Acquisition Corp.
            1,537  
NAC Holdings Corporation
            1,479  
Montefiore Nyack Hospital
            1,034  
Enverus Holdings, Inc.
            1,004  
American Teleconferencing Services, Ltd.
            1,090  
BayMark Health Services, Inc.
            391  
  
 
 
    
 
 
 
Total Commitments
   $ 248,692      $ 364,163  
  
 
 
    
 
 
 
 
*
The Company controls the funding of these commitments and may cancel them at its discretion.
The credit agreements of the above loan commitments contain customary lending provisions and/or are subject to the respective portfolio company’s achievement of certain milestones that allow relief to the Company from funding obligations for previously made commitments in instances where the underlying company experiences materially adverse events that affect the financial condition or business outlook for the company. Since these commitments may expire without being drawn upon, unfunded commitments do not necessarily represent future cash requirements or future earning assets for the Company. As of December 31, 2023 and December 31, 2022, the Company had sufficient cash available and/or liquid securities available to fund its commitments and had reviewed them for any appropriate fair value adjustment.
 
15
6

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
Note 16. Capital Share Transactions
As of December 31, 2023 and December 31, 2022, 200,000,000 shares of $0.01 par value capital stock were authorized.
Transactions in capital stock were as follows:
 
    
Shares
   
Amount
 
    
For the year
ended
December 31,
2023
   
For the year
ended
December 31,
2022
   
For the year
ended
December 31,
2023
   
For the year
ended
December 31,
2022
 
Shares issued in connection with the Mergers
           12,511,825     $     $ 226,839  
Shares repurchased
     (746     (217,271     (10     (3,038
  
 
 
   
 
 
   
 
 
   
 
 
 
Net increase (decrease)
     (746     12,294,554     $ (10   $ 223,801  
  
 
 
   
 
 
   
 
 
   
 
 
 
Note 17. Stock Repurchase Program
On May 9, 2023, our Board authorized an extension of a program for the purpose of repurchasing up to $50,000 of our outstanding shares of common stock. Under the repurchase program, we may, but are not obligated to, repurchase shares of our outstanding common stock in the open market from time to time provided that we comply with our code of ethics and the guidelines specified in Rule
10b-18
of the 1934 Act, including certain price, market volume and timing constraints. In addition, any repurchases will be conducted in accordance with the 1940 Act. Unless further amended or extended by our Board, we expect the repurchase program to be in place until the earlier of May 10, 2024 or until $50,000 of our outstanding shares of common stock have been repurchased. The timing and number of additional shares to be repurchased will depend on a number of factors, including market conditions. There are no assurances that we will engage in any repurchases beyond what is reported herein. For the fiscal year ended December 31, 2023, the Company repurchased 746 shares at an average price of approximately $14.02 per share, inclusive of commissions. The total dollar amount of shares repurchased for the fiscal year ended December 31, 2023 was $10. During the fiscal year ended December 31, 2022, the Company repurchased 217,271 shares at an average price of approximately $13.98 per share, inclusive of commissions. The total dollar amount of shares repurchased for the fiscal year ended December 31, 2022 was $3,038.
Note 18. SLR Senior Lending Program LLC
On October 12, 2022, the Company entered into an amended and restated limited liability company agreement with Sunstone Senior Credit L.P. (the “Investor”) to create a joint venture vehicle, SLR Senior Lending Program LLC (“SSLP”). SSLP is expected to invest primarily in senior secured cash flow loans. The Company and the Investor each have made initial equity commitments of $50,000, resulting in a total equity commitment of $100,000. Investment decisions and all material decisions in respect of SSLP must be approved by representatives of the Company and the Investor.
On December 1, 2022, SSLP commenced operations. On December 12, 2022, SSLP as servicer and SLR Senior Lending Program SPV LLC (“SSLP SPV”), a newly formed wholly owned subsidiary of SSLP, as borrower entered into a $100,000 senior secured revolving credit facility (the “SSLP Facility”) with Goldman
 
15
7

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
Sachs Bank USA acting as administrative agent.
On October 20, 2023, the SSLP Facility was expanded to $150,000.
 
The SSLP Facility is scheduled to mature on December 12, 2027. The SSLP Facility generally bears interest at a rate of SOFR plus 3.25%. SSLP and SSLP SPV, as applicable, have made certain customary representations and warranties and are required to comply with various covenants, including leverage restrictions, reporting requirements and other customary requirements for similar credit facilities. The SSLP Facility also includes usual and customary events of default for credit facilities of this nature. As of December 31, 2023 and December 31, 2022, borrowings outstanding on the SSLP Facility totaled $106,900 and $0, respectively.
As of December 31, 2023 and December 31, 2022, the Company and the Investor had contributed combined equity capital in the amount of $85,750 and $19,000, respectively. As of December 31, 2023 and December 31, 2022, the Company and the Investor’s combined remaining commitments to SSLP totaled $14,250 and $81,000, respectively. The Company, along with the Investor, controls the funding of SSLP, and SSLP may not call the unfunded commitments of the Company or the Investor without approval of both the Company and the Investor.
As of December 31, 2023 and December 31, 2022, SSLP had total assets of $195,868 and $19,105, respectively. For the same periods, SSLP’s portfolio consisted of floating rate senior secured loans to 32 and 7 different borrowers, respectively. For the year ended December 31, 2023 and the period December 1, 2022 (commencement of operations) through December 31, 2022, SSLP invested $188,741 in 32 portfolio companies and $18,100 in 7 portfolio companies, respectively. For the same periods, investments prepaid totaled $21,070 and $68, respectively.
SSLP Portfolio as of December 31, 2023
 
Description
 
Industry
 
Spread
Above
Index
(1)
    
Floor
   
Interest
Rate
(2)
   
Maturity
Date
   
Par
Amount
   
Cost
   
Fair
Value
(3)
 
Aegis Toxicology Sciences Corporation
(4)
  Health Care Providers & Services     S+550        1.00     11.13     5/9/25     $ 2,947     $ 2,947     $ 2,947  
Alkeme Intermediary Holdings, LLC
(4)
  Insurance     S+650        1.00     11.96     10/28/26       3,017       2,934       3,017  
All States Ag Parts, LLC
 (4)
  Trading Companies & Distributors     S+600        1.00     11.61     9/1/26       2,133       2,133       2,133  
Apex Service Partners, LLC
  Diversified Consumer Services     S+700        1.00     11.87     10/24/30       4,905       4,784       4,783  
Atria Wealth Solutions, Inc.
(4)
  Diversified Financial Services     S+650        1.00     11.97     5/31/24       2,468       2,468       2,468  
BayMark Health Services, Inc.
(4)
  Health Care Providers & Services     S+500        1.00     10.61     6/11/27       4,033       4,033       4,033  
CC SAG Holdings Corp.
 (4)
  Diversified Consumer Services     S+575        0.75     11.22     6/29/28       8,969       8,969       8,969  
CVAUSA Management, LLC
(4)
  Health Care Providers & Services     S+650        1.00     11.74     5/22/29       5,412       5,251       5,412  
ENS Holdings III Corp. & ES Opco USA LLC 
(4)
  Trading Companies & Distributors     S+475        1.00     10.20     12/31/25       1,086       1,086       1,086  
Erie Construction
Mid-west,
LLC
  Building Products     S+475        1.00     10.20     7/30/27       8,457       8,457       8,457  
 
15
8

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 

Description
 
 
 
 
Industry
 
Spread
Above
Index
(1)
 
 
Floor
 
 
Interest
Rate
(2)
 
 
Maturity
Date
 
 
Par
Amount
 
 
Cost
 
 
Fair
Value
(3)
 
Fertility (ITC) Investment Holdco, LLC
(4)
  Health Care Providers & Services     S+650       1.00     11.97     1/3/29     $ 5,955     $ 5,791     $ 5,955  
Foundation Consumer Brands, LLC
(4)
  Personal Products     S+625       1.00     11.79     2/12/27       8,641       8,641       8,641  
GSM Acquisition Corp.
 (4)
  Leisure Equipment & Products     S+500       1.00     10.47     11/16/26       8,541       8,541       8,541  
Higginbotham Insurance Agency, Inc.
(4)
  Insurance     S+550       1.00     10.96     11/25/28       7,573       7,573       7,573  
High Street Buyer, Inc.
  Insurance     S+575       0.75     11.25     4/16/28       7,604       7,604       7,604  
iCIMS, Inc.
(4)
  Software     S+725       0.75     12.62     8/18/28       3,089       3,066       3,089  
Kaseya, Inc.
(4)
  Software     S+600       0.75     11.38     6/23/29       9,058       9,058       9,058  
Kid Distro Holdings, LLC
(4)
  Software     S+550       1.00     11.00     10/1/27       8,939       8,939       8,939  
Maxor Acquisition, Inc.
(4)
  Health Care Providers & Services     S+675       1.00     12.48     3/1/29       6,120       5,940       6,120  
ONS MSO, LLC
(4)
  Health Care Providers & Services     S+625       1.00     11.62     7/8/26       5,922       5,784       5,922  
Pinnacle Treatment Centers, Inc.
(4)
  Health Care Providers & Services     S+650       1.00     11.95     1/2/26       6,951       6,951       6,951  
Plastics Management, LLC
(4)
  Health Care Providers & Services     S+500       1.00     10.45     8/18/27       5,637       5,471       5,637  
RQM+ Corp.
(4)
  Life Sciences Tools & Services     S+575       1.00     11.36     8/12/26       5,955       5,955       5,955  
RxSense Holdings LLC
(4)
  Diversified Consumer Services     S+500       1.00     10.48     3/13/26       8,968       8,968       8,968  
SunMed Group Holdings, LLC
(4)
  Health Care Equipment & Supplies     S+550       0.75     10.96     6/16/28       8,948       8,948       8,948  
The Townsend Company, LLC
(4)
  Commercial Services & Supplies     S+625       1.00     11.61     8/15/29       3,642       3,555       3,642  
Tilley Distribution, Inc.
(4)
  Trading Companies & Distributors     S+600       1.00     11.50     12/31/26       5,850       5,850       5,850  
Ultimate Baked Goods Midco LLC
(4)
  Packaged Foods & Meats     S+625       1.00     11.71     8/13/27       8,954       8,954       8,865  
United Digestive MSO Parent, LLC
(4)
  Health Care Providers & Services     S+675       1.00     12.25     3/30/29       3,411       3,311       3,411  
Urology Management Holdings, Inc.
(4)
  Health Care Providers & Services     S+650       1.00     11.93     6/15/26       3,179       3,102       3,155  
Vessco Midco Holdings, LLC
(4)
  Water Utilities     S+450       1.00     9.96     11/2/26       4,304       4,304       4,304  
West-NR
Parent, Inc.
(4)
  Insurance     S+625       1.00     11.70     12/27/27       6,822       6,691       6,822  
             
 
 
   
 
 
 
              $ 186,059     $ 187,255  
             
 
 
   
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the SOFR. These instruments are typically subject to a SOFR floor.
 
15
9

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to the SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2023.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
SSLP Portfolio as of December 31, 2022
 
Description
 
Industry
 
Spread
Above
Index
(1)
   
Floor
   
Interest
Rate
(2)
   
Maturity
Date
   
Par
Amount
   
Cost
   
Fair
Value
(3)
 
Atria Wealth Solutions, Inc.
(4)
  Diversified Financial Services     S+600       1.00     10.84     2/29/24     $ 2,494     $ 2,494     $ 2,494  
BayMark Health Services, Inc.
(4)
  Health Care Providers & Services     L+500       1.00     9.73     6/11/27       2,992       2,992       2,992  
ENS Holdings III Corp. & ES Opco USA LLC 
(4)
  Trading Companies & Distributors     L+475       1.00     9.43     12/31/25       1,097       1,097       1,097  
Foundation Consumer Brands, LLC
(4)
  Personal Products     L+550       1.00     10.15     2/12/27       2,963       2,963       2,963  
High Street Buyer, Inc.
 (4)
  Insurance     L+600       0.75     10.73     4/16/28       2,494       2,494       2,494  
Ivy Fertility Services, LLC
(4)
  Health Care Providers & Services     L+625       1.00     10.39     2/25/26       3,000       3,000       3,030  
Kid Distro Holdings, LLC
(4)
  Software     L+575       1.00     10.48     10/1/27       2,992       2,992       2,992  
             
 
 
   
 
 
 
              $ 18,032     $ 18,062  
             
 
 
   
 
 
 
 
(1)
Floating rate instruments accrue interest at a predetermined spread relative to an index, typically the LIBOR or SOFR. These instruments are typically subject to a LIBOR or SOFR floor.
(2)
Floating rate debt investments typically bear interest at a rate determined by reference to either the LIBOR (“L”) or SOFR (“S”), and which typically reset monthly, quarterly or semi-annually. For each debt investment we have provided the current interest rate in effect as of December 31, 2022.
(3)
Represents the fair value in accordance with ASC Topic 820. The determination of such fair value is not included in the Board’s valuation process described elsewhere herein.
(4)
The Company also holds this security on its Consolidated Statements of Assets and Liabilities.
 
1
60

SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
Below is certain summarized financial information for SSLP as of December 31, 2023 and December 31, 2022, for the year ended December 31, 2023 and for the period December 1, 2022 (commencement of operations) through December 31, 2022:
 
    
December 31,
2023
    
December 31,
2022
 
Selected Balance Sheet Information for SSLP:
     
Investments at fair value (cost $186,059 and $18,032, respectively)
   $ 187,255      $ 18,062  
Cash and other assets
     8,613        1,043  
  
 
 
    
 
 
 
Total assets
   $ 195,868      $ 19,105  
  
 
 
    
 
 
 
Debt outstanding ($
106,900
and $
0
face amounts, respectively, reported net of unamortized debt issuance costs of $
1,697
and $
0
, respectively)
   $ 105,203      $  
Distributions payable
     1,900         
Interest payable and other credit facility related expenses
     551        165  
Accrued expenses and other payables
     416        89  
  
 
 
    
 
 
 
Total liabilities
   $ 108,070      $ 254  
  
 
 
    
 
 
 
Members’ equity
   $ 87,798      $ 18,851  
  
 
 
    
 
 
 
Total liabilities and members’ equity
   $ 195,868      $ 19,105  
  
 
 
    
 
 
 
 
    
Year ended
December 31,
2023
    
For the Period
December 1,
2022
(commencement
of operations)
through
December 31,
2022
 
Selected Income Statement Information for SSLP:
     
Interest income
   $ 10,209      $ 152  
  
 
 
    
 
 
 
Service fees*
   $ 224      $ 4  
Interest and other credit facility expenses
     6,517        166  
Organizational costs
            73  
Other general and administrative expenses
     195        88  
  
 
 
    
 
 
 
Total expenses
   $ 6,936      $ 331  
  
 
 
    
 
 
 
Net investment income (loss)
   $ 3,273      $ (179
  
 
 
    
 
 
 
Realized gain on investments
     30         
Net change in unrealized gain on investments
     1,166        30  
  
 
 
    
 
 
 
Net realized and unrealized gain on investments
     1,196        30  
  
 
 
    
 
 
 
Net income (loss)
   $ 4,469      $ (149
  
 
 
    
 
 
 
 
*
Service fees are included within the Company’s Consolidated Statements of Operations as other income.
 
16
1
SLR INVESTMENT CORP.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (continued)
December 31, 2023
(in thousands, except share amounts)
 
Note 19. Subsequent Events
The Company has evaluated the need for disclosures and/or adjustments resulting from subsequent events through the date the consolidated financial statements were issued.
On February 27, 2024, the Board declared a quarterly distribution of $0.41 per share payable on March 28, 2024 to holders of record as of March 14, 2024.
 
16
2

Item 9.
Changes in and Disagreements With Accountants on Accounting and Financial Disclosure
None.
 
Item 9A.
Controls and Procedures
(a) Evaluation of Disclosure Controls and Procedures
As of December 31, 2023 (the end of the period covered by this report), we, including our
Co-Chief
Executive Officers and Chief Financial Officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule
13a-15(e)
of the 1934 Act). Based on that evaluation, our management, including the
Co-Chief
Executive Officers and Chief Financial Officer, concluded that our disclosure controls and procedures were effective and provided reasonable assurance that information required to be disclosed in our periodic SEC filings is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our
Co-Chief
Executive Officers and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. However, in evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of such possible controls and procedures.
(b) Management’s Report on Internal Control Over Financial Reporting
Management’s Report on Internal Control Over Financial Reporting, which appears in Item 8 of this
Form 10-K,
is incorporated by reference herein.
(c) Attestation Report of the Independent Registered Public Accounting Firm
Our independent registered public accounting firm, KPMG LLP, has issued an attestation report on the Company’s internal control over financial reporting, which is set forth above under the heading “Report of Independent Registered Public Accounting Firm” in Item 8.
(d) Changes in Internal Controls Over Financial Reporting
Management has not identified any change in the Company’s internal control over financial reporting that occurred during the fourth fiscal quarter of 2023 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.
 
Item 9B.
Other Information
Rule
10b5-1
Trading Plans
During the fiscal year ended December 31, 2023, none of our directors or officers (as defined in Rule
16a-1(f)
under the 1934 Act) adopted or terminated any contract, instruction or written plan for the purchase or sale of our securities to satisfy the affirmative defense conditions of Rule
10b5-1(c)
under the 1934 Act or any
“non-Rule
10b5-1
trading arrangement” as defined in Item 408(c) of Regulation
S-K.
 
Item 9C.
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections
Not Applicable.
 
16
3

PART III
 
Item 10.
Directors, Executive Officers and Corporate Governance
Information about Directors
Certain information with respect to each of the current directors is set forth below, including their names, ages, a brief description of their recent business experience, including present occupations and employment, certain directorships that each person holds, the year in which each person became a director of the Company, and a discussion of their particular experience, qualifications, attributes or skills that lead us to conclude that such individual should serve as a director of the Company, in light of the Company’s business and structure. There were no legal proceedings of the type described in Item 401(f) of Regulation
S-K
in the past 10 years against any of the directors or officers of the Company and none are currently pending. There is no arrangement or understanding between any of the Company’s directors or officers pursuant to which they were selected as directors or officers and the Company or any other person or entity.
Mr. Gross is an “interested person” of the Company as defined in the 1940 Act due to his position as
Co-Chief
Executive Officer and President of the Company and a managing member of SLR Capital Partners, LLC (“SLR Capital Partners”), the Company’s investment adviser. Mr. Spohler is an “interested person” of the Company as defined in the 1940 Act due to his position as
Co-Chief
Executive Officer and Chief Operating Officer of the Company and a managing member of SLR Capital Partners, the Company’s investment adviser. Each of Ms. Roberts, Mr. Wachter, Mr. Hochberg and Mr. Potter is not an “interested person” of the Company as defined in the 1940 Act.
 
Name, Address and
Age(1)
 
Position(s)
Held with
Company
 
Terms of Office
and Length of
Time Served
 
Principal Occupation(s) During
Past 5 Years
 
Number of
Portfolios in Fund
Complex Overseen
by Director(2)
 
Other Directorships
Held by Director or
Nominee for Director
During Past 5 Years
That Are Not Part of
the Fund Complex
Interested Director
         
Michael S. Gross,
62
  Chairman of the Board of Directors,
Co-Chief
Executive Officer and President.
  Class III Director since 2007; Term expires 2024.  
Co-Chief
Executive Officer of SLR Investment Corp. and SCP Private Credit Income BDC LLC since June 2019, of SLR HC BDC LLC since September 2020 and of SLR Private Credit BDC II LLC since April 2022, and President of SLR Investment Corp. since 2007, of SCP Private Credit Income BDC LLC since 2018, of SLR HC BDC LLC since 2020 and of SLR Private Credit BDC II LLC since 2022; Sole Chief Executive Officer of SLR Investment Corp. (February 2007-June 2019), and of SCP Private Credit Income BDC LLC (June 2018- June 2019). Previously,
Co-Chief
Executive Officer and President of SLR Senior Investment Corp.
  4   Chairman of the Board of Directors of Global Ship Lease Inc. Previously Chairman of the Board of Directors of SLR Senior Investment Corp., where he served from 2010 to April 2022.
 
164

Mr. Gross’ intimate knowledge of the business and operations of SLR Capital Partners, extensive familiarity with the financial industry and the investment management process in particular, and experience as a director of other public and private companies not only gives the board of directors valuable insight but also positions him well to continue to serve as the Chairman of our board of directors.
 
Name, Address
and Age(1)
 
Position(s) Held
with Company
 
Terms of Office
and Length of
Time Served
 
Principal Occupation(s) During
Past 5 Years
 
Number of
Portfolios in Fund
Complex Overseen
by Director(2)
 
Other Directorships
Held by Director or
Nominee for
Director During
Past 5 Years That
Are Not Part of the
Fund Complex
Interested Director
         
Bruce Spohler,
63
 
Co-Chief
Executive Officer, Chief Operating Officer and Director
  Class II Director since 2009; Term expires 2026.  
Co-Chief
Executive Officer of SLR Investment Corp. and SCP Private Credit Income BDC LLC since June 2019, of SLR HC BDC LLC since September 2020 and of SLR Private Credit BDC II LLC since April 2022; Chief Operating Officer of SLR Investment Corp. since February 2007, of SCP Private Credit Income BDC LLC since June 2018, of SLR HC BDC LLC since September 2020 and of SLR Private Credit BDC II LLC since April 2022.
  4   Previously a member of the board of directors of SLR Senior Investment Corp., where he served from 2010 to April 2022.
Mr. Spohler’s depth of experience in managerial positions in investment management, leveraged finance and financial services, as well as his intimate knowledge of the Company’s business and operations, gives the board of directors valuable industry-specific knowledge and experience on these and other matters.
 
Name, Address
and Age(1)
 
Position(s) Held
with Company
 
Terms of Office
and Length of
Time Served
 
Principal Occupation(s) During
Past 5 Years
 
Number of
Portfolios in Fund
Complex Overseen
by Director(2)
 
Other Directorships
Held by Director or
Nominee for Director
During Past 5 Years
That Are Not Part of the
Fund Complex
Independent Director
         
Steven Hochberg, 62   Director   Class II Director since 2007; Term expires 2026.   Operating Partner of Deerfield Management, a healthcare investment firm, since 2022. Partner of Deerfield Management from 2013 to 2021.
Co-Founder
and Manager of Ascent Biomedical Ventures, a venture capital firm focused on early stage investment and development of biomedical companies, since 2004.
Co-Founder
and
Co-General
Partner of Triatomic Capital, a technology focused venture capital firm, since 2022.
  4   Since 2011, Mr. Hochberg had been the Chairman of the Board of Continuum Health Partners until its merger with Mount Sinai in 2013, where he is a Vice Chairman of Mount Sinai Health System, a
non-profit
healthcare integrated delivery system in New York City. Director of a number of private healthcare companies and the Cardiovascular
 
165

Name, Address
and Age(1)
 
Position(s) Held
with Company
 
Terms of Office
and Length of
Time Served
 
Principal Occupation(s) During
Past 5 Years
 
Number of
Portfolios in Fund
Complex Overseen
by Director(2)
 
Other Directorships
Held by Director or
Nominee for Director
During Past 5 Years
That Are Not Part of the
Fund Complex
          Research Foundation, an organization focused on advancing new technologies and education in the field of cardiovascular medicine. Previously a member of the board of directors of SLR Senior Investment Corp., where he served from 2011 to April 2022.
Mr. Hochberg’s varied experience in investing in medical technology companies provides the board of directors with particular knowledge of this field, and his role as chairman of other companies’ board of directors brings the perspective of a knowledgeable corporate leader.
 
Name, Address
and Age(1)
 
Position(s) Held
with Company
 
Terms of Office
and Length of
Time Served
 
Principal Occupation(s)
During Past 5 Years
 
Number of
Portfolios in Fund
Complex Overseen
by Director(2)
 
Other Directorships
Held by Director or
Nominee for Director
During Past 5 Years
That Are Not Part of
the Fund Complex
Independent Director
         
Leonard A. Potter, 62   Director   Class III Director since 2009; Term expires 2024.   President and Chief Investment Officer of Wildcat Capital Management, LLC since 2011; Senior Managing Director of Vida Ventures I and II, each a biotech venture fund, since 2017; Managing Director of Soros Private Equity at Soros Fund Management LLC from 2002 to 2009.   4   Director of Hilton Grand Vacations Inc. since 2017, of SuRo Capital Corp. since 2011, and of several private companies. Previously a member of the board of directors of SLR Senior Investment Corp., where he served from 2011 to April 2022.
 
166

Mr. Potter’s experience practicing as a corporate lawyer provides valuable insight to the board of directors on regulatory and risk management issues. In addition, his tenure in private equity and other investments and service as a director of both public and private companies provide industry-specific knowledge and experience to the board of directors.
 
Name, Address
and Age(1)
  
Position(s)
Held with
Company
  
Terms of
Office and
Length of
Time Served
  
Principal
Occupation(s) During
Past 5 Years
  
Number of
Portfolios in Fund
Complex Overseen
by Director(2)
  
Other Directorships
Held by Director or
Nominee for
Director During
Past 5 Years That
Are Not Part of the
Fund Complex
Independent Director
              
David S. Wachter, 60    Director    Class I Director since 2007; Term expires 2025.    Founding Partner and Managing Partner of W Capital Partners, a private equity fund manager, since 2001.    4    Previously a member of the board of directors of SLR Senior Investment Corp., where he served from 2011 to April 2022.
Mr. Wachter’s extensive knowledge of private equity and investment banking provides the board of directors with the valuable insight of an experienced financial manager.
 
Name, Address
and Age(1)
  
Position(s)
Held with
Company
  
Terms of
Office and
Length of
Time Served
  
Principal
Occupation(s) During
Past 5 Years
  
Number of
Portfolios in Fund
Complex Overseen
by Director
  
Other Directorships
Held by Director or
Nominee for
Director During
Past 5 Years That
Are Not Part of the
Fund Complex
Independent Director
              
Andrea C. Roberts, 67    Director    Class I Director since 2023; Term expires 2025.   
Co-Founder
and Managing Director of Genesis Capital Corporation, an investment banking firm, since 1994; President and sole owner of Orbis Associates, Inc., a consulting firm providing consulting services to Genesis Capital Corporation on an exclusive basis, since 1994.
   1    Director of Trinity Episcopal School from 2019 to 2022.
Ms. Roberts’ extensive knowledge of investment banking and asset-based financing provides the board of directors with the valuable insight of an experienced financial manager.
 
(1)
The business address of the director nominees and other directors is c/o SLR Investment Corp., 500 Park Avenue, New York, New York 10022.
 
167

(2)
The Company is part of a “Fund Complex,” as that term is defined in Schedule 14A and Regulation 14A under the 1934 Act. Messrs. Gross, Spohler, Hochberg, Potter and Wachter each also have served as directors of SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC since 2018, 2020 and 2022, respectively, which are investment companies that have each elected to be regulated as a business development company (“BDC”) and are part of the Fund Complex. Mr. Gross has served as Chairman of SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC since 2018, 2020 and 2022, respectively. Mr. Potter also serves as a director of SuRo Capital Corp., which is a
closed-end
management investment company that has elected to be regulated as a BDC.
Information about Executive Officers Who Are Not Directors
The following information, as of December 31, 2023, pertains to our executive officers who are not directors of the Company.
 
Name, Address, and Age
(1)
 
Position(s) Held with
Company
 
Number of
Portfolios in
Fund
Complex
Overseen by
Officer
 
Principal Occupation(s) During Past 5 Years
Shiraz Y. Kajee, 44   Chief Financial Officer and Treasurer   4   Chief Financial Officer and Treasurer of the Company, SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC since April 2023. From December 2015 through March 2023, Mr. Kajee served as a Managing Director at New Mountain Capital, L.L.C., which included serving as Chief Financial Officer and Treasurer of New Mountain Finance Corporation since 2015, of NMF SLF I, Inc. since 2019, of New Mountain Guardian III BDC, L.L.C. since 2019 and of New Mountain Guardian IV BDC, L.L.C. since 2022.
Guy Talarico, 68   Chief Compliance Officer and Secretary   4   Chief Compliance Officer of the Company since July 2008, chief compliance officer of SCP Private Credit Income BDC LLC since June 2018, chief compliance officer of SLR HC BDC LLC since September 2020, and chief compliance officer of SLR Private Credit BDC II LLC since April 2022. Secretary of the Company, SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC since November 2023; Mr. Talarico currently serves as General Counsel and Chief Compliance Officer for SLR Capital Partners, LLC since May 2023. In addition, Mr. Talarico previously served as the chief compliance officer of SLR Senior Investment Corp. from December 2010 until April 2022. Mr. Talarico previously served as managing director of ACA Group, LLC (successor to Foreside Consulting Services LLC, and ultimate successor to Alaric Compliance Services, LLC, which he founded in December 2005). Mr. Talarico holds a B.S. ChE from Lehigh University, an M.B.A. from Fairleigh Dickinson University and a J.D. from New York Law School.
 
(1)
The business address of the executive officers is c/o SLR Investment Corp., 500 Park Avenue, New York, New York 10022.
 
168

Our common stock is listed on the NASDAQ Global Select Market under the symbol “SLRC.”
Audit Committee
The Audit Committee operates pursuant to a charter approved by our board of directors, a copy of which is available on our website at
http://www.slrinvestmentcorp.com.
The charter sets forth the responsibilities of the Audit Committee. The Audit Committee’s responsibilities include selecting the independent registered public accounting firm for the Company, reviewing with such independent registered public accounting firm the planning, scope and results of their audit of the Company’s financial statements,
pre-approving
the fees for services performed, reviewing with the independent registered public accounting firm the adequacy of internal control systems, reviewing the Company’s annual financial statements and periodic filings and receiving the Company’s audit reports and financial statements. The Audit Committee also establishes guidelines and makes recommendations to our board of directors regarding the valuation of our investments. The Audit Committee is responsible for aiding our board of directors in determining the fair value of debt and equity securities that are not publicly traded or for which current market values are not readily available. The board of directors and Audit Committee utilize the services of nationally recognized third-party valuation firms to help determine the fair value of these securities. The Audit Committee is currently composed of Messrs. Hochberg, Wachter and Potter and Ms. Roberts, all of whom are considered independent under the rules of the NASDAQ Stock Market and are not “interested persons” of the Company as that term is defined in Section 2(a)(19) of the 1940 Act. Mr. Hochberg serves as Chairman of the Audit Committee. Our board of directors has determined that Mr. Hochberg is an “audit committee financial expert” as that term is defined under Item 407 of Regulation
S-K,
as promulgated under the 1934 Act. Mr. Hochberg meets the current independence and experience requirements of Rule
10A-3
of the 1934 Act.
Communication with the Board of Directors
Stockholders with questions about the Company are encouraged to contact the Company’s investor relations department. However, if stockholders believe that their questions have not been addressed, they may communicate with the Company’s board of directors by sending their communications to SLR Investment Corp., c/o Guy Talarico, Secretary, 500 Park Avenue, New York, New York 10022. All stockholder communications received in this manner will be delivered to one or more members of the board of directors.
Code of Ethics
The Company has adopted a code of ethics that applies to, among others, its senior officers, including its
Co-Chief
Executive Officers and its Chief Financial Officer, as well as every officer, director and employee of the Company. The Company’s code of ethics can be accessed via its website at
http://www.slrinvestmentcorp.com
. The Company intends to disclose amendments to or waivers from a required provision of the code of ethics on Form
8-K.
Nomination of Directors
There have been no material changes to the procedures by which stockholders may recommend nominees to our Board of Directors implemented since the filing of our Proxy Statement for our 2023 Annual Meeting of Stockholders.
 
Item 11.
Executive Compensation
Compensation of Executive Officers
None of our officers receives direct compensation from the Company. As a result, we do not engage any compensation consultants. Mr. Gross, our
Co-Chief
Executive Officer and President, and Mr. Spohler, our
 
169

Co-Chief
Executive Officer and Chief Operating Officer, through their ownership interest in SLR Capital Partners, our investment adviser, are entitled to a portion of any profits earned by SLR Capital Partners, which includes any fees payable by us to SLR Capital Partners under the terms of the Advisory Agreement, less expenses incurred by SLR Capital Partners in performing its services under the Advisory Agreement. Messrs. Gross and Spohler do not receive any additional compensation from SLR Capital Partners in connection with the management of our portfolio.
Mr. Kajee,
our
Chief Financial Officer and Treasurer, and Mr. Talarico, our Chief Compliance Officer and Secretary, are paid by the Investment Adviser, subject to reimbursement by us of an allocable portion of such compensation for services rendered by such persons to the Company.
Compensation of Directors
The following table sets forth the compensation of the Company’s directors, for the year ended December 31, 2023.
 
Name
  
Fees Earned or Paid

in Cash
(1)
    
Stock

Awards
(2)
    
All Other

Compensation
    
Total
 
Interested Directors
           
Michael S. Gross
     —         —         —         —   
Bruce Spohler
     —         —         —         —   
Independent Directors
           
Steven Hochberg
   $ 133,000        —         —       $ 133,000  
David S. Wachter
   $ 128,000        —         —       $ 128,000  
Leonard A. Potter
   $ 128,000        —         —       $ 128,000  
Andrea C. Roberts
(3)
   $ 41,239        —         —       $ 41,239  
 
(1)
For a discussion of the independent directors’ compensation, see below.
(2)
We do not maintain a stock or option plan,
non-equity
incentive plan or pension plan for our directors. However, our independent directors have the option to receive all or a portion of the directors’ fees to which they would otherwise be entitled in the form of shares of our common stock issued at a price per share equal to the greater of our then current net asset value per share or the market price at the time of payment. No shares were issued to any of our independent directors in lieu of cash during 2023.
(3)
Ms. Roberts was appointed to the board of directors on August 28, 2023.
Our independent directors’ annual fee is $100,000. The independent directors also receive $2,500 ($1,500 if participating telephonically) plus reimbursement of reasonable
out-of-pocket
expenses incurred in connection with attending each board meeting and $1,000 plus reimbursement of reasonable
out-of-pocket
expenses incurred in connection with each committee meeting attended. In addition, the Chairman of the Audit Committee receives an annual fee of $7,500, the Chairman of the Nominating and Corporate Governance Committee receives an annual fee of $2,500 and the Chairman of the Compensation Committee receives an annual fee of $2,500. Further, we purchase directors’ and officers’ liability insurance on behalf of our directors and officers. In addition, no compensation was paid to directors who are interested persons of the Company as defined in the 1940 Act.
Compensation Committee
The Compensation Committee operates pursuant to a charter approved by our board of directors, a copy of which is available on our website at
http://www.slrinvestmentcorp.com.
The charter sets forth the responsibilities of the Compensation Committee. The Compensation Committee is responsible for reviewing and recommending for approval to our board of directors the Advisory Agreement and the Administration Agreement. In addition,
 
170

although we do not directly compensate our executive officers currently, to the extent that we do so in the future, the Compensation Committee would also be responsible for reviewing and evaluating their compensation and making recommendations to the board of directors regarding their compensation. Lastly, the Compensation Committee would produce a report on our executive compensation practices and policies for inclusion in our proxy statement if required by applicable proxy rules and regulations and, if applicable, make recommendations to the board of directors with matters related to compensation generally. The Compensation Committee has the authority to engage compensation consultants and to delegate their duties and responsibilities to a member or to a subcommittee of the Compensation Committee. The members of the Compensation Committee are Messrs. Hochberg, Wachter and Potter and Ms. Roberts, all of whom are considered independent under the rules of the NASDAQ Stock Market and are not “interested persons” of the Company as that term is defined in Section 2(a)(19) of the 1940 Act. Mr. Potter serves as Chairman of the Compensation Committee.
Compensation Committee Interlocks and Insider Participation
During fiscal year 2023 none of the Company’s executive officers served on the board of directors (or a compensation committee thereof or other board committee performing equivalent functions) of any entities that had one or more executive officers serve on the Compensation Committee of the Company or on the Board of Directors of the Company. No member of the Compensation Committee had any relationship requiring disclosure under any paragraph of Item 404 of Regulation
S-K.
Compensation Committee Report
Currently, none of our executive officers are compensated by the Company, and as such the Company is not required to produce a report on executive officer compensation for inclusion in our annual report on Form
10-K.
Clawback Policy
While the Company, as an externally-managed business development company under the 1940 Act, currently neither pays nor has any plans to pay or otherwise award incentive-based compensation to its executive officers, the Board adopted our Clawback Policy, effective November 6, 2023 (the “Clawback Policy”), in accordance with Rule
10D-1
of the 1934 Act and Nasdaq listing standards. The Clawback Policy applies to current and former covered executive officers of the Company and is administered by the Compensation Committee. In the event the Company is required to prepare an accounting restatement to correct material noncompliance with any financial reporting requirement under U.S. federal securities laws, including restatements that correct an error in previously issued financial statements that is material to the previously issued financial statements or that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period, it is the Company’s policy to recover erroneously awarded incentive-based compensation, if any, received by its executive officers. The recovery of such compensation applies regardless of whether an executive officer engaged in misconduct or otherwise caused or contributed to the requirement for a restatement.
During the fiscal year ended December 31, 2023 and continuing through the date of this Annual Report on Form
10-K,
we were not required to prepare an accounting restatement that required recovery of erroneously awarded compensation under the Clawback Policy nor was there an outstanding balance as of December 31, 2023 of erroneously awarded compensation to be recovered under the Clawback Policy from a prior restatement.
 
Item 12.
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
The following table sets forth, as of February 23, 2024, the beneficial ownership of each current director, the nominees for directors, the Company’s executive officers, each person known to us to beneficially own 5% or more of the outstanding shares of our common stock, and the executive officers and directors as a group.
 
171

Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with respect to the securities. Ownership information for those persons who beneficially own 5% or more of our shares of common stock is based upon reports filed by such persons with the SEC and other information obtained from such persons, if available.
Unless otherwise indicated, the Company believes that each beneficial owner set forth in the table has voting and investment power and has the same address as the Company. Our address is 500 Park Avenue, New York, New York 10022.
 
Name and Address of Beneficial Owner
  
Number of Shares

Owned Beneficially(1)
    
Percentage

of Class(2)
 
Interested Directors
     
Michael S. Gross(3)(4)
     3,829,913        7.0
Bruce Spohler(3)
     3,516,273        6.4
Independent Directors
     
Steven Hochberg
     2,742       
Leonard A. Potter
     14,872       
David S. Wachter
     53,494       
Andrea C. Roberts
     —         —   
Executive Officers
     
Shiraz Y. Kajee
     7,500       
Guy Talarico
     31,899       
All executive officers and directors as a group (8 persons)
  
 
4,458,780
 
  
 
8.2
Thornburg Investment Management Inc.(5)
     4,338,599        8.0
 
*
Represents less than one percent.
(1)
Beneficial ownership has been determined in accordance with Rule
13d-3
under the 1934 Act. Assumes no other purchases or sales of our common stock since the most recently available SEC filings. This assumption has been made under the rules and regulations of the SEC and does not reflect any knowledge that we have with respect to the present intent of the beneficial owners of our common stock listed in this table.
(2)
Based on a total of 54,554,634 shares of the Company’s common stock issued and outstanding as of February 23, 2024.
(3)
Includes 1,285,013 shares held by Solar Capital Investors, LLC and 715,000 shares held by Solar Capital Investors II, LLC, 355,107 shares held by Solar Senior Capital Investors, LLC and 77 shares held by SLR Capital Management, LLC, a portion of each which may be deemed to be indirectly beneficially owned by Michael S. Gross, by Bruce Spohler and a grantor retained annuity trust (“GRAT”) setup by and for Mr. Gross by virtue of their collective ownership interest therein. Also includes 642,716 shares held by Solar Capital Partners Employee Stock Plan LLC, which is controlled by SLR Capital Partners, LLC. Mr. Gross and Mr. Spohler may be deemed to beneficially own a portion of the shares held by Solar Capital Partners Employee Stock Plan LLC by virtue of their collective ownership interest in SLR Capital Partners, LLC. Each of Mr. Gross and Mr. Spohler disclaim beneficial ownership of any shares of our common stock directly held by Solar Capital Partners Employee Stock Plan LLC, Solar Capital Investors, LLC, Solar Capital Investors II, LLC, Solar Senior Capital Investors, LLC and SLR Capital Management, LLC, except to the extent of their respective pecuniary interest therein. Also includes 199,466 shares held in a trust of which Bruce Spohler became
co-trustee
in which he and certain members of his immediate family are beneficiaries (the “Spohler Trust”) and 243,021 shares held by a limited liability company in which he owns a pro rata interest (the “Spohler LLC”). Mr. Spohler disclaims beneficial ownership of the shares in the Spohler Trust and the Spohler LLC.
(4)
Includes 152,166 shares directly held by Michael S. Gross’ profit sharing plan (the “Profit Sharing Plan”). Mr. Gross may be deemed to directly beneficially own these shares as the sole participant in the Profit
 
172

 
Sharing Plan. Also includes 117,617 shares held by certain trusts for the benefit of family members for which Mr. Gross serves as trustee (the “Family Trusts”). The total includes 334,428 shares held by the GRAT. Mr. Gross may be deemed to directly beneficially own these shares by virtue of his control with respect to the Family Trusts, and disclaims beneficial ownership of the securities held by the Family Trusts except to the extent of his pecuniary interest therein.
(5)
Based upon information contained in the Schedule 13G filed February 9, 2024 by Thornburg Investment Management Inc. Such securities are held by certain investment vehicles controlled and/or managed by Thornburg Investment Management Inc. or its affiliates. The address for Thornburg Investment Management Inc. is 2300 North Ridgetop Road, Santa Fe, New Mexico 87506.
Set forth below is the dollar range of equity securities beneficially owned by each of our directors as of February 24, 2023. The Company is part of a “Fund Complex,” as that term is defined in Schedule 14A and Regulation 14A under the 1934 Act. For purposes of this Annual Report on Form
10-K,
the term Fund Complex includes the Company, SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC.
 
Name of Director
 
Dollar Range

of Equity

Securities

Beneficially

Owned in the
Company(1)(2)
 
Dollar Range

of Equity

Securities

Beneficially

Owned in the Fund
Complex(1)(2)(3)
Interested Directors
   
Michael S. Gross
  Over $ 100,000   Over $ 100,000
Bruce Spohler
  Over $ 100,000   Over $ 100,000
Independent Directors
   
Steven Hochberg
 
$10,001- $50,000
 
$10,001- $50,000
Leonard A. Potter
  Over $ 100,000   Over $ 100,000
David S. Wachter
  Over $ 100,000   Over $ 100,000
Andrea C. Roberts
  None   None
 
(1)
The dollar ranges are: None,
$1-$10,000,
$10,001-$50,000,
$50,001-$100,000,
or Over $100,000.
(2)
The dollar range of equity securities beneficially owned in us is based on the closing price for our common stock of $14.89 on February 23, 2024 on the NASDAQ Global Select Market. Beneficial ownership has been determined in accordance with Rule
16a-1(a)(2)
of the 1934 Act.
(3)
The dollar range of equity securities in the Fund Complex beneficially owned by directors of the Company, if applicable, is the total dollar range of equity securities in the Company beneficially owned by the directors, as no director has beneficial ownership of SCP Private Credit Income BDC LLC, SLR HC BDC LLC or SLR Private Credit BDC II LLC.
 
Item 13.
Certain Relationships and Related Transactions, and Director Independence
We have entered into the Advisory Agreement with SLR Capital Partners. Mr. Gross, our Chairman,
Co-Chief
Executive Officer and President, and Mr. Spohler, our
Co-Chief
Executive Officer, Chief Operating Officer and board member, are managing members and senior investment professionals of, and have financial and controlling interests in, SLR Capital Partners. In addition, Mr. Kajee, our Chief Financial Officer and Treasurer, serves as the Chief Financial Officer for SLR Capital Partners, and Mr. Talarico, our Chief Compliance Officer and Secretary serves as General Counsel and Chief Compliance Officer for SLR Capital Partners.
SLR Capital Partners and its affiliates may also manage other funds in the future that may have investment mandates that are similar, in whole and in part, with ours. For example, SLR Capital Partners presently serves as investment adviser to private funds and managed accounts as well as to SCP Private Credit Income BDC LLC, an unlisted BDC, which focuses on investing primarily in senior secured loans, including
non-traditional
asset-based loans and first lien loans, SLR HC BDC LLC, an unlisted BDC whose principal focus is to invest directly and
 
173

indirectly in senior secured loans and other debt instruments typically to middle market companies within the healthcare industry, and SLR Private Credit BDC II LLC, an unlisted BDC whose principal focus is to investment in first lien senior secured floating rate loans primarily to upper middle market leveraged companies with EBITDA between approximately $25 million and $250 million that have significant free cash flow and are in
non-cyclical
industries in which the Investment Adviser has significant experience. In addition, Michael S. Gross, our Chairman and
Co-Chief
Executive Officer, Bruce Spohler, our
Co-Chief
Executive Officer and Chief Operating Officer, Shiraz Y. Kajee, our Chief Financial Officer, and Guy F. Talarico, our Chief Compliance Officer and Secretary, serve in similar capacities for SCP Private Credit Income BDC LLC, SLR HC BDC LLC and SLR Private Credit BDC II LLC.
SLR Capital Partners and certain investment advisory affiliates may determine that an investment is appropriate for us and for one or more of those other funds. In such event, depending on the availability of such investment and other appropriate factors, SLR Capital Partners or its affiliates may determine that we should invest
side-by-side
with one or more other funds. Any such investments will be made only to the extent permitted by applicable law and interpretive positions of the SEC and its staff, and consistent with SLR Capital Partners’ allocation procedures.
Related party transactions may occur among us, SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL and SLR Equipment. These transactions may occur in the normal course of business. No administrative or other fees are paid to the Investment Adviser by SLR Senior Lending Program LLC, SLR Senior Lending Program SPV LLC, SLR Credit, Equipment Operating Leases LLC, KBH, Loyer Capital LLC, SLR Business Credit, SLR Healthcare ABL or SLR Equipment.
In addition, we have adopted a formal code of ethics that governs the conduct of our officers and directors. Our officers and directors also remain subject to the duties imposed by both the 1940 Act and the Maryland General Corporation Law.
Regulatory restrictions limit our ability to invest in any portfolio company in which any affiliate currently has an investment. The Company obtained its most recent exemptive order from the SEC on June 13, 2017 (the “Exemptive Order”). The Exemptive Order permits us to participate in negotiated
co-investment
transactions with certain affiliates, each of whose investment adviser is an investment adviser that controls, is controlled by or is under common control with SLR Capital Partners and is registered as an investment adviser under the Advisers Act, in a manner consistent with our investment objective, positions, policies, strategies and restrictions as well as regulatory requirements and other pertinent factors, and pursuant to the conditions to the Exemptive Order. We believe that it will be advantageous for us to
co-invest
with funds managed by SLR Capital Partners where such investment is consistent with the investment objectives, investment positions, investment policies, investment strategy, investment restrictions, regulatory requirements and other pertinent factors applicable to us.
We have entered into a license agreement with SLR Capital Partners, pursuant to which SLR Capital Partners has agreed to grant us a
non-exclusive,
royalty-free license to use the names “SLR” and “SOLAR”. In addition, pursuant to the terms of the Administration Agreement, SLR Capital Management provides us with the office facilities and administrative services necessary to conduct our
day-to-day
operations.
Board Consideration of the Advisory Agreement
Our board of directors determined at a meeting held on October 25, 2023 to approve the Advisory Agreement between the Company and SLR Capital Partners. In reliance on certain exemptive relief provided by the SEC, the Board ratified the approval of the Investment Management Agreement at its next
in-person
meeting held on November 6, 2023. In its consideration of the approval of the Advisory Agreement, the board of directors focused on information it had received relating to, among other things:
 
   
the nature, extent and quality of advisory services to be rendered, including information about the investment performance of the Company relative to its stated objectives and in comparison to the
 
174

 
performance of the Company’s peer group and relevant market indices, and concluded that such services are satisfactory and the Company’s investment performance is reasonable;
 
   
the experience and qualifications of the personnel of SLR Capital Partners providing such services, including information about the backgrounds of the investment personnel, the allocation of responsibilities among such personnel and the process by which investment decisions are made, and concluded that SLR Capital Partners’ personnel have extensive experience and are well qualified;
 
   
the current fee structure, the existence of any fee waivers, and the Company’s anticipated expense ratios in relation to those of other investment companies having comparable investment policies and limitations, and concluded that the proposed fee structure is reasonable;
 
   
the fees charged by SLR Capital Partners to the Company, to SCP Private Credit Income BDC LLC, to SLR HC BDC LLC and to SLR Private Credit BDC II LLC, and comparative data regarding the advisory fees charged by other investment advisers to similar investment companies, and concluded that the fees to be charged by SLR Capital Partners to the Company are reasonable;
 
   
the direct and indirect costs, including for personnel and office facilities, that may be incurred by SLR Capital Partners and its affiliates in performing services for the Company and the basis of determining and allocating these costs, and concluded that the direct and indirect costs, including the allocation of such costs, are reasonable;
 
   
possible economies of scale arising from the Company’s size and/or anticipated growth, and the extent to which such economies of scale are reflected in the advisory fees charged by SLR Capital Partners to the Company, and concluded that some economies of scale may be possible in the future;
 
   
other possible benefits to SLR Capital Partners and its affiliates arising from their relationships with the Company, and concluded that all such other benefits were not material to SLR Capital Partners and its affiliates; and
 
   
possible alternative fee structures or bases for determining fees, and concluded that the Company’s current fee structure and bases for determining fees are satisfactory.
Based on the information reviewed and the discussions detailed above, the board of directors, including a majority of the directors who are not “interested persons” as defined in the 1940 Act, concluded that the fees payable to SLR Capital Partners pursuant to the Advisory Agreement were reasonable, and comparable to the fees paid by other management investment companies with similar investment objectives, in relation to the services to be provided. The board of directors did not assign relative weights to the above factors or the other factors considered by it. Individual members of the board of directors may have given different weights to different factors.
Director Independence
In accordance with rules of the NASDAQ Stock Market, our board of directors annually determines each director’s independence. We do not consider a director independent unless the board of directors has determined that he has no material relationship with us. We monitor the relationships of our directors and officers through a questionnaire each director completes no less frequently than annually and updates periodically as information provided in the most recent questionnaire changes.
Our governance guidelines require any director who has previously been determined to be independent to inform the Chairman of the board of directors, the Chairman of the Nominating and Corporate Governance Committee and our Secretary of any change in circumstance that may cause his status as an independent director to change. The board of directors limits membership on the Audit Committee, the Nominating and Corporate Governance Committee and the Compensation Committee to independent directors.
In order to evaluate the materiality of any such relationship, the board of directors uses the definition of director independence set forth in the rules promulgated by the NASDAQ Stock Market. Rule 5605(a)(2)
 
175

provides that a director of a BDC shall be considered to be independent if he or she is not an “interested person” of such BDC, as defined in Section 2(a)(19) of the 1940 Act.
The board of directors has determined that each of the directors is independent and has no relationship with us, except as a director and stockholder, with the exception of Michael S. Gross, as a result of his positions as the
Co-Chief
Executive Officer and President of the Company and a Managing Member of SLR Capital Partners, and Bruce Spohler, as a result of his positions as the
Co-Chief
Executive Officer and Chief Operating Officer of the Company and a Managing Member of SLR Capital Partners.
Indemnification Agreements
We have entered into indemnification agreements with our directors. The indemnification agreements are intended to provide our directors the maximum indemnification permitted under Maryland law and the 1940 Act. Each indemnification agreement provides that SLR Capital shall indemnify the director who is a party to the agreement (an “Indemnitee”), including the advancement of legal expenses, if, by reason of his or her corporate status, the Indemnitee is, or is threatened to be, made a party to or a witness in any threatened, pending, or completed proceeding, to the maximum extent permitted by Maryland law and the 1940 Act.
 
Item 14.
Principal Accountant Fees and Services
KPMG LLP has advised us that neither the firm nor any present member or associate of it has any material financial interest, direct or indirect, in the Company or its affiliates.
Table below in thousands
 
    
Fiscal Year

Ended

December 31,

2023
    
Fiscal Year

Ended

December 31,

2022
 
Audit Fees
   $ 803.0      $ 828.1  
Audit-Related Fees
     —         —   
Tax Fees
     186.6        166.3  
All Other Fees
     —         20.0  
Total Fees:
   $ 989.6      $ 1,014.4  
Audit Fees:
Audit fees consist of fees for professional services rendered for the audit of our
year-end
financial statements and quarterly reviews and services that are normally provided by KPMG LLP in connection with statutory and regulatory filings.
Audit-Related Fees:
Audit-related services consist of fees for assurance and related services that are reasonably related to the performance of the audit or review of our financial statements and are not reported under “Audit Fees.” These services include attest services that are not required by statute or regulation and consultations concerning financial accounting and reporting standards.
Tax Services Fees:
Tax services fees consist of fees for professional tax services. These services also include assistance regarding federal, state, and local tax compliance.
All Other Fees:
Other fees would include fees for products and services other than the services reported above.
Pre-Approval
Policy
The Audit Committee has established a
pre-approval
policy that describes the permitted audit, audit-related, tax and other services to be provided by KPMG LLP, the Company’s independent registered public accounting
 
176

firm (“KPMG”). The policy requires that the Audit Committee
pre-approve
the audit and
non-audit
services performed by the independent auditor in order to assure that the provision of such service does not impair the auditor’s independence.
Any requests for audit, audit-related, tax and other services that have not received general
pre-approval
must be submitted to the Audit Committee for specific
pre-approval,
irrespective of the amount, and cannot commence until such approval has been granted. Normally,
pre-approval
is provided at regularly scheduled meetings of the Audit Committee. However, the Audit Committee may delegate
pre-approval
authority to one or more of its members. The member or members to whom such authority is delegated shall report any
pre-approval
decisions to the Audit Committee at its next scheduled meeting. The Audit Committee does not delegate its responsibilities to
pre-approve
services performed by the independent registered public accounting firm to management. During the fiscal year ended December 31, 2023, the Audit Committee
pre-approved
100% of the services described in this policy.
 
177

PART IV
 
Item 15.
Exhibit and Financial Statement Schedules
a. Documents Filed as Part of this Report
The following reports and consolidated financial statements are set forth in Item 8:
 
    
Page
 
     107  
     108  
     111  
     112  
     113  
     114  
     115  
     136  
 
178

b. Exhibits
The following exhibits are filed as part of this report or hereby incorporated by reference to exhibits previously filed with the SEC:
 
Exhibit
Number
  
Description
  2.1    Agreement and Plan of Merger among SLR Investment Corp., SLR Senior Investment Corp., Solstice Merger Sub, Inc. and SLR Capital Partners, LLC (for the limited purposes set forth therein), dated as of December 1, 2021(14)
  3.1    Articles of Amendment and Restatement(1)
  3.2    Articles of Amendment (13)
  3.3    Second Amended and Restated Bylaws(14)
  4.1    Form of Common Stock Certificate(2)
  4.2    Indenture, dated as of November 16, 2012, between the Registrant and U.S. Bank National Association as trustee(5)
  4.3    Second Supplemental Indenture, dated November 22, 2017, relating to the 4.50% Notes due 2023, between the Registrant and U.S. Bank National Association as trustee, including the Form of 4.50% Notes due 2023(8)
  4.4    Description of Securities(17)
 10.1    Dividend Reinvestment Plan(1)
 10.2    Form of Senior Secured Credit Agreement dated as of August 28, 2019 (as amended December 28, 2021) among SLR Investment Corp., Citibank, N.A., as Administrative Agent, the lenders party thereto, JPMorgan Chase Bank, N.A., as syndication agent, and Citibank, N.A., J.P. Morgan Securities LLC, and Sumitomo Mitsui Banking Corporation as Joint Lead Bookrunners and Joint Lead Arrangers(15)
 10.3    Third Amended and Restated Investment Advisory and Management Agreement by and between the Registrant and SLR Capital Partners, LLC(9)
 10.4    Form of Custodian Agreement(7)
 10.5    Amended and Restated Administration Agreement by and between Registrant and SLR Capital Management, LLC(6)
 10.6    Form of Indemnification Agreement by and between Registrant and each of its directors(1)
 10.7    First Amended and Restated Trademark License Agreement by and between Registrant and SLR Capital Partners, LLC(13)
 10.8    Form of Share Purchase Agreement by and between Registrant and SLR Capital Investors II, LLC(2)
 10.9    Form of Registration Rights Agreement(3)
 10.10    Form of Subscription Agreement(3)
 10.11    Form of Note Purchase Agreement by and between the Registrant and the lenders party thereto(10)
 10.12    Form of First Supplement to Note Purchase Agreement by and between the Registrant and the lenders party thereto(10)
 10.13    Form of Second Supplement to Note Purchase Agreement by and between the Registrant and the lenders party thereto(10)
 
179

Exhibit
Number
  
Description
 10.14    Form of Third Supplement to Note Purchase Agreement by and between the Registrant and the lenders party thereto(10)
 10.15    Form of Fifth Supplement to Note Purchase Agreement(16)
 10.16    Form of Contribution Agreement, dated as of August 26, 2011, by and between SUNS SPV LLC, as the contributee, and SLR Senior Investment Corp., as the contributor(4)
 10.17    Form of Loan and Servicing Agreement, dated as of August 26, 2011 (as amended through the Eleventh Amendment dated as of August 29, 2023), by and among SUNS SPV LLC, as the borrower, SLR Investment Corp., as the servicer and the transferor, each of the conduit lenders from time to time party thereto, each of the liquidity banks from time to time party thereto, each of the lender agents from time to time party thereto, Citibank, N.A., as the administrative agent and collateral agent, and Wells Fargo Bank, N.A., as the account bank, the backup servicer and the collateral custodian (21)
 10.18    Letter Agreement, dated as of April 1, 2022, between SLR Investment Corp. and SLR Capital Partners, LLC(18)
 10.19    Credit Facility Assumption Agreement, dated as of April 1, 2022, by SLR Investment Corp.(18)
 10.20    Assumption Agreement, dated as of April 1, 2022, made by SLR Investment Corp. for the benefit of the holders of Notes issued under the Note Purchase Agreement(18)
 10.21    Note Purchase Agreement, dated as of March 31, 2020, between SLR Senior Investment Corp. and the purchasers party thereto(18)
 10.22    Form of SLR Senior Lending Program LLC Amended and Restated Limited Liability Company Agreement, dated as of October 7, 2022, by and between SLR Investment Corp. and Sunstone Senior Credit L.P. (19)
 14.2    Code of Business Conduct(6)
 19.1    Joint Code of Ethics and Insider Trading Policy(20)
 21.1    Subsidiaries of SLR Investment Corp.*
 23.1    Consent of Independent Registered Public Accounting Firm*
 23.2    Consent of Independent Auditor*
 23.3    Consent of Independent Auditor*
 23.4    Consent of Independent Auditor*
 23.5    Consent of Independent Auditor*
 23.6    Consent of Independent Auditor*
 31.1    Certification of Co-Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*
 31.2    Certification of Co-Chief Executive Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*
 31.3    Certification of Chief Financial Officer pursuant to Rule 13a-14 of the Securities Exchange Act of 1934, as amended.*
 32.1    Certification of Co-Chief Executive Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.*
 
180

Exhibit
Number
  
Description
 32.2    Certification of Co-Chief Executive Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.*
 32.3    Certification of Chief Financial Officer pursuant to Section 906 of The Sarbanes-Oxley Act of 2002.*
 97.1    Clawback Policy*
 99.1    Crystal Financial LLC (A Delaware Limited Liability Company) Consolidated Financial Statements for the years ended December 31, 2023 and December 31, 2022*
 99.2    NEF Holdings, LLC and Subsidiaries (A Limited Liability Company) Consolidated Financial Statements for the years ended December 31, 2023 and December 31, 2022*
 99.3    KBH Topco, LLC (A Delaware Limited Liability Company) Consolidated Financial Statements for the years ended December 31, 2023 and December 31, 2022*
 99.4    Gemino Healthcare Finance, LLC and Subsidiary Consolidated Financial Statements years ended December 31, 2023 and December 31, 2022*
 99.5    North Mill Holdco LLC and Subsidiaries Consolidated Financial Report years ended December 31, 2023 and December 31, 2022*
 99.6    Report of Independent Registered Public Accounting Firm on Supplemental Information*
101.INS    Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.CAL    Inline XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF    Inline XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB    Inline XBRL Taxonomy Extension Label Linkbase Document*
101.PRE    Inline XBRL Taxonomy Extension Presentation Linkbase Document*
101.SCH    Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents*
104    Cover Page Interactive Data File – The cover page interactive data file does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
 
(1)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
Pre-Effective
Amendment No. 7 (File
No. 333-148734)
filed on January 7, 2010.
(2)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
(File No
333-148734)
filed on February 9, 2010.
(3)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on November 29, 2010.
(4)
Previously filed in connection with SLR Senior Investment Corp.’s report on Form
8-K
(File
No. 814-00849)
filed on August 31, 2011.
(5)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
Post-Effective Amendment No. 6 (File
No. 333-172968)
filed on November 16, 2012.
(6)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
Post-Effective Amendment No. 10 (File
No. 333-172968)
filed on November 12, 2013.
(7)
Previously filed in connection with SLR Investment Corp.’s report on Form
10-K
filed on February 25, 2014.
(8)
Previously filed in connection with SLR Investment Corp.’s registration statement on Form
N-2
Post-Effective Amendment No. 5 (File
No. 333-194870)
filed on November 22, 2017.
(9)
Previously filed in connection with SLR Investment Corp.’s report on Form
10-Q
filed on August 6, 2018.
 
181

(10)
Previously filed in connection with SLR Investment Corp.’s report on Form
10-K
filed on February 20, 2020.
(11)
Previously filed in connection with SLR Senior Investment Corp.’s report on Form
10-Q
(File
No. 814-00849)
filed on May 7, 2020.
(12)
Previously filed in connection with SLR Investment Corp.’s report on Form
10-K
filed on February 24, 2021.
(13)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on February 25, 2021.
(14)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on December 1, 2021.
(15)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on January 3, 2022.
(16)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on January 12, 2022.
(17)
Previously filed in connection with SLR Investment Corp.’s report on Form
10-K
filed on March 1, 2022.
(18)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on April 1, 2022.
(19)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on October 12, 2022.
(20)
Previously filed in connection with SLR Investment Corp.’s report on Form
10-K
filed on February 28, 2023.
(21)
Previously filed in connection with SLR Investment Corp.’s report on Form
8-K
filed on August 30, 2023.
*
Filed herewith.
c. Consolidated Financial Statement Schedules
Separate Financial Statements of Subsidiaries Not Consolidated:
Consolidated Financial Statements for Crystal Financial LLC’s (A Delaware Limited Liability Company) years ended December 31, 2023 and December 31, 2022 are attached as Exhibit 99.1 hereto.
Consolidated Financial Statements for NEF Holdings, LLC’s (A Delaware Limited Liability Company) years ended December 31, 2023 and December 31, 2022 are attached as Exhibit 99.2 hereto.
Consolidated Financial Statements for KBH Topco LLC’s (A Delaware Limited Liability Company) years ended December 31, 2023 and December 31, 2022 are attached as Exhibit 99.3 hereto.
Consolidated Financial Statements for Gemino Healthcare Finance, LLC and Subsidiary year ended December 31, 2023 and December 31, 2022 are attached as Exhibit 99.4 hereto.
Consolidated Financial Statements for North Mill Holdco LLC year ended December 31, 2023 and December 31, 2022 are attached as Exhibit 99.5 hereto.
 
Item 16.
Form
10-K
Summary
None.
 
182

SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
SLR INVESTMENT CORP.
     
By:  
/
S
/ M
ICHAEL
S. G
ROSS
     
/
S
/ B
RUCE
J. S
POHLER
 
Michael S. Gross
Co-Chief
Executive Officer, President, Chairman of the Board and Director
Date: February 27, 2024
     
Bruce J. Spohler
Co-Chief Executive Officer, Chief
Operating Officer and Director
Date: February 27, 2024
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacity and on the dates indicated.
 
Date
  
Signature
 
Title
February 27, 2024   
/
S
/ M
ICHAEL
S. G
ROSS
Michael S. Gross
 
Co-Chief
Executive Officer, President, Chairman of the Board and Director (Principal Executive Officer)
February 27, 2024   
/
S
/ B
RUCE
J. S
POHLER
Bruce J. Spohler
 
Co-Chief
Executive Officer, Chief Operating Officer and Director (Principal Executive Officer)
February 27, 2024   
/
S
/ S
TEVEN
H
OCHBERG
Steven Hochberg
  Director
February 27, 2024   
/
S
/ D
AVID
S. W
ACHTER
David S. Wachter
  Director
February 27, 2024   
/
S
/ L
EONARD
A. P
OTTER
Leonard A. Potter
  Director
February 27, 2024   
/
S
/ A
NDREA
C. R
OBERTS
Andrea C. Roberts
  Director
February 27, 2024   
/
S
/ S
HIRAZ
Y. K
AJEE
Shiraz Y. Kajee
  Chief Financial Officer (Principal Financial Officer)
 
183